0001493152-15-005492.txt : 20151116 0001493152-15-005492.hdr.sgml : 20151116 20151116074515 ACCESSION NUMBER: 0001493152-15-005492 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 9 CONFORMED PERIOD OF REPORT: 20150930 FILED AS OF DATE: 20151116 DATE AS OF CHANGE: 20151116 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Synergy CHC Corp. CENTRAL INDEX KEY: 0001562733 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 990379440 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55098 FILM NUMBER: 151231666 BUSINESS ADDRESS: STREET 1: 865 SPRING STREET CITY: WESTBROOK STATE: ME ZIP: 04092 BUSINESS PHONE: 615-939-9004 MAIL ADDRESS: STREET 1: 865 SPRING STREET CITY: WESTBROOK STATE: ME ZIP: 04092 FORMER COMPANY: FORMER CONFORMED NAME: Synergy Strips Corp. DATE OF NAME CHANGE: 20140429 FORMER COMPANY: FORMER CONFORMED NAME: Oro Capital Corporation, Inc. DATE OF NAME CHANGE: 20121121 10-Q 1 form10-q.htm

U. S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

[X]	QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2015

[ ]	TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to ____________

Synergy CHC Corp.

Nevada	000-55098	99-0379440
(State or other jurisdiction	(Commission	(IRS Employer
of Incorporation)	File Number)	Identification Number)

865 Spring Street

Westbrook, Maine 04092

(Address of principal executive offices)

(615) 939-9004

(Issuer’s Telephone Number)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. [X] Yes [ ] No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every, Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Sec.232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule12b-2 of the Exchange Act.

Large accelerated filer [ ]	Accelerated filer [ ]	Non-accelerated filer [ ]	Smaller reporting company [X]
		(Do not check if smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). [ ] Yes [X] No

APPLICABLE ONLY TO CORPORATE ISSUERS

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: As of November 3, 2015, 69,238,044 shares of our common stock were issued and outstanding.

SYNERGY CHC CORP.

(FORMERLY SYNERGY STRIPS CORP.)

INDEX

Table of Contents

PART I	FINANCIAL INFORMATION
Item 1.	Condensed Consolidated financial statements	3
	Condensed Consolidated balance sheets as of September 30, 2015 (unaudited) and December 31, 2014	3
	Condensed Consolidated statements of operations for the three and nine months ended September 30, 2015 and 2014 (unaudited)	4
	Condensed Consolidated statements of cash flows for the nine months ended September 30, 2015 and 2014 (unaudited)	5
	Notes to unaudited condensed consolidated financial statements	6
Item 2.	Management’s discussion and analysis of financial condition and results of operations	17
Item 3.	Quantitative and qualitative disclosures about market risk	23
Item 4.	Controls and procedures	24

PART II	OTHER INFORMATION
Item 1.	Legal proceedings	25
Item 1A.	Risk factors	25
Item 2.	Unregistered sales of equity securities and use of proceeds	25
Item 3.	Defaults upon senior securities	25
Item 4.	Mine Safety Disclosures	25
Item 5.	Other information	25
Item 6.	Exhibits	25
Signatures		26

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

Synergy CHC Corp.

(formerly Synergy Strips Corp.)

Condensed Consolidated Balance Sheet

	September 30, 2015			December 31, 2014
	(Unaudited)
Assets
Current Assets:
Cash	$	824,948		$	338
Accounts Receivable		1,327,154			2,898
Receivable from related party		175,422			16,077
Prepaid expenses		122,576			10,000
Inventory		499,448			26,064
Total Current Assets		2,949,548			55,376

Fixed assets, net		3,614			-
Investment in Hand MD Corp.		1,500,000			-
Goodwill		2,935,383			-
Intangible assets, net		2,759,201			-
Debt issuance cost, net		198,429			-
Total Assets	$	10,346,175		$	55,376

Liabilities and Stockholders’ Equity (Deficit)
Current Liabilities:
Accounts payable and accrued liabilities	$	1,653,296		$	74,642
Notes payable, related party		-			100,000
Current portion of long-term debt		750,000			-
Current portion of long-term debt, related party		300,000			6,400
Total Current Liabilities		2,703,296			181,042

Long-term Liabilities:
Note payable		750,000			-
Note payable, net of debt discount, related party		5,047,178			-
Total Long-term Liabilities		5,797,178			-
Total Liabilities		8,500,474			181,042

Commitments and contingencies		-			-

Stockholders’ Equity (Deficit):
Common stock, $0.00001 par value; 300,000,000 shares and 75,000,000 authorized, respectively; 69,238,044 and 62,100,000 shares issued and outstanding, respectively		692			621
Common stock to be issued		68,000			40,000
Additional paid in capital		5,882,448			867,004
Accumulated deficit		(4,105,439	)		(1,033,291	)
Total stockholders’ equity (deficit)		1,845,701			(125,666	)
Total Liabilities and Stockholders’ Equity (Deficit)	$	10,346,175		$	55,376

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

Synergy CHC Corp.

(formerly Synergy Strips Corp.)

Unaudited Condensed Consolidated Statements of Operations

	For the three months ended						For the nine months ended
	September 30, 2015			September 30, 2014			September 30, 2015			September 30, 2014
Revenue	$	3,181,623		$	-		$	7,237,619		$	2,748
Cost of sales		1,469,910			-			3,103,244			1,685
Gross profit		1,711,713			-			4,134,375			1,063

Operating expenses
Selling and marketing		814,640			-			2,228,418			-
General and administrative		706,806			142,236			1,407,458			787,858
Depreciation and amortization		103,103			-			282,256			-
Total operating expenses		1,624,549			142,236			3,918,132			787,858

Income (loss) from operations		87,164			(142,236	)		216,243			(786,795	)

Other income (expenses)
Interest expense		(212,904	)		-			(612,094	)		-
Amortization of debt discount		(304,117	)		-			(2,575,192	)		-
Amortization of debt issuance cost		(37,753	)					(101,105	)		-

Total other expenses		(554,774	)		-			(3,288,391	)		-

Net Loss	$	(467,610	)	$	(142,236	)	$	(3,072,148	)	$	(786,795	)

Net loss per share – basic and diluted	$	(0.01	)	$	(0.00	)	$	(0.05	)	$	(0.01	)

Weighted average common shares – basic and diluted		68,096,740			60,491,304			67,033,094			108,850,549

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

Synergy CHC Corp.

(formerly Synergy Strips Corp.)

Unaudited Condensed Consolidated Statements of Cash Flows

	For the nine months ended
	September 30, 2015			September 30, 2014
Cash Flows from Operating Activities
Net loss	$	(3,072,148	)	$	(786,795	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization		282,256			-
Amortization of debt issuance cost		101,105			-
Stock based compensation expense		28,000			310,247
Loss on acquisition		-			109,040
Amortization of debt discount		2,575,192			-
Changes in operating assets and liabilities:
Accounts receivable		1,660,167			(150	)
Inventory		(201,346	)		(30,500	)
Prepaid expense		(118,976	)		(10,000	)
Accounts payable and accrued liabilities		(454,220	)		9,705
Net cash provided by (used in) operating activities		800,030			(398,453	)

Cash Flows from Investing Activities
Payments for acquisition of fixed assets		(4,045	)		-
Payments for acquisition of Factor Nutrition Labs		(4,500,000	)		-
Payments for acquisition transaction with Knight Therapeutics Inc.		(250,000	)		-
Net cash used in investing activities		(4,754,045	)		-

Cash Flows from Financing Activities
Proceeds from notes payable		6,000,000			-
Repayment of notes payable		(762,500	)		(92,840	)
Payment of debt issuance cost		(299,531	)		-
(Repayments to) advances from related party note		(159,345	)		-
Warrant exercise		1			-
Proceeds from issuance of common stock		-			500,000
Net cash provided by financing activities		4,778,625			407,160

Net increase in cash and cash equivalents		824,610			8,707

Cash and Cash Equivalents, beginning of period		338			3,230

Cash and Cash Equivalents, end of period	$	824,948		$	11,937

Supplemental Disclosure of Cash Flow Information:
Cash paid during the period for:
Interest	$	612,094		$	-
Income taxes	$	-		$	-

Supplemental Disclosure of Non-cash Investing and Financing Activities:
Common stock issued for settlement of debt	$	100,000		$	-
Beneficial conversion feature on warrants issued concurrent with debt	$	3,415,514		$	-
Assumption of liabilities as part of acquisition transaction	$	9,332,559		$	84,040
Assumption of liabilities as part of acquisition transaction with Knight Therapeutics Inc.	$	1,400,315		$	-
Note issued as part of asset purchase agreement	$	1,500,000		$	-
Common stock issued as part of contribution agreement	$	1,500,000		$	-
Cancellation of common stock as part of purchase transaction	$	-		$	1,359
Financing for prepaid insurance	$	-		$	20,000
Issuance of shares as part of acquisition transaction	$	-		$	25,000

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

Synergy CHC Corp.

(formerly Synergy Strips Corp.)

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 1 – Nature of the Business

Synergy CHC Corp. (“Synergy”, “we”, “us”, “our” or the “Company”) (formerly Synergy Strips Corp.) was incorporated on December 29, 2010 in Nevada under the name “Oro Capital Corporation.” On April 21, 2014, the Company changed its fiscal year end from July 31 to December 31. On April 28, 2014, the Company changed its name to “Synergy Strips Corp.”. On August 5, 2015, the Company changed its name to “Synergy CHC Corp.”

The Company is a consumer health care company that is in the process of building a portfolio of best-in-class consumer product brands. Synergy’s strategy is to grow its portfolio both organically and by further acquisition.

Synergy is the sole owner of a subsidiary, Neuragen Corp., and the results have been consolidated in these statements.

Loan and Warrants

On January 22, 2015, the Company entered into a Loan and Security Agreement (“Loan Agreement”) with Knight Therapeutics (Barbados) Inc. (“Knight”), pursuant to which Knight agreed to loan the Company $6.0 million (the “Loan”), and which amount was borrowed at closing (the “Financing”) for the purpose of acquiring the Focus Factor Business (defined below). At closing, the Company paid Knight an origination fee of $120,000 and a work fee of $60,000 and also paid $40,000 of Knight’s expenses associated with the Loan. The Loan bears interest at a rate of 15% per year; provided, however, that upon the occurrence of an equity or convertible equity offering by the Company of at least $1.0 million, the interest rate will drop to 13% per year. Interest accrues quarterly and is payable in arrears on March 31, June 30, September 30 and December 31 in each year, beginning on March 31, 2015.

All outstanding principal and accrued and unpaid interest is due on the earliest to occur of either January 20, 2017 (the “Maturity Date”), or the date that Knight, in its discretion, accelerates the Company’s obligations due to an event of default. The Company may extend the Maturity Date for two successive additional 12-month periods if at March 31, 2016 and March 31, 2017, respectively, the Company’s revenues exceed $13.0 million and its EBITDA exceeds $2.0 million for the respective 12-month period then ending. Principal payments under the Loan Agreement commenced on June 30, 2015 and continue quarterly as set forth on the Repayment Schedule to the Loan Agreement.

Subject to certain restrictions, the Company may prepay the outstanding principal of the Loan (in whole but not in part) at any time if the Company pays a concurrent prepayment fee equal to the greater of (i) the total unpaid annual interest that would have been payable during the year in which the prepayment is made if the prepayment is made prior to the first anniversary of the closing, and (ii) $300,000. The Company’s obligations under the Loan Agreement are secured by a first priority security interest in all present and future assets of the Company. The Company also agreed to not pledge or otherwise encumber its intellectual property assets, subject to certain customary exceptions.

The Loan Agreement includes customary representations, warranties, and affirmative and restrictive covenants, including covenants to attain and maintain certain financial metrics, and to not merge or dispose of assets, acquire other businesses (except for businesses substantially similar or complementary to the Company’s business and the aggregate consideration to be paid does not exceed $100,000) or make capital expenditures in excess of $100,000 over the Company’s annual business plan in any year. The Loan Agreement also includes customary events of default, including payment defaults, breaches of covenants, change of control and material adverse effect default. Upon the occurrence of an event of default and during the continuation thereof, the principal amount of the Loan will bear a default interest rate of an additional 5%.

In connection with the Loan Agreement, the Company issued to Knight a warrant that entitled Knight to purchase 4,595,187 shares of common stock of the Company (“Common Stock”) on or prior to close of business on January 30, 2015 (the “ST Warrant”). The aggregate exercise price of the Common Stock under the ST Warrant is $1.00. Knight exercised the ST Warrant on January 22, 2015. Also in connection with the Loan Agreement, the Company issued to Knight a warrant to purchase 3,584,759 shares of Common Stock on or prior to the close of business of January 22, 2025 (the “LT Warrant”). The exercise price per share of the Common Stock under the LT Warrant is $0.34. The LT Warrant provides for cashless exercise. The LT Warrant also provides that in the event the closing price of the Common Stock remains above $1.00 for six consecutive months, Knight will forfeit the difference between the number of shares acquired under the LT Warrant prior to 90 days after such six-month period, and 25% of the shares purchasable under the LT Warrant.

Asset Purchase Agreement with Factor Nutrition Labs, LLC

On January 22, 2015 (the “Closing Date”), the Company entered into an Asset Purchase Agreement (the “Purchase Agreement”) with Factor Nutrition Labs, LLC, a Delaware limited liability company (the “Seller”), Vita Partners, LLC, RPR Partners, LLC, and Thor Associates, Inc. (each a “Principal Owner”). Pursuant to the Purchase Agreement, the Company purchased all of the assets of the Seller’s line of business and products called FOCUS Factor (the product plus the business related to the product is collectively referred to as the “Focus Factor Business”) and assumed the accounts payable and contractual obligations of the Focus Factor Business for an aggregate purchase price of $6.0 million, with $4.5 million paid on the Closing Date, and $750,000 to be paid on or before January 20, 2016 and an additional $750,000 to be paid on or before January 20, 2017.

Distribution Agreement

On January 22, 2015, the Company and Knight entered into a Distribution, License and Supply Agreement (the “Distribution Agreement”), pursuant to which the Company granted to Knight an exclusive license to commercialize FOCUSFactor, FOCUSFactor Kids and Synergy Strip and all improvements thereto (together the “Licensed Products”) and appointed Knight as the exclusive distributor to offer to sell and sell the Licensed Products in Canada, and, at Knight’s election, one or more of Israel, Russia, and Sub-Saharan Africa. The Distribution Agreement provides that Knight may sublicense its rights or use sub-distributors under the Distribution Agreement on terms consistent with the terms of the Distribution Agreement. During the term of the Distribution Agreement, Knight agrees to obtain from the Company all its requirements for the Licensed Products and the Company agrees to supply the Licensed Products at its adjusted production cost plus a designated percentage and any applicable taxes.

In the event of a long term inability by the Company to supply Knight with the Licensed Products, Knight is entitled to require, among other remedies, the Company to grant a Knight-designated third party a non-exclusive license to use all relevant intellectual property to manufacture and supply Knight with the Licensed Products for commercialization in the Territory. The term of the Distribution Agreement runs until 15 years from the date of the first commercial sale of a Licensed Product in Canada, and the Distribution Agreement will automatically renew for successive 15-year periods unless either party provides the other with written notice of its intention not to renew (a “Non-Renewal Notice”). The Company agrees that in the event it issues a Non-Renewal Notice, the Company will pay to Knight a non-renewal fee equal to the net sales of the Licensed Products achieved by Knight in the Territory during the eight calendar quarters preceding the date of such notice, plus all applicable taxes.

Distribution Option Agreement

In connection with the Loan Agreement, the Company entered into a Product Distribution Option Agreement, dated January 22, 2015 (the “Option Agreement”), pursuant to which the Company granted Knight the exclusive right to negotiate the exclusive distribution rights of any one or more of the Company’s products, including products from the Focus Factor Business, for the territories of Canada, Russia, Sub-Saharan Africa and Israel (the “Option”), pursuant to designated parameters. The Option Agreement is effective upon the date of the Option Agreement, will run until January 31, 2045, and will automatically renew thereafter for successive five-year periods unless either party provides a notice of termination prior to the Option Agreement’s expiration. If Knight does not exercise the option then the Company is free to contract for distribution with other parties, but only on terms no less favorable than those offered by Knight pursuant to the Option Agreement.

Asset Purchase Agreement with Knight Therapeutics Inc.

On June 26, 2015 (the “Closing Date”), Neuragen Corp., a Delaware corporation (“Neuragen”) and our wholly owned subsidiary, entered into an Asset Purchase Agreement (the “Purchase Agreement”) with Knight Therapeutics Inc., a Canadian corporation (“Knight”). Pursuant to the Purchase Agreement, Neuragen purchased the U.S. rights related to an innovative OTC product that helps relieve pain caused by diabetic nerve damage (the “Purchased Assets”) for an aggregate purchase price of $1.2 million, with (i) $250,000 paid on the Closing Date, (ii) $250,000 to be paid on or before June 30, 2016, (iii) $700,000 to be paid in quarterly installments (beginning with the quarter ending September 30, 2015) equal to the greater of $12,500 or 5% of U.S. net sales, and (iv) 2% of U.S. net sales of Neuragen for 60 months thereafter. The payment of such amounts is secured by a security interest in certain assets, undertakings and property (“Collateral”) pursuant to the Security Agreement, which will be released upon receipt of total payments of $1.2 million (collectively, “Total Consideration”).

Security Agreement

On the Closing Date, Neuragen entered into a Security Agreement with Knight, pursuant to which Neuragen granted a lien and security interest to Knight in Collateral in connection with the Purchase Agreement.

The Security Agreement was made to secure the payment of all indebtedness, obligations and liabilities of Neuragen of the Purchase Agreement, including all expenses and charges, legal or otherwise, suffered or incurred by Knight in collecting or enforcing such indebtedness of the Purchase Agreement.

The Security Agreement includes customary events of default, including but not limited to: payment defaults; Neuragen becoming insolvent or entering into bankruptcy; or if any contemplated security ceases to be a valid and perfected first-priority security interest that is not remedied within fifteen business days by Neuragen. Upon the occurrence of an event of default and during the continuation thereof, the principal amount of the outstanding Total Consideration will bear a default interest rate of an additional 10% per annum.

Contribution Agreement

On August 18, 2015 (the “Closing Date”), we entered into a Contribution Agreement with Hand MD Corp., a Delaware corporation, whereby we contributed to Hand MD Corp. 2,142,857 shares of our common stock in exchange for 50% of Hand MD Corp.’s outstanding capital securities valued at $0.70 per share. Simultaneously, Hand MD, LLC, a California limited liability company, entered into a Contribution Agreement with Hand MD Corp., the principal owners of Hand MD, LLC, and us whereby Hand MD LLC contributed to Hand MD Corp. all of its right, title and interest in its intellectual property associated with skincare, nail care and nail polish products (the “Hand MD Business”) in exchange for the other 50% of Hand MD Corp.’s outstanding capital securities. In the Contribution Agreement among Hand MD Corp., Hand MD, LLC, the principal owners of Hand MD, LLC and us, Hand MD, LLC and its principal owners agreed to not compete or solicit customers or employees for five years. As part of the transaction, we also purchased from Hand MD Corp. all inventory related to the Hand MD Business for approximately $97,000.

We also entered into a license agreement with Hand MD Corp. on August 18, 2015, whereby we acquired the exclusive worldwide license to commercialize Hand MD Corp. skincare products and all improvements thereto. The license runs in perpetuity unless earlier terminated. We will pay Hand MD Corp. a royalty of 5% of the net sales price of product sold, transferred or otherwise disposed of by us, as well as 5% of any amount we receive from sublicensees, subject to a minimum royalty of $250,000 in the second year of the license and $500,000 in the third year of the license, after which the minimum royalty terminates. We are solely responsible for any regulatory and intellectual property filings, including those necessary to maintain regulatory approvals for the licensed products. Either we or Hand MD Corp. can terminate the agreement in the event of bankruptcy or insolvency of the other party, or the uncured material breach of the agreement by the other party. Upon termination we would be entitled to sell any inventory of licensed product in the normal course of business and consistent with sales of licensed product during the term of the agreement.

The Contribution Agreements and the License Agreement contain customary representations and warranties and covenants by the respective parties.

We also entered into a Consulting Agreement on August 18, 2015, with Kara Harshbarger, the co-founder of Hand MD, LLC, pursuant to which she will provide marketing and sales related services. We will pay Ms. Harshbarger $10,000 a month for one year unless the Consulting Agreement is terminated earlier by either party. If we terminate the Consulting Agreement without cause, we will be obligated to pay the remaining term of the Agreement. Ms. Harshbarger agreed not to compete with us in the United States in any marketing or sales of skincare, nail polish and nail care products during the term of the Consulting Agreement and for 12 months after its termination. Ms. Harshbarger also agreed not to solicit customers or employees for the same period.

Note 2 – Summary of Significant Accounting Policies

General

The accompanying condensed consolidated financial statements as of September 30, 2015 and December 31, 2014 and for the three and nine months ended September 30, 2015 and 2014 are unaudited. These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and are presented in accordance with the requirements of Rule S-X of the Securities and Exchange Commission (the “SEC”) and with the instructions to Form 10-Q. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2015 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2015. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements as of and for the year ended December 31, 2014 and footnotes thereto included in the Company’s Annual Report on Form 10-K filed with the SEC.

Basis of Presentation

The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all cash on hand and in banks, including accounts in book overdraft positions, certificates of deposit and other highly-liquid investments with maturities of three months or less, when purchased, to be cash and cash equivalents. As of September 30, 2015 the Company had no cash equivalents.

Capitalization of Fixed Assets

The Company capitalizes expenditures related to property and equipment, subject to a minimum rule, that have a useful life greater than one year for: (1) assets purchased; (2) existing assets that are replaced, improved or the useful lives have been extended; or (3) all land, regardless of cost. Acquisitions of new assets, additions, replacements and improvements (other than land) costing less than the minimum rule in addition to maintenance and repair costs, including any planned major maintenance activities, are expensed as incurred.

Intangible Assets

We evaluate the recoverability of intangible assets periodically and take into account events or circumstances that warrant revised estimates of useful lives or that indicate that impairment exists. Intangible assets that are subject to amortization are amortized on a straight-line basis over their useful lives.

Long-lived Assets

Long-lived assets include equipment and intangible assets other than those with indefinite lives. We assess the carrying value of our long-lived asset groups when indicators of impairment exist and recognize and impairment loss when the carrying amount of a long-lived asset is not recoverable when compared to undiscounted cash flows expected to result from the use and eventual disposition of the asset.

Indicators of impairment include significant underperformance relative to historical or projected future operating results, significant changes in our use of the assets or in our business strategy, loss of or changes in customer relationships and significant negative industry or economic trends. When indications of impairment arise for a particular asset or group of assets, we assess the future recoverability of the carrying value of the asset (or asset group) based on an undiscounted cash flow analysis. If carrying value exceeds projected, net, undiscounted cash flows, an additional analysis is performed to determine the fair value of the asset (or asset group), typically a discounted cash flow analysis, and an impairment charge is recorded for the excess of carrying value over fair value.

Goodwill

An asset purchase is accounted for under the purchase method of accounting. Under that method, assets and liabilities of the business acquired are recorded at their estimated fair values as of the date of the acquisition, with any excess of the cost of the acquisition over the estimated fair value of the net tangible and intangible assets acquired recorded as goodwill.

Revenue Recognition

Revenue is recognized in accordance with Staff Accounting Bulletin (“SAB”) No. 101, Revenue Recognition in Financial Statements, as revised by SAB No. 104. We recognize revenue when persuasive evidence of an arrangement exists, delivery has occurred, the sales price is fixed or determinable and collectability is reasonably assured. Ownership of and title to our products pass to customers upon delivery of the products to customers. Certain of our distributors may also perform a separate function as a co-packer on our behalf. In such cases, ownership of and title to our products that are co-packed on our behalf by those co-packers who are also distributors, passes to such distributors when we are notified by them that they have taken transfer or possession of the relevant portion of our finished goods.

Revenue is presented net of estimated returns and allowances, discounts, sales incentives and promotions including, price reductions, coupons, rebate offers and placement/slotting fees.

Accounts receivable

Accounts receivable are generally unsecured. The Company establishes an allowance for doubtful accounts receivable based on the age of outstanding invoices and management’s evaluation of collectability. Accounts are written off after all reasonable collection efforts have been exhausted and management concludes that likelihood of collection is remote. Any future recoveries are applied against the allowance for doubtful accounts.

Advertising Expense

The Company expenses marketing, promotions and advertising costs as incurred. Such costs are included in general and administrative expense in the accompanying condensed consolidated statements of operations.

Research and Development

Costs incurred in connection with the development of new products and processing methods are charged to general and administrative expenses as incurred.

Income Taxes

The Company utilizes Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) 740-10-25, “Income Taxes,” which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the tax basis of assets and liabilities and their financial reporting amounts based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. A valuation allowance is recorded when it is “more likely-than-not” that a deferred tax asset will not be realized.

The Company generated a deferred tax asset through net operating loss carry-forward. However, a valuation allowance of 100% has been established due to the uncertainty of the Company’s realization of the net operating loss carry forward prior to its expiration.

Net Earnings (Loss) Per Common Share

The Company computes earnings per share under ASC subtopic 260-10, Earnings Per Share. Basic earnings (loss) per share is computed by dividing the net income (loss) attributable to the common stockholders (the numerator) by the weighted average number of shares of common stock outstanding (the denominator) during the reporting periods. Diluted loss per share is computed by increasing the denominator by the weighted average number of additional shares that could have been outstanding from securities convertible into common stock (using the “treasury stock” method), unless their effect on net loss per share is anti-dilutive. As of September 30, 2015, an option to purchase 1,000,000 shares of common stock and warrants to purchase 3,584,759 shares of common stock were outstanding.

Going Concern

The Company’s unaudited condensed consolidated financial statements are prepared using U.S. GAAP applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company had an accumulated deficit at September 30, 2015 of $4,105,439. The Company had working capital of $246,252 as of September 30, 2015. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it establishes a revenue stream and becomes profitable. If the Company is unable to obtain adequate capital it could be forced to cease operations.

In order to continue as a going concern and to develop a reliable source of revenues, and achieve a profitable level of operations the Company will need, among other things, additional capital resources. Management’s plans to continue as a going concern include raising additional capital through borrowing and sales of common stock. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans.

The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Fair Value Measurements

The Company measures and discloses the fair value of assets and liabilities required to be carried at fair value in accordance with ASC 820, Fair Value Measurements and Disclosures. ASC 820 defines fair value, establishes a framework for measuring fair value, and enhances fair value measurement disclosure.

ASC 825 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825 establishes three levels of inputs that may be used to measure fair value:

Level 1 - Quoted prices for identical assets or liabilities in active markets to which we have access at the measurement date.

Level 2 - Inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly.

Level 3 - Unobservable inputs for the asset or liability.

The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

As of September 30, 2015, the Company has determined that there were no assets or liabilities measured at fair value.

Inventory

Inventory consists of raw materials, components and finished goods. The Company’s inventory is stated at the lower of cost (FIFO cost basis) or market.

Stock-Based Compensation

The Company has adopted the provisions of ASC 718. We estimate the fair value of stock options using a binomial model, consistent with the provisions of ASC 718 and SEC Staff Accounting Bulletin No. 107, Share-Based Payment. Option-pricing models require the input of highly subjective assumptions, including the price volatility of the underlying stock. We determined that the use of implied volatility is expected to be more reflective of market conditions and, therefore, could reasonably be expected to be a better indicator of our expected volatility than historical volatility. The expected term assumption used in calculating the estimated fair value of our stock-based compensation awards using the binomial model is based on detailed historical data about employees’ exercise behavior, vesting schedules, and death and disability probabilities. In addition, we are required to estimate the expected forfeiture rate and only recognize expense for those shares expected to vest. We estimate the forfeiture rate based on historical experience of our stock-based awards that are granted, exercised and cancelled. We believe the resulting binomial calculation provides a more refined estimate of the fair value of our employee stock options.

Recent Accounting Pronouncements

ASU 2015-03

In April 2015, the FASB issued Accounting Standards Update (“ASU”) No. 2015-03, Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. The amendments in this ASU require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this ASU. The amendments are effective for financial statements issued for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. The amendments are to be applied on a retrospective basis, wherein the balance sheet of each individual period presented is adjusted to reflect the period-specific effects of applying the new guidance. The Company is evaluating the possible effect of this guidance on its financial statements.

ASU 2015-02

In February 2015, the FASB issued ASU No. 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis, which is intended to improve targeted areas of consolidation guidance for legal entities such as limited partnerships, limited liability corporations, and securitization structures (collateralized debt obligations, collateralized loan obligations, and mortgage-backed security transactions). The ASU focuses on the consolidation evaluation for reporting organizations that are required to evaluate whether they should consolidate certain legal entities. In addition to reducing the number of consolidation models from four to two, the new standard simplifies the FASB Accounting Standards Codification and improves current U.S. GAAP by placing more emphasis on risk of loss when determining a controlling financial interest, reducing the frequency of the application of related-party guidance when determining a controlling financial interest in a variable interest entity (“VIE”), and changing consolidation conclusions for companies in several industries that typically make use of limited partnerships or VIEs. The ASU will be effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. We do not expect the adoption of ASU 2015-02 to have a material effect on our financial position, results of operations or cash flows.

ASU 2015-01

In January 2015, the FASB issued ASU No. 2015-01, “Income Statement - Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items.” This ASU eliminates from U.S. GAAP the concept of extraordinary items. ASU 2015-01 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. A reporting entity may apply the amendments prospectively. We do not expect the adoption of ASU 2015-01 to have a material effect on our financial position, results of operations or cash flows.

ASU 2014-17

In November 2014, the FASB issued ASU No. 2014-17, “Business Combinations (Topic 805): Pushdown Accounting.” This ASU provides an acquired entity with an option to apply pushdown accounting in its separate financial statements upon occurrence of an event in which an acquirer obtains control of the acquired entity. An acquired entity may elect the option to apply pushdown accounting in the reporting period in which the change-in-control event occurs. If pushdown accounting is applied to an individual change-in-control event, that election is irrevocable. ASU 2014-17 was effective on November 18, 2014. The adoption of ASU 2014-17 did not have any effect on our financial position, results of operations or cash flows.

ASU 2014-16

In November 2014, the FASB issued ASU 2014-16, “Derivatives and Hedging (Topic 815).” ASU 2014-16 addresses whether the host contract in a hybrid financial instrument issued in the form of a share should be accounted for as debt or equity. ASU 2014-16 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. We do not currently have issued, nor are we investors in, hybrid financial instruments. Accordingly, we do not expect the adoption of ASU 2014-16 to have any effect on our financial position, results of operations or cash flows.

ASU 2014-15

In August 2014, the FASB issued ASU No. 2014-15, “Presentation of Financial Statements - Going Concern (Subtopic 205-40)”. ASU 2014-15 provides guidance related to management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosure. ASU 2014-15 is effective for annual periods ending after December 15, 2016, and for interim and annual periods thereafter. Early application is permitted. We do not expect the adoption of ASU 2014-15 to have a material effect on our financial position, results of operations or cash flows.

ASU 2014-12

In June 2014, the FASB issued ASU No. 2014-12, “Compensation – Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period.” This ASU requires that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. ASU 2014-12 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. We do not expect the adoption of ASU 2014-12 to have a material effect on our financial position, results of operations or cash flows.

ASU 2014-09

In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606).” ASU 2014-09 affects any entity using U.S. GAAP that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards (e.g., insurance contracts or lease contracts). ASU 2014-09 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. We are still evaluating the effect of the adoption of ASU 2014-09. On April 1, 2015, the FASB voted to propose to defer the effective date of the new revenue recognition standard by one year.

ASU 2014-08

In April 2014, the FASB issued ASU No. 2014-08, “Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360) and Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity.” ASU 2014-08 amends the definition for what types of asset disposals are to be considered discontinued operations, as well as amending the required disclosures for discontinued operations and assets held for sale. ASU 2014-08 is effective for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2014. The adoption of ASU 2014-08 did not have any effect on our financial position, results of operations or cash flows.

There were various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company’s condensed financial position, results of operations or cash flows.

Change in Fiscal Year End

On April 21, 2014, the Company’s board of directors approved a change to the Company’s fiscal year end from July 31 to December 31 of each year.

Note 3 – Asset Purchases

Asset Purchase Agreement with Factor Nutrition Labs, LLC:

The Company has accounted for this transaction under the acquisition method of accounting. Under the acquisition method of accounting, the total acquisition consideration price is allocated to the assets acquired and liabilities assumed based on their preliminary estimated fair values. The Company expects the purchase price allocations for the acquisition of Focus Factor Business to be completed by December 31, 2015. The preliminary allocation of the purchase price to the assets acquired and liabilities assumed based on the estimated fair values is as follows:

Assets
Accounts Receivable	$	2,926,369
Inventory		67,113
Intellectual Property		1,000,000
Non-compete provision		50,000
Non-solicitation provision		50,000
Intangible assets-Customer relationships		1,941,030
Goodwill		1,798,047
Liabilities
Accounts Payable		(891,113	)
Accrued Expenses		(941,446	)
	$	6,000,000

The Customer relationships, the non-compete and the non-solicitation provisions will be amortized over their estimated useful lives of 5 years.

Pro forma Results of Operations. The historical operating results of the Focus Factor Business prior to its acquisition date have not been included in the Company’s historical consolidated operating results. Pro forma results of operations data (unaudited) for the years ended December 31, 2014 and 2013, as if the acquisition had occurred on January 1, 2013, are as follows:

	December 31,
	2014			2013
Revenue	$	12,695,295		$	10,629,171
Net income (loss)		(183,471	)		932,209

Pro forma revenue amount above does not include adjustment/reductions relating to certain discounts, coupons and placement fees and is presented gross.

The amounts of revenue and earnings of the FOCUS Factor Business since the acquisition date included in the unaudited condensed consolidated statement of operations for the nine months ended September 30, 2015 are approximately $7,015,763 and $(3,067,567), respectively.

Asset Purchase Agreement with Knight Therapeutics Inc.:

The Company has accounted for this transaction under the acquisition method of accounting. Under the acquisition method of accounting, the total acquisition consideration price is allocated to the assets acquired and liabilities assumed based on their preliminary estimated fair values. The Company expects the purchase price allocations for the acquisition of the Purchased Assets to be completed by December 31, 2015. The preliminary allocation of the purchase price to the assets acquired and liabilities assumed based on the estimated fair values is as follows:

Assets
Accounts Receivable	$	58,054
Inventory		204,925
Goodwill		1,137,336
Liabilities
Accounts Payable		(51,795	)
Accrued Expenses		(148,520	)
	$	1,200,000

Note 4 – Inventory

Inventory consists of raw materials, components and finished goods. The Company’s inventory is stated at the lower of cost (FIFO cost basis) or market.

The carrying value of inventory consisted of the following:

	September 30, 2015		December 31, 2014
Energy product	$	24,451	$	26,064
Components		172,936		-
Finished goods		266,655		-
Raw Materials		35,406		-
Total inventory	$	499,448	$	26,064

As of January 22, 2015, inventory was pledged to Knight Therapeutics under the Loan Agreement (see note 1).

Note 5 – Fixed Assets and Intangible Assets

As of September 30, 2015 and December 31, 2014, fixed assets and intangible assets consisted of the following:

	September 30, 2015			December 31, 2014

Property and equipment	$	4,044		$	-
Less accumulated depreciation		(430	)		-
Fixed assets, net	$	3,614		$	-

	September 30, 2015			December 31, 2014

FOCUSfactor intellectual property	$	1,000,000		$	-
Intangible assets subject to amortization		2,041,030			-
Less accumulated amortization		(281,829	)		-
Intangible assets, net	$	2,759,201		$	-

Depreciation and amortization expense for the nine months ended September 30, 2015 and 2014 was $282,256 and $0, respectively. Depreciation and amortization expense for the three months ended September 30, 2015 and 2014 was $103,103 and $0, respectively. Annual amortization expense will be $408,206 per year through 2020.

Note 6 – Related Party Transactions

On April 2, 2014, the Company granted an option to purchase 1,000,000 shares of the Company’s common stock, valued at approximately $282,000 to the Company owned by Mr. Jack Ross, Chief Executive Officer of the Company.

On October 31, 2014, the Company borrowed $100,000 through a promissory note bearing interest at 10% with a maturity date of October 31, 2015 from a company owned by Mr. Ross, the Company’s chief executive officer. During the nine months ended September 30, 2015, the note was converted into 400,000 shares of the Company’s common stock.

The Company accrued and paid consulting fees of $15,000 per month to a company owned by Mr. Jack Ross, Chief Executive Officer of the Company. As of September 30, 2015, the total outstanding balance was $0.

At September 30, 2015, $175,422 was due from a company owned by Mr. Jack Ross, Chief Executive Officer of the Company in a form of a note receivable.

On January 22, 2015, the Company entered into a Loan Agreement with Knight Therapeutics (Barbados) Inc. (“Knight”), a related party, for the purchase of the Focus Factor assets. At September 30, 2015, the Company owed Knight $5,047,178 on this loan, net of discount (see Note 8).

On June 26, 2015, the Company entered into a Loan Agreement with Knight Therapeutics, through its wholly owned subsidiary, for the purchase of the Neuragen assets. At September 30, 2015, the Company owed Knight $937,500 on this loan (see Note 8).

Note 7 – Accounts Payable and Accrued Liabilities

As of September 30, 2015 and December 31, 2014, accounts payable and accrued liabilities consisted of the following:

	September 30, 2015		December 31, 2014
Accrued payroll	$	-	$	10,867
Accrued legal fees		56,683		47,916
Manufacturers		1,391,472		-
Promotions		15,000		-
Other		190,141		15,859
Total	$	1,653,296	$	74,642

Note 8 – Notes Payable

On January 22, 2015, the Company entered into a Loan and Security Agreement, pursuant to which Knight Therapeutics (Barbados) Inc. (“Knight”) agreed to loan the Company $6.0 million (the “Loan”), and which amount was borrowed at closing for the purpose of acquiring the Focus Factor Business (see note 1). The Loan bears interest at a rate of 15% per year; provided, however, that upon the occurrence of an equity or convertible equity offering by the Company of at least $1.0 million, the interest rate will drop to 13% per year. Interest accrues quarterly and is payable in arrears on March 31, June 30, September 30 and December 31 in each year, beginning on March 31, 2015. All outstanding principal and accrued and unpaid interest is due on the earliest to occur of either January 20, 2017, or the date that Knight, in its discretion, accelerates the Company’s obligations due to an event of default.

In connection with the Loan, the Company issued warrants that were recorded as a debt discount at an initial aggregate value of $3,415,514 (see note 1). The value of these warrants was amortized during the nine months ended September 30, 2015, resulting in a final debt discount balance of $840,322 as of September 30, 2015.

On January 22, 2015, the Company issued a 0% promissory note in a principal amount of $1,500,000 in connection with an Asset Purchase Agreement (see note 1). The note has a maturity date of January 20, 2017, with $750,000 to be paid on or before January 20, 2016 and an additional $750,000 to be paid on or before January 20, 2017.

On June 26, 2015, the Company, through its wholly owned subsidiary, Neuragen Corp. (“Neuragen”), issued a 0% promissory note in a principal amount of $950,000 in connection with an Asset Purchase Agreement (see note 1). The note requires $250,000 to be paid on or before June 30, 2016, and $700,000 to be paid in quarterly installments (beginning with the quarter ending September 30, 2015) equal to the greater of $12,500 or 5% of U.S. net sales, and 2% of U.S. net sales of Neuragen for 60 months thereafter. The payment of such amounts is secured by a security interest in certain assets, undertakings and property (“Collateral”) pursuant to the Security Agreement, which will be released upon receipt of total payments of $1.2 million. The balance at September 30, 2015 was $937,500.

Note 9 – Stockholders’ Deficit

The total number of shares of all classes of capital stock which the Company is authorized to issue is 75,000,000 shares of common stock with $0.00001 par value. On July 30, 2014, the Company’s board of directors approved an increase of the Company’s authorized common stock from 75,000,000 to 300,000,000 shares, which increase was approved by the Company’s shareholders and became effective on August 5, 2015.

During the nine months ended September 30, 2015, the Company issued 4,595,187 shares of its common stock upon exercise of the ST Warrant at an aggregate exercise price of $1.00 in connection with the Loan Agreement (see note1).

During the nine months ended September 30, 2015, the Company issued 400,000 shares of its common stock to a note holder in a note conversion at $0.25 per share. At the time of conversion, the note was valued at $100,000 for outstanding principal.

During the nine months ended September 30, 2015, the Company issued 2,142,857 shares of its common stock valued at $0.70 per share in accordance with Contribution Agreement entered into with Hand MD Corp. in exchange for 50% of Hand MD Corp.’s outstanding capital securities.

As of September 30, 2015, there were 69,238,044 shares of the Company’s common stock issued and outstanding.

Note 10 – Commitments & Contingencies

From time to time the Company may become a party to litigation in the normal course of business. Management believes that there are no current legal matters that would have a material effect on the Company’s financial position or results of operations.

Note 11 – Stock Options

On July 30, 2014, the Company’s board of directors approved the Company’s 2014 Equity Incentive Plan and the reservation of 15,525,000 shares of common stock for issuance under such plan. Such plan was approved by the Company’s shareholders and became effective on August 5, 2015.

On April 2, 2014, the Company granted 1,000,000 options with an exercise price of $0.25 per share.

The following table summarizes the changes in options outstanding and the related prices for the shares of the Company’s common stock issued to employees and consultants under a stock option plan at September 30, 2015:

		Options Outstanding					Options Exercisable
	Exercise Prices ($)		Number Outstanding	Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price ($)		Number Exercisable		Weighted Average Exercise Price
$	0.25		1,000,000	3.50	$	0.25		1,000,000	$	0.25

The stock option activity for the nine months ended September 30, 2015 is as follows:

	Options Outstanding		Weighted Average Exercise Price
Outstanding at December 31, 2014		1,000,000	$	0.25
Granted		—		—
Exercised		—		—
Expired or canceled		—		—
Outstanding at September 30, 2015	$	1,000,000	$	0.25

Note 12 – Stock Warrants

The following table summarizes the warrants outstanding and the related prices for the shares of the Company’s common stock at September 30, 2015:

		Warrants Outstanding					Warrants Exercisable
	Exercise Prices ($)		Number Outstanding	Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price ($)		Number Exercisable		Weighted Average Exercise Price
$	0.34		3,584,759	9.32	$	0.34		3,584,759	$	0.34

The warrant activity for the nine months ended September 30, 2015 is as follows:

	Warrants Outstanding			Weighted Average Exercise Price
Outstanding at December 31, 2014		—		$	—
Granted		8,179,946			0.15
Exercised		(4,595,187	)		0.00000022
Expired or canceled		—			—
Outstanding at September 30, 2015	$	3,584,759		$	0.34

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of the results of operations and financial condition of Synergy for the nine months ended September 30, 2015 and 2014, should be read in conjunction with the financial statements of Synergy, and the notes to those financial statements that are included elsewhere in this Form 10-Q. Our discussion includes forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors, including those set forth under the Risk Factors, Cautionary Notice Regarding Forward-Looking Statements and Business sections in our Annual Report Form 10-K filed on March 31, 2015. We use words such as “anticipate,” “estimate,” “plan,” “project,” “continuing,” “ongoing,” “expect,” “believe,” “intend,” “may,” “will,” “should,” “could,” and similar expressions to identify forward-looking statements.

Overview

The Company is in the business of marketing and distributing best-in-class consumer-branded products through various distribution channels primarily in the health and wellness industry. The Company’s strategy is to grow both organically and by future acquisitions.

On April 7, 2014, an Agreement and Plan of Merger (the “Merger Agreement”) was entered into by and among the Company, Synergy Merger Sub, Inc., a Delaware corporation and the wholly owned subsidiary of the Company formed for the purpose of the transactions under the Merger Agreement (“Merger Sub”), and Synergy Strips Corp., a Delaware corporation incorporated on January 24, 2012 (“SSC”). The Merger Agreement provided for the merger of Merger Sub with and into SSC (the “Merger”), with SSC surviving the merger as the wholly owned subsidiary of the Company. The Merger was consummated on April 21, 2014.

On April 21, 2014, the Company changed its fiscal year end from July 31 to December 31.

During the nine months ended September 30, 2015, management has been undertaking a rebranding of the FOCUSfactor product. The focus has been on the “evolution” of the label and brand so as not to alienate current customers, but to give the product a fresh look. All marketing materials are planned to be updated early in 2016.

Management has also launched a direct to consumer campaign with national radio and television commercials.

Our management’s discussion and analysis of our financial condition and results of operations are only based on Synergy’s current business. Our previous shell company’s results of operations are immaterial and will not be included in the discussion below. Key factors affecting our results of operations include revenues, cost of revenues, operating expenses and income and taxation.

Results of Operations for the Three months Ended September 30, 2015 and 2014

Revenue

For the three months ended September 30, 2015, we had revenue of $3,181,623 from sales of our products, as compared to revenue of $0 for the same period in 2014. The increase was due to the purchase of the assets of Factor Nutrition Labs (FOCUSfactor).

Cost of Revenue

For the three months ended September 30, 2015, our cost of revenue was $1,469,910. Our cost of revenue for the three months ended September 30, 2014, was $0. The increase was due to the purchase of the assets of Factor Nutrition Labs (FOCUSfactor).

Gross Profit

Gross profit was $1,711,713 for the three months ended September 30, 2015, as compared to gross profit of $0 for the same period in 2014.

Operating Expenses

For the three months ended September 30, 2015, our operating expenses were $1,624,549. Selling and marketing expenses were $814,640, and included primarily retail promotions of $418,158, and marketing costs of $384,240. General and administrative expenses were $706,806, which included professional fees of $148,157 and wages of $203,015. Amortization and depreciation expense was $103,103 during the three months ended September 30, 2015. For the three months ended September 30, 2014, our operating expenses were $142,236. The increase was due to the purchase of the assets of Factor Nutrition Labs (FOCUSfactor).

Other Expenses

For the three months ended September 30, 2015, we incurred interest expense of $212,904 related to interest on notes payable, amortization of debt issuance cost of $37,753 and amortization of debt discount of $304,117 in connection with our loan from Knight. There were no such expenses during the three months ended September 30, 2014.

Net Loss

For the three months ended September 30, 2015, our net loss was $467,010, as compared to $142,236 for the same period in 2014.

Results of Operations for the Nine months Ended September 30, 2015 and 2014

Revenue

For the nine months ended September 30, 2015, we had revenues of $7,237,619 from sales of our products, as compared to revenue of $2,748 for the same period in 2014. The increase was due to the purchase of the assets of Factor Nutrition Labs (FOCUSfactor).

Cost of Revenue

For the nine months ended September 30, 2015, our cost of revenue was $3,103,244. Our cost of revenue for the nine months ended September 30, 2014, was $1,685. The increase was due to the purchase of the assets of Factor Nutrition Labs (FOCUSfactor).

Gross Profit

Gross profit was $4,134,375 for the nine months ended September 30, 2015, as compared to gross profit of $1,063 for the same period in 2014.

Operating Expenses

For the nine months ended September 30, 2015, our operating expenses were $3,918,132. Selling and marketing expenses were $2,228,418, and included primarily retail promotions of $1,242,611, in-store demonstrations of $263,060, and marketing costs of $705,449. General and administrative expenses were $1,407,458, which included professional fees of $298,192 and wages of $325,268. Amortization and depreciation expense was $282,256 during the nine months ended September 30, 2015. For the nine months ended September 30, 2014, our operating expenses were $787,858. The increase was due to the purchase of the assets of Factor Nutrition Labs (FOCUSfactor).

Other Expenses

For the nine months ended September 30, 2015, we incurred interest expense of $612,094 related to interest on notes payable, amortization of debt issuance cost of $99,780 and amortization of debt discount of $2,575,192 in connection with our loan from Knight. There were no such expenses during the nine months ended September 30, 2014.

Net Loss

For the nine months ended September 30, 2015, our net loss was $3,072,148, as compared to $786,795 for the same period in 2014.

Non-GAAP Financial Measures

We currently focus on Adjusted EBITDA to evaluate our business relationships and our resulting operating performance and financial position. Adjusted EBITDA is defined as EBITDA (net income plus interest expense, income tax expense, depreciation and amortization), further adjusted to exclude certain non-cash expenses and other adjustments as set forth below. We present Adjusted EBITDA because we consider it an important measure of our performance and it is a meaningful financial metric in assessing our operating performance from period to period by excluding certain items that we believe are not representative of our core business, such as certain non-cash items and other adjustments.

We believe that Adjusted EBITDA, viewed in addition to, and not in lieu of, our reported results in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”), provides useful information to investors.

	Three months ended September 30, 3015			Nine months ended September 30, 3015
Net Loss	$	(467,610	)	$	(3,072,148	)
Interest		212,904			612,094
Taxes		1,524			1,524
Depreciation		217			430
Amortization		444,756			2,958,123
EBITDA	$	191,791		$	500,023
Stock-based compensation		4,000			28,000
One-time expenses for Acquisition		37,642			105,491
Adjusted EBITDA	$	233,433		$	633,514

Liquidity and Capital Resources

Overview

As of September 30, 2015, we had $824,948 of cash on hand and $246,252 of working capital.

Going Concern

The Company’s unaudited condensed consolidated financial statements are prepared using U.S. GAAP applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company had an accumulated deficit at September 30, 2015 of $4,105,439. The Company had working capital of $246,252 as of September 30, 2015. The ability of the Company to continue as a going concern is dependent on whether the Company can obtain adequate capital to fund operating losses until it establishes a revenue stream and becomes profitable, if at all. If the Company is unable to obtain adequate capital it could be forced to cease operations.

Nine months Ended September 30, 2015 and 2014

Net Cash Used in Operating Activities

For the nine months ended September 30, 2015, operating activities provided $800,030 to us. Non-cash adjustments included $282,256 related to the depreciation and amortization, $28,000 for stock based compensation, $2,575,192 related to amortization of debt discount, $101,105 related to amortization of debt discount issuance cost, and net changes in operating assets and liabilities of $885,625. During the nine months ended September 30, 2014, we used $398,453 of cash in operating activities.

Net Cash Used in Investing Activities

For the nine months ended September 30, 2015, we used net cash of $4,754,045 in investing activities, as compared to $0 used in investing activities for the nine months ended September 30, 2014. The increase was primarily attributable to the purchase of the assets of Factor Nutrition Labs (FOCUSfactor) and Neuragen Corp.

Net Cash Provided by Financing Activities

Financing activities provided $4,778,625 to us during the nine months ended September 30, 2015. We received $6,000,000 in proceeds from notes payable, and $1 in proceeds from warrant exercise. We also used $762,500 to repay the notes. During the nine months ended September 30, 2014, financing activities provided $407,160.

Contractual Obligations and Off-Balance Sheet Arrangements

Contractual Obligations

None.

Off-Balance Sheet Arrangements

None.

Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared on the accrual basis of accounting in accordance with U.S. GAAP.

Use of Estimates

The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates. Significant estimates include, but are not limited to, the collectability of accounts receivable and the estimates used when evaluating long-lived assets for impairment. Estimates are used for, but are not limited to, determining the following: allowance for doubtful accounts and inventory valuation reserves, recoverability of long-lived assets, and useful lives used in depreciation and amortization.

Cash and Cash Equivalents

The Company considers all highly liquid temporary cash investments with an original maturity of three months or less to be cash equivalents. At September 30, 2015, the Company had no cash equivalents.

Capitalization of Fixed Assets

Intangible assets

Long-lived Assets

Long-lived assets include equipment and intangible assets other than those with indefinite lives. We assess the carrying value of our long-lived asset groups when indicators of impairment exist and recognize an impairment loss when the carrying amount of a long-lived asset is not recoverable when compared to undiscounted cash flows expected to result from the use and eventual disposition of the asset.

Goodwill

Advertising Expense

Research and development

Costs incurred in connection with the development of new products and processing methods are charged to general and administrative expenses as incurred.

Revenue Recognition

Revenue is recognized in accordance with Staff Accounting Bulletin (“SAB”) No. 101, Revenue Recognition in Financial Statements, as revised by SAB No. 104. We recognize revenue when persuasive evidence of an arrangement exists, delivery has occurred, the sales price is fixed or determinable and collectability is reasonably assured. Ownership and title of our products pass to customers upon delivery of the products to customers. Certain of our distributors may also perform a separate function as a co-packer on our behalf. In such cases, ownership of and title to our products that are co-packed on our behalf by those co-packers who are also distributors, passes to such distributors when we are notified by them that they have taken transfer or possession of the relevant portion of our finished goods.

Revenue is presented net of estimated returns and allowances, discounts, sales incentives and promotions including, price reductions, coupons, rebate offers and placement/slotting fees.

Accounts receivable

Income Taxes

The Company accounts for income taxes under Financial Accounting Standards Board (“FASB”) Codification Topic 740-10-25 (“ASC 740-10-25”) Income Taxes. Under ASC 740-10-25, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740-10-25, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

Fair Value of Financial Instruments

We may hold certain financial assets, which are required to be measured at fair value on a recurring basis in accordance with the Statement of Financial Accounting Standard No. 157, “Fair Value Measurements” (“ASC Topic 820-10”). ASC Topic 820-10 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). ASC Topic 820-10 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. Level 1 instruments include cash, accounts receivable, prepaid expenses, inventory and accounts payable and accrued liabilities. The carrying values are assumed to approximate the fair value due to the short term nature of the instrument.

The three levels of the fair value hierarchy under ASC Topic 820-10 are described below:

Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access. We believe our carrying value of level 1 instruments approximate their fair value at September 30, 2015 due to their short term nature.

Level 2 - Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.

Level 3 - Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. We consider depleting assets, asset retirement obligations and net profit interest liability to be Level 3. We determine the fair value of Level 3 assets and liabilities utilizing various inputs, including NYMEX price quotations and contract terms.

Earnings (Loss) Per Share

Net earnings (loss) per share is computed by dividing net income (loss) less preferred dividends for the period by the weighted average number of common stock outstanding during each period. Diluted earnings (loss) per share is computed by dividing net income (loss) less preferred dividends for the period by the weighted average number of common stock, common stock equivalents and potentially dilutive securities outstanding during each period.

Inventory

Inventory consists of raw materials, components and finished goods. The Company’s inventory is stated at the lower of cost (FIFO cost basis) or market.

Stock-Based Compensation

Recent Accounting Pronouncements

ASU 2015-03

ASU 2015-02

ASU 2015-01

ASU 2014-17

ASU 2014-16

ASU 2014-15

ASU 2014-12

ASU 2014-09

ASU 2014-08

Fiscal Year

The Company has adopted December 31, as its fiscal year end.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide the information required by this item.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our Chief Executive Officer (our principal executive officer, principal financial officer and principal accounting officer) reviewed the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report and concluded that as of September 30, 2015, (i) the Company’s disclosure controls and procedures were not effective to ensure that material information relating to the Company is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission (the “Commission”), and (ii) the Company’s controls and procedures have not been designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934, as amended, is accumulated and communicated to the Company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Based on this evaluation, our Chief Executive Officer concluded as of the evaluation date that our disclosure controls and procedures were not effective.

Changes in Internal Controls Over Financial Reporting

There were no changes in our internal control over financial reporting during the fiscal quarter covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Inherent Limitations on Effectiveness of Controls

The Company’s management does not expect that its disclosure controls or its internal control over financial reporting will prevent or detect all error and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

From time to time, we may become involved in various lawsuits and legal proceedings, which arise, in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims that we believe will have a material adverse effect on our business, financial condition or operating results.

ITEM 1A. RISK FACTORS

None.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULT UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not Applicable.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

Exhibit Number		Description

31.1		Section 302 Certification by the Corporation’s Chief Executive Officer and Chief Financial Officer *

32.1		Section 906 Certification by the Corporation’s Chief Executive Officer and Chief Financial Officer *

101.INS		XBRL Instance Document* **
101.SCH		XBRL Taxonomy Extension Schema Document* **
101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document* **
101.DEF		XBRL Taxonomy Extension Definition Linkbase Document* **
101.LAB		XBRL Taxonomy Extension Label Linkbase Document* **
101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document* **

	*	Filed herewith

	**	Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Signatures	Title	Date

/s/ Jack Ross	Chief Executive Officer and	November 16, 2015
	Chief Financial Officer

EX-31.1 2 ex31-1.htm

Exhibit 31.1

CERTIFICATION

I, Jack Ross, certify that:

1.	I have reviewed this Quarterly-Report on Form 10-Q of Synergy CHC Corp.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

	a.	All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 16, 2015	By:	/s/ Jack Ross
		Jack Ross
		Chief Executive Officer and Chief Financial Officer
		(Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)

EX-32.1 3 ex32-1.htm

Exhibit 32.1

CERTIFICATION

In connection with the transition report of Synergy CHC Corp. (the “Company”) on Form 10-Q for the quarter ended September 30, 2015, as filed with the Securities and Exchange Commission (the “Report”), I, Jack Ross, Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:

	(1)	The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and

	(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

Date: November 16, 2015	By:	/s/ Jack Ross
		Jack Ross
		Chief Executive Officer and Chief Financial Officer
		(Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)

EX-101.INS 4 snyr-20150930.xml XBRL INSTANCE FILE 0001562733 2015-01-01 2015-09-30 0001562733 2014-01-01 2014-09-30 0001562733 2014-12-31 0001562733 2014-09-30 0001562733 SNYR:StockOptionPlanMember 2015-01-01 2015-09-30 0001562733 SNYR:StockOptionPlanMember 2015-09-30 0001562733 SNYR:EquityIncentivePlanTwoThousandsAndFourteenMember 2014-09-30 0001562733 us-gaap:BoardOfDirectorsChairmanMember us-gaap:MaximumMember 2015-09-30 0001562733 us-gaap:BoardOfDirectorsChairmanMember us-gaap:MinimumMember 2015-09-30 0001562733 2014-03-30 2014-04-02 0001562733 2015-09-30 0001562733 us-gaap:ChiefExecutiveOfficerMember 2014-04-01 2014-04-02 0001562733 us-gaap:ChiefExecutiveOfficerMember 2014-10-01 2014-10-31 0001562733 us-gaap:ChiefExecutiveOfficerMember 2014-10-31 0001562733 us-gaap:MinimumMember 2014-01-01 2014-12-31 0001562733 2013-12-31 0001562733 SNYR:LTWarrantMember 2015-09-30 0001562733 SNYR:FocusFactorBusinessMember 2015-01-01 2015-09-30 0001562733 SNYR:FocusFactorBusinessMember SNYR:JanuaryTwentyTwoThousandSixteenMember 2015-01-01 2015-09-30 0001562733 SNYR:FocusFactorBusinessMember SNYR:JanuaryTwentyTwoThousandSeventeenMember 2015-01-01 2015-09-30 0001562733 SNYR:FocusFactorBusinessMember 2014-01-01 2014-12-31 0001562733 SNYR:FocusFactorBusinessMember 2013-01-01 2013-12-31 0001562733 us-gaap:WarrantMember 2015-01-01 2015-09-30 0001562733 us-gaap:WarrantMember 2015-09-30 0001562733 SNYR:StockOptionPlanMember 2014-12-31 0001562733 us-gaap:WarrantMember 2014-12-31 0001562733 2015-07-01 2015-09-30 0001562733 2014-07-01 2014-09-30 0001562733 2015-11-03 0001562733 SNYR:FactorNutritionLabsLLCMember 2015-01-01 2015-09-30 0001562733 SNYR:STWarrantMember 2015-09-30 0001562733 SNYR:FactorNutritionLabsLLCMember 2014-12-31 0001562733 SNYR:KnightTherapeuticsIncMember 2015-09-30 0001562733 SNYR:KnightTherapeuticsIncMember 2015-06-24 2015-06-26 0001562733 SNYR:KnightTherapeuticsIncMember 2015-06-26 0001562733 SNYR:KnightTherapeuticsIncMember SNYR:JuneThirtyTwoThousandSixteenMember 2015-06-24 2015-06-26 0001562733 SNYR:KnightTherapeuticsIncMember SNYR:SeptemberThirtyTwoThousandFifteenMember 2015-06-24 2015-06-26 0001562733 SNYR:KnightTherapeuticsIncMember SNYR:SeptemberThirtyTwoThousandFifteenMember SNYR:USMember us-gaap:MaximumMember 2015-06-24 2015-06-26 0001562733 SNYR:KnightTherapeuticsIncMember SNYR:USMember 2015-06-24 2015-06-26 0001562733 SNYR:KnightTherapeuticsIncMember SNYR:ClosingDateMember 2015-06-24 2015-06-26 0001562733 SNYR:KnightTherapeuticsIncMember 2015-01-01 2015-09-30 0001562733 SNYR:ContributionAgreementMember 2015-08-17 2015-08-18 0001562733 SNYR:ContributionAgreementMember SNYR:HandMDCorpMember 2015-08-17 2015-08-18 0001562733 SNYR:ContributionAgreementMember SNYR:HandMDCorpMember 2015-08-18 0001562733 SNYR:LicenseAgreementMember SNYR:HandMDCorpMember 2015-08-17 2015-08-18 0001562733 SNYR:ConsultingAgreementMember SNYR:HandMDLLCMember 2015-08-17 2015-08-18 0001562733 SNYR:ContributionAgreementMember SNYR:HandMDCorpMember 2015-09-30 iso4217:USD iso4217:USD xbrli:shares xbrli:shares xbrli:pure

2898

1327154

10000

122576

55376

2949548

55376

10346175

0.00001

75000000

300000000

75000000

300000000

62100000

69238044

621

692

2142857

-40000

-68000

-1033291

-4105439

-125666

1845701

55376

10346175

Note 1 Nature of the Business   Synergy CHC Corp. (Synergy, we, us, our or the Company) (formerly Synergy Strips Corp.) was incorporated on December 29, 2010 in Nevada under the name Oro Capital Corporation. On April 21, 2014, the Company changed its fiscal year end from July 31 to December 31. On April 28, 2014, the Company changed its name to Synergy Strips Corp.. On August 5, 2015, the Company changed its name to Synergy CHC Corp.   The Company is a consumer health care company that is in the process of building a portfolio of best-in-class consumer product brands. Synergys strategy is to grow its portfolio both organically and by further acquisition.   Synergy is the sole owner of a subsidiary, Neuragen Corp., and the results have been consolidated in these statements.   Loan and Warrants   On January 22, 2015, the Company entered into a Loan and Security Agreement (Loan Agreement) with Knight Therapeutics (Barbados) Inc. (Knight), pursuant to which Knight agreed to loan the Company $6.0 million (the Loan), and which amount was borrowed at closing (the Financing) for the purpose of acquiring the Focus Factor Business (defined below). At closing, the Company paid Knight an origination fee of $120,000 and a work fee of $60,000 and also paid $40,000 of Knights expenses associated with the Loan. The Loan bears interest at a rate of 15% per year; provided, however, that upon the occurrence of an equity or convertible equity offering by the Company of at least $1.0 million, the interest rate will drop to 13% per year. Interest accrues quarterly and is payable in arrears on March 31, June 30, September 30 and December 31 in each year, beginning on March 31, 2015.   All outstanding principal and accrued and unpaid interest is due on the earliest to occur of either January 20, 2017 (the Maturity Date), or the date that Knight, in its discretion, accelerates the Companys obligations due to an event of default. The Company may extend the Maturity Date for two successive additional 12-month periods if at March 31, 2016 and March 31, 2017, respectively, the Companys revenues exceed $13.0 million and its EBITDA exceeds $2.0 million for the respective 12-month period then ending. Principal payments under the Loan Agreement commenced on June 30, 2015 and continue quarterly as set forth on the Repayment Schedule to the Loan Agreement.   Subject to certain restrictions, the Company may prepay the outstanding principal of the Loan (in whole but not in part) at any time if the Company pays a concurrent prepayment fee equal to the greater of (i) the total unpaid annual interest that would have been payable during the year in which the prepayment is made if the prepayment is made prior to the first anniversary of the closing, and (ii) $300,000. The Companys obligations under the Loan Agreement are secured by a first priority security interest in all present and future assets of the Company. The Company also agreed to not pledge or otherwise encumber its intellectual property assets, subject to certain customary exceptions.   The Loan Agreement includes customary representations, warranties, and affirmative and restrictive covenants, including covenants to attain and maintain certain financial metrics, and to not merge or dispose of assets, acquire other businesses (except for businesses substantially similar or complementary to the Companys business and the aggregate consideration to be paid does not exceed $100,000) or make capital expenditures in excess of $100,000 over the Companys annual business plan in any year. The Loan Agreement also includes customary events of default, including payment defaults, breaches of covenants, change of control and material adverse effect default. Upon the occurrence of an event of default and during the continuation thereof, the principal amount of the Loan will bear a default interest rate of an additional 5%.   In connection with the Loan Agreement, the Company issued to Knight a warrant that entitled Knight to purchase 4,595,187 shares of common stock of the Company (Common Stock) on or prior to close of business on January 30, 2015 (the ST Warrant). The aggregate exercise price of the Common Stock under the ST Warrant is $1.00. Knight exercised the ST Warrant on January 22, 2015. Also in connection with the Loan Agreement, the Company issued to Knight a warrant to purchase 3,584,759 shares of Common Stock on or prior to the close of business of January 22, 2025 (the LT Warrant). The exercise price per share of the Common Stock under the LT Warrant is $0.34. The LT Warrant provides for cashless exercise. The LT Warrant also provides that in the event the closing price of the Common Stock remains above $1.00 for six consecutive months, Knight will forfeit the difference between the number of shares acquired under the LT Warrant prior to 90 days after such six-month period, and 25% of the shares purchasable under the LT Warrant.   Asset Purchase Agreement with Factor Nutrition Labs, LLC   On January 22, 2015 (the Closing Date), the Company entered into an Asset Purchase Agreement (the Purchase Agreement) with Factor Nutrition Labs, LLC, a Delaware limited liability company (the Seller), Vita Partners, LLC, RPR Partners, LLC, and Thor Associates, Inc. (each a Principal Owner). Pursuant to the Purchase Agreement, the Company purchased all of the assets of the Sellers line of business and products called FOCUS Factor (the product plus the business related to the product is collectively referred to as the Focus Factor Business) and assumed the accounts payable and contractual obligations of the Focus Factor Business for an aggregate purchase price of $6.0 million, with $4.5 million paid on the Closing Date, and $750,000 to be paid on or before January 20, 2016 and an additional $750,000 to be paid on or before January 20, 2017.   Distribution Agreement   On January 22, 2015, the Company and Knight entered into a Distribution, License and Supply Agreement (the Distribution Agreement), pursuant to which the Company granted to Knight an exclusive license to commercialize FOCUSFactor, FOCUSFactor Kids and Synergy Strip and all improvements thereto (together the Licensed Products) and appointed Knight as the exclusive distributor to offer to sell and sell the Licensed Products in Canada, and, at Knights election, one or more of Israel, Russia, and Sub-Saharan Africa. The Distribution Agreement provides that Knight may sublicense its rights or use sub-distributors under the Distribution Agreement on terms consistent with the terms of the Distribution Agreement. During the term of the Distribution Agreement, Knight agrees to obtain from the Company all its requirements for the Licensed Products and the Company agrees to supply the Licensed Products at its adjusted production cost plus a designated percentage and any applicable taxes.   In the event of a long term inability by the Company to supply Knight with the Licensed Products, Knight is entitled to require, among other remedies, the Company to grant a Knight-designated third party a non-exclusive license to use all relevant intellectual property to manufacture and supply Knight with the Licensed Products for commercialization in the Territory. The term of the Distribution Agreement runs until 15 years from the date of the first commercial sale of a Licensed Product in Canada, and the Distribution Agreement will automatically renew for successive 15-year periods unless either party provides the other with written notice of its intention not to renew (a Non-Renewal Notice). The Company agrees that in the event it issues a Non-Renewal Notice, the Company will pay to Knight a non-renewal fee equal to the net sales of the Licensed Products achieved by Knight in the Territory during the eight calendar quarters preceding the date of such notice, plus all applicable taxes.   Distribution Option Agreement   In connection with the Loan Agreement, the Company entered into a Product Distribution Option Agreement, dated January 22, 2015 (the Option Agreement), pursuant to which the Company granted Knight the exclusive right to negotiate the exclusive distribution rights of any one or more of the Companys products, including products from the Focus Factor Business, for the territories of Canada, Russia, Sub-Saharan Africa and Israel (the Option), pursuant to designated parameters. The Option Agreement is effective upon the date of the Option Agreement, will run until January 31, 2045, and will automatically renew thereafter for successive five-year periods unless either party provides a notice of termination prior to the Option Agreements expiration. If Knight does not exercise the option then the Company is free to contract for distribution with other parties, but only on terms no less favorable than those offered by Knight pursuant to the Option Agreement.   Asset Purchase Agreement with Knight Therapeutics Inc.   On June 26, 2015 (the Closing Date), Neuragen Corp., a Delaware corporation (Neuragen) and our wholly owned subsidiary, entered into an Asset Purchase Agreement (the Purchase Agreement) with Knight Therapeutics Inc., a Canadian corporation (Knight). Pursuant to the Purchase Agreement, Neuragen purchased the U.S. rights related to an innovative OTC product that helps relieve pain caused by diabetic nerve damage (the Purchased Assets) for an aggregate purchase price of $1.2 million, with (i) $250,000 paid on the Closing Date, (ii) $250,000 to be paid on or before June 30, 2016, (iii) $700,000 to be paid in quarterly installments (beginning with the quarter ending September 30, 2015) equal to the greater of $12,500 or 5% of U.S. net sales, and (iv) 2% of U.S. net sales of Neuragen for 60 months thereafter. The payment of such amounts is secured by a security interest in certain assets, undertakings and property (Collateral) pursuant to the Security Agreement, which will be released upon receipt of total payments of $1.2 million (collectively, Total Consideration).   Security Agreement   On the Closing Date, Neuragen entered into a Security Agreement with Knight, pursuant to which Neuragen granted a lien and security interest to Knight in Collateral in connection with the Purchase Agreement.   The Security Agreement was made to secure the payment of all indebtedness, obligations and liabilities of Neuragen of the Purchase Agreement, including all expenses and charges, legal or otherwise, suffered or incurred by Knight in collecting or enforcing such indebtedness of the Purchase Agreement.   The Security Agreement includes customary events of default, including but not limited to: payment defaults; Neuragen becoming insolvent or entering into bankruptcy; or if any contemplated security ceases to be a valid and perfected first-priority security interest that is not remedied within fifteen business days by Neuragen. Upon the occurrence of an event of default and during the continuation thereof, the principal amount of the outstanding Total Consideration will bear a default interest rate of an additional 10% per annum.   Contribution Agreement   On August 18, 2015 (the Closing Date), we entered into a Contribution Agreement with Hand MD Corp., a Delaware corporation, whereby we contributed to Hand MD Corp. 2,142,857 shares of our common stock in exchange for 50% of Hand MD Corp.s outstanding capital securities valued at $0.70 per share. Simultaneously, Hand MD, LLC, a California limited liability company, entered into a Contribution Agreement with Hand MD Corp., the principal owners of Hand MD, LLC, and us whereby Hand MD LLC contributed to Hand MD Corp. all of its right, title and interest in its intellectual property associated with skincare, nail care and nail polish products (the Hand MD Business) in exchange for the other 50% of Hand MD Corp.s outstanding capital securities. In the Contribution Agreement among Hand MD Corp., Hand MD, LLC, the principal owners of Hand MD, LLC and us, Hand MD, LLC and its principal owners agreed to not compete or solicit customers or employees for five years. As part of the transaction, we also purchased from Hand MD Corp. all inventory related to the Hand MD Business for approximately $97,000.   We also entered into a license agreement with Hand MD Corp. on August 18, 2015, whereby we acquired the exclusive worldwide license to commercialize Hand MD Corp. skincare products and all improvements thereto. The license runs in perpetuity unless earlier terminated. We will pay Hand MD Corp. a royalty of 5% of the net sales price of product sold, transferred or otherwise disposed of by us, as well as 5% of any amount we receive from sublicensees, subject to a minimum royalty of $250,000 in the second year of the license and $500,000 in the third year of the license, after which the minimum royalty terminates. We are solely responsible for any regulatory and intellectual property filings, including those necessary to maintain regulatory approvals for the licensed products. Either we or Hand MD Corp. can terminate the agreement in the event of bankruptcy or insolvency of the other party, or the uncured material breach of the agreement by the other party. Upon termination we would be entitled to sell any inventory of licensed product in the normal course of business and consistent with sales of licensed product during the term of the agreement.   The Contribution Agreements and the License Agreement contain customary representations and warranties and covenants by the respective parties.   We also entered into a Consulting Agreement on August 18, 2015, with Kara Harshbarger, the co-founder of Hand MD, LLC, pursuant to which she will provide marketing and sales related services. We will pay Ms. Harshbarger $10,000 a month for one year unless the Consulting Agreement is terminated earlier by either party. If we terminate the Consulting Agreement without cause, we will be obligated to pay the remaining term of the Agreement. Ms. Harshbarger agreed not to compete with us in the United States in any marketing or sales of skincare, nail polish and nail care products during the term of the Consulting Agreement and for 12 months after its termination. Ms. Harshbarger also agreed not to solicit customers or employees for the same period.

Note 10 Commitments & Contingencies   From time to time the Company may become a party to litigation in the normal course of business. Management believes that there are no current legal matters that would have a material effect on the Companys financial position or results of operations.

26064

499448

Note 9 Stockholders Deficit   The total number of shares of all classes of capital stock which the Company is authorized to issue is 75,000,000 shares of common stock with $0.00001 par value. On July 30, 2014, the Companys board of directors approved an increase of the Companys authorized common stock from 75,000,000 to 300,000,000 shares, which increase was approved by the Companys shareholders and became effective on August 5, 2015.   During the nine months ended September 30, 2015, the Company issued 4,595,187 shares of its common stock upon exercise of the ST Warrant at an aggregate exercise price of $1.00 in connection with the Loan Agreement (see note1).   During the nine months ended September 30, 2015, the Company issued 400,000 shares of its common stock to a note holder in a note conversion at $0.25 per share. At the time of conversion, the note was valued at $100,000 for outstanding principal.   During the nine months ended September 30, 2015, the Company issued 2,142,857 shares of its common stock valued at $0.70 per share in accordance with Contribution Agreement entered into with Hand MD Corp. in exchange for 50% of Hand MD Corp.s outstanding capital securities.   As of September 30, 2015, there were 69,238,044 shares of the Companys common stock issued and outstanding.

Note 2 Summary of Significant Accounting Policies   General   The accompanying condensed consolidated financial statements as of September 30, 2015 and December 31, 2014 and for the three and nine months ended September 30, 2015 and 2014 are unaudited. These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (GAAP) for interim financial information and are presented in accordance with the requirements of Rule S-X of the Securities and Exchange Commission (the SEC) and with the instructions to Form 10-Q. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2015 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2015. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements as of and for the year ended December 31, 2014 and footnotes thereto included in the Companys Annual Report on Form 10-K filed with the SEC.   Basis of Presentation   The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.   Use of Estimates   The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.   Cash and Cash Equivalents   The Company considers all cash on hand and in banks, including accounts in book overdraft positions, certificates of deposit and other highly-liquid investments with maturities of three months or less, when purchased, to be cash and cash equivalents. As of September 30, 2015 the Company had no cash equivalents.   Capitalization of Fixed Assets   The Company capitalizes expenditures related to property and equipment, subject to a minimum rule, that have a useful life greater than one year for: (1) assets purchased; (2) existing assets that are replaced, improved or the useful lives have been extended; or (3) all land, regardless of cost. Acquisitions of new assets, additions, replacements and improvements (other than land) costing less than the minimum rule in addition to maintenance and repair costs, including any planned major maintenance activities, are expensed as incurred.   Intangible Assets   We evaluate the recoverability of intangible assets periodically and take into account events or circumstances that warrant revised estimates of useful lives or that indicate that impairment exists. Intangible assets that are subject to amortization are amortized on a straight-line basis over their useful lives.   Long-lived Assets   Long-lived assets include equipment and intangible assets other than those with indefinite lives. We assess the carrying value of our long-lived asset groups when indicators of impairment exist and recognize and impairment loss when the carrying amount of a long-lived asset is not recoverable when compared to undiscounted cash flows expected to result from the use and eventual disposition of the asset.   Indicators of impairment include significant underperformance relative to historical or projected future operating results, significant changes in our use of the assets or in our business strategy, loss of or changes in customer relationships and significant negative industry or economic trends. When indications of impairment arise for a particular asset or group of assets, we assess the future recoverability of the carrying value of the asset (or asset group) based on an undiscounted cash flow analysis. If carrying value exceeds projected, net, undiscounted cash flows, an additional analysis is performed to determine the fair value of the asset (or asset group), typically a discounted cash flow analysis, and an impairment charge is recorded for the excess of carrying value over fair value.   Goodwill   An asset purchase is accounted for under the purchase method of accounting. Under that method, assets and liabilities of the business acquired are recorded at their estimated fair values as of the date of the acquisition, with any excess of the cost of the acquisition over the estimated fair value of the net tangible and intangible assets acquired recorded as goodwill.   Revenue Recognition   Revenue is recognized in accordance with Staff Accounting Bulletin (SAB) No. 101, Revenue Recognition in Financial Statements, as revised by SAB No. 104. We recognize revenue when persuasive evidence of an arrangement exists, delivery has occurred, the sales price is fixed or determinable and collectability is reasonably assured. Ownership of and title to our products pass to customers upon delivery of the products to customers. Certain of our distributors may also perform a separate function as a co-packer on our behalf. In such cases, ownership of and title to our products that are co-packed on our behalf by those co-packers who are also distributors, passes to such distributors when we are notified by them that they have taken transfer or possession of the relevant portion of our finished goods.   Revenue is presented net of estimated returns and allowances, discounts, sales incentives and promotions including, price reductions, coupons, rebate offers and placement/slotting fees.   Accounts receivable   Accounts receivable are generally unsecured. The Company establishes an allowance for doubtful accounts receivable based on the age of outstanding invoices and managements evaluation of collectability. Accounts are written off after all reasonable collection efforts have been exhausted and management concludes that likelihood of collection is remote. Any future recoveries are applied against the allowance for doubtful accounts.   Advertising Expense   The Company expenses marketing, promotions and advertising costs as incurred. Such costs are included in general and administrative expense in the accompanying condensed consolidated statements of operations.   Research and Development   Costs incurred in connection with the development of new products and processing methods are charged to general and administrative expenses as incurred.   Income Taxes   The Company utilizes Financial Accounting Standards Boards (FASB) Accounting Standards Codification (ASC) 740-10-25, Income Taxes, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the tax basis of assets and liabilities and their financial reporting amounts based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. A valuation allowance is recorded when it is more likely-than-not that a deferred tax asset will not be realized.   The Company generated a deferred tax asset through net operating loss carry-forward. However, a valuation allowance of 100% has been established due to the uncertainty of the Companys realization of the net operating loss carry forward prior to its expiration.   Net Earnings (Loss) Per Common Share   The Company computes earnings per share under ASC subtopic 260-10, Earnings Per Share. Basic earnings (loss) per share is computed by dividing the net income (loss) attributable to the common stockholders (the numerator) by the weighted average number of shares of common stock outstanding (the denominator) during the reporting periods. Diluted loss per share is computed by increasing the denominator by the weighted average number of additional shares that could have been outstanding from securities convertible into common stock (using the treasury stock method), unless their effect on net loss per share is anti-dilutive. As of September 30, 2015, an option to purchase 1,000,000 shares of common stock and warrants to purchase 3,584,759 shares of common stock were outstanding.   Going Concern   The Companys unaudited condensed consolidated financial statements are prepared using U.S. GAAP applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company had an accumulated deficit at September 30, 2015 of $4,105,439. The Company had working capital of $246,252 as of September 30, 2015. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it establishes a revenue stream and becomes profitable. If the Company is unable to obtain adequate capital it could be forced to cease operations.   In order to continue as a going concern and to develop a reliable source of revenues, and achieve a profitable level of operations the Company will need, among other things, additional capital resources. Managements plans to continue as a going concern include raising additional capital through borrowing and sales of common stock. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans.   The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.   Fair Value Measurements   The Company measures and discloses the fair value of assets and liabilities required to be carried at fair value in accordance with ASC 820, Fair Value Measurements and Disclosures. ASC 820 defines fair value, establishes a framework for measuring fair value, and enhances fair value measurement disclosure.   ASC 825 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825 establishes three levels of inputs that may be used to measure fair value:   Level 1 - Quoted prices for identical assets or liabilities in active markets to which we have access at the measurement date.   Level 2 - Inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly.   Level 3 - Unobservable inputs for the asset or liability.   The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement.   As of September 30, 2015, the Company has determined that there were no assets or liabilities measured at fair value.   Inventory   Inventory consists of raw materials, components and finished goods. The Companys inventory is stated at the lower of cost (FIFO cost basis) or market.   Stock-Based Compensation   The Company has adopted the provisions of ASC 718. We estimate the fair value of stock options using a binomial model, consistent with the provisions of ASC 718 and SEC Staff Accounting Bulletin No. 107, Share-Based Payment. Option-pricing models require the input of highly subjective assumptions, including the price volatility of the underlying stock. We determined that the use of implied volatility is expected to be more reflective of market conditions and, therefore, could reasonably be expected to be a better indicator of our expected volatility than historical volatility. The expected term assumption used in calculating the estimated fair value of our stock-based compensation awards using the binomial model is based on detailed historical data about employees exercise behavior, vesting schedules, and death and disability probabilities. In addition, we are required to estimate the expected forfeiture rate and only recognize expense for those shares expected to vest. We estimate the forfeiture rate based on historical experience of our stock-based awards that are granted, exercised and cancelled. We believe the resulting binomial calculation provides a more refined estimate of the fair value of our employee stock options.   Recent Accounting Pronouncements   ASU 2015-03   In April 2015, the FASB issued Accounting Standards Update (ASU) No. 2015-03, Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. The amendments in this ASU require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this ASU. The amendments are effective for financial statements issued for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. The amendments are to be applied on a retrospective basis, wherein the balance sheet of each individual period presented is adjusted to reflect the period-specific effects of applying the new guidance. The Company is evaluating the possible effect of this guidance on its financial statements.   ASU 2015-02   In February 2015, the FASB issued ASU No. 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis, which is intended to improve targeted areas of consolidation guidance for legal entities such as limited partnerships, limited liability corporations, and securitization structures (collateralized debt obligations, collateralized loan obligations, and mortgage-backed security transactions). The ASU focuses on the consolidation evaluation for reporting organizations that are required to evaluate whether they should consolidate certain legal entities. In addition to reducing the number of consolidation models from four to two, the new standard simplifies the FASB Accounting Standards Codification and improves current U.S. GAAP by placing more emphasis on risk of loss when determining a controlling financial interest, reducing the frequency of the application of related-party guidance when determining a controlling financial interest in a variable interest entity (VIE), and changing consolidation conclusions for companies in several industries that typically make use of limited partnerships or VIEs. The ASU will be effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. We do not expect the adoption of ASU 2015-02 to have a material effect on our financial position, results of operations or cash flows.   ASU 2015-01   In January 2015, the FASB issued ASU No. 2015-01, Income Statement - Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items. This ASU eliminates from U.S. GAAP the concept of extraordinary items. ASU 2015-01 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. A reporting entity may apply the amendments prospectively. We do not expect the adoption of ASU 2015-01 to have a material effect on our financial position, results of operations or cash flows.   ASU 2014-17   In November 2014, the FASB issued ASU No. 2014-17, Business Combinations (Topic 805): Pushdown Accounting. This ASU provides an acquired entity with an option to apply pushdown accounting in its separate financial statements upon occurrence of an event in which an acquirer obtains control of the acquired entity. An acquired entity may elect the option to apply pushdown accounting in the reporting period in which the change-in-control event occurs. If pushdown accounting is applied to an individual change-in-control event, that election is irrevocable. ASU 2014-17 was effective on November 18, 2014. The adoption of ASU 2014-17 did not have any effect on our financial position, results of operations or cash flows.   ASU 2014-16   In November 2014, the FASB issued ASU 2014-16, Derivatives and Hedging (Topic 815). ASU 2014-16 addresses whether the host contract in a hybrid financial instrument issued in the form of a share should be accounted for as debt or equity. ASU 2014-16 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. We do not currently have issued, nor are we investors in, hybrid financial instruments. Accordingly, we do not expect the adoption of ASU 2014-16 to have any effect on our financial position, results of operations or cash flows.   ASU 2014-15   In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40). ASU 2014-15 provides guidance related to managements responsibility to evaluate whether there is substantial doubt about an entitys ability to continue as a going concern and to provide related footnote disclosure. ASU 2014-15 is effective for annual periods ending after December 15, 2016, and for interim and annual periods thereafter. Early application is permitted. We do not expect the adoption of ASU 2014-15 to have a material effect on our financial position, results of operations or cash flows.   ASU 2014-12   In June 2014, the FASB issued ASU No. 2014-12, Compensation Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. This ASU requires that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. ASU 2014-12 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. We do not expect the adoption of ASU 2014-12 to have a material effect on our financial position, results of operations or cash flows.   ASU 2014-09   In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606). ASU 2014-09 affects any entity using U.S. GAAP that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards (e.g., insurance contracts or lease contracts). ASU 2014-09 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. We are still evaluating the effect of the adoption of ASU 2014-09. On April 1, 2015, the FASB voted to propose to defer the effective date of the new revenue recognition standard by one year.   ASU 2014-08   In April 2014, the FASB issued ASU No. 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360) and Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity. ASU 2014-08 amends the definition for what types of asset disposals are to be considered discontinued operations, as well as amending the required disclosures for discontinued operations and assets held for sale. ASU 2014-08 is effective for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2014. The adoption of ASU 2014-08 did not have any effect on our financial position, results of operations or cash flows.   There were various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Companys condensed financial position, results of operations or cash flows.   Change in Fiscal Year End   On April 21, 2014, the Companys board of directors approved a change to the Companys fiscal year end from July 31 to December 31 of each year.

Note 11 Stock Options   On July 30, 2014, the Companys board of directors approved the Companys 2014 Equity Incentive Plan and the reservation of 15,525,000 shares of common stock for issuance under such plan. Such plan was approved by the Companys shareholders and became effective on August 5, 2015.   On April 2, 2014, the Company granted 1,000,000 options with an exercise price of $0.25 per share.   The following table summarizes the changes in options outstanding and the related prices for the shares of the Companys common stock issued to employees and consultants under a stock option plan at September 30, 2015:   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="3" style="text-align: center; line-height: 115%"> </td> <td colspan="12" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Options Outstanding</td> <td style="line-height: 115%"> </td> <td colspan="7" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Options Exercisable</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="width: 20%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Exercise Prices ($)</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="width: 15%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Number Outstanding</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="width: 15%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Weighted Average Remaining Contractual Life (Years)</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="width: 11%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Weighted Average Exercise Price ($)</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="width: 11%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Number Exercisable</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="width: 11%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Weighted Average Exercise Price</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.25</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,000,000</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">3.50</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.25</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,000,000</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.25</td> <td style="line-height: 115%"> </td></tr> </table>   The stock option activity for the nine months ended September 30, 2015 is as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Options Outstanding </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Weighted Average Exercise Price</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; line-height: 115%">Outstanding at December 31, 2014</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 16%; text-align: right; line-height: 115%">1,000,000</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; text-align: right; line-height: 115%">0.25</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Granted</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"></td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"></td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Exercised</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"></td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"></td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Expired or canceled</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"></td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"></td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Outstanding at September 30, 2015</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">1,000,000</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">0.25</td> <td style="line-height: 115%"> </td></tr> </table>

The stock option activity for the nine months ended September 30, 2015 is as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Options Outstanding </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Weighted Average Exercise Price</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; line-height: 115%">Outstanding at December 31, 2014</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 16%; text-align: right; line-height: 115%">1,000,000</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; text-align: right; line-height: 115%">0.25</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Granted</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"></td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"></td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Exercised</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"></td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"></td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Expired or canceled</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"></td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"></td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Outstanding at September 30, 2015</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">1,000,000</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">0.25</td> <td style="line-height: 115%"> </td></tr> </table>

62100000

69238044

2015-09-30 false --12-31 Smaller Reporting Company 69238044 2015 Q3

867004

5882448

400000

2142857

0.25

0.34

1.00

0.70

1500000

950000

10-Q

100000

181042

2703296

6000000

100000

246252

266655

16077

175422

The following table summarizes the changes in options outstanding and the related prices for the shares of the Companys common stock issued to employees and consultants under a stock option plan at September 30, 2015:   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="3" style="text-align: center; line-height: 115%"> </td> <td colspan="12" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Options Outstanding</td> <td style="line-height: 115%"> </td> <td colspan="7" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Options Exercisable</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="width: 20%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Exercise Prices ($)</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="width: 15%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Number Outstanding</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="width: 15%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Weighted Average Remaining Contractual Life (Years)</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="width: 11%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Weighted Average Exercise Price ($)</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="width: 11%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Number Exercisable</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="width: 11%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Weighted Average Exercise Price</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.25</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,000,000</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">3.50</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.25</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,000,000</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.25</td> <td style="line-height: 115%"> </td></tr> </table>

Synergy CHC Corp.

60000

100000

Note 6 Related Party Transactions   On April 2, 2014, the Company granted an option to purchase 1,000,000 shares of the Companys common stock, valued at approximately $282,000 to the Company owned by Mr. Jack Ross, Chief Executive Officer of the Company.   On October 31, 2014, the Company borrowed $100,000 through a promissory note bearing interest at 10% with a maturity date of October 31, 2015 from a company owned by Mr. Ross, the Companys chief executive officer. During the nine months ended September 30, 2015, the note was converted into 400,000 shares of the Companys common stock.   The Company accrued and paid consulting fees of $15,000 per month to a company owned by Mr. Jack Ross, Chief Executive Officer of the Company. As of September 30, 2015, the total outstanding balance was $0.   At September 30, 2015, $175,422 was due from a company owned by Mr. Jack Ross, Chief Executive Officer of the Company in a form of a note receivable.   On January 22, 2015, the Company entered into a Loan Agreement with Knight Therapeutics (Barbados) Inc. (Knight), a related party, for the purchase of the Focus Factor assets. At September 30, 2015, the Company owed Knight $5,047,178 on this loan, net of discount (see Note 8).   On June 26, 2015, the Company entered into a Loan Agreement with Knight Therapeutics, through its wholly owned subsidiary, for the purchase of the Neuragen assets. At September 30, 2015, the Company owed Knight $937,500 on this loan (see Note 8).

Note 7 Accounts Payable and Accrued Liabilities   As of September 30, 2015 and December 31, 2014, accounts payable and accrued liabilities consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30, 2015</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31, 2014</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 54%; line-height: 115%">Accrued payroll</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 20%; text-align: right; line-height: 115%">-</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 20%; text-align: right; line-height: 115%">10,867</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Accrued legal fees</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">56,683</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">47,916</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Manufacturers</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,391,472</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Promotions</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">15,000</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Other</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">190,141</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">15,859</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Total</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">1,653,296</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">74,642</td> <td style="line-height: 115%"> </td></tr> </table>

Basis of Presentation   The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.

Use of Estimates   The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents   The Company considers all cash on hand and in banks, including accounts in book overdraft positions, certificates of deposit and other highly-liquid investments with maturities of three months or less, when purchased, to be cash and cash equivalents. As of September 30, 2015 the Company had no cash equivalents.

Capitalization of Fixed Assets   The Company capitalizes expenditures related to property and equipment, subject to a minimum rule, that have a useful life greater than one year for: (1) assets purchased; (2) existing assets that are replaced, improved or the useful lives have been extended; or (3) all land, regardless of cost. Acquisitions of new assets, additions, replacements and improvements (other than land) costing less than the minimum rule in addition to maintenance and repair costs, including any planned major maintenance activities, are expensed as incurred.

Revenue Recognition   Revenue is recognized in accordance with Staff Accounting Bulletin (SAB) No. 101, Revenue Recognition in Financial Statements, as revised by SAB No. 104. We recognize revenue when persuasive evidence of an arrangement exists, delivery has occurred, the sales price is fixed or determinable and collectability is reasonably assured. Ownership of and title to our products pass to customers upon delivery of the products to customers. Certain of our distributors may also perform a separate function as a co-packer on our behalf. In such cases, ownership of and title to our products that are co-packed on our behalf by those co-packers who are also distributors, passes to such distributors when we are notified by them that they have taken transfer or possession of the relevant portion of our finished goods.   Revenue is presented net of estimated returns and allowances, discounts, sales incentives and promotions including, price reductions, coupons, rebate offers and placement/slotting fees.

Accounts receivable   Accounts receivable are generally unsecured. The Company establishes an allowance for doubtful accounts receivable based on the age of outstanding invoices and managements evaluation of collectability. Accounts are written off after all reasonable collection efforts have been exhausted and management concludes that likelihood of collection is remote. Any future recoveries are applied against the allowance for doubtful accounts.

Income Taxes   The Company utilizes Financial Accounting Standards Boards (FASB) Accounting Standards Codification (ASC) 740-10-25, Income Taxes, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the tax basis of assets and liabilities and their financial reporting amounts based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. A valuation allowance is recorded when it is more likely-than-not that a deferred tax asset will not be realized.   The Company generated a deferred tax asset through net operating loss carry-forward. However, a valuation allowance of 100% has been established due to the uncertainty of the Companys realization of the net operating loss carry forward prior to its expiration.

Net Earnings (Loss) Per Common Share   The Company computes earnings per share under ASC subtopic 260-10, Earnings Per Share. Basic earnings (loss) per share is computed by dividing the net income (loss) attributable to the common stockholders (the numerator) by the weighted average number of shares of common stock outstanding (the denominator) during the reporting periods. Diluted loss per share is computed by increasing the denominator by the weighted average number of additional shares that could have been outstanding from securities convertible into common stock (using the treasury stock method), unless their effect on net loss per share is anti-dilutive. As of September 30, 2015, an option to purchase 1,000,000 shares of common stock and warrants to purchase 3,584,759 shares of common stock were outstanding.

Fair Value Measurements   The Company measures and discloses the fair value of assets and liabilities required to be carried at fair value in accordance with ASC 820, Fair Value Measurements and Disclosures. ASC 820 defines fair value, establishes a framework for measuring fair value, and enhances fair value measurement disclosure.   ASC 825 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825 establishes three levels of inputs that may be used to measure fair value:   Level 1 - Quoted prices for identical assets or liabilities in active markets to which we have access at the measurement date.   Level 2 - Inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly.   Level 3 - Unobservable inputs for the asset or liability.   The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement.   As of September 30, 2015, the Company has determined that there were no assets or liabilities measured at fair value.

Inventory   Inventory consists of raw materials, components and finished goods. The Companys inventory is stated at the lower of cost (FIFO cost basis) or market.

Stock-Based Compensation   The Company has adopted the provisions of ASC 718. We estimate the fair value of stock options using a binomial model, consistent with the provisions of ASC 718 and SEC Staff Accounting Bulletin No. 107, Share-Based Payment. Option-pricing models require the input of highly subjective assumptions, including the price volatility of the underlying stock. We determined that the use of implied volatility is expected to be more reflective of market conditions and, therefore, could reasonably be expected to be a better indicator of our expected volatility than historical volatility. The expected term assumption used in calculating the estimated fair value of our stock-based compensation awards using the binomial model is based on detailed historical data about employees exercise behavior, vesting schedules, and death and disability probabilities. In addition, we are required to estimate the expected forfeiture rate and only recognize expense for those shares expected to vest. We estimate the forfeiture rate based on historical experience of our stock-based awards that are granted, exercised and cancelled. We believe the resulting binomial calculation provides a more refined estimate of the fair value of our employee stock options.

Recent Accounting Pronouncements   ASU 2015-03   In April 2015, the FASB issued Accounting Standards Update (ASU) No. 2015-03, Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. The amendments in this ASU require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this ASU. The amendments are effective for financial statements issued for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. The amendments are to be applied on a retrospective basis, wherein the balance sheet of each individual period presented is adjusted to reflect the period-specific effects of applying the new guidance. The Company is evaluating the possible effect of this guidance on its financial statements.   ASU 2015-02   In February 2015, the FASB issued ASU No. 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis, which is intended to improve targeted areas of consolidation guidance for legal entities such as limited partnerships, limited liability corporations, and securitization structures (collateralized debt obligations, collateralized loan obligations, and mortgage-backed security transactions). The ASU focuses on the consolidation evaluation for reporting organizations that are required to evaluate whether they should consolidate certain legal entities. In addition to reducing the number of consolidation models from four to two, the new standard simplifies the FASB Accounting Standards Codification and improves current U.S. GAAP by placing more emphasis on risk of loss when determining a controlling financial interest, reducing the frequency of the application of related-party guidance when determining a controlling financial interest in a variable interest entity (VIE), and changing consolidation conclusions for companies in several industries that typically make use of limited partnerships or VIEs. The ASU will be effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. We do not expect the adoption of ASU 2015-02 to have a material effect on our financial position, results of operations or cash flows.   ASU 2015-01   In January 2015, the FASB issued ASU No. 2015-01, Income Statement - Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items. This ASU eliminates from U.S. GAAP the concept of extraordinary items. ASU 2015-01 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. A reporting entity may apply the amendments prospectively. We do not expect the adoption of ASU 2015-01 to have a material effect on our financial position, results of operations or cash flows.   ASU 2014-17   In November 2014, the FASB issued ASU No. 2014-17, Business Combinations (Topic 805): Pushdown Accounting. This ASU provides an acquired entity with an option to apply pushdown accounting in its separate financial statements upon occurrence of an event in which an acquirer obtains control of the acquired entity. An acquired entity may elect the option to apply pushdown accounting in the reporting period in which the change-in-control event occurs. If pushdown accounting is applied to an individual change-in-control event, that election is irrevocable. ASU 2014-17 was effective on November 18, 2014. The adoption of ASU 2014-17 did not have any effect on our financial position, results of operations or cash flows.   ASU 2014-16   In November 2014, the FASB issued ASU 2014-16, Derivatives and Hedging (Topic 815). ASU 2014-16 addresses whether the host contract in a hybrid financial instrument issued in the form of a share should be accounted for as debt or equity. ASU 2014-16 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. We do not currently have issued, nor are we investors in, hybrid financial instruments. Accordingly, we do not expect the adoption of ASU 2014-16 to have any effect on our financial position, results of operations or cash flows.   ASU 2014-15   In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40). ASU 2014-15 provides guidance related to managements responsibility to evaluate whether there is substantial doubt about an entitys ability to continue as a going concern and to provide related footnote disclosure. ASU 2014-15 is effective for annual periods ending after December 15, 2016, and for interim and annual periods thereafter. Early application is permitted. We do not expect the adoption of ASU 2014-15 to have a material effect on our financial position, results of operations or cash flows.   ASU 2014-12   In June 2014, the FASB issued ASU No. 2014-12, Compensation Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. This ASU requires that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. ASU 2014-12 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. We do not expect the adoption of ASU 2014-12 to have a material effect on our financial position, results of operations or cash flows.   ASU 2014-09   In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606). ASU 2014-09 affects any entity using U.S. GAAP that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards (e.g., insurance contracts or lease contracts). ASU 2014-09 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. We are still evaluating the effect of the adoption of ASU 2014-09. On April 1, 2015, the FASB voted to propose to defer the effective date of the new revenue recognition standard by one year.   ASU 2014-08   In April 2014, the FASB issued ASU No. 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360) and Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity. ASU 2014-08 amends the definition for what types of asset disposals are to be considered discontinued operations, as well as amending the required disclosures for discontinued operations and assets held for sale. ASU 2014-08 is effective for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2014. The adoption of ASU 2014-08 did not have any effect on our financial position, results of operations or cash flows.   There were various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Companys condensed financial position, results of operations or cash flows.

Change in Fiscal Year End   On April 21, 2014, the Companys board of directors approved a change to the Companys fiscal year end from July 31 to December 31 of each year.

The carrying value of inventory consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30, 2015</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31, 2014</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 54%; line-height: 115%">Energy product</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 20%; text-align: right; line-height: 115%">24,451</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 20%; text-align: right; line-height: 115%">26,064</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Components</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">172,936</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Finished goods</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">266,655</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Raw Materials</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">35,406</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Total inventory</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">499,448</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">26,064</td> <td style="line-height: 115%"> </td></tr> </table>

P5Y

P1Y

1.00

3614

2935383

2759201

198429

750000

5047178

5797178

181042

8500474

120000

40000 13000000 7015763 2000000 -3067567

300000

100000

3584759 0.25

250000

6000000

97000

4500000 750000 750000 1200000 250000 700000 250000

Intangible Assets   We evaluate the recoverability of intangible assets periodically and take into account events or circumstances that warrant revised estimates of useful lives or that indicate that impairment exists. Intangible assets that are subject to amortization are amortized on a straight-line basis over their useful lives.

Long-lived Assets   Long-lived assets include equipment and intangible assets other than those with indefinite lives. We assess the carrying value of our long-lived asset groups when indicators of impairment exist and recognize and impairment loss when the carrying amount of a long-lived asset is not recoverable when compared to undiscounted cash flows expected to result from the use and eventual disposition of the asset.  	 Indicators of impairment include significant underperformance relative to historical or projected future operating results, significant changes in our use of the assets or in our business strategy, loss of or changes in customer relationships and significant negative industry or economic trends. When indications of impairment arise for a particular asset or group of assets, we assess the future recoverability of the carrying value of the asset (or asset group) based on an undiscounted cash flow analysis. If carrying value exceeds projected, net, undiscounted cash flows, an additional analysis is performed to determine the fair value of the asset (or asset group), typically a discounted cash flow analysis, and an impairment charge is recorded for the excess of carrying value over fair value.

Goodwill   An asset purchase is accounted for under the purchase method of accounting. Under that method, assets and liabilities of the business acquired are recorded at their estimated fair values as of the date of the acquisition, with any excess of the cost of the acquisition over the estimated fair value of the net tangible and intangible assets acquired recorded as goodwill.

Advertising Expense   The Company expenses marketing, promotions and advertising costs as incurred. Such costs are included in general and administrative expense in the accompanying condensed consolidated statements of operations.

Research and Development   Costs incurred in connection with the development of new products and processing methods are charged to general and administrative expenses as incurred.

Note 3 Asset Purchases   Asset Purchase Agreement with Factor Nutrition Labs, LLC:   On January 22, 2015 (the Closing Date), the Company entered into an Asset Purchase Agreement (the Purchase Agreement) with Factor Nutrition Labs, LLC, a Delaware limited liability company (the Seller), Vita Partners, LLC, RPR Partners, LLC, and Thor Associates, Inc. (each a Principal Owner). Pursuant to the Purchase Agreement, the Company purchased all of the assets of the Sellers line of business and products called FOCUS Factor (the product plus the business related to the product is collectively referred to as the Focus Factor Business) and assumed the accounts payable and contractual obligations of the Focus Factor Business for an aggregate purchase price of $6.0 million, with $4.5 million paid on the Closing Date, and $750,000 to be paid on or before January 20, 2016 and an additional $750,000 to be paid on or before January 20, 2017.   The Company has accounted for this transaction under the acquisition method of accounting. Under the acquisition method of accounting, the total acquisition consideration price is allocated to the assets acquired and liabilities assumed based on their preliminary estimated fair values. The Company expects the purchase price allocations for the acquisition of Focus Factor Business to be completed by December 31, 2015. The preliminary allocation of the purchase price to the assets acquired and liabilities assumed based on the estimated fair values is as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-decoration: underline; line-height: 115%">Assets</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 79%; padding-left: 10pt; line-height: 115%">Accounts Receivable</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 18%; text-align: right; line-height: 115%">2,926,369</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Inventory</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">67,113</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Intellectual Property</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,000,000</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Non-compete provision</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">50,000</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Non-solicitation provision</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">50,000</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Intangible assets-Customer relationships</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,941,030</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Goodwill</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,798,047</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-decoration: underline; line-height: 115%">Liabilities</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Accounts Payable</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(891,113</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Accrued Expenses</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(941,446</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">6,000,000</td> <td style="line-height: 115%"> </td></tr> </table>   The Customer relationships, the non-compete and the non-solicitation provisions will be amortized over their estimated useful lives of 5 years.   Pro forma Results of Operations. The historical operating results of the Focus Factor Business prior to its acquisition date have not been included in the Companys historical consolidated operating results. Pro forma results of operations data (unaudited) for the years ended December 31, 2014 and 2013, as if the acquisition had occurred on January 1, 2013, are as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31,</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2014</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2013</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; line-height: 115%">Revenue</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; text-align: right; line-height: 115%">12,695,295</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; text-align: right; line-height: 115%">10,629,171</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Net income (loss)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(183,471</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">932,209</td> <td style="line-height: 115%"> </td></tr> </table>   Pro forma revenue amount above does not include adjustment/reductions relating to certain discounts, coupons and placement fees and is presented gross.   The amounts of revenue and earnings of the FOCUS Factor Business since the acquisition date included in the unaudited condensed consolidated statement of operations for the nine months ended September 30, 2015 are approximately $7,015,763 and $(3,067,567), respectively.   Asset Purchase Agreement with Knight Therapeutics Inc.:   On June 26, 2015 (the Closing Date), Neuragen Corp., a Delaware corporation (Neuragen) and our wholly owned subsidiary, entered into an Asset Purchase Agreement (the Purchase Agreement) with Knight Therapeutics Inc., a Canadian corporation (Knight). Pursuant to the Purchase Agreement, Neuragen purchased the U.S. rights related to an innovative OTC product that helps relieve pain caused by diabetic nerve damage (the Purchased Assets) for an aggregate purchase price of $1.2 million, with (i) $250,000 paid on the Closing Date, (ii) $250,000 to be paid on or before June 30, 2016, (iii) $700,000 to be paid in quarterly installments (beginning with the quarter ending September 30, 2015) equal to the greater of $12,500 or 5% of U.S. net sales, and (iv) 2% of U.S. net sales of Neuragen for 60 months thereafter. The payment of such amounts is secured by a security interest in certain assets, undertakings and property (Collateral) pursuant to the Security Agreement, which will be released upon receipt of total payments of $1.2 million (collectively, Total Consideration).   The Company has accounted for this transaction under the acquisition method of accounting. Under the acquisition method of accounting, the total acquisition consideration price is allocated to the assets acquired and liabilities assumed based on their preliminary estimated fair values. The Company expects the purchase price allocations for the acquisition of the Purchased Assets to be completed by December 31, 2015. The preliminary allocation of the purchase price to the assets acquired and liabilities assumed based on the estimated fair values is as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-decoration: underline; line-height: 115%">Assets</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 79%; padding-left: 10pt; line-height: 115%">Accounts Receivable</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 18%; text-align: right; line-height: 115%">58,054</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Inventory</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">204,925</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Goodwill</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,137,336</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-decoration: underline; line-height: 115%">Liabilities</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Accounts Payable</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(51,795</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Accrued Expenses</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(148,520</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">1,200,000</td> <td style="line-height: 115%"> </td></tr> </table>

Pro forma results of operations data (unaudited) for the years ended December 31, 2014 and 2013, as if the acquisition had occurred on January 1, 2013, are as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31,</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2014</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2013</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; line-height: 115%">Revenue</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; text-align: right; line-height: 115%">12,695,295</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; text-align: right; line-height: 115%">10,629,171</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Net income (loss)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(183,471</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">932,209</td> <td style="line-height: 115%"> </td></tr> </table>

12695295

10629171

-183471

932209

Note 4 Inventory   Inventory consists of raw materials, components and finished goods. The Companys inventory is stated at the lower of cost (FIFO cost basis) or market.   The carrying value of inventory consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30, 2015</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31, 2014</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 54%; line-height: 115%">Energy product</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 20%; text-align: right; line-height: 115%">24,451</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 20%; text-align: right; line-height: 115%">26,064</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Components</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">172,936</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Finished goods</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">266,655</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Raw Materials</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">35,406</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Total inventory</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">499,448</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">26,064</td> <td style="line-height: 115%"> </td></tr> </table>   As of January 22, 2015, inventory was pledged to Knight Therapeutics under the Loan Agreement (see note 1).

26064 24451 172936 Note 5 Fixed Assets and Intangible Assets   As of September 30, 2015 and December 31, 2014, fixed assets and intangible assets consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30, 2015</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31, 2014</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 52%; line-height: 115%">Property and equipment</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 21%; text-align: right; line-height: 115%">4,044</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 21%; text-align: right; line-height: 115%">-</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Less accumulated depreciation</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(430</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Fixed assets, net</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">3,614</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30, 2015</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31, 2014</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 52%; line-height: 115%">FOCUSfactor intellectual property</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 21%; text-align: right; line-height: 115%">1,000,000</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 21%; text-align: right; line-height: 115%">-</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Intangible assets subject to amortization</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">2,041,030</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Less accumulated amortization</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(281,829</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Intangible assets, net</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">2,759,201</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> </table>   Depreciation and amortization expense for the nine months ended September 30, 2015 and 2014 was $282,256 and $0, respectively. Depreciation and amortization expense for the three months ended September 30, 2015 and 2014 was $103,103 and $0, respectively. Annual amortization expense will be $408,206 per year through 2020. As of September 30, 2015 and December 31, 2014, fixed assets and intangible assets consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30, 2015</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31, 2014</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 52%; line-height: 115%">Property and equipment</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 21%; text-align: right; line-height: 115%">4,044</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 21%; text-align: right; line-height: 115%">-</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Less accumulated depreciation</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(430</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Fixed assets, net</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">3,614</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30, 2015</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31, 2014</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 52%; line-height: 115%">FOCUSfactor intellectual property</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 21%; text-align: right; line-height: 115%">1,000,000</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 21%; text-align: right; line-height: 115%">-</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Intangible assets subject to amortization</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">2,041,030</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Less accumulated amortization</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(281,829</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Intangible assets, net</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">2,759,201</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> </table>

408206

4044

430

2041030

281829

2759201

Note 8 Notes Payable   On January 22, 2015, the Company entered into a Loan and Security Agreement, pursuant to which Knight Therapeutics (Barbados) Inc. (Knight) agreed to loan the Company $6.0 million (the Loan), and which amount was borrowed at closing for the purpose of acquiring the Focus Factor Business (see note 1). The Loan bears interest at a rate of 15% per year; provided, however, that upon the occurrence of an equity or convertible equity offering by the Company of at least $1.0 million, the interest rate will drop to 13% per year. Interest accrues quarterly and is payable in arrears on March 31, June 30, September 30 and December 31 in each year, beginning on March 31, 2015. All outstanding principal and accrued and unpaid interest is due on the earliest to occur of either January 20, 2017, or the date that Knight, in its discretion, accelerates the Companys obligations due to an event of default.   In connection with the Loan, the Company issued warrants that were recorded as a debt discount at an initial aggregate value of $3,415,514 (see note 1). The value of these warrants was amortized during the nine months ended September 30, 2015, resulting in a final debt discount balance of $840,322 as of September 30, 2015.   On January 22, 2015, the Company issued a 0% promissory note in a principal amount of $1,500,000 in connection with an Asset Purchase Agreement (see note 1). The note has a maturity date of January 20, 2017, with $750,000 to be paid on or before January 20, 2016 and an additional $750,000 to be paid on or before January 20, 2017.   On June 26, 2015, the Company, through its wholly owned subsidiary, Neuragen Corp. (Neuragen), issued a 0% promissory note in a principal amount of $950,000 in connection with an Asset Purchase Agreement (see note 1). The note requires $250,000 to be paid on or before June 30, 2016, and $700,000 to be paid in quarterly installments (beginning with the quarter ending September 30, 2015) equal to the greater of $12,500 or 5% of U.S. net sales, and 2% of U.S. net sales of Neuragen for 60 months thereafter. The payment of such amounts is secured by a security interest in certain assets, undertakings and property (Collateral) pursuant to the Security Agreement, which will be released upon receipt of total payments of $1.2 million. The balance at September 30, 2015 was $937,500.

The following table summarizes the warrants outstanding and the related prices for the shares of the Companys common stock at September 30, 2015:   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="3" style="text-align: center; line-height: 115%"> </td> <td colspan="12" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Warrants Outstanding</td> <td style="line-height: 115%"> </td> <td colspan="7" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Warrants Exercisable</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="width: 20%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Exercise Prices ($)</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="width: 15%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Number Outstanding</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="width: 15%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Weighted Average Remaining Contractual Life (Years)</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="width: 11%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Weighted Average Exercise Price ($)</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="width: 11%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Number Exercisable</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="width: 11%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Weighted Average Exercise Price</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.34</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">3,584,759</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">9.32</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.34</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">3,584,759</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.34</td> <td style="line-height: 115%"> </td></tr> </table> Going Concern   The Companys unaudited condensed consolidated financial statements are prepared using U.S. GAAP applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company had an accumulated deficit at September 30, 2015 of $4,105,439. The Company had working capital of $246,252 as of September 30, 2015. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it establishes a revenue stream and becomes profitable. If the Company is unable to obtain adequate capital it could be forced to cease operations.   In order to continue as a going concern and to develop a reliable source of revenues, and achieve a profitable level of operations the Company will need, among other things, additional capital resources. Managements plans to continue as a going concern include raising additional capital through borrowing and sales of common stock. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans.   The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

As of September 30, 2015 and December 31, 2014, accounts payable and accrued liabilities consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30, 2015</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31, 2014</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 54%; line-height: 115%">Accrued payroll</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 20%; text-align: right; line-height: 115%">-</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 20%; text-align: right; line-height: 115%">10,867</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Accrued legal fees</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">56,683</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">47,916</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Manufacturers</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,391,472</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Promotions</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">15,000</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Other</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">190,141</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">15,859</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Total</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">1,653,296</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">74,642</td> <td style="line-height: 115%"> </td></tr> </table>

SNYR Note 12 Stock Warrants   The following table summarizes the warrants outstanding and the related prices for the shares of the Companys common stock at September 30, 2015:   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="3" style="text-align: center; line-height: 115%"> </td> <td colspan="12" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Warrants Outstanding</td> <td style="line-height: 115%"> </td> <td colspan="7" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Warrants Exercisable</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="width: 20%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Exercise Prices ($)</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="width: 15%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Number Outstanding</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="width: 15%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Weighted Average Remaining Contractual Life (Years)</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="width: 11%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Weighted Average Exercise Price ($)</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="width: 11%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Number Exercisable</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="width: 11%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Weighted Average Exercise Price</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.34</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">3,584,759</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">9.32</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.34</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">3,584,759</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.34</td> <td style="line-height: 115%"> </td></tr> </table>   The warrant activity for the nine months ended September 30, 2015 is as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Warrants Outstanding  </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Weighted Average Exercise Price</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Outstanding at December 31, 2014</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"></td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%"></td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 72%; line-height: 115%">Granted</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 11%; text-align: right; line-height: 115%">8,179,946</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 11%; text-align: right; line-height: 115%">0.15</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Exercised</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(4,595,187</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">0.00000022</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Expired or canceled</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"></td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"></td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Outstanding at September 30, 2015</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">3,584,759</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">0.34</td> <td style="line-height: 115%"> </td></tr> </table>

The warrant activity for the nine months ended September 30, 2015 is as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Warrants Outstanding  </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Weighted Average Exercise Price</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Outstanding at December 31, 2014</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"></td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%"></td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 72%; line-height: 115%">Granted</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 11%; text-align: right; line-height: 115%">8,179,946</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 11%; text-align: right; line-height: 115%">0.15</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Exercised</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(4,595,187</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">0.00000022</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Expired or canceled</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"></td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"></td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Outstanding at September 30, 2015</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">3,584,759</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">0.34</td> <td style="line-height: 115%"> </td></tr> </table>

General   The accompanying condensed consolidated financial statements as of September 30, 2015 and December 31, 2014 and for the three and nine months ended September 30, 2015 and 2014 are unaudited. These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (GAAP) for interim financial information and are presented in accordance with the requirements of Rule S-X of the Securities and Exchange Commission (the SEC) and with the instructions to Form 10-Q. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2015 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2015. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements as of and for the year ended December 31, 2014 and footnotes thereto included in the Companys Annual Report on Form 10-K filed with the SEC. 0.05 0.10 P15Y 1000000 3584759 2926369 58054 67113 204925 1000000 50000 50000 1941030 1798047 1137336 891113 51795 941446 148520 6000000 1200000

35406

750000

937500

The preliminary allocation of the purchase price to the assets acquired and liabilities assumed based on the estimated fair values is as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-decoration: underline; line-height: 115%">Assets</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 79%; padding-left: 10pt; line-height: 115%">Accounts Receivable</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 18%; text-align: right; line-height: 115%">2,926,369</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Inventory</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">67,113</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Intellectual Property</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,000,000</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Non-compete provision</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">50,000</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Non-solicitation provision</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">50,000</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Intangible assets-Customer relationships</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,941,030</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Goodwill</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,798,047</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-decoration: underline; line-height: 115%">Liabilities</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Accounts Payable</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(891,113</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Accrued Expenses</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(941,446</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">6,000,000</td> <td style="line-height: 115%"> </td></tr> </table>

The preliminary allocation of the purchase price to the assets acquired and liabilities assumed based on the estimated fair values is as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-decoration: underline; line-height: 115%">Assets</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 79%; padding-left: 10pt; line-height: 115%">Accounts Receivable</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 18%; text-align: right; line-height: 115%">58,054</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Inventory</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">204,925</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Goodwill</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,137,336</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-decoration: underline; line-height: 115%">Liabilities</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Accounts Payable</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(51,795</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Accrued Expenses</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(148,520</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">1,200,000</td> <td style="line-height: 115%"> </td></tr> </table>

0001562733

6400

300000

1500000

7237619

2748

3181623

3103244

1685

1469910

4134375

1063

1711713

2228418

814640

10000

1407458

787858

706806

142236

282256

103103

3918132

787858

1624549

142236

216243

-786795

87164

-142236

612094

212904

-2575192

-304117

101105

37753

-3288391

-554774

-3072148

-786795

-467610

-142236

-0.05

-0.01

-0.00

67033094

108850549

68096740

60491304

101105

28000

310247

109040

2575192

-1660167

150

201346

30500

118976

10000

-454220

9705

800030

-398453

4045

4500000

-4754045

762500

92840

299531

-159345

-1

500000

4778625

407160

824610

8707

338

11937

824948

3230

612094

100000

3415514

9332559

84040

1400315 1500000 1359 20000 25000

0.50

0.05

500000

2015-08-18 2015-08-18 2015-08-18 1000000

1000000

282000

0.15

0.10

2015-10-31

400000

15000

5047178

10867

47916

56683

1391472 15000

15859

190141

74642

1653296

6000000

1000000

0.13

840322

12500

0.05 0.02

1200000

100000

4595187

0.50

15525000

0.25

0.34

1000000

3584759

P3Y6M

P9Y3M26D

0.25

0.34

1000000

3584759

0.25

0.34

1000000

0.25

3584759

8179946

-4595187

0.34 0.15 0.00000022

EX-101.SCH 5 snyr-20150930.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheet link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheet (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - Nature of the Business link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Asset Purchase link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Fixed Assets and Intangible Assets link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Accounts Payable and Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Notes Payable link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Stockholders' Deficit link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Commitments & Contingencies link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Stock Options link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Stock Warrants link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Asset Purchase (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Fixed Assets and Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Stock Options (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Stock Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Nature of the Business (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Asset Purchase (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Asset Purchase - Purchase Price Allocation Assets Acquired and Liabilities Assumed on Estimated Fair Values (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Asset Purchase - Pro forma Results of Acquisition (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Inventory - Schedule of Carrying Value of Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Fixed Assets and Intangible Assets (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Fixed Assets and Intangible Assets - Summary of Fixed and Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Notes Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Stockholders' Deficit (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Stock Options (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Stock Options - Summary of Options Outstanding by Price Range (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Stock Options - Summary of Stock Options Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Stock Warrants - Summary of Warrants Outstanding by Price Range (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Stock Warrants - Summary of Stock Warrants Activity (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 snyr-20150930_cal.xml XBRL CALCULATION FILE EX-101.DEF 7 snyr-20150930_def.xml XBRL DEFINITION FILE EX-101.LAB 8 snyr-20150930_lab.xml XBRL LABEL FILE Synergy Merger Sub Inc [Member] Business Acquisition [Axis] Common Stock [Member] Class of Stock [Axis] Scenario, Plan [Member] Scenario [Axis] Stock Option Plan [Member] Plan Name [Axis] Employee Stock Option [Member] Award Type [Axis] Equity Incentive Plan 2014 [Member] Board of Directors [Member] Title of Individual [Axis] Maximum [Member] Range [Axis] Minimum [Member] Investor [Member] Related Party [Axis] Merger Agreement [Member] Type of Arrangement and Non-arrangement Transactions [Axis] Equity Components [Axis] Additional Paid-In Capital [Member] Accumulated Deficit [Member] Shipman Diamond Project [Member] Directors [Member] President And Director [Member] Common Stock To Be Issued [Member] Dunhill Distribution Group [Member] Mr. Jack Ross [Member] LT Warrant [Member] Focus Factor Business [Member] January 20, 2016 [Member] Report Date [Axis] January 20, 2017 [Member] Warrant [Member] Knight [Member] Factor Nutrition Labs, LLC [Member] ST Warrant [Member] Knight Therapeutics Inc [Member] June 30, 2016 [Member] September 30, 2015 [Member] U.S [Member] Geographical [Axis] Closing Date [Member] Contribution Agreement [Member] Hand Md Corp [Member] Legal Entity [Axis] License Agreement [Member] Consulting Agreement [Member] Hand MD LLC [Member] Document And Entity Information [Abstract] Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Filer Category Entity Common Stock, Shares Outstanding Trading Symbol Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] Assets Current Assets: Cash Accounts Receivable Receivable from related party Prepaid expenses Inventory Total Current Assets Fixed assets, net Investment in Hand MD Corp. Goodwill Intangible assets, net Debt issuance cost, net Total Assets Liabilities and Stockholders' Equity (Deficit) Current Liabilities: Accounts payable and accrued liabilities Notes payable, related party Current portion of long-term debt Current portion of long-term debt, related party Total Current Liabilities Long-term Liabilities: Note payable Note payable, net of debt discount, related party Total Long-term Liabilities Total Liabilities Commitments and contingencies Stockholders' Equity (Deficit): Common stock, $0.00001 par value; 300,000,000 shares and 75,000,000 authorized, respectively; 69,238,044 and 62,100,000 shares issued and outstanding, respectively Common stock to be issued Additional paid in capital Accumulated deficit Total stockholders' equity (deficit) Total Liabilities and Stockholders' Equity (Deficit) Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenue Cost of sales Gross profit Operating expenses Selling and marketing General and administrative Depreciation and amortization Total operating expenses Income (loss) from operations Other income (expenses) Interest expense Amortization of debt discount Amortization of debt issuance cost Total other expenses Net Loss Net loss per share - basic and diluted Weighted average common shares - basic and diluted Statement of Cash Flows [Abstract] Cash Flows from Operating Activities Net loss Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Amortization of debt issuance cost Stock based compensation expense Loss on acquisition Amortization of debt discount Changes in operating assets and liabilities: Accounts receivable Inventory Prepaid expense Accounts payable and accrued liabilities Net cash provided by (used in) operating activities Cash Flows from Investing Activities Payments for acquisition of fixed assets Payments for acquisition of Factor Nutrition Labs Payments for acquisition transaction with Knight Therapeutics Inc. Net cash used in investing activities Cash Flows from Financing Activities Proceeds from notes payable Repayment of notes payable Payment of debt issuance cost (Repayments to) advances from related party note Warrant exercise Proceeds from issuance of common stock Net cash provided by financing activities Net increase in cash and cash equivalents Cash and Cash Equivalents, beginning of period Cash and Cash Equivalents, end of period Supplemental Disclosure of Cash Flow Information: Cash paid during the period for: Interest Income taxes Supplemental Disclosure of Non-cash Investing and Financing Activities: Common stock issued for settlement of debt Beneficial conversion feature on warrants issued concurrent with debt Assumption of liabilities as part of acquisition transaction Assumption of liabilities as part of acquisition transaction with Knight Therapeutics Inc. Note issued as part of asset purchase agreement Common stock issued as part of contribution agreement Cancellation of common stock as part of purchase transaction Financing for prepaid insurance Issuance of shares as part of acquisition transaction Organization, Consolidation and Presentation of Financial Statements [Abstract] Nature of the Business Accounting Policies [Abstract] Summary of Significant Accounting Policies Business Combinations [Abstract] Asset Purchase Inventory Disclosure [Abstract] Inventory Fixed Assets And Intangible Assets Fixed Assets and Intangible Assets Related Party Transactions [Abstract] Related Party Transactions Payables and Accruals [Abstract] Accounts Payable and Accrued Liabilities Debt Disclosure [Abstract] Notes Payable Equity [Abstract] Stockholders' Deficit Commitments and Contingencies Disclosure [Abstract] Commitments & Contingencies Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Stock Options Stock Warrants Stock Warrants General Basis of Presentation Use of Estimates Cash and Cash Equivalents Capitalization of Fixed Assets EX-101.PRE 9 snyr-20150930_pre.xml XBRL PRESENTATION FILE XML 10 R39.htm IDEA: XBRL DOCUMENT

Stock Options - Summary of Stock Options Activity (Details) - $ / shares		9 Months Ended
	Apr. 02, 2014	Sep. 30, 2015
Options Outstanding, Granted	1,000,000
Weighted Average Exercise Price, Exercised	$ 0.25
Stock Option Plan [Member]
Options Outstanding, Outstanding at Beginning balance		1,000,000
Options Outstanding, Granted
Options Outstanding, Exercised
Options Outstanding, Expired or canceled
Options Outstanding, Outstanding at Ending balance		1,000,000
Weighted Average Exercise Price, Outstanding at Beginning balance		$ 0.25
Weighted Average Exercise Price, Granted
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Expired or canceled
Weighted Average Exercise Price, Outstanding at Ending balance		$ 0.25

EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0````(`"H^<$?SW$M9R0$``$H:```3````6T-O;G1E;G1?5'EP97-= M+GAM;,V9RT[#,!!%?Z7*%C6N[?(494/9`A+\@$FFC=4XMFRWE+_'3@%!51"O M2G>31^]X[DW&.9N>WS\Y"H.U:;LP*9H8W1ECH6K(J%!:1UU29M8;%=.MGS.G MJH6:$Q.CT1&K;!>IB\.8>Q07YS;"/7X4C?)4WT6?YKO[VWA? ML+\<>:[]]6=#[\7`^M,>(?&C'`(DAP3),0;)<0B2XP@DQS%(CA.0'*<@.?@( M)0@*43D*4CD*4SD*5#D*53D*5CD*5SD*6#D*604*604*604*604*604*604* M604*604*604*604*624*624*624*624*624*624*624*624*624*624*6<[%````*P(```L```!?.0Q(OW[CMB` MPD.MQ-*O>X^NO`ZIK`XTHO8<4M?'5$Q^#*G*_=ITJK$"2+8CCVG!D4*>-BP> M-9?20D0[8$NP+,L5R*V.V:SGVL7.U49V[M,41Y26M#;3"&>6X9MY6&3I//B) M]!=C;IK>TI;MR5/0!_ZS#0//>997'L=V+YRO+0O]C^AY%.!)T:'B1?4C9@,2 M[2F]@OIZ`(4QOCLEFI2"(S>C@KN_V/P"4$L#!!0````(`"H^<$<;CBH[JP$` M`(@9```:````>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'/%V<>$5==>.V[0L$'8UH+F2FM+Y]4Q?%7N:C"^';)"0#9_X0^!&291/R MQ9,_E_'8-J$Z=F'T7I^;L!CNK[(JQF[A7-A6OB[#0]OY9EC=MWU=QN&R/[BN MW)[*@W>:YQ/7W\[)ULN?LT>;W2KK-SO)1B]E?_!QE;VU_2E4WL?@KB=YX MEB^=_\_V[7Y_W/K'=OM:^R;^4>&^-LA<.DC304H)LG2048**=%!!"1JG@\:4 MH$DZ:$()FJ:#II2@63IH1@F:IX/FE"#)@8PY)PEAS=%:`-?"\5H`V,(16P#9 MPC%;`-K"45L`V\)Q6P#RM%;@=Y*>M=&+]LBM'+T5Z*TBM'+T5Z*TAM'+T-Z&TAC"4=O`WH;1V\#>AM';P-Z&T=O`WH;1V\#>AM';P-Z&T?O`NA=#G[^Z=(^_739?T!4$L#!!0````(`"H^<$?P0`,AY`(``!@+```0````9&]C M4')O<',O87!P+GAM;+U646_:,!#^*Q8/6_?0!BBK)D8CM=!IE;H6%=8^N\Y! MK"9V9%\0Z:_?.8$0VD`##^,%Y_Q]9]_WV2P_(&91Y`B(U$C._76"JH1PS$3R" M(:WESWADH4!M@CEFJ..$J\PKONZD>K5_DZD><80J:WNBR!YR`P$MNI6]#.:8 MWQG5&3GN,.1J#D$5^W%RK<43&.LJ[73/VO0K)5C'B]S``ZGF8RZ-]0<+["]` MH#8KFQ9XK$N!%LYT^S2E_=D6>^$6W/"RM>!&F5E_DJVK;I=9"HQ`OLP&W.#_TF* MO*:U$+U.JU+].@7C*F`W"NDXLEM5+$7F524I1T--]T)9"!B-K(YD0,SZ"\[V6<\\Q-<#TC&$([#JU4H&UM=!)&L?<9`X[D7,E MR07RG5T)H5,2KY9S92T@&Z=&A-S=IAK(K5J0!]IDM;._Y))*R-/8W*=;A70% MY4L$+EK+>80H+]R=LHQ-#5>6"^=H/7Q5@"5\QEU>MPP%34HY[NKKNM<():%> M+=3B-=110)W@*QL!J25QAVUQ+-$=1,N^\#CYZ>Q#NCB@!#7>W=G90[*[J@+Q MS`V5CT<8VOG1P%!V,G4"V&_[G=T/VVMQMW.X9]WNYYKMW]*V>/NQ]3>(G8P` MN8R.4+Y[T4CY57YV[W;9Z/JQ4[89CXT4S3C46%G>%-DCV/03IT_9A#IWD$:Y M(D/:6R;KN]5>V\_K;=_/J;=]=S?(-3S\>)WW/F\)'^Q9-&\2&VZ38]Q\G9)# M'FW.GPL>RG%33>[-%HFB!W-H[L/#I/K">/>>\+;?P?X_4$L#!!0````(`"H^ M<$<2U/:%/P$``&D#```1````9&]C4')O<',O8V]R92YX;6S-DTU/PS`,AO\* MZKU+L\$FHJX'0)R8A,00B%M(O"VL^5#BJ>N_)\M*RX#+;MSJVN_CUW%2"L>$ M]?#HK0./"L+%7M[7R=8%(0J$&#P4#HB)*L>C9;8QM3 MDD%?E=%QS0,NK%0K!?*F'Z#ZJN:IADU MDU07!Z;D=?'PE,XF5R8@-P*B*BB&K8-Y]M7Y97)[M[S/JG%!KW)*97)PC$`8``)PG```3````>&PO=&AE;64O=&AE;64Q+GAM;.U: M6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X?A1%8C6QY9)&$?[]'-A#+ ME@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@V2_;UKNW+][@5S(D$4$P M&:>O\,`*I4Q>M5II`,,X?+&A`T%116F]?(+3E'S/X%/F7/ MZ3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1TDB`@LE]E`6Z2?:CTQ4( M,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP'`3@4;N>PIWT;+^D00FT MHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG`J-6T_3:W?=TXZ)QJW0>`V^\4^'PZZ) MQJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@`%AP=M;,T@.67BGZ=90:V1V[ MW4%<\%CN.8D1_L;%!-9ITAF6-$9RG9`%#@`WQ-%,4'RO0;:*X,*2TER0UL\I MM5`:")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']IJP&G[;N;SY/\<^CDGZ>3 MUTU"SG"\+`GQ^R-;88C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZY!$XM4D-,A,_")V&F&I0 M'`*D"3&6H8;XM,:L$>`3?;>^",C?C8CWJV^:/5>A6$G:A/@01AKBG'/F<]%L M^P>E1M'V5;SOX%^9PU M"AR1&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38:CFED)O816:I^JAS0^J!XR M"@7QN1X^Y7IX"C>6QKQ0KH)[`?_1VC?"J_B"P#E_+GW/I>^Y]#VATK\>WZV22$KYI9 M+2,6D$N!LT$DN/R+RO`JQ`GH9%LE"0AMNZ5/U2I77Y:^Y*+@\ M6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KTL@ M'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K34I!OP_GIQ7@:XCG9!+E] MF%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.'>7M?F&>5QE`T%&ULK"0L M1K=@N-?Q+!3@9&`MH`>#KU$"\E)58#%;Q@,KD*)\3(Q%Z'#GEUQ?X]&2X]NF M9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^:CVT%4[/_EFMR)\,$4X6 M"Q)(8Y07IDJB\QE3ON>;G*YZ(G;ZEW?!8/+]<,E'#^4[YU_T74.N M?O;=X_INDSM(3)QYQ1$!=$4"(Y4U#VT%SU& M\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83+$.D?L%]BHJ`$:MBOKJO M3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL'?!^2!F.,6_0T7X\48JVF ML:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5`Y3_;U`UH]@TT')$%7C&9 MMC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%`````@`*CYP1R\-5+)6`@``W@H` M``T```!X;"]S='EL97,N>&ULS59=:]LP%/TK0BFCA1';V9IVJVT8A M17"A5/G=\ZIT@1FJQJ+$7*_D0C*D]%067E5*C++*!#'J37Q_ZC%$.(Q#7K,9 M4Q5(1^T=Q&$N>'\5$^B` M.*R>P!)1[1\8]U10(8'2=ZUU6(0CAIW'+:(DD<2`.6*$KAP\,8`MC]:/$2ZD MS>TR#/.,_3Z3+)((^NWS\G1)SVX'LSU"Z?;V-!"')5(*2S[3$]#:\U6I-\<% MQTZD]=OC74BT"B:7&P%VT'D3(3,LN\P!7$-Q2'&N=(`DQ<*,2I1&NE!*,&UD M!!6"(VHHUQ&MH6E33.F#>1G_Y%O<30ZX46T%>TV^2^&Q6WY+3:<_M5Z-+L'W/IZCDUOHKF8)EC/[ M<3QK_5=FWTXXD/F^57.$A!,YN:.HFTZU=*\]K.L-%^ MMII/AX*D)E01OM:`S._"G=%-M_I"WW@T9];T/<>N*I3HG\VM+)HLPSFJJ;HG M2Z'L8@1[^Y>1'TP[KWE'$<'>_HTS4K-O5D'_1QO_!U!+`P04````"``J/G!' MHH0:`O`#``#/#0``#P```'AL+W=ON_'#];=W5A[QQYK;?S83;)E"*MQK^?+I:R%_]NNI*%G"^MJ$>C6W?;L8J%* M>6'+II8F]'B_/^HYJ450UOBE6OEL2_._0_,K)T7EEU*&6F]@M5`F^_#>CQ=* MR^_2>0(SL5I=BEI.LD>=,2U\^%2I(*M)-J!;^R`[#:Y9G35*QYMA?YCU(NQI MJ%>.E;:2&]A\J?R/[8.,57(A&AWFU-FG]TZRG`\X'VT8\6_?E7SP"(P-3)1! MWW2BM MPGJ2M==:QI'TG@VEG?[]%3/MY#REF`E3L4\F$(5-S29Y-#6Q#_3G:=6^V(T5 M7;AIE6^F"D'GUE32>%DQNO)6JXIFI6)G0@M32@8@#B#^6E`!H`)`Q6^#9H%^ M:,@`&@!H\%K0$$!#``T/09::[:%_I6LBEI;VZCI;$5!>NC8?U#U'4L0`2[$HXLG3MA?/PD M*2=(Z7B:$'4[6YXP:Q%[$3M%C:XA]%>S/T2]^B>J&:C^2%,JV9D/=#)/2-GV MA7U;'4PDRIBG;&P#?PA'B0B=2+0O3^AWU./\%%$H9)XPLFLR>S./J?!_(0(% MS1.&[J1.17.4DB>D/.HWSQ&%9O+7FLDYHCHU-&%F)ZG)<:&B_"5%=]E-(E!2 MGI`T7>[8FPL9A-)H#$=)>4K28\;0R@THU)8GM'UNS+8W[#(.M5-$.7K,?UE& MV0G;7U\Y52(*/>:_]OB$`):URS"[EKY!%/K,C_I\PF:T*:L:W2;AG`:X5KCN M%2AW\5JY"Y2[0+F+A-S'42AW@7(7";E?7@?:;"*JLT5(6'[TDRL&B$+;BY3M MN!@<:'6/*+2]>*DD/U\>]DA$H>W%BT5Z5PB.]0IM+U)5NX,BM_;?9&Q$%-I> M)&P_@HJ/$(6V%PG;G]6I#HM:<9>'M@\2MA]#T3-$H>V#?+O=WN^PZ9!!M:Z* MYP_?OH8V\&4\E-#/9F5219/$W1P:+0^I[9OYJL5[9Y[0WXZ MAGSX'U!+`P04````"``J/G!'+]!^[50"``#T!P``&````'AL+W=O"+5K78>H64S09"<2H(Q>*% M-:167RZ,4RS5D%^A:#C!9V.B%42^GT"*R]K+,S/WQO.,W615UN2-`W&C%/,_ M>U*Q=NL%7C_Q7EX+J2=@GL'!=RXIJ47):L#)9>OM@LTAB+3$*'Z5I!7..]#) M'QG[T(,?YZWGZQQ(14Y2A\#J<2<'4E4ZDB)_=D$?3&UTW_OHWTRY*OTC%N3` MJM_E618J6]\#9W+!MTJ^L_8[Z6J(=<`3JX3Y!:>;D(SV%@]0_&6?96V>K?T2 MA9UMWH`Z`QH,*/FO(>P,X6"P2P=M9J:N5RQQGG'6`M%@_6\'&R7G.HB*#(2) MQNURJ6,[%S0-@#['`7 M.O;HN3WJ[9&U1XX]'N=G%7M7D3P'Q!-`[-C3,2"V`*NH[0K'"4K#!C3XQ$AF86,->D"2C"EC!IS-;>S#IW&;JUDC<*5'RWHD0!-66Z/!NOY MBD:=[B^@A%.*V\HH&%.2CC+2H`64:<,';C^C<+8C.TW=U?+/+H#.(4L)OYK+ M1X`3N]72GK'#['#![9`YI!_R/&OPE?S$_%K6`AR95$>].9&PO=V]R:W-H965T&ULE9A=;Z,X%(;_"LK] M#O:QC:%*(PU9K68N5AK-Q>XU;9PP,T&;VWZ_Y2H_=DXG3BR:0]Y@'8S\8 MUN>F_=$=C.FC7W5U[!Y7A[X_/<1Q]WPP==%]:D[F:'_9-VU=]':S?8F[4VN* MW5A45S$PEL1U41Y7F_6X[UN[63>O?54>S;Z75F;8UB,]NF^K?< M]0=+RU;1SNR+UZK_WIR_F/D3F"+',9*"S&1*Q;8X)D1Z&T5Z*!*C>,=0$XI$Q^`"-%>2 MRFUQ#M(L`$9Y,`K#9"2,PC!:20"2Q8DE3.O;,(D'DR`8P4B8!!\%0.F$A'%B MS/[=AM$>C,8PG(31Z"@RRZ0_8F88'(.$)?(V3.K!I!B&[/\\Q4?)9*:NC%^< M4TKH@,F4>309IA$D389G2<*]X3NULW7:">@5SCR00<+O+2B29,[,8T$Q9S1@ M&K>Q$!SNXV#+"7)DYG-FN4Y"B530./Q>'/!QL#2%IG$`XVB5`>,T#MR+XRN8 M8P<+6GPVE\"W.L84&;CSL>9D(FUG_DI'*2@;.*7UP\W^,X MEK$,4!;W!X>@KU&._2?).WS.'9$2\EKZ!^<2&=([X-L4 ML``E;5-@CB_8Q]$S`SE!GG(6,GR`>U,"L`1EP*0"7X*`O25I"0*$77*XUX'@ M.Q"PM^CE0@[8@8I)S75*X]PK0?`E"%B"DI8@.&K3V74<>2^.OQ@%+$!%#O0< M\#HSM==*:MH83C!X`/I&!6Q41=X:?P.Y3M/L$ M5II*[3/BE06_$TP3;0=I`)*_FA38?8I>30J\FOQ#IP`Y4M$\%.%-/*NTO*AGYR*%_-WT;Z4QRYZ:OJ^JZR49E]/WS50Q=, M+XVFC;XY+>_`+B_B-O\#4$L#!!0````(`"H^<$<*W>C[X`$``&<%```8```` M>&PO=V]R:W-H965T&ULC91=;YLP%(;_BL7]:K[;1@2I89JV MBTE5+[9K)QP"JHV9[83NW\\?D#J(K,T%]C'O^Y['1'8QR2@V09/T:;*C<(* M?G4P2F^.#/N>\U=3_*BW06@0@,)!F02BAS-40*D)THW_3)GO+8W1G\_IW^QN M-?V>2*@X_=W5JM6P88!J:,B)JA<^?H=I"YD)/'`J[1,=3E)Q-EL"Q,B;&[O> MCJ-[D^>3;=T03X;X8HC2_QJ2R9`L#-B1V7U])8J4A>`CD@,Q?W:TT7)A0G0R MDC9-N,^E=R;UZKG,'@M\-CF3)+:2G2^)UQ35E2*[2+#NOPH1SQ"N?(H]?QY^ M[$]F?^K\B>^/KA$?W":2"+Z$V9JJNJVZR9(N6%*?9?&Y,L>2>EV29\MA#>1L@52YB,EJTB9URA_C).',$U7B:Z$) M\H^)L'-FST'"N0,>%=SJVU;?>I:#0*#.]-_W<1>`* MQ8?Y6KO4_4$L#!!0````(`"H^<$=&!K5`)`0``.\1```8````>&PO=V]R M:W-H965T&ULC5C)CN)($/T5BWN5<\\THI":I35S&*G5A^FS M"Y)%[86V3='S]Y->H"*SPX!4*G#RXD6\"#N?[=FEK'[6!VN;Z'>>%?7;Y-`T MIVD49S$C1,5Y>BPF\UFW]JV: MS\ISDQT+^ZV*ZG.>I]5_"YN5E[<)G5P7OA_WAZ9=B.>S^!:W/>:VJ(]E$55V M]S;Y0J=K1EI(A_CW:"\U^!ZUQ;^7Y<_VX._MVX2T-=C,;IJ6(G4?'W9ILZQE M?``/@3PSP!Q M-T`,`>+9#'((D$&&N-?>=6Z5-NE\5I67J#ZE[?E$IPY>M22..:H[MJH?B.M= M[58_YDK.XH^69X"P#K+P(`J#K""$WA"QRX\6P29^!@;"&99@"1%*HS4\)%F/ MD(R6R:]E\KY7',:;Q_'B&B_Z>`'C$[]$W7>BAQ0=A%-#%>,^KJ=:0BHN,*H5 MI-*,:T71E&N(8UH\H4L&NB0H1A,_21^QD"`)%2I)*$%UR3NZ>JJ5]%I$.!,H M;NVE5$8^UJ4"70KJHJ@N!9-HZO[P>:G'NB"5H%QP+=%Y>2F)XH]UZ>`\UE`7 M>QQO@KX8&,_1OAA0I'$#%_BXS>.V0";&F!'48%3K$:I144D@*H&BT%(6";RB MB#)$80-:)MZYSAA7J#`?1K20!IVWE]5H(Y^X0BD)U+66^2E/HO(&S/7,:J\M M=&@>U\C4/"YF&),*G=H8U[@R&BJ#WJ/15B\&S'4O8$(*="]<^L#QV7DXGKB- MFC-T>![PZ>FQ4"-T+JUQC0Q>2)K9:& MWDJAN>IGFA2Z*X6>J!.\2=#L7AAE"1'X.7[/8*\=\L@4921!R=9C9./:0H>E MT!<-;K$4&MX+)\*Y$:[M"9/UR9C4DB8,%S?"-BXNM%D*S='@/DN5)TYKB?K. MRL=10BF1>-DCCCQ>M@[+AC9J&%ZVAN5(*71H+=>9Z"=FXI%Q9HS;>7!Q(VSC MXD*+I]!.#7KE+RBTYA>AW!TFP?<<\VC/&6Y9?2`GFE&!FZ*/?'K7"4V?0M_>(]31 MICP73?^`=EN]O:OXPMJGX6!]0:=+BJROZ'3=OXGXI)_/3NG>_I-6^V-11^]E MXY[!NP?F75DVUM5.7IV&@TVWMX/,[IKVJV[%]>\C^H.F/%U?K]S>\W?QVAR(_U8?RM*CRY_OE M`]REVG0FO<7?A_Q2.]\7G?C'LOS17?RYNU^J3D-^S)^:+D36?KSE:7X\=I': MD?\=@[Z/V3FZWZ_1?^_3;>4_9G6>EL=_#KMFWZI5R\4N?\Y>C\WW\O)'/N;0 M*WPJCW7_=_'T6C=E<759+HKLY_!Y./6?E^$_B1K=9`<<'?#FLR3;KJKPLZG/6S3;95%Z2-O*C[:-50KC:SNKW[MDFB]>JM MBS.:8&^R=4W@9K%J@XLCX)*[H^..T@"I:Q'%GX]`UQ&&RP=R`D95Y#]W#_R$HH<_]APG69( M*')T8H)HO+D?(J5N)-*?*XD]);&;"8A*8D<)*`!E1"7Q3"6)IR1Q_*T2)SEA M-5%*M$I=*P*%.N")LYX8ZXH!*=^ME?-UE5A6.:NT^EP)*$]*A[KW*9(+,]J, ME3&Q`8OB)+%@(;,$X#WZX-+&&64Z`OH)N3BQ)#YSH\U8NBA2X'#'+3$S_`(F MI,+D"W+Y1/)+,-J,XZ`"TI%DF')#4D:%2/*)!R[RK)8E,90!)#:>D,0-E0J2 M9'Q)+O3T1)6,.Y(V&E')DEQ#&ZL`!H,/47#99V6*@HO1CA@D,X/9?2&;:$,! MDF+_Y7`A:*.`"#X%@6$PEI-*6)65EH',0@6]ZSX%@6$PD<58/N5*?>#R5<\$ M,:<;%1^%Z-++6E$/*O:BFDDY.!>%"+XXX?( M!(7T@CX+D5@(E'-R&1>IZ2EGT8)2\D&(FNF15POD35V$9J(UX(86DY`5&7T2 MHF&:9#HC0R%::_R5Y5HC,[=&/@@Q8GID$B(C'!A+4X_AW)82_9X28Z8GDJ9B MBZRME)7,;2G1IRDF3$DL#;/%"4ZR!\=%KL>X:3D^3]$R.?).!EV@ZKC=HJ`X MHRDW5#%$`9K(9RHIIDF&*KE035!'("_KW"Y6(7M%GZK$J"H/M"67JD3BTI1R M(Z20\OC-*C&D@MSV$/+RV(F])[,#L!12GP^;:49H".C`R80CD!@"0>XHB>V9-1@CST)*FN&,^7;W]A/"`W;'X-[]+=REPP\![V$VZW/VDO^552^'4[UX+)NF+/H3 M\>>R;/)6G_K:ZMOGV>YV<+V"GO0_D^#1G'G4],R MVQO@=20IR?(LNV:*"TW+(M:>35G@X*30\&R('93BYM\!)(Y[NJ)SX46TG0L% M5A9LX=5"@;8"-3'0[.G=:G?8!$0$_!$PVK.8!.]'Q->0/-5[F@4+(*%R08'[ MY03W(&40\HW?)LW/EH%X'L_J#W%:[_[(+=RC_"MJUWFS&24U-'R0[@7'1YA& MV`;!"J6-7U(-UJ&:*90H_IY6H>,ZIC^WV43[GI!/A/P+@:5&T>8O[GA9&!R) M[7DXN]7.PTT0\RE6^+=@I"$V81#E<8!8$\^K?MLCI)3T_ MH^<_T]1I"3+L^P34UQH6E>Q]FCJ"BY`[W?[8QD0$?!+P&PO M8A*\GQ"?0_*C/=`L6``)C0L*W"]G>``I@Y!O_&?1?&T9B)?QJOXM3NO=G[B% M!Y2_1>L&;S:CI(6.3](]X?P=EA%N@V"#TL8O:2;K4*T42A1_2:O0<9W3G[)8 M:.\3\H60;X2[+!I/C:+-K]SQNC(X$SOR<':[O8>;(.*5B8UJ)DWOC5I?/=>[ M_*YBYR"T8!+E>(79$,RKO]LBI]?T_(*>?TPO5GJ1'!97#K]\+%"N`F42*/\W M8L(2!B?MTI9NU>UVWN?Q3%[A=37R'GYRTPMMR0F= M/]EX#!VB`V\BN[FE9/#O9TLD="Z$GWULTI5*B<-Q?2#;*ZW_`5!+`P04```` M"``J/G!'S?>K!Z$!``"Q`P``&````'AL+W=OZ:EE42$Y"HD9:5_7SXDQ0Z" MMA=Q=S4S.\M'-:-YM@.`(Z]*:GN@@W/CGC';#*"XO<$1M/_3H5'<^=3TS(X& M>!M)2K(BRSXQQ86F=15KCZ:N<')2:'@TQ$Y*!"@=45 MVWBM4*"M0$T,=`=ZE^^/NX"(@)\"9GL1D^#]A/@;$9)"QV?I'O"^1LL(]P& MP0:EC5_23-:A6BF4*/Z:5J'C.J<_9;G0/B84"Z'8"%^R:#PUBC:_5[#S=!Q"L3&]5,FMX;M;YZKO,RK]@Y""V81#E>838$\^H?MBCH-;VX MH!?_III8TN"D7=K2 MK;K=SKLBGLD;O*Y&WL,/;GJA+3FA\R<;CZ%#=.!-9#>WE`S^_6R)A,Z%\+./ M3;I2*7$XK@]D>Z7U'U!+`P04````"``J/G!'-,D9^:(!``"O`P``&````'AL M+W=OVF95"F2/MK!T. MC)FJ`\G-#0Z@W)\&M>36I;IE9M#`ZT"2@J5)\HU)WBM:%J'VI,L"1RMZ!4^: MF%%*KO^=0.!TI#NZ%)[[MK.^P,J"K;RZEZ!,CXIH:([T=G`@BHK%?@;KG`'0CAA5SCO[/FM:4G;N-%_6>8UKD_V<\O+0N-$S,#]V>T.#JZ]B%,F)JCI.+TS:ESU4F:[ M@EV\S@R)C-,6OHU/5OH6328;;MG^=<"^2*01X'\DPDC MY)2_Z;%_UX-M=E2";L/%,:3"4=FXH6MUO9NWX0C9%5X6`V_AD>NV5X:SUK(J"Q/OSN8ATO5$PL#LOS6-]H^1]02P,$%`````@` M*CYP1_A*#GBA`0``L0,``!D```!X;"]W;W)K&UL MA5/;;J,P$/T5RQ]0$TC:*B)(3:K5]J%2U8?=9P<&L&I[J&U"]^_7ET"35;5] MP3/#.6?.^%).:-YL#^#(AY+:[FCOW+!ES-8]*&YO<`#M_[1H%'<^-1VS@P'> M1)*2+,^R6Z:XT+0J8^W%5"6.3@H-+X;842EN_NQ!XK2C*SH77D77NU!@5;4=)`RT?I7G'Z"><1-D&P M1FGCE]2C=:AF"B6*?Z15Z+A.Z4\QT[XFY&="OA#NLV@\-8HV'[GC56EP(G;@ MX>Q66P\W0<0K$QO53)K>&[6^>JI6Q6W)3D'HC$F4_15F03"O_F6+G%[3\PMZ M_CV]F.E%5AM^QH@$``+$#```9````>&PO M=V]R:W-H965TE# MI2@/Z;,7!K!B,]0V2_KW\04(&T7-"YX9SCESQI=B0OUB.@!+7I7LS8%VU@Y[ MQDS5@>+F"@?HW9\&M>+6I;IE9M#`ZT!2DJ5)X!RF]D&O\=]9\;^F)VWA1_QFF=>Y/W,`] MRC^BMITSFU!20\-':9]P>H!YA&LO6*$TX4NJT5A4"X42Q5_C*OJP3O%/=CO3 M/B>D,R%=";=),!X;!9L_N.5EH7$B9N#^['9[!]=>Q"D3$]1TG-X9-:YZ+G?9 M]X*=O=",B93C!69%,*?^:8N47M+3#3W]FIXM]"PZS+;=\^1K@7P1R*-`_K\1 M(^9X@ZI`M^'J&%+AV-NXI6MUO9UW:3B3=WA9#+R%WURWHC?DA-:= M;#B&!M&",Y%<75/2N?>S)A(:Z\-O+M;Q2L7$XK`\D/65EF]02P,$%`````@` M*CYP1Q?/B<.A`0``L0,``!D```!X;"]W;W)K&UL MA5/;;IPP$/T5RQ\0`TO::L4B95-%[4.E*`_MLQ<&L&)[B&V6]._K"Y#=*&I> M\,QPSIDSOE0SFF<[`#CRJJ2V!SHX-^X9L\T`BML;'$'[/QT:Q9U/3<_L:("W MD:0D*[+L"U-<:%I7L?9HZ@HG)X6&1T/LI!0W?X\@<3[0G*Z%)]$/+A187;&- MUPH%V@K4Q$!WH'?Y_E@&1`3\%C#;BY@$[R?$YY#\;`\T"Q9`0N."`O?+&>Y! MRB#D&[\LFF\M`_$R7M4?XK3>_8E;N$?Y1[1N\&8S2EKH^"3=$\X_8!GA-@@V M*&W\DF:R#M5*H43QU[0*'=F=BH9M+TWJCUU7.=ET7%SD%HP23*\0JS(9A7_[!%0:_IQ06] M^)R^6^F[Y'!WY7#WN4"Y"I1)H/S?B`ESO,:4[YJPBSU58/IX=2QI<-(N;>E6 MW6[G71'/Y`U>5R/OX1&PO M=V]R:W-H965T&+"!.4;2' M`D$.[9F65A(1DJN2E)7^??F0%#L(FHNXNYJ9G>6CG-"\V![`D5U#9?=,<:%I5<;:DZE*')T4&IX, ML:-2W/P]@<3I2#=T*3R+KG>AP*J2K;Q&*-!6H"8&VB-]V!Q.14!$P"\!D[V* M2?!^1GP)R8_F2+-@`234+BAPOUS@$:0,0K[QGUGSK64@7L>+^K M4?X6C>N]V8R2!EH^2O>,TW>81]@%P1JEC5]2C]:A6BB4*/Z:5J'C.J4_^7ZF M?4S(9T*^$KYDT7AJ%&U^Y8Y7I<&)V(&'L]LCL?\G@F;_"J''@'/[GIA+;DC,Z? M;#R&%M&!-Y'=[2CI_?M9$PFM"^'>QR9=J90X')8'LK[2ZA]02P,$%`````@` M*CYP1T(D&B"C`0``L0,``!D```!X;"]W;W)K&UL MA5/+;MLP$/P5@A\0RK+N6'/F*U[4-S>X`#:_VG1*.Y\:CIF!P.\ MB20E69YE7YCB0M.JC+5'4Y4X.BDT/!IB1Z6X^7L$B=.!;NA2>!)=[T*!525; M>8U0H*U`30RT!WJWV1^+@(B`WP(F>Q&3X/V$^!R2G\V!9L$"2*A=4.!^.<,] M2!F$?..76?.M92!>QHOZ0YS6NS]Q"_\+I!\PC[()@ MC=+&+ZE'ZU`M%$H4?TVKT'&=TI\\GVD?$_*9D*^$VRP:3XVBS>_<\:HT.!$[ M\'!VF[V'FR#BE8F-:B9-[XU:7SU7F^*V9.<@-&,2Y7B%61',JW_8(J?7]/R" MGG].WR[T;7*XO7+X[7.!8A$HDD#QOQ$3YGB%V67OFK"+/55@NGAU+*EQU"YM MZ5I=;^==/$3V!J_*@7?PBYM.:$M.Z/S)QF-H$1UX$]G-CI+>OY\UD="Z$'[U ML4E7*B4.A^6!K*^T^@=02P,$%`````@`*CYP1Q=)XX>B`0``L0,``!D```!X M;"]W;W)K&ULC5/+;MLP$/P5@A\02K*=%H8L($Y1 M)(<`00[MF996$A&2JY*4E?Y]^9`4.PC:7L3=U357BZ*30 M\&R('97BYO<1)$X'FM.E\"*ZWH4"JTJV\AJA0%N!FAAH#_0NWQ^W`1$!/P1, M]B(FP?L)\34DC\V!9L$"2*A=4.!^.<,]2!F$?.-?L^9[RT"\C!?U[W%:[_[$ M+=RC_"D:UWNS&24-M'R4[@6G!YA'V`7!&J6-7U*/UJ%:*)0H_I96H>,ZI3^[ M8J9]3BAF0K$2OF;1>&H4;7[CCE>EP8G8@8>SR_<>;H*(5R8VJIDTO3=J??5< MY;N\9.<@-&,2Y7B%61',JW_:HJ#7].*"7OR;OEGHF^1P<^7P/P2VB\`V"6S_ M-F+"'*\QFP]-V,6>*C!=O#J6U#AJE[9TK:ZW\RX>(GN'5^7`.WCBIA/:DA,Z M?[+Q&%I$!]Y$=K.CI/?O9TTDM"Z$7WQLTI5*B<-A>2#K*ZW^`%!+`P04```` M"``J/G!'N4;L:J(!``"Q`P``&0```'AL+W=OP)$W);4]T-ZY8<^8K7M0W-[@`-K_:=$H[GQJ.F8' M`[R))"59GF6W3'&A:57&VI.I2AR=%!J>#+&C4MS\/8+$Z4`W="D\BZYWH<"J MDJV\1BC05J`F!MH#O=_LCT5`1,!O`9.]B$GP?D)\"NL^=XR$"_C1?TQ3NO=G[B%!Y1_1.-Z;S:CI(&6C](]X_0#YA%V M0;!&:>.7U*-UJ!8*)8J_I57HN$[ISUTQTSXGY#,A7PG?LF@\-8HVOW/'J]+@ M1.S`P]EM]AYN@HA7)C:JF32]-VI]]5QM=D7)SD%HQB3*\0JS(IA7_[1%3J_I M^04]_YJ^7>C;Y'![Y7#WM4"Q"!1)H/C?B`ESO,;GBU;&DQE&[ MM*5K=;V=]WD\DW=X50Z\@U_<=$);0XOHP)O(;G:4]/[]K(F$UH7P MSLY)>5SH`$``+$#```9```` M>&PO=V]R:W-H965T9)!:V)]A.P_[]^I*$=@6[+_',Y)PS9WPI1C1OM@-PY$-);?>T MKG:'34!$P(N` MT9[%)'@_(KZ%Y*'>TRQ8``F5"PK<+R>X`RF#D&_\/FE^M@S$\WA6OX_3>O=' M;N$.Y:NH7>?-9I34T/!!NF<&D6;/[GC96%P)+;GX>Q6.P\W0<0K$QO53)K>&[6^>BI7 MV^N"G8+0A$F4PP5F03"O_F6+G%[2\S-Z_G_Z>J:OD\/U-PZ_%=C,`ILDL/G7 MB`ESN,3<_-6$G>VI`M/&JV-)A8-V:4N7ZG([;_-X)I_PLNAY"X_0X/HP)O(KK:4=/[]+(F$QH7PVL&PO=V]R:W-H965TV$![]>7(>$>D6O)3 M(`9.R6$,ZMH`AV$:=*3I_:H<]]YX5;*S;)N>OG%/G+N.\'];VK+KQD?^O/'> MG&JI-X*J#):X0]/17C2L]S@];OP7]+S%D8:,B-\-O8K5NZ>3WS'VH1<_#QL_ MU#G0ENZEIB#J<:&OM&TUDU+^>R/]TM2!Z_>9_?MX7)7^C@CZRMH_S4'6*MO0 M]P[T2,ZM?&?7'_1VAD03[EDKQE]O?Q:2=7.([W7D>A9P;DF4&-GX='J5J%"[EPHE11E< M--$-,X5L`69!!(K=*H%]&(Y7X?AQ>#2'1U.&T5H=%X\)XID@G@CB-4$:PB-. MF"W$.!PR,4020("M(A`3/19)#9$4$,16$8A)'HMDAD@&"%*K",1DCT5R0R0' M!+E5!&(<+KXP1(HU06:_>(AQN'@4&BK:^BL*^]4;((>[1\C46=LPLM\+P*`L M=I#!I@P&%(E=!X)2!YW(U%G[&MLK`&!0YE!GR#0_`L[.[NA`D$.I(=/_")@[ MMQ>;`7*I-K,%(.#O_$ZU09!+M9E=``&+Y_9>8X`&PO=V]R M:W-H965T1$FU!66+422.%(G.$X#/>8$]H$6>IR[S)+1:<9;>!=(M5Q M3N2_$S#1'X,H&!,?M*JU3>`LQ1.OH!P:146#))3'X#DZG!*+<(#?%'HUFR/K M_2S$IPU>BV,06@O`(-=6@9CA`B_`F!4RA?\.FM\E+7$^']5_NMT:]V>BX$6P M/[30M3$;!JB`DG1,?XC^%PQ;V%G!7##EOBCOE!9\I`2(DR\_TL:-O5]Y#`?: M=4(\$.(5`?M"SN8/HDF62M$CU1+[[Z*#@4LK8I21T>/;],U(WWJ'FX7#QZ5#CSDM,4^WBVQ71;9S MCV%X6V"W$M@M!**K+I>8.XYBORJR7PAL;@LD*X'D#I=+S'95!,_:BX.LW"U2 M*!==HWUW3=GIHC['KCV_X5G:D@K>B*QHH]!9:-/DKB-+(308$^&#.:O:/"53 MP*#4=IJ8N?2WRP=:M.-;,3U8V7]02P,$%`````@`*CYP1ZK*D>ZE`0``L0,` M`!D```!X;"]W;W)K&ULA5/;;IPP$/T5RQ\0LRR; M5"L6*9NJ:A\J17EHG[TP@!7;0VVSI']?7X"P5:2\X)GAG#-G?"DG-*^V!W#D M34EM3[1W;C@R9NL>%+=W.(#V?UHTBCN?FH[9P0!O(DE)EF?9/5-<:%J5L?9L MJA)')X6&9T/LJ!0W?\\@<3K1'5T*+Z+K72BPJF0KKQ$*M!6HB8'V1!]WQW,1 M$!'P2\!D-S$)WB^(KR'YT9QH%BR`A-H%!>Z7*SR!E$'(-_XS:[ZW#,1MO*A_ MB]-Z]Q=NX0GE;]&XWIO-*&F@Y:-T+SA]AWF$0Q"L4=KX)?5H':J%0HGB;VD5 M.JY3^E-D,^UC0CX3\I7P)1)8:A1M?N6.5Z7!B=B!A[/;'3W8O9K0CFU3]LD=-;>KYM\3E]O]#WR>%^VWU??"Y0 M+`)%$BAN1KR_'3%ASK>8A_^:L,V>*C!=O#J6U#AJE[9TK:ZW\S&/9_(.K\J! M=_"3FTYH2R[H_,G&8V@1'7@3V=V!DMZ_GS61T+H0/OC8I"N5$H?#\D#65UK] M`U!+`P04````"``J/G!'5/>^1*0!``"Q`P``&0```'AL+W=O/="`%9LF MMAFR?Q\_@#"K2+G@[J:JNMJ/8D+]:CH`2]Z5[,V!=M8.>\9,U8'BY@H'Z-V? M!K7BUJ6Z96;0P.M`4I)E27+#%!<]+8M0>])E@:.5HH81[CV@A5*$[ZD&HU%M5`H4?P]KJ(/ZQ3_Y/E,^YJ0S81L)=PFP7AL M%&S^XI:7A<:)F('[LTOW#JZ]B%,F)JCI.+TS:ESU7&;);<'.7FC&1,IQBTE7 M!'/J7[;(Z"4]V[;XGKY;Z+OH<'?A\.?W`ODBD$>!?"N0)ID-.:-W)AF-H$"TX$\G5 M-26=>S]K(J&Q/OSA8AVO5$PL#LL#65]I^0%02P,$%`````@`*CYP1R(`$[*D M`0``L0,``!D```!X;"]W;W)K&ULA5/;;IPP$/T5 MRQ\0<]NV6K%(V511^U`IRD/[[(4!K-@,LP)(W)0=SHKVUXY$Q4_>@N+G#$0;WIT6MN'6I[I@9-?`FD)1D69)\88J+ M@59EJ#WIJL3)2C'`DR9F4HKKOV>0.)]H2M?"L^AZZPNL*MG&:X2"P0@8])-P1SZA^VR.@M/=NW^)R>K_0\.LSW MW8O\:?4/4$L#!!0````(`"H^<$&PO=V]R:W-H M965T.95U$.0E,ID(+Z$-TG^V/F$![P3F'0BSURV4]2?KC# M2W6(8ABX4&R?[0RK0T; M1ZB"FO3,O,GA&<86?,)2,NU_4=EK(_E$B1`G7V&EPJ]#^++;CK3+A'0DI#/A M+O;!@Y&/^4@,*7(E!Z0[XF:7["U<.1&KC+174Z%[&U3;ZKE(DRS'9RY9=%]A.`ML@L%VU>+MN,6".:\SN MNDGVRR1;"=Q=-%EC_OPRP8O!<5"-OY\:E;(7)LQMKLY/X#[U@_^!%WE'&OA+ M5$.%1B=I[/7QLZZE-&!#Q#E7TP%8]":X-"?<6=L?"3%5!X*:.]6#=%\:I06U M[JA;8GH-M`XDP4F6)-^(H$SBL@BU9UT6:K"<27C6R`Q"4/WO#%R-)YSBN?#" MVL[Z`BD+LO!J)D`:IB32T)SP?7H\[STB`'XS&,UJCWSVBU*O_O"S/N'$1P`. ME?4*U"U7>`#.O9`S_CMIOEMZXGH_JS^&;EWZ"S7PH/@?5MO.A4TPJJ&A`[Q"DC$]1T[-X%-:YZ+;,L*F"($[] MID6&M_1L;?$Y?3?3=S'A;NV^/WPND,\">13(-RVFVQ8CYKS%?"'E_H/)?B.P MNVFRQ>0?3,AJ<`)T&^ZG094:I(US6ZK+$[C/PN#?X671TQ9^4=TR:=!%67=] MPJP;I2RX$,F=2]&Y1[H<.#36;P]NK^.]C0>K^OD5+G\%Y7]02P,$%`````@` M*CYP1WT?P\L[!0``=AX``!D```!X;"]W;W)K&UL MG5G)3/Y5>P/]<-TVS3'^]FL?MKF15;?EMDWWQ6PQG[W';79%?JAWY6%2Y<\/TT_B_HO1':1' M?-_EI]IY/^G(/Y;EC^[#7YN':=1QR/?Y4].ER-J7MWR5[_==IK;RSS'I[YI= MH/O^G#WMF]O2?\SJ?%7N_]EMFFW+-II.-OES]KIOOI6G/_.Q#=`E?"KW=?]_ M\O1:-V5Q#IE.BNS7\+H[]*^GX9[<=FG3798EZ5ITE]S+H9*^Y;>-4E:3-/ZCY; M-0QY.SIU^^W;0DJ8S]ZZ1"-&]I@EQA@?9H4QUH=9(XP/\=E%&&^2]&:2+X$D ML[8WO%TBSUVBARZ1J"DQKC&$K`?,8:@1]7\^7'H-%R2D""&%""5>0LHI).0E M'QCX7($%Z6A"1[MTE+^.INV^709(&4!EA+=[P2FC>64,*6-0&3*C!LP:8Y0/ MDX8P02*6$+$H@?:.LG6'[\JTNX8+$HH)H1@1`F^K,<;<+I*0(@E*8+VM2=S6 M*&YS1$1*=0N34ROV3MP1-!23[%J"UD(VI1)?K?4(&FHISVB>.5W!A2E16Q/( MU[1WXJR%O)@Y?DI7<&%*U-@$MQ5N,D<>P[3H58GD-?I@/^X9J>9 MLUU2JY/(ZK1_RR!=JXN%-M03AF2?43+_PI2B7++=-6D1>[LQE"S<-FJM$EDK M>#FG!"08=2ZV@<@O03)24'^3R-_`ZR=+`N)T"34WB2P)&+J4U)(DW+:)I01D M`-;K)1Q0&@2%&5-CD^:VNI?2M:S$\M1$/4O:V\)=2M>SI-`R!DZKJ&=)Y%E@ M_%,&@SAUJ!E)9$80WTZAJ,FHB#&["8@QNQ45O,):3OQU$(BS*BLJ>(4$;[P; MI*5R-S[`/=!=G.B0Y@W#GA35O-*I,2BXO90LE2MGP>P4*FB%!,U* M096JL%*]N[P5!AF&L2NJ4H4$:)2O4U;*W5D,AVU.FZA2%5*J\:Z_*Y5\I):F MDM9(K8:QD&BJ5HV$:+P&MB(@AH%IJE:-U*?ZC(6.!8!U`Q`C[!6W^QBRM,UGA?W&(R5)L"/NIS:U'9`I8M M8[4'*EM@R#8%)%NFR0"5+6#9,M8:H+*%Y+:!IY!\@*VANC5(DI9QTVFH)`W> MHH*O;]?&O>OS7X@%(&$B5-@&"=LR)&2H7HVZUI;Q)&A;]PSY_;KJWMAOKX;'H\*$IC^>GO.^/FA?_`5!+`P04````"``J M/G!'%8OD,T<"``".!P``&0```'AL+W=O=KY@B9 M7!OYP88?=*P!:\,C:X3Y]HY7(5E[#_&]EGS99]V9YV#?)&@,6P^`8P"<`B;. M>@`:`]`C(#:5VLQ,7=^()$7.V>")GNA?.WQ5!M`KH3(ELH@:)L1+1B1PT"K#%?S!`0O(-@QP*L05Q-O0^(%)'8,$A>"+<1J.GLL`O/9 M!B4+4.*`TE50,@,AG$8)SK9!Z0*4SD`X=CF)Y:0S3A0&.$+9FJY,G<(1@MD3 M)SY;Y),YA:^"]MD,!*,88KC-"8,%2-]E#U(6K!X81_3,T0_#)<:Y`Y[9D1`N M+>#V_Z=T1=ER1\#L^FLIOYBV(+PCNW;2WG[3ZM1ZWDSG`0]YD??D0G\1?JD[ MX1V85)>PN3'/C$FJL@A>U-&L5'.<)@T]2SU,])FU[<).).OOW6]JP<5_4$L# M!!0````(`"H^<$=Y]A3JUP(``'L,```9````>&PO=V]R:W-H965TS MXT!M+P5K?2!Q./>#GOGSUURSD_R;IJV5,7B5/3T.[/ MBM7\O(A1?'GP7.T/4C](EO/D6K>M&M:*BK=1QW:+^!'-UH`UI$?\K-A96/>1 M-O_"^:L>?-\NXE1[8#7;2$U!U>6-E:RN-9-2_CV0?FCJ0OO^POZUGZZR_T(% M*WG]J]K*@W*;QM&6[>BIEL_\_(T-7,IB:.&OIMKU?;7 ML_EFD@YEXP4P%,"U`.4W"[*A(`LMR(>"W"M(S%3Z1JRII,MYQ\^1.%*]/-!, MP3M-HI@CT;-UIK^J%4(]?5O"-)LG;YIHP$"/63D8(&.8TL&,(=8V`G^0),KD MJ%.X.#7#1[`5;6?%&6ILZ,/U4J/*7"49JX2H51*NS.A@IA3PC;0B$$Q",@3N.+ ML9ZLB-T3"'0Z\80FMA#.1X4F_R,T]82FCE!QGP"E'H/>W"P*/+8:5QXH('X( M^3I.Q/$T@,*/,(*`_Q^Z$>+/I?R((B=_)(3"#R#*;[DM!K=V!$G@(D!^`I$3 M08("*/QL(2=#^VX,8VX-@$/[80$-L2G-@&;C+@QQ;F>_:#=OFI%],*E>H'LW_9VG$NFV-('Y?J@?@E&ULE99-CYLP$(;_"N*>Q0,V'Q%!*JFJ M]E!IM8?V["1.0`N88B?9_OO:0%)CH4)S"&!FWF<&SPRD=]Z]BX(QZ7S452-V M;B%EN_4\<2Q83<4+;UFC[IQY5U.I+KN+)]J.T5/O5%>>CU#HU;1LW"SMUUZ[ M+.57694->^T<<:UKVOW.6<7O.Q?2FD7O"RU'OZGPHM015AQO;LZK22HK\:Q3] MR]2.YOE#_4N?K@K_0`7;\^IG>9*%BA:YSHF=Z;62;_S^E8TY$"UXY)7H_YWC M54A>/UQP1\=_*<#X'\Z!*-#8#EX0V1]7I^II%G: M\;LC6JIW&[;*O-,B2MD1O5HW/"Z5F5"KM\Q/PM2[::'1QN]M\HG-G,5^8D&> M)IX*8#8*_Q$%'J+P37\4+`L$ED!@"L33&*,AQL&D&3/UPR!,ECG8XF"#$\"4 M0P8.-CAA!+`B&V)1R&13HED,,3"`^M\R*+1`X004SX)"`T3682(+$TTPR2PF M^G],;&%B\.)TR<%L>Q(C@E>`[+X'LCA>S\U5- M14&P9J_MYH=HN89S,-M_0U3'K,G*'@`0+Y=P#N8(V`".B;^F*.P9`,EB">

$;9;B0O'U\&PO=V]R:W-H965TY-Y)JZ: MU0V\2:2NG%/Y^P!,=/L@"H;`>WVIM`W@/,,CKZ@Y-*H6#9)0[H/G:'=,+,(! M?M30J\G(3[LXENQ#T)K`1BZ M<6/G_VS#GK9,(#V!C(1H_5="W!/B.\%M'?;.7%TO5-,\DZ)#JJ7VL*.=@4LK M8I21I3)GH+8_#.,,W*]1CB,,AH)P!PS5)H\U_5)T\.$IF M)2UF.B233%^B;9Q,$DT=37%I3$B8/OC!DV/G("^N'10ZBVNC_8&,T;'CGHF] M-@_Q@^E$WSAWF3QKZ06^4WFI&X5.0IM+Z6Y0*80&XR]\6@6H,F_%N&!0:CO= MF+GT[>,76K3#8S"^2/D?4$L#!!0````(`"H^<$>7SC]1^@$``+X%```9```` M>&PO=V]R:W-H965TF7OGXA4XM8!-XXDS:7W"Z2,6[V1*` MCGRXL>WM.+HW63S9M@WQ9(AOA@C]U9!,AF1E@([,]O5,%"ERP4<@!V+^[&BO MY<*$Z&0@;9IPGTMW)O7JM4C"-(=7$S1I8JMY6FKB+47I*?!-`C7`)D4\4[CI M8^Q19/<#DCD`N8#$"_CD0V:N#:?I'21".-I2E9XJ#5-T'P:M8)`'L_/+8`># M%F6B+-XEJT_OHDHOZA]0\`H%+_U1N(F"O8[3%.--%/R?*.D*)?50HDV4=(&2 M8+38CW\LDZW*9%Z9>',G9(LR:+=#:'/#E-F=K0`71VT@9_J-B'/;2W#D2I]: M>\1JSA756>&#[K#1E^EMPFBMS&-F6G?WBYLH/LRWY>W*+GX!4$L#!!0````( M`"H^<$?DS$0<#P(``-8%```9````>&PO=V]R:W-H965T-]Q_F8.OPZK(#06""5[ M912P7LZD))0:(9WX?="\I#1$?S^J/]MJM?L=EJ3D]&]]4)4V&P;@0(ZXH^J5 M]S_)4()UN.=4VG^P[Z3B;*0$@.$/M]:-77OW)!MI\P0T$-!$B#XGQ`,AOA"2 M3PG)0$B^FR$=".E-!NAJMYW;8(6+7/`>R!:;ZQ0M-5P8$:T,I%43[H7HWDD= M/1=Q%.?P;(0&#+*8M8_)LCG(QH=$$P)J`[,N4'"=`7ET-)>@]!'98M;#ER+; M.R)W;<:CS=@U*_8SA#^^%DA&@<0)))[`(KWVN'"M<)#&=3*,]>\:YI1*7RE. MYI0VOA)Z1"C-YI2V=Y3NUI3>U)1>W:!Y*ZEG)0D?49C=Y('>K65$G.R\D&#/ MNT:Y]S!%IY'TA,RMOXFOHV49S<0W>H2YB7.1+_(6G\AO+$YU(\&.*_VMV0_C MR+DBVG?XH(U7>LA.!TJ.RFP7IA=N[KB#XNTX1:=17OP'4$L#!!0````(`"H^ M<$?.AA*;'P(``.\&```9````>&PO=V]R:W-H965T0V-7(^*MH")'!6T=[L0T;*8=-%(E#0SHL'MA`>O7DQ'B'I0KY.1(# M)_AH1!V-(`!9U.&V#^O*K#WSNF(72=N>//-`7+H.\[]/A+)Q&\;AO/#2GANI M%Z*ZBFZZ8]N17K2L#S@Y;+,K=89)^-6243CS0+/O&7O5P8_C-@0:@5!R MD-H!J^%*=H12;:0V_C-YOF^IA>Y\=O]FJE7T>RS(CM'?[5$V"A:$P9&<\(7* M%S9^)U,)J38\,"K,=W"X",FZ61(&'7ZS8]N;<;1/"C#)_`(X">!-$*,/!

N*LS$0`]8O.]ZH=*Y-E',@C!NW[5*5";5ZK9,XK:*K-IIR MH,EYE)\;)+,!L@;)HHQL"9G;,FQ.;W(0 M0&B99(UV"R/T.0A:@:`%2+[<([4@R`'Y@A+@!4%W@J0KD-35)UZ.U.%(LMC? MD/1.CFS%D2T:4GA!,@%D*]X<"B[B`I9>EN).E7+&4KC[W_GE*MRUY6D(0>U'*CU`BYVP:\)G\ MQ/S<]B+8,ZF..7,FG1B31!F!!]6#1MT^MX"2D]337#?''L@VD&R8KY?;'5?_ M`U!+`P04````"``J/G!'JQ][?,$"``!-"P``&0```'AL+W=OY>[$RG%]MKJJB9)L$- M6+MOOY!$!99MJ!-F,4'*8_W22(V!U93<<>/ MK%&_['A;4ZF&[3X1QY;1;4>JJP2F*4YJ6C;Q?-H]>VKG4WZ25=FPIS82I[JF M[9\'5O'S+`;QY<%SN3](_2"93Y,K;UO6K!$E;Z*6[6;Q-W"_!H6&=(A?)3L+ MXS[2Q;]R_J8'/[:S.-4UL(IMI):@ZO+.%JRJM))R_CV(WCPUT;R_J#]VTU7E MOU+!%KQZ*;?RH*I-XVC+=O14R6=^_LZ&.2`MN.&5Z+ZCS4E(7E\H<533C_Y: M-MWUW/^"R$#S$^!`@%<"R#\E9`,A"R7D`R&_$?"G!#004*@#'@@XE$`&`G$( M2=_=;FV65-+YM.7G2!RIWK'@7L%;+:*4(]&IM?V2J]41ZNG[/(-@FKQKH0$# M.\R#C8$^S"(`L[0QF0^S,C%>E4<3@8D/LK9$T!62J'YXFP(O3DS384#:?<:-,LO5UY;,)P2,E[-Q*EF8E4#O-5,#!N"_K=?UY,O[E>0 M.K7H/YK;;@Q9/@!<"2N2,NB=SP#J)X32G`!2!'BYH0+@9[T;]B0P8V62Z?8% M6+FQ`JPL"'E/@9L&(!_/P,4`^F((`C<4@)4*6>[KS`*8L0`+&&;EY@+`XXF[ M!/B?:058N=D`R'B@+BT0Q##`QPT(8"<$\OO8(.SX),:AX4CW["=M]V4CHE&ULE97-CILP%(5?!?$`@_FQ@8@@35*-VD6ET2S:M9,X`8W!C.V$Z=O7 MQI#:R&W438S-.>=^UT@WUV$!Z]>;, M>(>EVO)+)`9.\&DR=31*`$!1A]L^K*OI[)77%;M*VO;DE0?BVG68_]H1RL9M M&(?+P5M[::0^B.HJNOM.;4=ZT;(^X.2\#9_CS;[0BDGPHR6CL)X#S7Y@[%UO MOIVV(=`(A)*CU`E8+3>R)Y3J(%7X8\[\4U(;[>N*LS$0`]8?.]XH.=&%N5Y66,'L/` M%0QT6@9N&6A@H-US6L99GOBN;P_]U_=7%K1B08X_]K(@FP4"`+PDZ#])\A5) M[O@3+TENDY0@7@//W\B1P0*6CVF*%4UAT?BK[`J["H)I4B(OC:W+,V2U9F@B M:S8,^$*^8WYI>Q$K'7-^0&8AF(]FP MC/?[?TS]&U!+`P04````"``J/G!'4UI\7BP#``"V#@``&0```'AL+W=OI$ M$P8&S-+$`#`79F5A7(A[$Y$YDSQ82=(+)%)U.(N!0U;,T)+3.`&XS9,CGMS@ M(1`[>7)S!U-[!\V:\T_67"`MA16?.;44AA:6?B3EH?BD%!(C+7J`OW>33\L2 M@E.0:VO+IL%%C(**U,\=!$\58HV5PMDN2V+.%:7'DPL/%F)-C/%Y)ZM-X$FK8JT=WG086'#,FLY?-XA!`\&PBS4F3N M5;%!S(,'SP:26RD*CQ38TJ2XUICG9C%-#9X>`.Q8L!S+?%)@QP+QL!&8CF6> MG0W_O0=8CF7$(P4V(EA&9.!<6["-Z-6S@&T(U*/A;!#U>)L`;$.P'N',)P6V M%V2WMW`%YE.O)M`5M9'Q_G\H=_QGV>VJ5@;/HE>?$L-[_U:(GJML\1-GU7C1B\/Y*_'RJ;KX!U!+`P04````"``J/G!'+6IP$L@"``#""P`` M&0```'AL+W=O;A/$K'>LY:*.WY@G7JSY7U+I5KVNT0<>D8W0U#;)"A-\Z2E M=1IUL`:MI8Z!567-_;( MFD9G4LQ_IZ0?G#K0O#]G_SYL5\E_H8(]\N9/O9%[I3:-HPW;TF,CG_GI!YOV M0'3"-6_$\!VMCT+R]AP21RU]'Z]U-UQ/XQN23V'^`#0%H$L`X$\#LBD@"PW` M4P!V`I)Q*T,A5E32Q:SGIT@<*_@O4ZB,D=BR-:/]56E$.KIVR+#U2QY MTXDF#!HP2Q.#4.[#/%H8'V)E(<@%DBB17J7HK'1,_$+G!@P-Y"H>GL'@RFZ<: M>0J#)[T+.=VEPU):+-B[F]+<#:D(E,5MHLHAJLRCDGEY*OO(9F6*O8)6E7UN M`PL,J2-)V_.')O_>)TR`*!L9K@I<598UDH#?%%S+@@#/@J]9$;A>!+89Y0$I M7!]<8E2RQP+KX%>!5T7X_8K MLOO5X<$3CSV%N#R),3P=Z([]HOVN[D3TPJ6:PX:A:J=JN5<#]671 ML*W4MX4N\CABC@O)#^>)^3*V+_X#4$L#!!0````(`"H^<$>MFKLVNP$``&$$ M```9````>&PO=V]R:W-H965T3JEYLUT[X":@VIK83NK>?#\`@B]9Q@4_?Z3RA\ZNU%()9NQ0G;'N%;#*DP3')(ZW6+"VBXKPM7 M3L0J(^W55-@N6YFVL]D\3^^=@HO3%*5P4_K(T>@E&Z,(HWA'[LDMVX9$N7[7_$ MI#<"="60W-N/DB[W@U)"_]X0O#@-/3O#=Z;.;:?141I[L/PIJ*4T8.7BC=5K M['V?!QQJX[H[YQ>N0!@8V4\7>OZK%+\!4$L#!!0````(`"H^<$?M\7FJ[`$` M`'8%```9````>&PO=V]R:W-H965T7(!2-*+\4)RUX`J:V(41R'88H9 M:;N@+.S>BR@+?E:T[>!%('EFC(@_>Z!\V`51<-UX;4^-,ANX+/"DJUL&G6QY MAP0<=\%CM-WG)L(&_&IAD+,Y,KD?.'\SBQ_U+@A-"D"A4L:!Z.$"3T"I,=+@ M]]'S$VF$\_G5_9NM5F=_(!*>./W=UJK1R88!JN%(SE2]\N$[C"4DQK#B5-HW MJLY2<7:5!(B1#S>VG1T']R4/1]EM03P*XDFPM@+L0#;-9Z)(60@^(-D3\^^B MK0X7QD0[(VG=A*M>)RKU[J5P8;/\<'!W$QG8T)5W%RG[)94#8>)?$IB:-L9I0HM,]]4+(`)1XH M]4$N9N_'9/@;YS3-+__G,L@4E\R@/-\\L^Y\SRQ>@?`[*PIOEY%^7 M@V>-P4"<;/]+5/%SIUQ?3+O3%?,8V\;Z#"^+GIS@)Q&GMI/HP)5N3]M+1\X5 MZ"S"E2Z[T9?@M*!P5&::F?-P]X);*-Y?;[GIJBW_`E!+`P04````"``J/G!' M$LN!L"\"``#\!P``&0```'AL+W=O1B2$\!&RB" MM3+JJ$R;CS@3]/O+2GALN) MH"R"JUW==JAG+>D]BHX[_PO85B"1$J7XU:*1+=X]&?R>D%_^FTA7A[R%#%<&_VYHW(MK0]VITA&?, M7\CX'4TYI-+A@6"F_KW#F7'2S2:^U\$W_6Q[]1SUERR>S-P&T60070UT)3XT MB">#V#((=&0JKZ^0P[*@9/38`.5J@ZV04^E$>/:8\D9UN41F3,Q>RC@#17"1 MCB9-I#1/AB:*7)IJJ7E7!"("9QC1'$:BPX@,1&(B4AV&UO1*`T+UNP^*+5!L MY&OELM&@>`$*5U%ZGY)8E,2@Q/<=I):#U'#@K$>5?J8>:PNTOE5XK:D,37*? MD5F,S$@F=3*R!QFYQ<@-QMK)R!]D;"S&QF!DSD79?&910&B1Y/FS0.6N;5I- MHD?V*0`VR.S_C;-NIN@_"@?L]@;1K;:;,=&C&+NY@='=>>C&Q(]B[.X&1GOG MP+TZR>W5"1;G]`!/Z">DI[9GWIYP<>2K\_E("$?"5[@2FZL15_%U@-&1R]=, M[CI].>D!)\-\UUXO_/(?4$L#!!0````(`"H^<$>5M`07[0$``'8%```9```` M>&PO=V]R:W-H965T*U:UIE+G!5XBGNV#'H9<=[)."T"Y[6VWUA M%%;PLX-1SO;(Y'[@_,T%$SE2]\O$;7$M(C6'-J;2_J#Y+Q=DM)$", MO+NUZ^TZNB]%>`V['Q!=`Z(I(+8!V(%LFE^((E4I^(CD0,Q_M]YJN3`FVAE) MZR9<]3I1J6\O55Q$);X8HZO&A>SGFO6DP-K]+B(*_/!HCLCBQP;QS2!Q.<9> MCK&?X\9!G*:WFG`5)X\IR8*2>)3$IZ2.DLPH<5HD>;IY#$H7H-0#I3[(:?:^ M)GL,R1:0S#/([[Y9]L]OEB\HN4&ULE95-;Z,P$(;_"N+> MV.:;B"`U7:UV#RM5/>R>'>($5,"L[83NOU]_`,44B?828_N=>68F]CCK*7OE M)2'">6OJEA_<4HAN#P`O2M)@OJ,=:>7.A;(&"SEE5\`[1O!9&S4U\"",0(.K MULTSO?;,\HS>1%VUY)DY_-8TF/T[DIKV!Q>YX\)+=2V%6@!Y!B:[<]60EE>T M=1BY'-Q'M#\B3TFTXG=%>C[[=E3P)TI?U>3G^>!"%0.I22&4"RR'.WDB=:T\ M2?+?P>D[4QG.OT?OWW6Z,OP3YN2)UG^JLRAEM-!USN2";[5XH?T/,N00*H<% MK;G^=8H;%[0935RGP6]FK%H]]F8G@8/9NH$W&'B3@:\-@`'I,+]A@?.,T=[A M'59_'MI+.5-.I&>':V_,9"\#Y7+UGOLIS,!=.1HTQN0XUZ!)`:3W583GVN;> M'!'YVP[\T4%@8O2M&)$=H]$<+4VPS0@6C,!B>#8C-`RC:;4F07&:!M$V*%R` M0@ODKX+"&>@A"-,0)?$V*5J0(HL4K)8M^F+9X@4CMACA:C;Q+!L_3((X3+=! MR0*46*!H-9GDB\FD"T9J,6*;D1I&.DL&[E"X34%P@5&]8L9);([:U9<.SDC> MSB,/\!-G`*$ES+[@Z6KA;-$G*H>\)69^R0,(5VLWB,;B?0"!6>MJ"+OJ#LV= M@MY:83K7M#J]`H_Z$0#O\CSK\)7\PNQ:M=PY42$;J.YV%TH%D6'`G3R7I7RG MIDE-+D)]QNK`FLYM)H)VXT,TO8;Y?U!+`P04````"``J/G!'=CA\G1Q?``!Q M:@$`%````'AL+W-H87)E9%-T&UL[;UK>I75'2H[Y`1 M11H`"3[L'D?H07>K6Y;5HM3>B8G]4``*9+4!%+H*$,6)_15CQ[W_1[]LSS/S M9%46`/._''YIFDVY7Y3^VQ?-JN]K\V^].!\/?I1^7 MBU7S;[^[W6S67W[Q13.]+99YS]&JU*3?WZ#+!T-AN/VCZ^K M#\?IX"3^H]O/T_A^_N/II-G4^73S/]M?RN"WQ4V)(V"*U_FRZ.SL?E74-_?I M\S\]3Y]7]?JX9YKGL(C[^[7G56&@Z._]G[PIJC+"@\W M2U_DF^X.!7;)O_Q+#$!/88X9S?/-(K]I_SK/%TUGQN?;NJ8/RF8*1_KW(J][ M5S\Z&HZ.3H8]4/FF7!1U^AR^NZGJ#DBNE_D"?W];K*MZ4ZYN`,++=;[J#%08 M5\LE7.GUIIK^D*77A&?I=]M-LP%DA,_;G[VK<_QS>GV_G%2+SNJO__UM+\SE MZ`+Z;^#/'8S^Z\FNKPEPT6^?5X`FJZ:8P9E63;4H9P"B6?HL7^2K:0%'@^<' M3^G]]8OTX,EA9YUB"C<^I`=QVG=Y3YNFV#1?=G[.F]L.BDRG2"H:N(AI47[( M)XO.-?M?TGE=+=.Z6-".UWF]Z5S7F[I8Y^4L+3ZN\9"=T[]NF M*SS$:IXNJM7-T::HE^D,SOGH#W8L&.+#J_Y3O'*S/@0C/*L>]:'?Z()PL[C% M=`:/&4&[UUZC&^D9VC\`"5U)R-G0/4Z!=0(A*U;3R&`BA[?58E;4S;^F5__8 M(JD\>%',RVFY.>P2`":B#1/1)X/C`?R_(9XI_9`OML57P$L&V8#_5Y@Y;>)\ M[/Z:;S>W55W^9S%#H#3K8KHI/Q2+^Z_2L\ML='*1#4Y/Z9NS438,9\*7@.\7 M?JP\Y0ZG>6C+Z:9*)X5,TWD$LUF)B`;0)0($+WN:KTN`=N2Y;)=;OLX9@RI^ M2TT`W4*@*Y]T*'/G9NF@#]_09_&&@SP`1$ MZ0"EORE7,$V)O*UJRATB4H@K#D4>'J8HXW!DK^'Q"XT.K?HY?@_L'`0:!,%W MZZ(FX;!)#]ZO\BW@3#$[[&>W)WN+KAUF_'(UK9:%7_\!6+\M@"G&8-O0O37Y MHGNS?ZRK!HAW7+"`@QZRZ%&YZ^L<&=Y# M#8^>/]$I._<)?+L`/-KHHEV)V>^[PP7V&ARP^YZCTU[[COT:GO@K.'+L[PNZ M<_B8G@.@[21ORBE!?%8NMILNBGY?E#>W^`[R#P"Z&]P6/RM^3WO,L->[0M$2 ME(SJ;L]W9<;3Q7J,?8J,("ZN"`"ZE/_OVT8X)G`(0,0*J!R(02N%&/P5_SW% M1>'%?"CA+:<3H,-;/%:Y.C38F+OU.^R3:#D"K$"VO,3KX[OO02:\Q10?Q!3( M/A/<#AQN08Q$$KBR6R!)D.YDL8_85_>*[BUI/`;11P)EUT6R;/WP1;[)[_FV M0%6WP$%$FAL1_S'??0-;A+^^WFYJ_MNK?++_!&@#:/"0\.^[,PN+,`D)W/@/%/9`WL'#1F\/!](_KOS`#(33 MFW*UPG5AUVNR'SSBZP+EXK[OKK?K]8+H+3"0%\"0@+!MZR*@O=;XU:$6ROEZ MN.PF_QB1$OH7?5VMC@A2_L'CJ6*H_*`:HDH!ODAX\YM%83&R_>4SD$A0$S_CG'FKQ M2\[U2,J#2JMJ5&9NI)SI>EM/;Q&Q\YNZ((CNT\`#F/.8@*:V%S%.0R-)GVZ9< M%5WYXKOZ)E^)F)<9(4AEW3=H:8(GXEB14[.,C-0O_--%#M-/_V\:WT[:,4.G M!Y]^E#]^^BE+/OUX5\#_33_]N&WX_U;;^M-/*8`1Y_GTHUA6/_UTF!X@@2CJ MQ;V;]1KN>=WPQ(?P?AH2HNMU52,]3^!(+T"\6$Y`Z!Q=DJ8S0'+YNOB0S_)T M"[(A+[/*E[C6=W4%!(GT;IJS8GG]&/;SW2I]NJ[+13H2\V5&'\KNTBF)0G#E MFR:9LQ'U'HVH2!:))?QY"]L^&:(TY[9T,CPV\U[LF)?=@*:":`-HCN`'Z"-Z(W\=%N3RF*>E9N9 M9H,MPZ,`U+V#O]$#3)OMI"EG95[?9\GK8HNZQXJ!D]&T^`T\G.T"=G`+R@D< M"`9,K8K!P`"RT;AW=`RJ4<[/[GLE]7!E?\Y76U@I'8UBEU80ZYLEY0IN*_\U0)'+XL^MG]!1]-+UT^>);7DWQ6@7J*)!J_YF'P598`U4,:M4$< MN;LMIVX.HJ`,P['OR=-&FG,5TYZS-);`"8(%AD_R>VZX@NJIBQ',,>!N<4<"+!B262# MSH!$_SJ?%P38R7T`)/P4=%*0.3<`#G_5#$JW4=HCNAW265VM$5&&)WZWQZFS M8K"1OTG_`=B_0;*>(`1+[PF`)P3/A,``!_DV!SY,WJ,_;U<%6:ZNB_5&2"F# MWY!6_+K(X0M<-9!N[53XW@`M8+/&.`<`!392KM5ZQ,X(VMUV)9Q=S@"[G6U) M>$,8P$J+$O\,AR:8(\R*DLB/>^5L<3O7!_(M\DT$.SHIZ:4(KB,9H7L4Q,Q( M0P.2@1:=NF"&#GLK%JCH%HV]*\2U:K(H;\1`DU'D.].LXH/7+ M'`C.QTTA)$[WEN#>^!'>54`F@@@6(=V*(#"$,@.3JVZ^EM,=LNZ+*ZRP';VD[^#F?`GZ?P:G/`"$3#NB0)L2'H)?8R213E M9QQ'<)'7:*$#F.[N%EDAR,ZH!B/&H51Z2-0'.7T)4D,Y;]'.>Y$01%E)>%$Z M$))(("NPD)P(S@*X1`_CH#RD/VW(KB@O*U^M<+1[8$3([JKM8F88K1*(V=8Q M`)*V:/_`8A(60]PNX)4N\YG;>>07``BB">]Q7M9(GH!J M]R3+`J>4!05,()PRE(#V.@%$8,""2"&&\8G('G"N`P8`$2#S9Y0M-W@H$E*; M$N@4H"ZQXJ4:+``6@HN&H.L<3@+-;P"8-TB:4?($"8#5%?$TTG.:5;`BGL"1 M3\;70UQPF?]0J)^111.@YH!+38*\\Z,*\?I-"K"LVYN2]^KVME[D*\)2P#?F M]Y&K)T3LWC\S)W@[CCO9J]0G*S^AQ:I&!E\TK+V[VV_1_D)%UP5QNS2)2U98DFTF$@`+U3&U9?%]+7` M,"6@!/HS#'16C]-L?#G.AA?GSHO9,I54(3LX()4=?D[(XX#2.UH6:D]BD8H6 MK!T*TE1>"7+\4\2CZW>J*\%,C$P>[=4:BW-/B\3OQ$5;&=KK9T*JCP(L4&TY ML$XT:X^LNNH9BHN$ONUK2"+7D.Y[#0;B)]GXXC0['U\:B`=G:L%3.1,!P,-T MWMKYR,'T51>F(22-E^YAF/J9$H3IX/CD5!Z\!Z%H)^RW0*OK`K>G"W:&LP:E MW[!I0:1K>H:&#\MF/Q`S2F.^8"XHT`89;XS`@5/0"\K"'J0W!-;Y)ACL-(WBD:>W!*-8-TX"7U,6?KJU?.8 M#4)1Y;DHY4XYB9@F4C9-K/HW()-U?W$&BK8'+'&[`WB`6K?([Q`;%\`M-R8N M[#Y5&Y22"Q16:MKIWX"MI6]`>ET!N9>IWKYYV_X30OO=+:S]5%7R)DO8($+J M8XX;=V3\.[01T:MY8PPDN';W<"T3@_P^(P%.[C84VF3SP%47\(8#"HF[%.L8 M,$R,/IVEWWSW_/VU0NY`+&]D/ULOMJP.NN_5PR6;U8$E&M](O"/M"P0PP/:: MQ^6-6&"CMA6\.9+(T&<@=#./A?(1#\Y9?K1"L4"`)D_:AAMR<:X,I7?$T3UY M:VS*&(F>G!Z/G=I'XH\H6(+%I&+SC3\Y'[-,0[)2HH-14BM@\:*MKK/F&C+C M<(YTYQSGQ^B&\IX)_SYV&@%A<35/A8\NF!$P&H"S:ACPY/^Z[[["^![HR72, M?H$4<8-D)N1?)"8"LB$I7V+0,"'4H,`18KD^)B)^4ZHLN:?D%FCX@?1\MJ%%<@K/*1SQ MQG9BB0G][WPZ.0-F=5$]Q102L#/40M('2"T+@S4BW#E=+;E@2 MD[F.S"$WMV6M<1(Y*):KHR@!0)S#>P*V4WP@B3MJ1H"12Z![Y,FG'S%.XBW^)QSS-7WE M%(;V<^K(Z25'Y*!LG';G"5&.3D]VRLIY80BY:OFH8T;$B#B*+'4:=?<%3V]+ MV`I9UO11M+##*O$4:HBB5;&:Y74B%EL,4BVFQ4Q'*2:0Z+Z2HS`MP`OLO/?@ MNK];MV[],U3Y%OM73'MPG2QEEV2?D-\>W^,`C,D":C`(&&NM1H15<0,@8C]& ME//BLLJIYD0R#<=,0LL"LO1;66%ZI,V3#D MA!DR/5[FW2'(.D*390O'N/]%"`5`FE M9"PY(:&(&U57VE@DNA@%?L_ M2XFI2%^J8]0:*=DH0!A?K=6>%GJ92[SI0N1,UBWH.`%2T5NJW-Z)R:%3HUHM M[KULLZI2.N4\_U#5_&QOR:?-QI1Y40?D8]U2^=HGW*6"]T5'D?R/SJ/1V0[M MNQ.+X%7CJ8]701N1G*/)]9\2]TDLK\U5[ MKR[LX#C91ZMV0/`J-0Y]?WQ]K,3$J+MDCEY5']AI\-V[YT[Y)9YU6RS6-!YY M!>J!&$Q)\;!P[[#9"2:J`"&KD6SE2Y3N6D"82?*;QBGLTEN'QZ-0;TW0$?9D M),IDO][*#J?1+J73>"'/Z"/\ZGS0^0I.ZCWOY:K9`*5@8?K`.\L=3Y*AXB4- M/.^,LX>]?KXGPU$V1O=!G;)5BV[*<7`B6@"##X?I*/(SQ6OJC2-\SP9BM3/T MC$FLB1PF_LPV=PRG#+UL,;=:HHX@=>N0AK3)?X#3.O,+2ZUDX<;`0$4N!GTE%`U!MRF(EBG0;X-Z&@#*R@V;2M:KWD`&^ M\=@V8(\;I$"N,)BVF+%D8.U2K<2%`/V$+\>(DI='<'H?YP.H M#6/K&\3S!="$1>!K10^JL)F*$H"V==V66/7*46W#]P=O@")-"<7M.?JWUPNL MB`^6?7#&VV7/IG$!:H?=5%]V_')?>7A-"M"3\+L2`^-8YZT9U?BO2([RU0_U M=KV9WG\%/R8EBX'(V8OEFJFX0Y\I/II&B%B..7TE9V3"PT1)"D.Q43T[>L"# MKL&*>`Q1@#D&BYS`0$R*5>+,IF2LA]O0$WDO822FZA?S$JK\9R,V(@_]00=B M&G<@#@<H10I;G0,=0!$@N^G57>&,BJ"/HEF)8Z],7,J# MT2(VV#%M@*EB`'&6KG+08O"?-!O]U[I:E)P1PUJ=()[L*;'^A_;->GO'Y]VQ M,\_UP)YM9RW@AT#>YRKD)K+N'RF@N?VU"]A)D&11ZMZ&=&2,-9Z6&Z'=M!`0 M5R":U7TA[E;4ZR@,HT'=Q&48D!;L,POH%;/?U+4?Y@\@.\JZ+=(4D`OUP[8,#G=5O9C= M`>7L]U*$RRB*)FMK1VY[)5+Q2C!_U:G)E(B1!"%`1A MZ8[<'8VL0#8]"=`N)#FS2`@;O(>A"$._\A33JY?;I6Z8Y%955,3HUF!FZXSC M].0D"^.M>C(>!,/9T"RC$S,Z$^>YMTFU%W?0;1C5:H[O)S,(```X*%6#(54- M_W:#Y100I96B=2A8,B\QX3PP.Y&1`"X#32AH@R%;M@25V3GQ"0#O\"Z*A5HJ M%;6.TRNVLMS1LPZ18)JO_($(#KF1WD)G@A>E6)IDF6OJPA>]/>3>11EO5ZP8 MN?`H#JIR#FJW&/LD$C.'"D/&`'172*SFI`C<#^)2NS?T@S+,0DCH@5:8!XA) M^F-"X$4YMLY+.7I.**I=!3]9-9`23;%N\*/[)\/`07"`-MZB/^I:BZZ M(..MQDYS.%&IGCJ)US#Z5?NPPK3%I:),FZYGZQ*EWJ]*5XR@T:!)#VAD\8K; M+9&)A:3$"4TD0CE6U8/W44!0!#&L-!RI587)*XHBYF5'3@AXFH3'W$,@(4Z` MJ6=L9^XDAEYOETL)N+XN;U;EO)PB7DJU`-SZ&UJDF^X;&;(K;W&$>8OQ%9/8 M=%I2Y)W$NI#@SE'&6F7"IH`E+J;8Y(`AI\6E.O:S=OX*9P.Z^V&>B'9ONG2, M#Y+[*K"X2V1"P@Z>HT8Z+W4MB.@UY@\]NT^CNS+ZZ'_HZ[CVJAY5B%3%@DI:-8U):;N^>JY6=3<[ MVD]KC@]H,'3[&]A@BL41CPEW:Q09)+OE/IU5DEQ!QA>2*GF.\%CSJMIP!039 M.QF&(E#TX$X]N).Y"RG'W)W(93IUIUH#;>/TWV6^RF_$I$4>35.>Y$`XKY0( M$"Y=(]QJ+E[8\*<(NDM`=&]%_V41E%.-!MW)_I4C3/V M*8?^+,_\:PVB(V&A,Z80KES5$28V^;,E@@1:=E6;\3FU^/ MP9M9$FDC+P413I=P+Z;!G8?%04@?4)TDP)*;!`FEDH?&O%Y61WX`-'9KNVA- MSLEA9,\Y"8(?`=XCFKB6#I;Q8CZ95%RR)35&J2ZKN;L(9 MTXU<4[O*JR)(8,F.+9$C?LI3>DP8LF)<]90]I"%<=6C1A+E'QK#D+8BP5UQHS9PI M;GO8+@I)?*;GF6,4VGR[`'R<>W\D.?B=V@$/ZLOT8'BHB.X@]55R,#J$?0F[ MDY_YR=2$?HM\B@`5<]#,Z=.Z)ER6)1.45`OSXKB#DT-"I@6%CJ*GN)XMQ(&# MP86(S*Y6`1%QC-YP^69BS6\RW89_0H%QZH"QB$Z,2QW2Y'@R-Y`FTSN!_+1%"1(,)?9K@ M8&U$LIAL"_*129S_P,G%.57`H'!,2@Z8,#>5C+RREJTEM+5C+N>*_W9OS_Q% M-J$,U#TL(6CMS1HT8AI*[`<]CT#*@6VGLN;W_(6H\:"2UJ0-$/3.+UB[@ M75;;-7DE5HD`LF*3>1N0DO`YK8!;_V>AZ*Y#J%3>G<8*N<5]VEW>7=MY`06K M`(EH!N+_D@6Q76D!Q4+(Y9QJGSGQD"(FD>?X^+.MV#0)SY`IL>&UM"R?=H"H MT7-DO1PCG'!N$;HZ4?+&=T6D$N58V,0M@*C":+4%)X=5?Q?QE=.#J[9$G05R MS]24\MMRS'@K1:5.Y#=GC-.2+!D#'V^XMA.I&4"V"13K%JO5D/W(++W"2!D\ M!%P_?%&3\1*-Q=6RG(+855`IF.\-@FC^B`$72/:-V'39FC;=8E8MWS/\E=#, M9NW>!<@J0.K2%XM,B<-D!Q>@L;5%Y$,IL$@:7`_NP"_YXAY>+YFK6L]$*QBX M^Z.2SEDP5>+1,&NY=W5JJJ+!B,(H.BO8F,-TE)2P/4X#[/1^K:0TC>W`K9AI M@HRY%`Y\P+T@8.N94:9\=G&;3B!%\_L#"5>*F(.ZT:X/AI6)I@I?G)D>"(=[ MZ)AE`31KQ@5C5$L&P5S2'U#=HP%9CZBK\/$6:'4PY8(O="P6[9=+-"T227`GCY#(\KKZA@T M1E!!8RO!R%@Y,O):*7N>W*GQ(0\CY#B(2(%%VCD)G=@@29M'[E! M'%_T)N;9&3P8Y!0URKJ-QGK,,K%?>N<;!J.2A`OT4=^827TC3Y*2$P)8WE0X M@)SB6Q)[**4026,JVCJ[US$#9EM[H^XZYUJPWKA*L6-NGW+G;KP="H*Y1+<) M&PYR@=#@P=Y?IA@4(463@O>TI0XG`+DRK/TA'NV)XC(Q`59'ZCV*C@D(0"=^P-Q.#E M>Z-\0HMXHN5U)J.5Q M8K4]."H,1L@T].+TC!RY76TG&Y2K\\CTCJ&RZTXD21_&`6IQA0'-C`##B`.'T)7FNA8O"@[F*.5;O";6[VYS3Q,)-H/U/ M`NP(Q1;E#_!<;RMF2&9*(@UPD\#OGJ[N6^((V5$0XS&[!->XP=1V-JSL`"1, M-Z/R7A3R><5J5Z"&.^.*\SME!JM((\C-%*3XA6K;-;XU^7M=!`;#F]X:[+JN MFA7C[I0D,'(V0=%N7TT='UE34%$I]J%\*!85*33I<]J6BZN,1Y<"X?9?B+(= MA'U(04/<&DL+?%(6;TB\VGW0IJWK4N':=Y@E%-S'=E.R3<1S/L]!DVO$^KR& M#3RKX/^@%19XZ3=/KXF9&E;K!SX'97@N4C,.?GI-WHOST\'1<'`T&F,4L=U- M]NFGA'W`SJRHJK?R98YQE$3Q_&.?Z.1EO76@BN`G5(/A']N"]&XDA1\DGD:L M-TG@$%`LB9H.<16844BHE^VPM)/(=OOL%F_42'H$\.]I1[V9/!V+[+,PIY-?$,>1V`C;QH*6SVM[<,A=U:BWIH*1,'`'B MW0'N'Z=_TG*(N3^3(9EP:\/!X/I[,PG2J%SPB9%86'OJ[Q>4=;!P2MJ'O$&.Y%)<1.JR1*:IY?K+2)$H5^Y MP%2I10(/'LU,FPHTN71TAL\^\VO@Y-<:1UA2\%0\4B:#5)C@$I M6NWQ*RY(;EI>Y!L6OLBLHE5J3%RNM)5AI^H*R[^B&>10HV/NVJT?.B57JG8= M(B,4T*3`0RKRS<"TR0.^`TK3I.X1[185K1-+Q767"^KGW[WKQ&CI<@!Z(M-6 M:3M["HZZ\WYI4ZN3#9K!^0^V;F>??MS@1K>`<0T784J8%!YF)M(&U54F`9C\ MVVW0@>HU<),C:JT!K*S?.4!F",W7,Y6,AMIX*>FY,Q,GU>RL@11\>5?408`\ M&@JX$1\^UE6K'%_,Q9CLX4&M"Q_GP.#U7K>0`N>@-8OL@NMKPH_)8U`^ZJA% MTN8:Z.9Q=,0RD5UQ<2'Y1.],3NIXNU,4VBG<[27.M8/1FJ?9<##.3D\NNW-A MK5L;,$W!G:=GV6@\ZHUFD4I=H2'-U#/0RI@)Z94!Z*BF:H$.(:U#83[EHA#$ M.F>8;[;Q!>Q@5M!69RW"6VA6/YP^4$+4.)`T^%:6=`64KU)H8R*\6K+1V0V4 MA$MRZ5*BHK.54M_UA.3R*?-;REX)Y-:7F+@WXZHCKE9H%R+L?T8C'LFIM'=$ MCP4&ML*+(5S00JEBB./D=[2&NK.D"_P^E)V#LS%G+M#.8^,'G^8KJG,I M88P4%-!(6?[&*?XA"":%YD:C+B66+7C$@#DHA$LM9`K6QV/^8KA.!AVJ.B)S M;2JS$8[XD7VPQ$=`!NUR"IS62\F^8@$:<6[J?$V*4:+NB(6D16E`L%PA[MST M'D$DXGJ9!H,L\G:BX#XOC*,=#(479'LBD8V6*?NP5&_)/S0VSH'I=Q*:SGN$?A>OI>[VNB[92FP^C\3-H:AV@=6B M^C:)U^A;F:!ZSU^D7.B\,?-G+7(WQW($7+88%B2JF[$I0_Q`Y1J%BT3>N3D)V>+9L>04/Q6@XF>7I)8==UY1$84EVI,4 M`51S2@(,:#5G<'$F`C?-`L)B&.C]Q(Y%6%VHVJJQQJMZI8)7P2'V9Q>ZXN-^ M$@ERZX!(9D#7']O+X>H4'NYFW#5DDF*-P@F&BJ''O&Q^\-DGK<+4Y+R%`13- M4*V,%].C40MA_1T`+ZO1OB.M)IQA(E]QEH%D7WPLEVCU5Q@MR M/!NT*."A-7*[ZHQE,,1>2GS+'(%#3);=DSR+#2K$P@*H#`E2F2F_3%\1=QZF M1^E?MQ67G"*[)L7`(G]`1USBW+%M`3'G5`*^V,9'\M\5$@Y#?"3M?0>\_`B6 M?\G[-F[_?]@-)9(LJ_MU5GP#0#7]Q/!&(O9G<(/3S4)25?2_=!\GV'TO;-)H&%"HV\B*(=I9I. M;#W:6D8\2D0>TJ(,/4C0*.'M44Y205MU03Z,-(X*LE2+VQRGKG>U^9<$]-)^ MZOS.)0&!L(=\O5JYP")U:Z3BUFBI5SZM!T&Q8=O-QH&MULBF].";E]]\Q_\D MRYG4H4:;2K4?/R7B M\A:+@41"LF:7IY,2%7J@ND(V'Q_+(Y*#"'RE>=479E>)W3]2YP]0:';ABQ;$WBQN/O-/6[`Y* M!C@X"PC48L)MWP.#/G%L2>J19*;(-X>^4OLW2<&=<`$@,=%HFI2[-(<35.3* M5<$BVWI,A^4'W%3IU@R2GNEI5:'9FL?/I]7OB$$>#$[PT M:1CF6`;Z?[2X>-19]'Y-<2?D_7FO818;\@#K1V.GXYWNAX-KM1]?G(R/ M3@:'7V+-`R`)\WO%;QO4CX3X!;;D='WNR`\G*B,<:>:"VHGKXO$\K M84DG&WA"8[UV,#&I0(DHQ!+'CTF-Q8:50I8WX&/QD?O@O4CHH-^3$6/:S"%H MMLQG3:S3C`1/(W7=H+'/.6XC!];4%7;3N&B%'@!V@(L.`%]?CHL!Q!(+?`=+ MD^`B`KNF7JEKR8E*^*3#X;YD%+O/-;\D&8X#BV"P027PXMBF,->ZV-25RXPE M(4$R_*.WB;[#G`OAH#^"LK:YJ8]!`U/'E<(UB449I]D1KH?2FQC$V:&'A4B] M?^/.W5AH(44^*,XE9;I5PRGF/!F[C&"8NW&Q\L1SLOQ;'^%;_Z:8U%)$.OK< MK]\G_C&/VAT>#][QJQWBDWWJ8>^:B]C!3UTHGRB54AQTQF"3V/)T@U[O#4?` MD?G7&-)QF@"QN>01*6DE]3YAG5'+H*RE%CL&AF;1XBBN*HR@I+I#Q.'&67>4 M-T"UL;B,E"<,IK)3EK8&4/^Z8`"]T:K>W(":#=R$(I)06&^VKD.R"_J&+%O6:)&;N:MK!)0E@'[)W1 M'FB=PV?G30LW+)(G4<,Y\BS$E+LJUFJ3:[.7!44PF5Q1YF%9>/YY MS=$'3B(6;XZR/N$V1USXTJ'TP\N:)D)!PR:0`NI2M%CYLY@M@"/_[>65ZX]( MP=-BK327PE%$K'1H5B=@#^O]#9J\Z:`4/5T6(OKXR%W*`Q-!/O;P4`6#730> MI]4*WN8?^_&'Y#'\(?7\X2JG!FDS<21R"#/;T8)4$S=@Q<4=[1Y0F$O$I,S" M)M^N?D,ZFR>P&#?/N4*N_H5WB4HXGR"2!O!G+L4L=*1(PEC&B.EC4;CHU%;2NO,&(AL M\/*N))51WPBY4KDL8;@T+<=M8D5Z*:J]D$,LU$;&>-DQT&8T"D-]OF=E;=K8Q^$2"`5XI6/J9< MP"FA[8D/$&#@KG5.D[\N=<1\_'%,9B637$_]/6<2]QNIQ4_;)-H/S`;4^XT> M4XI!:_/4$=.)BWL>(19E@G4)?%P6I\E0"V39DU3QP5-Q9DAT[L8)RUK:UHF] M/5-*2J3VI$!AN`2X?:BF[-^VV(.U,_WKJPPN28D9Z>X4P7'Z?E9R+1!&=(PN MC1/3Y+,Q_&Q/#)?1B-TO`/Q<_9=-F7\J9L1CG6P\/D14MFN`V%1SLSXC>Z6W M5;/Q):>)L=_>3^IR%O!]E$BE9`WM1D,7*R[$DDMPC<_V#U-8R.H[X3J9U(XW M//W#Y#'YYG@\--/X48< M257ITV9&!X'NOJZ9"QN(*0\3`/W&O[[("*N0YL\5X?MPD#*>9#3B8.`OP;)&9&(,_BH$[WQX@<8`SU00 MDA&O1,.N<5S[G?;[P;X4:%Y-WLB5O^,PWSH=!A.@-*[%2E,^#FM85S&"=L@4E/"HG&&<(ZXSDT(5M[=0>UV M(,7+E$M/L#)FP0ZL)ES5NS&\S0D5U< M:C98SB?4V8@3\G-2"38I;NPH!\7QS3$JPA*]9J8@0UMN9ST,K\>B:/*KH^B9K[NY04M" M:!]-%/WF_7@[N*2F&.SH&%KW..'5A\H4"*FXFBLE"K"GRCU&FVV+QBL-^;1V M>6?0FMR[NB`6>!>!QV4G=E_L+1`(<@/WYUIB;Z3829:^6>14?PO+D&EM!AU^ M\JJBY])^Q6K0<%+NV#] MEXU\4O%!S9EW8F>BN24D8^96\/9]7PZ,'22R5T-:@D*TM*`/UA=];&9.(NU> M8C,E4N8((R-NBP7+"1@O&M[IKT6S45ZH>Y[%0\H3;&E?Y6D7F4Y:9/J=#QI! M.R2&CVW)'\AIEBC1)RK,+R7=7!/`?,KJIIC>KLC["G)[74@=+/$C&`T5Q$;< M"$67UH',A<&LZF;QQDJ*R5%75Y"=U&%;6%E@VHX(1VG5AYL^FIX<:>W,F;Z<;GXL@%`%__V.[K] M^D/Q.RZ7>8)R9;A8\]E-A[_\K>OP;UV'?^LZ_$_I.MP)GPLL3N2;-LY-T\+< M5AQYN)#*[K&,E]S?R(Y5X]74(D^[8$DGT590PB;NN/:A4G6?#X4GR MTI;05ZG6Y`)B-U"MB.W"*=.Q_U'J2)MP*SNB4TWMZ'F\T-0PNSR%54\&B:LA M-,S.+R^RP>EY\LJ#R)_PC5"0@XO+(1XE/<3?:I0PKS2-_P`G/3T]@]^>I&=Z M*$:BZ#[$=^X/G6BQRU7O61OG@C5%X'RM-W]]84&Z>3K6;A\`=[(YYU@<0>4? MKQQP?)*M&=:IN&M)90>G@P1F^PI(Y2+)C5.\(UG\1G0R&PBR,3N[L0>*"W04 M,7G@)(.1]G9Y3@;78[Q/P;9V>@R&YX/D]>=%.J#X<5)=GH^3`_3RY-1-@)% MWD*!)Y0PM7R"L3G823,)TJE<*M47OAZ,X"=J6)5&C]A2,U(M)BP/@SUXI-B^QS)5O=YE8SEU"NJ?.!`.$0JL'*-AWH$S:U\6=GY7+G*FPI1HH1 M^U2.UHHKMG_->89FB/.S$V;F!R?9`$C>^.S\,#/='-`SO$\?4*R/$_;(_/*W M1J"_-0+]K1'H;XU`JU^N$>AOLO\_2?:W1,H5W?V_4O0?@P0]/C5R_VAP"MK` MV(K9PY/S[.3D;(>8/49Y?!R5LH>G%]EX-"`I>PBB#U.MMG'+[\$;NG=U?3E% M,]9_@VRX=[>Q(LIE>[M`.P1)^/9@])=)1)[IBKY7P,QN[AT7!)WN-#L=#_$? MH->`L@^U9!EIZ,L],!CF?"Y+?] M)#V]O`0%ZL*M(PF1;6-@9CZZRYL$GM!,RJW%9`M/N5YA7+<159J"E)$B'1YV M;*=!>7J\VDX1\@>_>+K/%X1U8\2Z!U9+=,9]V@,E)\X6S=5'34YZM\:K0Y3T M,Q'E3;0,/]XDJ-*G\'^/DE=<&]=6G,$R%*6(=J?QNJ;(Q?'R2G0UY MDKTV0^K#G+6'>+O1)][60--VRZ_W55T?P7G(8A`[43#R8'0QS"Y&EW2JS@)Z MM!%6,`+BA6_J",YB0$*&/3NCY,P]4DG1%D\8N?=D=`%*XIB-AD\&;9WD<G`XN`%YG5(6*/"-:[&TT&`TZK_>M2/=O M*$K_G4G0V'_D+G9QA@_W@<^]?RCB'M+DPV1'?2Q3Y:KCV_(5;C)I0HS,I*6: MXM6+6&^7)PT/8[N_!GTL[D MWGGM6RN/V4.6.^<+JZ]\N(3/U08>';-PQZSXF/`6?#6X?=Z9FO`PGBYW==A$ M3TY.'W.'HO$#^'X3!=B3X3E(`*,1L>Z91OK\4MOFZ%L?4TM7XXL&'\>;7@%ZFU-2]>/&Y!495YAF] MD`S?,\PM^WHR1D-V-CR_8-$>9$W,:,NTNK0:]%@`(EIV<7C<,3']$F#)W*OW MS;8BUJ4>:'BM7B"1/!82EZ!MD&'!P"$\=D^W2*^+X`M4+<0H+>WO9'CCQZ.P M^SG>]'/RID>VD42V\6BQ,.H456IC=<2?+1SJ;F$A3(,C28?LVA=GY^Y'3DTD MBC8&?>'B)`7,O1R>)=_"(T5A#O2V&CTV)Y?#[/1\!$+5&U_:7`C@4?(=A<0- M+P?9\'2(?[X87XJ"@4+?V?@D&UV>P;_/3[.STU%'77Q-K>T$UNT?*6-]?S7R M`N\OF/#SB`Z5#HG8B;H]>1]+CWSG>'H0B=V)]6.K'1.WXU(1)8E&.H%C@5SA M],BUIV*.-`^:PO#(Z(/&"&6N<3][H)$1/R1(3,A18Z6#G&M`P+3#\>^=3/B5 M!IS/LO162_Z1#=?5Z@F2@U#XXEP*BOHQ153UKU@CF7C;?4ACYK@)--!MT/IF M'/\XRFV4]D@2[`Q4$`3W\,3O]CAQ913X_37>VNK<*8)`)?6B(#!4&%"+)"6JZCQ9(C\FJAZ MI";_@T%='4CB?U"UK(@*T8Z%T9"=1\;0[([#V1W+<[Y#]'(R5/*@#!4Z_EH. MODQCDA]Y&Y<26O&+W(5/W'BDBRKA$*F''53IK^6@2O9T4/U*OJED']]4^BOX MII*=OJGT<;XI/J92F3PFRK/R*%)[MP>\*0__K\#AJ'1U>]`5L^X=0MJE2X62 M^3[]5R(3TB[Y)+'2\M3L=<$-A=!<+_6(I?BXR^,U56#R[>:VJHEL8UP,/D3\ M\_DX8N0)2YD321HU0R.!I-KX<9\.+
4_96, M_7%&]I`W`DGF+W+&#G)U3DC*!I%FO@3F!/0'EH8IO`[."4@X&OL.`&220'/% MIEQJDV<9W;*(>;NDLP,B%8R*F+_,L4>@`HY`_WOP:LVV!L?G`]O;H%M\F;+0 ML&,%U4+2"TN"D!@:^"=$X6]?"`=&J?NC!/GCF<<#X@_!()):#2P<-7&]'794 M!94$CN3L,AN=7)#792]KHY,'*/#'-TMH$TML+U)*Q>W_)U^NOR)HE-C/>QJQ M@MCA.'4P^!$Z]'"`]+FS>!+.]PV59@,4I#8BB(H6'[BR+H7-<>M/RG]&Z\9- MKF5B&%=[FR?XTO5:!]!7AJ^U99SFOTN9)1`U-URLV96V[D^S;-U0-TLEI>)0 MD;#&.'.4>J&=>S&0E_PNE_RK'HSGW+F9\WTG8;[OYYBQAD.?;2R[4KZ5]O&M M!S-F6K`B[Y(P^Y?:_(XRY+2U4LH;<>0UJA583SD/B1[M8GV.VO%2[EP?[-=+O.:&HOA>M*EEUKZ MR@*6/GG(BC7;5Z+&/S^*]&`Q`JU@ZJJ2`Z)3578&?AX4Q&381^7&+Q.'8F:W M^K^_4\E7X];XNE]!=Y;C)(7F$'^0-, M"6L.N]^$:]FES(YV?98\2>D>_?(MNU">A#=&[DZ9Q^O<]+4\-.\HN_KYX7XC877*+^\;__&SDY-Y(_<(+/GS]U>,H_I M(--GO&P;R`7>6CS&1[G@7_8QKVJRR"F)A"X-@3ANLT=>0G3WOO6;ZS0644Y\ M+&TBBA1:G7S;7327KS<^1^+]BC9"Y0:H1RA6Q-#`=,ULMZ69**G$AP;5IHPR M!D6W]\/4B^Q\S@CT=@M/^/KH?S@=VG>NHU(&JB61O,_-E#5_]NJYIB>XV;E: M%`?9H.#_#3K[AX.CO[9J1VVP*FJ[B=!B(7.$Q]+"1*9;R^0^!D63T.[!G6CM M38SE[:G>^U+\3VL@D"R.^DI-&>W+-C:^F7RNS[W#4BNOFZC))LL%>:7HO\BD],BMOF) MK2#/KN8P`YX2'.+1T>YI)8]Y6K[&6EWDVOWW[]K1W&&:>;6[^@&2+=`2$-U[ MT4]I%.5(F43+8&\ZG(;(<6D/U!X4Z?\"^P&RGK@]PXOIJ(;/M!6M+3^RUZ`0 MQH\BOOKD-K3N?4.&H[-=@=:1NH$('22"&Q)'-E#UN$V3;@UOJC M>LN^>FX'3.]9_;^2./B.$MW^7% MW7[P,?J-3W87R=Q4O))WAJB"_C>??!=O4)5I,PAC(9BJG643Y@ULO)]6HT*B MS\&)L=U-N+;7#S1>14I.LJ-2"Z[8Q3V+M2(_QA4X>'0-5UCHA$Q0^`^T$WS( M%T57LN\?V.JFZSIFH?T?AQ(]Q1HE%%L-V+CZH0G*$2O2XX]5]0/EZ<[J?+YQ MUAU,J<20`ZJ"S8+]K*`?V3!'[G+NZW+$74"EE"*#F5+#Q+59JEY@HG.I^E/# M5?)-+ESFNL_)R>D?A3]YO\TQ>+VW.?"B0Z6! M"!9AHXKO)KEO'0U1SX)(;^[[M5VF-0@J$C$B-CN71CWW"6O42$8K0B'!_S(] M&![JZW)@_BHY&!W"OH2-R\^FHCMET&(%ZZ58DH1U!*G;AI1]Y)+[7^&X@Y-# MPD2@@#-T[M_D]8R*B$D&";X@EX5$S`G+7*EW4+W53:;;\.]6=B-RB.GUA4L= MTN14SH51)X2=4WD^7``)9EES+XO@O:RHQOL*><`R_SLE MO+@O54]C>B7]RHD34:,Y3L/N8-[.#(S.`&H[HR4RF31-\=V:)IX^CT)[KC'1 MDJ+J1/N05G,L%Q,!;6./OB`^ESGLK#!\II]48$56=_J')78(RH`(QWM?;4!WEI" M6^O`_E6UNCE:4#O'..P[`U+S%]FT"A'NX6HAV];A#)HR8R">"E#BNF0%@X^K MSZ'G5HR=G20JS(%>M':!F>S;-7<62%RG*?8KM0"?,GY+"QI]3CK$]R<(%O?A M%GEW;0`XRM0."P'I:`:2@:0RSG:E(3S%S!3X"HIF,2/US6RPZC]11&G]*N79 M@J1%V@&B4L^1]7*,@,9V6UL:DRL*?*!@+%M5`C63ZN\B]F^Y+%A;$\D"V4], MTTA>\)JVWB?K^MTE\INK,X0(O"EN0!LDX.,-UW:B:;Q`"$+&+KU"!R\>0LJ3 M4;P@7`DV@9IB6=`5)OM];Q!$:PH9<(%&))VO^$2&CFQ31NO.61 M58#4I4<6F1(;/293'V@D.:]PZ+,^X;7$<0=^X8XO5&^\]4R*C].BF#7^_BBP M/`NF2CP:9JWP*)U:2NTBHA32Q%JZS/%Q@R99_:?)3#^+/(WMP*V8:;"6N13` MA?J&PC%<1)]J<'A.8:@M.H$4T'10[-BN--OUJ7:N=7'M92O/VJ15NS$/YU2C MUDP#LKY^LP(N7ZO+90$'<8L;)N))/.TW=_-88=]D-F?J>+HW@&+MI]E$QCN^ MTG<<&X)Y(R"/)()QO9&WOK#G'D-2_9O@A704"\QOK'+W M]W4\^/3C]=-GVE-MB,T[8BM18<%N$5"J.J/RP.0^A:FHENAP<$I'K*;F_'^M9<-^1PY>8U=BV4@R*>"K M:Z/JZZE1GJ7KP=S8EHW44)V,3'?24R85,\FFW'!+;B37KI+<.N>J6+[R+L7@ MN'U6<\[!U_%VZ''Z7&+@A(\#+>"P#>1^[-0:>D:J]SCN+G4I46%TKW>PI5BQ"BX.6QZ$VJCMSDWS@LW MD7!/JIGJ-HOR!WB]MQ5S-#,E40JX6`PF`VB%X@T9FVK?`#"_P38M4L_\84!V M+W5&:1V4ER)E)/88TBD`0C8K+L$@"*AHR96%S132IM$HIAP[XMLW6E.O(!*_ MBQEJTB2U$@V7O8A!..X(2P+SM+'"/1PO]!8>*B5_L#/L0[&H2,/:=QP'#+DC M]D0Y`L/P7X@5PM%&>=TH/5!C-Y)K&$`LEY%U% MN\D^_91HL677[L#Q?7W@,U<@-?_8)P]Z>78=J%OX":(.][MCP5',%,X"ED3K M]$5MOK@*S"A4W@NL9>,$UGUVBY?O^TTG`2ED^R\)-9-B()HVS3=1[T3I9B]$^_RBI7H@$0!131\H33_*LHD+LOB0;P:C\\(C$!Q-(07?-["5&[U1WTK-)83H" MQ,.6(,?IGS07+_=G,F0<0_,&@]^3%,J\Q7'.F>9QD$4U&-\`=C_GL!N*F?R<;UHN!NRQ MC*9L_=:I/YAD5,LC[)7=B`(XUT))_]:KM$@%?UH09&WFD<3"YQ,+&LBB"`R#!M\H#?",C.BW)!QZ+;[CVQ)"CH/&;^';LF-Z\W9L@!3%<9+R'9 M4Y#=S0=U![FFTC3$G/_`=X?_]",VG0$MZCZAW^!),S4]1(.+&.&I\JN+*<8+ M[)X>&SL=S1`XP#@?"BJ/%B1)8@5)PJ"SEM,=Z M\,=VO:V(YSK9PYE?%S[DIMT[)B3XK;Y7FO^"[E.,;75)JH8X)6TFA6X]1[8L MS]H=GV[)!]:CI=:&MM02)S39""\?PX81PJ?9<##.3D\NNW/=5?4/-B4!AX]. MS[+1>-0;6"7E7D/;I$XJK7&P+T<2:1F&^<,%^O!(4@PB(*1-(W'J&:;H87Z* M;`MF!?U]UJ+S!=X]B'#('@,]S'5Z:?!=+34Z&Z@=&33GY8;+A+QL514A7))+ MY]UTMU*:SE+`8:;,WJ><:&4*++_$J'X2CCQ$(DW4.*P![:(D07,-$>X6W``N M,..4XZAMD_M9<8D=.4NZP.]#92`X&PL"!5I^0`["@"-QIB#OR!)#[?2@\(II M`T&&!+XW=-\U.X[EW`9USMI29`%->.72`AH8ZQ(JP[(Y3KHP\1+3?(6BC?:? MHUB31MHC^12.$`03=(U-41E!=5)L?=@EMT%())+WCY("'?,7PW4R<5&U;-^E MSV^$@\]D'RQ@$I!!P9X"5_9".=;P*CBA*@>&5>=K4MD2]?#`1&RFT/Y1?(6X M!H,L\G8",C\O.J@=EX<79.+?V,Y-52TF1>H#V\H'GN4#.->M M[H>F[K^1Y?E;8J^\K3V'!;1RR3\T-HJ&J7X2^C!Z-!/;V7W"GIR2[?/F\TC@ M)PJ#%YA"WK=)O'S3Y>E8O^!F3:@8NOFS%I&W M_*+,5I=^#TG8YA%7'T=6U]8>G#9I\J8F6KJIF*D$Q>W4\Y5WFU$BN&W0EIMV M+-P)G*@M-FWV,6).@62+CCCDRC5%Y`MU,"Y?VTT*`JAZEP08$&8#^6@D@9MD[N-EH?LEGZ'9%H@A]G22$SI]M%3P*CA< M\HT$./FHLD2B-#L@DAG0!\M^![@ZA8>[&7<-F22THTB#L8X8ZE`V/V3^SC"- M':802RYYT6$`A:U4*^-.]FC40EA_!\`!:[17W3,1<=83U\:48U(^EDOTGJ@O M'-GCA++%6"0'38'M>A39TAJY777&,AAB+R6^98[3(M;,?F*>Q4;%8HEQ5+<$ MJD03YQ=OBY4Y9Z'QQ3:^D-"==&C(B?ND MO>^`EQ_!\B]YWR;^XA]V0XGT1M/].F^(`:`KFQS!&ZD8P]F`"W*[HX.=_TOW M<0+[>!^Y$IDXZ4[,;,SYLE3XON.L3O=FD\",AM9QU^H-.(]'M%(M1Z[,$%;S M;39>]*(=2>A.$X06B#X=)R([DG]=G9I;:@ZM1K/4I*B23DHT/<#4K%IDKNJ8E]<+E4K\?UU?,''-#L=C[/8BU\CR4W\D@) M-ZWO&!.MRS@+2W(`JL:-(>$P+")+?`2?8^+IAPK#::QD3!:L!4F,(K=_7\1P M5FELN63/CYFI#$.:)ACG6F//SOE"TVKGRJQ<1U["04F5Q](RF>AHQDL]*=KS MYB@>;(HZ=>%>ZOIT`_V^$B)[)K;)_\3([BI;V4VZF\*JW6/Z&..6LR#>W*@6K``;(.W'TAE1?5?@4WYZ(@$O64,$\3!\ M3F_&'8/?6-+%%KW)D/Q$?('H<0\R]^IJ5:'!/:H7[1JO[4O'1X.3H$NN[=6K M77)C;K7WU(>4_63O-89&)LQ25SDT4 M97ZOS\.FN2`=IRJ/+S7YGYR;VKT(%'67M[%I=2%GPD6%U%SE`/;SV@XS-HJ( MQGH596(2ZA+1Y;5&$K!-H&5<8HZ$'OA8`AY\*&[]6XL=X;1YE?K59WX=NK= M#2I_D+`$"I*NBTU=:3US%DTR%B6CMUE)QU9D+?"JJ4`]=Y@W:-"(-42#=XG# M&??BD6N86TB[J.C76\L-.XB&PWZ;E/D#Y>]I,G8N0;#W(V+@2J> MV>C?^@C?^C?%I);R=M'G?OT^\8]YE%%G&I>3I%L2IR4X<.[FF/I52Q>)G'H`2Q,_-"<2L^H@ZVJ;_*5'"+(8C', M6_,F`/E%'RSN-=?2F`2U6%T2PCJ0#ACM@=8Y?'9.PW##(K@2-9PCRT-,N:LR M]PA<&_>&&4`I+AE$RF1WJ(9)B6FTTH]Q!TTH9T5$:'3L+]>W'(JP(A,&^71< MW+\U'>792.`:,=1;-C0;L8>-#@]9Z.JBV M^F;)R<=Q4ZJCZ`&QAX>*'^RB\3BM!OS/:]V>/(8_I)X_7.54JE?;MG-`.QOS M@L0F-V#%Q??L'E`63,0:SK(JWVZW%SP16,RBZ*TF]:AN\-KH7+O!^U6&^!!] MD=+=5'QH@I=<"#,(9UPIC&2&FCT?AHU);2.C,& M(AN\O"M)[M4W0EY@KD09+DW+'7_Z"?!%I#>7%RRDP[]HH8DZ41%,5-)$B845 MLM//PKI'224&ZYXFGBK+JZ3H9N3^;7EK[243M)>ARKTGJ@W[42WYA5#M]&AX MCJCV&M,-\8R^[%4/KN$7B&OQUO4J.PS&@$AOMLWMK+I;&?TB0`"O4ZU\2H&` M4S(;$A\'PR"0>EQ7YC:V>7]1FIQ,3>)T.H@G\)O M])@R3%J;1UPHG+BXYQ%BP318W<-'L''2U%&)S8IY3U)7&T_%>4+1N1LG+&NG M32?V]DPI";B%!`JC,%P"W#Y44W;-6^S!0FQ!536'2\,+KK4@4GP7Q^G[63FC MY\"(CI&^<6*:?#:&G^V)X3(:L?L%@)^;D;(!]4_%C'BLDXW'AXC*=@T0FV!? MZ'_F'RF/SRY-'3.)'6%I+QP,?+,)Z&X]\+2::O:JQWEW5@DWK8-*W: M,G=[$E("@2.DOP9^CGM5C2T&'MC];!XIP+LBC*2I$:0LJDC91GF:L,HZC.B8C! M%!M3#EP$2R/A6]ER!Q]/`O0;__HB(ZQ"FC^7L._#04I?D]&(@X&[Q570"_XJ M!.]\>('&`,]4$)(1IT;#_GE<^QW`JA$V^Q2ML]@UAJ[\'0=$OS$IRN_(/@!+ M(WU[AAD_%$4U$QJ#\[TM.)$1:U?5']##\8:E=RM2F$!]6L/XK1.V0:2F2DOC M[.@[JGRZR[JOBT.[^ M"?@ZN$1\_3:_WP==!Y>(KIKC1MJ"EC>4ZJO/7;JB8.S9X"QDT;"@WKJT^T%B MU8XM9;F'7-Y<7;K1X.!@.9\=:<->N.LJG%CP@_X=G\45^'+9?Q1GX>'*WN+$ M!1AS>J)^3LQ3\0'P<0H0)\!S7)FSHQP4QS?'J`A+X)V9@@QMN9WU,+P>BZ+) MKXZB9UP9`J6<#5H20OMHHN@W[\?;P:6IX#NT/GK"JP^5*4>#^Z.XSKEF1+O' M:).MT7BET:K6+N\,6J`!:Q4:"[R+P..R$[LO]A8(!+F!^W-%/NW^FE'5Y0W? MRI7K`BO#3\X&//RMTR\P*DV8]"SYSC]7RC#S$6NXD1=4EB+G(!G3=IA)^Q6K M0<%+NV#]EXU\4O]#S9EW8F>BN24N9.96\/9]7U2/'22R5T-:*#_[KL"R?0TO MZ',21!^;F9.0RR0^4R*5O#`\X[98L)R`H:[AG?Y:-!OEA;KG63RD/,&6]E6> M=I'II$6FW_G(%;1#8@S;EOR!G"2+$GVBPOQ2J@UHJIS//]X4T]L5.6]!;J\+ MJ0RG#=*],`%B(VZ$`F/K0.;".%QULWAC)45>J*LKR./JL"VL,Q&M\^XC91_- MRQ(&4J=J%E?0I&H"=-%8;Q?>QVSO@:8`>:RAZZ[J[+FH\ZU&LUS5/JCFR"R4 MZ\"3EGY,#U,+T]&V0C8 MU;+9+AL&5"X?Q MH<[[%>A^QW'Q;.M%$[1?7YBL2W#BN"4E#ZU2(YUL4ME*#[$:#T^P2"Z-K19EA-CPYSTY.SA(#*S^;]IL\&`^S M<[CP0]=G\THSI0^&IQ?9>#2`W[`H^DBRNKJ1[]29\?5V4S-BOLHGP#=>O7K> M=]?_5]S`",!]EIV<79I+.#O/AO"B7MJ6\J[QO;HVVLAV#"D)D]7DM:J]617US MKP4)\/Y/L]/Q$/\!,#@[38S$.3P'Y#@Y2X^2;X*`5AAZEIV-Q_##V_P.E$J) M@TU/QMGI`,=S'UJ_[2?IZ>4E`/O"K=-]?K;D)>)^MU!AWP7$B^V96NT\=W32 MO6[EL1V'N7:0R83HUG3ZV;V&WT2K?"*DJ272$[B%5UP+RV9'8LI4*::FTQ,@ MB72Y?K?<,1LKX9\->9*]-O/-=\_?7\^9@):6:KA:I&$[BJ/NX^\MTCB"\]#K MCYTH&'DPNAAF%Z-+.E5G`3W:"#-S@0L,J3WSYS;#WHL:?&9G[5\&"7]K>QUK M>QUV9^J]1$\[8GU@)O;LZ=HW'NS6ZD=%1 M7D'TIZHN;S2!$J29]ICO*86\D,AJ^*#3K-D7<&LJE,6+6=@@M]/(DO(.3,R* MQJ=2\!5(UV@?SCN$Z>OA&&[L]]UVI;X,#P>O<-5(N+%^NRE%80?K=A8[B2]& M%.I?34Z25N_88^C5LY?O7CSM/%9I#-Z*#&\/^Q;3G;=+TZM8/1S.TBTMU7NZ M,03M%;K5$UT!CPG:>!^$3?0>7KEY0$=K!2JY,4_ M5ZQHQY=/'?S<%VY%W6>L):[C1G*\J7849J<]%FK*M:]P9TW.ZJ$R!W.7\1K6 M1%$.J:[?]AP8#L%V^\9W,NY=$0@3&;$CKR72![G7]NM'S")XH#0I^9=_B1&> M'6NE_TOZ*,^HCW*__=D1!#+?NY*]ZODN.@@_'L00]!5`%=,+/W\G;ZO[?($) MD;TD2D?$R>USUDGPWA_8Q(N'++1?#Z-G[&$U*SK`,[P_OAZSYM$M'>5KU=%9W.C*`%>5!1P\0(?L%GVL4X-BG,2'G[V M8H)1*AX$)['T3?/P:-B'ST1H0?SG MSG3>#\IW*O3V#GFU>T@+99GTR\,R3XW<'7VO;!3EEX_IO/D807$X2K]EH?P* MA?)HJRS3Z2GB>(WV6C)-E#KD-LYJ0M!%BH9V25N4MGW7J62XIW#0/.J;5JD\ MJ;L7M\SO5X.C(\%)@Z5>TDYPW.4P?Y32(*V`;,,?[V![X$JC_,1Z^AZ0=<+] M'J7IK^=`=M!X``91GU^'#L8AW1QZE>SH>][MVK<-MPM'2_W@Z:FK['&G[N4_?!0QX%CUP,&D)3=0>XD1GSWV`+>V MEU]RGTN+,Y\.VW[("]@YP2Y'WLZWV^?'V[FMAP:_%6WO#:7ZOK.-3Q]WJ>OZ M.,44?#2$=3CG=.,>9O?'KKD\2\6"%KD7[A=%85_8-0'T;GR(F'"QP[S3/&Q+ M>!-.IE65*8<)`-ZN,]U'$:=>M2*/'"(TV2:[@!=UQR1T$OS07O8^J\(HB/2K\ MWL[CD';O[W/>31-:OMB^G[TWMFLX,^[8V,U543B27[8K`F`$JPO&>JD^9"!ZF4_2+WK@>QU4P2M"LVTO@*_8-/]2 M^T)1O@&[;_K.%;.ZBFM*,O'DTAX^7R"@[`Y^"&B2G8EW_(#EYM@9;3SPXB", M\MX0DGM]$O%A_J^>6XM^[_V;ZGIK^SG;TYQ(;/29>/[V6F:'@Z]O#N,OS6(^ MU%U'#;Y_Y!X>0*%XX$.`-OV/9\@0>3P<,,_@U-H MM,O/FL3'QOS,:;H!-`].^'D0#*^E9X4OFF;S]?\&4$L!`A0#%`````@`*CYP M1_/<2UG)`0``2AH``!,``````````````(`!`````%M#;VYT96YT7U1Y<&5S M72YX;6Q02P$"%`,4````"``J/G!'2'4%[L4````K`@``"P`````````````` M@`'Z`0``7W)E;',O+G)E;'-02P$"%`,4````"``J/G!'&XXJ.ZL!``"(&0`` M&@``````````````@`'H`@``>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0 M2P$"%`,4````"``J/G!'\$`#(>0"```8"P``$```````````````@`'+!``` M9&]C4')O<',O87!P+GAM;%!+`0(4`Q0````(`"H^<$<2U/:%/P$``&D#```1 M``````````````"``=T'``!D;V-097)PC$`8``)PG```3``````````````"``4L)``!X;"]T:&5M92]T M:&5M93$N>&UL4$L!`A0#%`````@`*CYP1R\-5+)6`@``W@H```T````````` M`````(`!C`\``'AL+W-T>6QE&PO=V]R:V)O;VLN>&UL4$L!`A0# M%`````@`*CYP1R_0?NU4`@``]`<``!@``````````````(`!*A8``'AL+W=O M&PO=V]R:W-H965T&UL4$L!`A0#%`````@`*CYP1T8&M4`D M!```[Q$``!@``````````````(`!)A\``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`*CYP1YB:4J"C`0``L0,``!@````````` M`````(`!F"H``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0# M%`````@`*CYP1_A*#GBA`0``L0,``!D``````````````(`!(#```'AL+W=O M&PO=V]R:W-H965T&UL4$L!`A0#%`````@`*CYP1W%4 M7:"B`0``L0,``!D``````````````(`!J34``'AL+W=O&PO=V]R:W-H965T.'H@$``+$#```9``````````````"``5PY``!X;"]W;W)K&UL4$L!`A0#%`````@`*CYP1[E&[&JB`0``L0,``!D` M`````````````(`!-3L``'AL+W=O&PO M=V]R:W-H965T4^``!X;"]W;W)K&UL4$L!`A0#%`````@`*CYP1WJ]FWO#`0``O`0``!D``````````````(`! MQT$``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%``` M``@`*CYP1R(`$[*D`0``L0,``!D``````````````(`!>$<``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`*CYP1WT?P\L[ M!0``=AX``!D``````````````(`!(4T``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`*CYP1P;GMLJ:`@```PH``!D````` M`````````(`!'U@``'AL+W=O&PO=V]R M:W-H965T7SC]1^@$``+X% M```9``````````````"``0Q=``!X;"]W;W)K&UL M4$L!`A0#%`````@`*CYP1^3,1!P/`@``U@4``!D``````````````(`!/5\` M`'AL+W=O&PO=V]R:W-H965TK'WM\P0(``$T+```9```````````` M``"``=EC``!X;"]W;W)K&UL4$L!`A0#%`````@` M*CYP1P26'ZL=`@``;P8``!D``````````````(`!T68``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`*CYP1ZV:NS:[`0`` M800``!D``````````````(`!AV\``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`*CYP1Y6T!!?M`0``=@4``!D````````` M`````(`!`G8``'AL+W=O```>&PO=V]R:W-H M965T v3.3.0.814

Related Party Transactions (Details Narrative) - USD ($)
1 Months Ended 9 Months Ended

Apr. 02, 2014

Apr. 02, 2014

Oct. 31, 2014

Sep. 30, 2015

Sep. 30, 2014

Dec. 31, 2014

Options Outstanding, Granted 1,000,000

Proceeds from promissory note $ 6,000,000

Debt instruments interest rate 15.00%

Promissory note converted into number of shares 400,000

Accrued consulting fees per month $ 15,000

Repayment of related party debt 0

Due from related party 175,422 $ 16,077

Promissory note 750,000

Knight Therapeutics Inc [Member]

Loan net amount 5,047,178

Promissory note $ 937,500

Mr. Jack Ross [Member]

Options Outstanding, Granted 1,000,000

Value of granted options $ 282,000

Proceeds from promissory note $ 100,000

Debt instruments interest rate 10.00%

Debt instruments maturity date Oct. 31, 2015

X

- Definition
Accrued Consulting Fees Per Month.
+ References
No definition available.
+ Details

Name: SNYR_AccruedConsultingFeesPerMonth

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

+ Details

Name: us-gaap_DebtConversionConvertedInstrumentSharesIssued1

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(2))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentMaturityDate

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3(a)(2))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Subparagraph 2

-Article 4

+ Details

Name: us-gaap_DueFromRelatedPartiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying amount of long-term debt, net of unamortized discount or premium, including current and noncurrent amounts. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20, 22

-Article 5

+ Details

Name: us-gaap_LongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 13, 16

-Article 9

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

+ Details

Name: us-gaap_NotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The cash inflow from a borrowing supported by a written promise to pay an obligation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_ProceedsFromNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_RepaymentsOfRelatedPartyDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Value, after forfeitures, of stock or other type of equity granted of any equity-based compensation plan other than an employee stock ownership plan (ESOP).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 30

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51830203&loc=d3e3913-113898

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 30

-Section 35

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6418191&loc=d3e15009-113911

+ Details

Name: us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_KnightTherapeuticsIncMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TitleOfIndividualAxis=us-gaap_ChiefExecutiveOfficerMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 R25.htm IDEA: XBRL DOCUMENT v3.3.0.814

Nature of the Business (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended

Aug. 18, 2015

Jun. 26, 2015

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2015

Sep. 30, 2014

Loan amount $ 6,000,000 $ 6,000,000

Loan origination fee $ 120,000 120,000

Work fee for loan 60,000

Expenses associated with the Loan $ 40,000

Debt instrument interest rate percentage 15.00% 15.00%

Convertible equity offering $ 1,000,000 $ 1,000,000

Change in loan interest rate 13.00%

Company's expected revenues $ 13,000,000

Company's expected EBITDA 2,000,000

Secured loan obligation 300,000 300,000

Maximum aggregate consideration to be paid $ 100,000 100,000

Capital expenditures $ 100,000

Additional bear interest rate 5.00% 5.00%

Number of shares issued for business acquisition 4,595,187

Exercise price of common stock $ 0.25 $ 0.25

Warrant issued to purchase of common stock 3,584,759

Aggregate purchase price of business $ 250,000

Common stock shares contributed as per agreement 400,000

Amount paid for marketing and sales related services $ 814,640 $ 2,228,418

Term of distribution agreement 15 years

Contribution Agreement [Member]

Agreement date Aug. 18, 2015

Contribution Agreement [Member] | Hand Md Corp [Member]

Exercise price of common stock $ 0.70 $ 0.70 $ 0.70

Aggregate purchase price of business $ 97,000

Common stock shares contributed as per agreement 2,142,857

Percentage of ownership transfered 50.00%

License Agreement [Member] | Hand Md Corp [Member]

Agreement date Aug. 18, 2015

Royalty percentage 5.00%

Royalty amount $ 500,000

Consulting Agreement [Member] | Hand MD LLC [Member]

Agreement date Aug. 18, 2015

Amount paid for marketing and sales related services $ 10,000

Knight Therapeutics Inc [Member]

Additional bear interest rate 10.00%

Amount payable under purchase agreement $ 1,200,000

Total payments of acquire assets $ 1,200,000

Knight Therapeutics Inc [Member] | U.S [Member]

Percentage of sale revenue net 2.00%

Closing Date [Member] | Knight Therapeutics Inc [Member]

Amount payable under purchase agreement $ 250,000

June 30, 2016 [Member] | Knight Therapeutics Inc [Member]

Amount payable under purchase agreement 250,000

September 30, 2015 [Member] | Knight Therapeutics Inc [Member]

Amount payable under purchase agreement 700,000

September 30, 2015 [Member] | Knight Therapeutics Inc [Member] | U.S [Member] | Maximum [Member]

Net sales $ 12,500

Percentage of sale revenue net 5.00%

Focus Factor Business [Member]

Company's expected revenues $ 7,015,763

Company's expected EBITDA (3,067,567)

Aggregate purchase price of business 6,000,000

Amount payable under purchase agreement 4,500,000

Focus Factor Business [Member] | January 20, 2016 [Member]

Amount payable under purchase agreement 750,000

Focus Factor Business [Member] | January 20, 2017 [Member]

Amount payable under purchase agreement $ 750,000

ST Warrant [Member]

Exercise price of common stock 1.00 $ 1.00

LT Warrant [Member]

Exercise price of common stock $ 0.34 $ 0.34

Percentage of shares purchasable under the agreement 25.00% 25.00%

X

- Definition
Agreement date.
+ References
No definition available.
+ Details

Name: SNYR_AgreementDate

Namespace Prefix: SNYR_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount payable under the purchase agreement.
+ References
No definition available.
+ Details

Name: SNYR_AmountPayableUnderPurchaseAgreement

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Additional bear interest rate.
+ References
No definition available.
+ Details

Name: SNYR_DebtInstrumentAdditionalInterestRateStatedPercentage

Namespace Prefix: SNYR_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Expected earnings interest taxes depreciation and amortization.
+ References
No definition available.
+ Details

Name: SNYR_ExpectedEarningsInterestTaxesDepreciationAndAmortization

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Company's expected evenues.
+ References
No definition available.
+ Details

Name: SNYR_ExpectedEvenues

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Expenses associated with the Loan.
+ References
No definition available.
+ Details

Name: SNYR_ExpensesAssociatedWithLoan

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Percentage of sale revenue net.
+ References
No definition available.
+ Details

Name: SNYR_PercentageOfSaleRevenueNet

Namespace Prefix: SNYR_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of shares purchasable under the agreement.
+ References
No definition available.
+ Details

Name: SNYR_PercentageOfSharesPurchasableUnderAgreement

Namespace Prefix: SNYR_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Royalty percentage.
+ References
No definition available.
+ Details

Name: SNYR_RoyaltyPercentage

Namespace Prefix: SNYR_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Term of distribution agreement.
+ References
No definition available.
+ Details

Name: SNYR_TermOfDistributionAgreement

Namespace Prefix: SNYR_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Warrant issued to purchase of common stock.
+ References
No definition available.
+ Details

Name: SNYR_WarrantIssuedToPurchaseOfCommonStock

Namespace Prefix: SNYR_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of liability recognized arising from contingent consideration in a business combination.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 35

-Paragraph 1

-Subparagraph b

-URI http://asc.fasb.org/extlink&oid=6911338&loc=d3e6819-128478

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 25

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476

+ Details

Name: us-gaap_BusinessCombinationContingentConsiderationLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Future cash outflow to pay for purchases of fixed assets that have occurred.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

+ Details

Name: us-gaap_CapitalExpendituresIncurredButNotYetPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 20

-Section 50

-Paragraph 4

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6928298&loc=SL6031897-161870

+ Details

Name: us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of the fee that accompanies borrowing money under the debt instrument.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(b))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentFeeAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Incremental percentage increase (decrease) in the stated rate on a debt instrument.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentInterestRateIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Expenses paid for obtaining loans which includes expenses such as application and origination fees.
+ References
No definition available.
+ Details

Name: us-gaap_LoanProcessingFee

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.
+ References
No definition available.
+ Details

Name: us-gaap_LongTermDebtFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireBusinessesGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the purchase of all investments (debt, security, other) during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Revenue earned during the period from the leasing or otherwise lending to a third party the entity's rights or title to certain property. Royalty revenue is derived from a percentage or stated amount of sales proceeds or revenue generated by the third party using the entity's property. Examples of property from which royalties may be derived include patents and oil and mineral rights.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(e))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_RoyaltyRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.
+ References
No definition available.
+ Details

Name: us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.
+ References
No definition available.
+ Details

Name: us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.
+ References
No definition available.
+ Details

Name: us-gaap_SaleOfStockPricePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_SalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

+ Details

Name: us-gaap_SecuredDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
+ References
No definition available.
+ Details

Name: us-gaap_SellingAndMarketingExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Number of shares of stock issued during the period pursuant to acquisitions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28,29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesAcquisitions

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_TypeOfArrangementAxis=SNYR_ContributionAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=SNYR_HandMDCorpMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TypeOfArrangementAxis=SNYR_LicenseAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TypeOfArrangementAxis=SNYR_ConsultingAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=SNYR_HandMDLLCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_KnightTherapeuticsIncMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=SNYR_USMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreationDateAxis=SNYR_ClosingDateMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreationDateAxis=SNYR_JuneThirtyTwoThousandSixteenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreationDateAxis=SNYR_SeptemberThirtyTwoThousandFifteenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TitleOfIndividualAxis=SNYR_FocusFactorBusinessMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreationDateAxis=SNYR_JanuaryTwentyTwoThousandSixteenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreationDateAxis=SNYR_JanuaryTwentyTwoThousandSeventeenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=SNYR_STWarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=SNYR_LTWarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 15 R37.htm IDEA: XBRL DOCUMENT v3.3.0.814

Stock Options (Details Narrative) - $ / shares

Apr. 02, 2014

Sep. 30, 2014

Options Outstanding, Granted 1,000,000

Stock options exercise price per share $ 0.25

Equity Incentive Plan 2014 [Member]

Common stock shares reserved for issuance 15,525,000

X

- Definition
Aggregate number of common shares reserved for future issuance.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CommonStockCapitalSharesReservedForFutureIssuance

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price at which option holders acquired shares when converting their stock options into shares.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_PlanNameAxis=SNYR_EquityIncentivePlanTwoThousandsAndFourteenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 16 R9.htm IDEA: XBRL DOCUMENT v3.3.0.814

Inventory
9 Months Ended

Sep. 30, 2015

Inventory Disclosure [Abstract]

Inventory

Note 4 – Inventory

Inventory consists of raw materials, components and finished goods. The Company’s inventory is stated at the lower of cost (FIFO cost basis) or market.

The carrying value of inventory consisted of the following:

September 30, 2015 December 31, 2014

Energy product $ 24,451 $ 26,064

Components 172,936 -

Finished goods 266,655 -

Raw Materials 35,406 -

Total inventory $ 499,448 $ 26,064

As of January 22, 2015, inventory was pledged to Knight Therapeutics under the Loan Agreement (see note 1).

X

- References
No definition available.
+ Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 6

-Subparagraph a, b, c

-Article 5

+ Details

Name: us-gaap_InventoryDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 17 R29.htm IDEA: XBRL DOCUMENT v3.3.0.814

Asset Purchase - Pro forma Results of Acquisition (Details) - Focus Factor Business [Member] - USD ($)
12 Months Ended

Dec. 31, 2014

Dec. 31, 2013

Revenue $ 12,695,295 $ 10,629,171

Net income (loss) $ (183,471) $ 932,209

X

- Definition
The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (h)(2)-(3)

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463

+ Details

Name: us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (h)(2)-(3)

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463

+ Details

Name: us-gaap_BusinessAcquisitionsProFormaRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_TitleOfIndividualAxis=SNYR_FocusFactorBusinessMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 18 R28.htm IDEA: XBRL DOCUMENT v3.3.0.814

Asset Purchase - Purchase Price Allocation Assets Acquired and Liabilities Assumed on Estimated Fair Values (Details) - USD ($)

Sep. 30, 2015

Dec. 31, 2014

Factor Nutrition Labs, LLC [Member]

Accounts Receivable $ 2,926,369

Inventory 67,113

Intellectual Property 1,000,000

Non-compete provision 50,000

Non-solicitation provision 50,000

Intangible assets-Customer relationships 1,941,030

Goodwill 1,798,047

Accounts Payable (891,113)

Accrued Expenses (941,446)

Total Liabilities $ 6,000,000

Knight Therapeutics Inc [Member]

Accounts Receivable $ 58,054

Inventory 204,925

Goodwill 1,137,336

Accounts Payable (51,795)

Accrued Expenses (148,520)

Total Liabilities $ 1,200,000

X

- Definition
Business acquisitions pro forma accounts payable.
+ References
No definition available.
+ Details

Name: SNYR_BusinessAcquisitionsProFormaAccountsPayable

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Business acquisitions Pro forma accounts receivable.
+ References
No definition available.
+ Details

Name: SNYR_BusinessAcquisitionsProFormaAccountsReceivable

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Business acquisitions pro forma accrued expenses.
+ References
No definition available.
+ Details

Name: SNYR_BusinessAcquisitionsProFormaAccruedExpenses

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Business acquisitions pro forma goodwil.
+ References
No definition available.
+ Details

Name: SNYR_BusinessAcquisitionsProFormaGoodwill

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Business acquisitions pro forma Intangible assets-Customer relationships.
+ References
No definition available.
+ Details

Name: SNYR_BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Business acquisitions pro forma intellectual property.
+ References
No definition available.
+ Details

Name: SNYR_BusinessAcquisitionsProFormaIntellectualProperty

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Business acquisitions pro forma inventory.
+ References
No definition available.
+ Details

Name: SNYR_BusinessAcquisitionsProFormaInventory

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Business acquisitions pro forma non compete provision.
+ References
No definition available.
+ Details

Name: SNYR_BusinessAcquisitionsProFormaNonCompeteProvision

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Business acquisitions pro forma non-solicitation provision.
+ References
No definition available.
+ Details

Name: SNYR_BusinessAcquisitionsProFormaNonSolicitationProvision

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Business acquisitions pro forma total liabilities.
+ References
No definition available.
+ Details

Name: SNYR_BusinessAcquisitionsProFormaTotalLiabilities

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_FactorNutritionLabsLLCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_KnightTherapeuticsIncMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 19 R30.htm IDEA: XBRL DOCUMENT v3.3.0.814

Inventory - Schedule of Carrying Value of Inventory (Details) - USD ($)

Sep. 30, 2015

Dec. 31, 2014

Income Tax Disclosure [Abstract]

Energy product $ 24,451 $ 26,064

Components 172,936

Finished goods 266,655

Raw Materials 35,406

Total inventory $ 499,448 $ 26,064

X

- Definition
Inventory components.
+ References
No definition available.
+ Details

Name: SNYR_InventoryComponents

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Inventory energy product.
+ References
No definition available.
+ Details

Name: SNYR_InventoryEnergyProduct

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_InventoryFinishedGoods

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51655945&loc=d3e3927-108312

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.BB)

-URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a)(4))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section BB

+ Details

Name: us-gaap_InventoryRawMaterialsNetOfReserves

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 20 R31.htm IDEA: XBRL DOCUMENT v3.3.0.814

Fixed Assets and Intangible Assets (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2015

Sep. 30, 2014

Assets

Depreciation and amortization $ 103,103 $ 282,256

Annual amortization expense per year $ 408,206

X

- Definition
The amount of amortization of deferred charges applied against earnings during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.3)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_AmortizationOfDeferredCharges

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

ZIP 21 0001493152-15-005492-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-15-005492-xbrl.zip M4$L#!!0````(`*\]<$?]#\5TG)@``-*L!0`1`!P`O=#+EV,F,IQ,[8SN]NY^F(!*2,*$(#4A:UOSZ?>\!($%*MF7'A^*H MJRLE$\=[>/^GM/,GRB M/LI(:':HQI-(I`(&#*1]UFWL8_V#\Z[.CC2>-J M`&9U&2UMFL#15+IRZ M;:9*-S44E7F)"!I#=;D%`S"_U:TW6_5.RTW78G`MRMM;,.HFRD1UVZV=F\YG M9K@%65(?@(*.=YR M2K7AE`0%:S\A\3T3`T8RN3\B3B7Q3-?=@L95$F[8880/PQ)MR`;;;S7KV`GR\3<2K36?XT?RY#'!E(,%J$I2C1TMZN("W-9">!;:!'B@PGDL0)ETBG;G77$G3N_OAT[MZ'SMW'I/-!+Q9S'N"_ULU"PT5`S'PB-#/A0",E>32`8R-;BR4,),$\9:-[R/)\$([.!* M)AOOT%_M+SSG;UL+M_31V5J,SXNT[U:EUA+R?!+B&8;>8QJ&LO5TK/[P[PQP M/8:`'I"^%$B&BZFZ&*DLX7&8',3A1\BB4B%>KA3!(:A%`QI\SW%HA7)_ MN-8`Y64H#EZ/$+C>%-WPMHB*X<_$J\=5COS"4\H;&C4?%7SXR#&I?Y\E,A9) M\C*DX!H'2MR_]M#KSLU#B8^;\'<>9US/+J9`F)E7\CZ75R^GX/](LG87%`ZU MX-AC0NY[T)"F;%I^.) M3V6KXFXI\^:EZZX?[JF7[^6BI=1K2A? M4%Y?%'SV8OX37+,N%_#7FOPRV%NX\IV7]>K,SFHYQ")AVZF_J%=G[D[GIWAU MIE=O0434^<%H6W+?=(!G:S90$G22I5JBF_O$^\FG3XR^$HO1@)S2[+LB` MS]MK`5EI`:G&',B^.\<\"9+&X&$G]$4X%Y.4'LR1_J,+95,)-_WK^ MDE^(_WD5YUYUH[\*-82#CV10NFWB9.1AH:[:-P3\#,;!<7*MUX^EUP^G2VOI MOJMT'T8JD?$0T5J+^;.XKSD.K,7\COW,=7EH)+.1JM][:<7(%GW=S MVPBSM>QG2/&#H1;DHUZ&7%W,)N)T<(!=S2$=RS=(UQ_[N44(.75G$4*6KJ`( MN2E_@T3E\]&ATI.U:'VWKPV%W/\DACSZ0$3S0%?)O!;E:QHO:_%=B^]MO1Y? M#A^KUW.=2?TD`R"76(OC_F)*O'1)7'%#NE1,D&11"CG?C3+\8FY9W6)1%]/B M::1X9:Y^KI@0+[[SM8X&UM'`HFC@8:^99;$T0OCU_&A.?,:")YD6[^Q/]^S# M'+>9&RJ#P-VNW_^+T.($"XN*3;&Q^$6N>G7=`L(KDHET]H$-+MH!=90@3^+C\_D[5 M#X)`97&:G(E`R$O>C\2)2`\SK4$UF)74,_Q)H\H/N##""Q%BG:[M[-]1PP.DD2DR7<>O=?K^(!+>]X9X#)';>]U]WK=W3N! M?-##+0]B*]V]NY%\[$ MQ/.LGP2`D0C?9^G76!)+[4/Z'@LOOKLO)^O=FZ7Z+C@\]GF6$9+Z]NZCG>=, MI%S&(OS`=2SC80)1=C;.J%M_)`:8G=^;"Q#\=-I[GE+=#NMAL%N*IMU6L]?M M['T/=L2!D8I"H1/S1N[]:=7N;6][P>C\UO<#OE20NMOM[?CAUNW`/TG>EY%, MI<"?(7LX.E1"\MO`/`1:]POC[XK9"4\AL3\=G$ZP;H(J6<+EII\-_C5*WTQ8 MDLXB\79CS/50QONL.4DW?AVF;W!P:T*?_MSJV'^^:\$`T-IG+9B_%2L(Q2)V M(</)FS^W>DW\(7*D M`5,#EHX$DZ_KFV0?I2,60*Q$J`1V5CKB*4X%X41.3+0*P"*AA>IG,@HA M"H!=0`[3@8JDHN)R#0?BMBH48THC.L@P$P$M=]!8[R[?!KO_F/0"KR`_:)Q MUFXO\@.`KM#6E#'9@WD$@;"J;?90QCP,< M]`X_L)$.8#Y1"06@9$8UVG<B!R2M8&\-L+3AQ`(_1R*%@0@0$7.T!_A M[JW>+PS2$@J3WJ`KPSYJ6&,C(/BET#7C)K.),DQ5D!=C-R8PE(R9,+D5T`X, M)BQ(93\R?M:-#`:"B-V?E0B'RU,6"0X8O6H5(F+(FR-+>$YAB(5:35#`6IT" MXP8(KCM5$.@,:/)OT*X4HU9"`JD*KF'"9U2#`3L.MHG(`0?ZS#4(6@>B27R_ MGW6:J,KV#4WXBUCB18FX6G!8@9!K0%7@,A8+RENA3J]]@[5W!\`WE:5XT8(" M*@BQ04,GL#>).[$LS!F5Q23[.>^!<6$FF!4]('HD\3'(`(DABI"0%!GE1K5) M#-BIVIG/F'VB-.+-HY+!L>8!W3R)NJ?+-60X1F@A9!):I"2<@+.(,(T7B2_. MOGJJ/A#"YOF(/UIQD!S\'0E$&2P+AUC#Z*?3AC$'VW^5"AN..'P)&\39V+&I M@H`FP#!50IC"PY!B0:!FJUT?`_M&S%Q>`64G[2I)Y3;1O/1HIX:!ST0$^)N` MT:QVS8D("XT'0`435P&:^E>MCF?72<^`5!_>'U\<'=@Y"7O5]N8X4UR`K.*- MPS$F:R`K#?8E%Q907XJY")$BA2R[/#!`XS%:IA`E)M=HU$="#TLN$DY06`BP MGRP1*2*&@;<1LS-AH;'S8"3"+"(&SH-;Z[B+P+/^OX"=2*4`[#\'I4'MU=*\ M_T5"19CXLC[!6PS&(2RV#[901#3?A"VG(XSL^UG*8I6B8DZ`B:_)EV$N!TBC MS)<]\\SF@<9E&=4V@(F_Z(#!20$PR^`AOO9H,H=-^9H>I0H+$M8P\3C&V;E] M(MGF#YB=8,`*$0>TQ>`ZD1H<' MS@<<;H)VSU(KCU!0WC8^QJH!W1R55:1()'@XTG&+@,4@HTLC1Q*KL M@C#![9?7(/@0"#Q$9X^U!PC#30D4#]`7)BT(%4#'T^1.V*CW:P0^YM]@J:VA M4HX`\0&H6V*S25ID*EQN'0/ZZNL0M.8NQW,2@1`0`V8V^%X@&J2S\_)APA]K M;O(8R&>ULWAV"+C2UQAM"T+8DPY3*C4/XU2KR$H$6!V)@66(1A&L`N0=05I$ M6U]M"F-0F$MC*M$9[>F9T)F/U/18*G&QH&#"E#+FG5,M=ZI%"9CNI(#JN+S<&2/C MM>D2.?@2-PP3)QE$QAPDIUOK[?5JK=T=9BX`&U'#KCL<5`7?'(<=+*]L8IKS MA`VU!?U*A,+*0.'(T5<+4VVV^J6*XE`>N%;RF/,+5USS=C9Z6%@/<25T@(X1 M8`7"J9S%&$]!J'F>OM@5XPU,QB%>L(1QFX75F6J^E-5@!T;[JRPK%28\MK%E M6>9QIU/K[79K.[T]CSNE5$[3GZ/WI>GJ7J4P5"4*(W4QK M;T>RRD#O9J/3M;:T(*^MQ"3D>@*>C")$V0&=FVXJ1VZ-:6W8M)DLFQ<=6H3+ MP5>!JA;H7,'Z]\'D&F$@'!)Y17[)_H(\H[P-5-DRBRP=S!M`1FXR:HF%'S*Q M?9%.,32FMI\)U0"Z99_UO6$UM_-)85FYUX0\'8/Z`4;ID`F/$*M2!FE8Y\^':Y[`4OT`JKFY]`K=L]5KA:T#9AI&8")O8Y3%0#S,^8:![8RGK.4 MD,G9"OK&CD3$IVCY(@B$L18=V?LQ,^9ZK54WABF:+IWF#XA:&7Y%3`S1F]WZ M[,M9]1%J]\4(\#EPI>_$.'_3P*#R+/`K;-888&7:#/3^>'GX]=]3>M!UIZBM/HLS4 M&O/UVGRCCD/<3938E*;DE\IY-B<#*ZS-7)Y4+GTL['WX$D!)6X)M;INBV-=P M\BJ'*ZQI;C)NOY1@*41`")=JDP7="@:^>>22._G<1?G-HYH1R%?=1B^O*5)6 M9"MW5ENHQFLDY=5.SZ0YE$*9^H]=@`F=``1$M79LRJ3E>+R\#[MUCYT59WSMI-)DK2&=P!C-$L M#A$Z0IF@E/J;^"$!NT];X(?P"FDYO\P&?@%`WO']:O%B\2'3+/38W):"*:X,GR?R9M2ZBL6;--A1 M48C!^3=/KY7N)%#E4/5-D1!O`/K%+FH\HACA207E(21*>:MJGGNN6)>K8PXD M,0IVS;*4@/`0=5WDWM\Q)E")]?-8)TK`*I!_AYPFP%KB4%BG-$/Y!/Z0[TWY ME5B7J;U"49'NTMVO2*',H+S(V`:DA$KE(D+!NCR5=46F*AMST8)(*Z\@P7HK M.S4L`>)]`#(\*$LAE;[+T.SM/\K:[7YUC^?I2.J0NEO89(E57%]H/U$=470A M%!275+E9V/B`F4#.;(#AF3929`[K^Y#K#VRJ#YZI-@506UJX@,A2@AVP;9O; M59/IC%I,J8Q8JT&2*I7.(5HSJ32A0H8)G6)9. MS35+&R?'('Q4Z"@Z[*U>G7IWKJN>Q:8*8RX=&!YYEM0U$(B>4R`-F#NLUMM8 MUK6G8L((J_@D.@AWDU=N=Y\`W\]P"(Y]0CO,%:"J%FBNYH-?0X`U-30J\_N5 MQ9*H0AU95;K-1`*H[<*YAFD,228R)3?@"PQ?,)*`#O4,G?)4I,>OLPN:`6P1 M<N M;B1^C9E+Q[=5A^:8=OMMS46QNNN`E()<[;HBL1B";IG;40NC8$3!18D#"E&\ MB+72?*AV&">Y7_7Z@+GK<3YA896BEL=HJ;4CTO8"K!MP`;(7')L8F`)D\A(F MEEY,UFL3'S\\@TW'`FV3L9=X7H MUE:W9Z_)SCDRZTPH!S(U\HH_&\`_)8]FB^XW>#7N.3!T\.YB:ZF_6BR[10.B2SYI4:H75$_]D_N4N?8%%-\^Q6ON4 M/F;EW,FIO:'8WKY'Y7_N)9:B!!\4K\[Y?6FWHEKM4)FFFW6H'5.\[NZ]+U-M M*ACK^7"-A>OD`L]#1ESR^+KSS+V>8%ZR6Z:BGQ.O*.?CU*^-\X;S8UYYG6Z\ MQ.K2W%DZO3C,B^T4;X]$-*'Y&..Z^C)@S;/$F`\X1%_`T<"/_G][[]K<-G(L M@'Z_5?<_H'R<*JD*TO)-:C=)E2Q;NTYL2\>RLS>?MD!B*"(+`@P>DG5^_>W' MO`""%"F1%"5A*YNE2&"FIZ>GI]^=X*WI35&97X`LG_TV!9O4*C;RYG&K:"/G M[`@,_VM)P_5B.SF'";;N,W!;X;0]>@G?ZC?FWH+5%R/PJ&+)=Y<`$S6L1 M2CXNPWX+$?A\-@X71FF^;;;<+D8Q)0Y[?&D7M5;B:F/I07!SZ+0J'L%O-$4@ MKGL-Z=FVKE&^W56`DM(Y.-PGQ8NI$!=9%0C)1AX9JZ:BSLAXEGE_8KT!Y1)B MK;T041(B,29>:%-%^3J:3PURI<0G(Y#(3H`DQC<^BB*H304SCE>B*%<595VF M*>?`]BK9.<7?8D[7M:+5"F?R]?%U?2?.[\AKO^_F68\^>!59;Q7);M:M4>&+ M,*,IQ<9S@"U'TB1?/I/&0X&F(W/(9*ADE:XW?YN\1@K_5LEN*$^/(M7)$X+L MT`2Z&\9)QG98T1#VA[4XVV&,.Q6:VAH%WBQUI:H;W>B..+Q)CI.\'YY/KG&- M(1:H+82.8T"X%/5CC-"GH-"2J4KQ/K3KXB4%EP3F&/(=8*]E,8@UF=P7.<[1 MP5;\K;VK*NE#A9=D\<]ST<*_&$H9BA&6B;V&$=(X9'=`PBR&OT5IQ8O^3/)9 M-KK#4AA\Z-EX0859IC,6`#7;&.'=F4HYQW-N8,$^7]DB0?T>GB5K]=&2=`A5 M;P"7(GT#G+9)X>O4_I'=$RH\@F+=@!;5RDP,C.M$7A!2Z1D:C?Z: MQ6&03HR=NT2D$CZ"HRHDKTP!QNWX.%K`5'II<%VX/^S>+FU0<2-6V2ZY6^[\ MEU0/I_RVS@`D&/#Z1-(2&7D9L$8+50(D>8(F@\L>+O#X3LCH>;1Z4\(2K/$T M)<.PDM4RTZB0.`"'T6MS#+D@BOC4(2,1WKCHO2P%8ZK'BU&.,]CN'P$F*85W MSMN3/N5D[@\S?]K;[W>)^!*C4-$.WCT\`BU5)JDXAG*]4&F#1#M8A'_L M_"Z,4[[$LYPDOO-"&930@5GU951KI M5'+C1+O313+RB,V<.M>2,S1U*+R>C".LF#S-.$I_L;R(MT+FSP]%(:!*QE+> M66P6)BEC1"U*,J(12$OI7*"]C*]3T8?R@E:VW[DA_>I00^^5.OKN*[A7)2KH M($E.%9&'V*[3$14S[YU2XCB[MW7NN$PR4)G@,GS/JB(B7;WUUBR_3TT'LY)8 M5WE_DK'52SS@,TDZ&:(-+7&E+>%H''/D[YP,+LD-T$Q:O`(_P]\6))C!SF6SV%U#7!,#3^A&D->JE&;G%DW%`O55 MJVY?%1MJQT%0R,*M,$\O'A,1!A(V^_Y(F%2N%VGB9,ZFJIYPFF6@(E2M_"$K M[KF\:"D)R]!!)0735N6ZD.7WB!0Q:I.1JGQ]@W24F17W*^DIK)FPB*NT%=)= MM+"S@#M6(H3J?RN$M%D,P MQ9OGBS%757D/,N)DIY%_1I:S:[@;@<6\#U+,HH4!OL'9>Q>B2O[B2CDO-U-9 M]9T;=H%G"VORZ_:`P2I@D.#>4<7GO>?6OX`8-OKS.D%N>C2*PSCY&;EF)@BN M;BL+1YI M58H5S5_ZC%8>Y?4.:OF8?U2BY1?Q\*YIO4;/:EIB#[GN=*N4HN^NJT@$X=F2NK(-T]E*I;*'K_FBS M(QFSYV.2L7*W:;@$O(P2&/#K?A?%/1+Y%E1EX>1@V3X,N2%;MZFV.Y9])QAD M3%%G4:E#9X@]JPOZ<&F6!;$J MI:ISP3S5U$9;VR+9]C2W,;3NHWHM_AXTE:&7_!59-3JJ%*'KA6U_;` MG69:+R3ICZN>R3=<*=QES"+8F4?#J/)NI!57U=>LJ6##5%#EO9VC`VN'BJY6 M(HC1*$Y\#V,ZZ!@O\<,5##L5#I'->HEK6E'5K&E7YP.47:DLW0KI'.J=N*WV MP&UT.A8U++BUB^Y])B8.S==[4JG\K"S?SRD&L*X`!%JX:61799CBDHPK(JVU M`J=5T`KRZ506V+7PQG8ZC3Q'8:_6$*I0F^.'7T5$\;4(1%YCJ*A#(>LGQL`U M;Q'$E#NJZA8TTKVH#":F#PVZ9RNY4KE]`2L^VBS+3E3,J"-;[^*[3P^H#<,\ M3H(.02_W`W)7?Z/V./J+!:MP*E=@%<_&RM=\L\W=AYX^;](!3Z(,6K*OF;:P MH/L(R_7JACTE6[B55O'KZ>EE.#NJS)HI6F%9U2KCZ9(7_.\>/915U"L8E19W'*2YW',<92I>Z.`II MGQ78-EOCF&UABM5%D;&'0<7FZ["C>!9$9`$<8\4*:9-T.9F?JJ;(#"+IRB57 MQEA9-A/$)PERU%/""]-#7419GAWC@2>OOC/V@L2QW8X6&4K$`%E++P$,K,R2 MCSD[9$S-=#!`$**#VX\\.&A(E9?6*:DO M\*H+_+Y[;_'MK7AP-K&J*Y8*3*O(2,[4/2IGZF+991C3B*=\DZG:FT,OQ,LI MU=>W%?1HW[T"0W@CU>[.0%]W&ZPX&]_9(+HIM2AA)+3F!H^K^A(M2;8@I7YK[5JU'R"'8U;(6O.RBDI65;>A;CU9#8A.9+."+OA9 MDK,XP@&$.XI"5$+#B*YLKKVM*JA@_*'&2WV4RT?YS$LGM!GT`4TI-UA^*JO/ M]-(FNTJ\YGI;6*'>(1DZ,OWWQ@ M(T&\S#(ALP+I1S:,47C6)+B>P%T8!K!?/H6)*@U!%T"8?!#U/VHCYOR\Z;PIU(YYO[6#DH)BD)Z!<);\:*='4\?AX*V>)31N_D MJ1CG(5QH8U-I@ZHCZ>#*,48I'30/U4VI3P\CY:!U"/!)#5T^PG=O0O=7Z(WP MH,ET"5_'EJMY,0#)$DJI)R*,C<\=M`^)V814-Q>=HXD?RLQKK*"*MZ'ND*UU M32R)Y:E&3S(1-745*.8N+B1P'#"7H97C=(:EOPY"M(+)/ M6I!(\#@4$D&L#U[YX'V*H^LCQ$U]LR_"E84B2:G*$*2O;$N,+E.U=3FQ>D<: M,BX2-,T@$WQV.+,-P^\X%6($AXX\3!2&H-++PQ(D#H8CSRB5FOT;\N3%G,=; M/G6RC^,HOHXP8U)>I.H14)9YI"(`IE.>-S^_+I$A69'D/#0*V;1D-Y,\0G4< M!Q)24!^'\6UJ;.5471G58E-*-)?9A,2<4&_FM,?`ME`0%/6AUG5O%^R^HM>T MY!:GQ"`LBX(0H/!"LBGZ-V`_)D`Q,=9?#;E'6_P?Z=;@OK!QV=OB%LR:["0C MU1$I-S?!<^I3+PF'3Z\O.$^(91-RV*VP(M!G M[F9*-'$60:%G=56_'VN#N&04PH-(3GS+\69ZJ);9*4H(!L::@=B?6D10Z@D8$U#XR`5"DOZ669):7.M:3'^J263^I7%(\`R5]9K*O= MOE784DB2EP2)OZ6X)1-C<)5YX[%C10R^R\,0\W'MF*2KTW=VB,^7^!A`;KI. MQ7;@/.?:J72EG4I4M$,IU<,[!X;$<0B09J-#&H$1UA,Y,!O!!69N4V44@7G: MIK8K2S\::M@M7,XKL"9JZ4U6-SG=E`JZI/X)%V\G"*R4S=:-;O0.ID(82 M8@B97AKC`U16">M-''/O1A3*'!D[P@6:L+-3GICLY)F74HT^DR%,F18:5HMI MZ'?LQX^=,UFB5^I&A5Y7&(K#]8%81J%2O^3>1)%,1L5@I@XFR,^\T9^8#R4E M43'QPC&%.F'92"6)(,'%JRU-VS'4V'YQ;$X+0E503T[Q`FS?0*CMM;B$*J&# MQ:B696&Q1!*W*O\3?3$Z]6BJ\T/OV%"+MI](5Y8AP3XF:=52JG2;(O)?QAK# MJ*^F$WFA($>NS2D5#,;$'.)EA[[APD6<"%`((EV**+XE2YNK95]4H^A0@LZ& M559NA*XW/8U90=&6:%>>7#AW,J+01:?R3-K,AWR[CU6*F;:A_Y2&<::#,\>B MMHO-WZNGRO?)I9/(M%'?JV5A>!Y)Q(5,V&D>R7KK?*_93C(X%_`"Q53:#68J_U(\YA)BPFBFQBKDA#5F\`3*^20@)'6=,GABK?; ML:/7A@M2#<+@-,G*&-S/35Y_0E<>QF3!,2P@*SK&)AZW$BP!]#\BVA6O>W\M!3,57C*:R!25 M&Q'&,UWGN#X2%LK.B'9U9?KJ;&^I6FDT.C+JH5"C$OZ@-F!`PVP4XB/!IDXR MM]Y_(M(=!QP\=7E2Q'+;.AP8A4`H6PL7$V?:Z5FWH]%-E3C&9@5G%GX"MX/,+R@R`?4 MVVYD>5@9<$5@%%*.U*53&3*,,\&H4M\SAEZ0XY2A=Q6(\=QKWPI?9`7QE\.' MR0(T%-FMD.Y;''&H23[=IEZRPM2SG@7"]D.BZ!T))2FC2;F M]UBM,FOYIR0R8M6T#UX24;.T@T^`R4/G$IC?&9=/N,(R"[7XN#Q@?SK+D8\* MA49=?L0$;CAPIV*L7!;/@I'3ZN&-ZAK$(\:ON#(-9@>.S%@'(6V)5=$D53/* M1H@W@>[=C<>">:]ZS\O8]JS#?>3ILZMCJ-)6E!D=Y5,\5G%RJ"IBW5+O<.0= M&!5Q+2IKDA6J;=CV'1H4=B^F'#@8EH7JQ:DW)?]FJX'KM),N>:05G`EYZLJ8D.;&T<>A:E7;1/:P+/N(&SV,%RSD?^8@TT"D6IU)0?(AJ`VS:,3C- M0NFT!7MJE8Y."V^WW>Z@X_:[)POKQV$)E^JJ*Z_F,K:"-9`BSF*\_&KG[S*^ M:DL`%6G`\V:BZF3`1)CB%WP<3<)C4?#UG.M86J)P" MT(Z)4UI8L67X^XO&VM<*YCIYY/7.ISEGH?A<+Q/C1JHK:%'_AX[;;'3=3OMD M?KS;./G3KD5%[2(Z/;?5;2TL=\*CE*+AU*"R:7@0Y2J,O8Q&Y$^^P+0:,J`4 M>X_'PTP6Z_9\[$6+==LD:##R.,>LM(*4)U+9NAVP4/!)*)\[LS#DL5-5JC&> MDML\'@=T"U*P7:DV9AXI(F"(YL$)U+TP)-/\B-6>$9>LK"V2\]&M#NIVB4T@ MSCQQ:',S!262G8VV$D]-B)U#X)*A(R)W5P45CB984!FC//6V.B&^7S00%[:9 M]4*!T13<;DD%>U-CD;)`H/8=+C0"HE#1V69-F%R4WK-,'=.;>&Q1KYA(ZE]L M-(B3)+XM5/(OWZJ6&F9E:X^\"#5?U1&`:AQ@K(>5(3*'DB'F<(S0A(F>)AEG M`_P.#I8R.=%1Y;)[M-R:S.T:4YOAC!11@QA6XW'XB-P7+@HDMX5--$1WODA' M(-\;\]8,7:]RBZ9J1B,I'%<@[U!)>:`\(#.T#IG% MZIRY`EL/+]91KIN$=&O5)N*(2VH<.[1;_@1+&/F2XUB3;UDJ/<<`T']1`.AG MTDYX7VJKO.H'P$A)[6(5+`V6`G:76'!UJ2^5"I\D`<<`6Z]7E&=#P\&@!<+8 M@DW2Q]N4J,1T>GZ+1,8(C>EZ#KE%R]6'`- M\W2#]$_3/!"ES0R&D.&!E`$(#R@M,XHC*_]+G?%N^3R;_0`I.<%P@#N^0;5# M#OM:8U,XV33O1S#%J&65QX67GLZCN><9'57,I!IL M+B)"(CPG=?$H=JF^7"G]"#,3FC7LSS6_D0FPI`8UG2/G?_,XHP9\%%Y'A3@1 M5LS@,GZ?U*90::3PN*D!TWMJ.H[="EG,@J129Q&;J'?"WHD6[,1'IF8KN_B_ M]MZPSYP;UJOMTW'IUM%2#O$JSB*;JW%SC5#VGE1_O4:+*R.R#=C_7L&>)"HM M_Z>-SIJ$+1E8IY8HD^8M-[#25SN!4@CRR7YAKUICUEAP9"UI(L7$N]6MZZ2=%6U&<:0+1*E<)8?SE&RO MA6UI-2V+D3%D',Z2:2:2J&I5SL'YQ_,+_DAA58>D%)`T\\JH=`73#[6[.'I' M3!F1+D`?JA-3[S,((>_T_)B*M,NTQYL@M:NCH9;3;PXH,U1EE5646Y`!$[*6 M*CLH/6<88"P#0#V-?1&ZZCP)U6:[.*5CIJ/SA"7M_X'7?'O2!HCI0R2S!HI9WFYDL:IN5JD:H(%&H-ENK,A]WNV"Z-'312 M![HOMNPU`X*A<*6KS\J8'8KRV!Z:4:CMKBKDHE(O]8,&-F5$B.Q"+>9G9GEF M`NP`;/!(FB]%J'LA%C3)%"X7)/`3$(3$(Y:U1O:Q)HGWEL)_371*D=Z,E$9) MOIF'==UMR$'-\QQOB%V9=9]@PZE-6S5,H;T)XL1UL(HH[>T(^'P>"N5P0W.J M\+*),JPJXQ40]U!+')3?JUQFKLJ>M>VIA0-FU_0?BX!3K_!'*G(:A7'.UZU:Y3HN(E3N")#2V7# M3`[5OVQA*LCW&96'*>1P?"\7O9"X=K&/ MVHW#GYTKNG+'=^K.*#2OD$+/>S',G(\`*[FO*,=*^HGA"/BZ!#T9!7#WC4P! MK,_'EP/U,B<76O5W/;L<"#UK?!U#JWV0%#KX7N,6#<#0!5SXY`EFFQ@,(-/P M30V[BBIZ!B[+U%86QNAW71*`UBN%#I/R0J9SRU!ZC3%B.LVW8N&JI0TG5N@: M$0L0.8=D%7ML6M3B1-4M`9BT^'?=_$:Z'U3K)I40HJTZ>$T6'Q\*(&Z.Y:*D M:]5SAN!H=@O!9`5`E4`ETZ&I5&@BLB1.9Q)VTN)<-CQ5[BQF`'G4V9?"H;$` M(4-<)HM4QA6H*H8D%EHI+T$=DU3@`S[J.SA5+/%\DW1JE&B;XIS,4QRC(-9<%G`#8"@&-;? MZ`&4YAHPV6^G0SS7C,N M=48QI:5(71RJP/Y"<8UB,CHDT;RH?*38-8=\)%Z2R5(^,+7ZUO#^49S,8AF4 MQ$Q+Q>?+E"'NX:9+NA]@G0:T1W%J&'/?>`@85F.4'@BQY7/A`>+F<9)=>]<" MY'BJ&B0G+7C:TT/F$$B^XWB4ZX;MLFQK`2=6A0O$BDF+B)-K+Y*+*91\M_0? M56L:6*1T,HD[U6?,"L%R9,H5F^P+>"\H6!0DEL046%$*3@ND).06\3!...M4VRUD"+D2H*2\ MV?(?/G4AO=+V44*8=3,^L9+`NFYDE]+U[TEZ_WKXP=+UF/ZI#*L,NC- MVC"N8,)F(]5#$*B+';\I!I32XJD.:R`LQ=34_J1^0-(,4W5(T=H*$*6&]E6< M:5D:64W:D#"L+G$X1MKXX&'P"UGJ9%T6'6]2Z!*@'Z"@F2(;ON@+-]6#H\LSR4)355)=G6KH6((,^Z1KO!:"P1S`D&S M1HD6"/[A16O)`\V*A'Y=\Q"4PP\_X#*C%JHG3]$9Y)+2VQU>H> MMXK"4&C4CD;XX/4UY;/@<I1>H&>_(B,G>#O&75 M@*(P8,`#TB5DR(G$^`?QJ;6T(HM'G4IM4=WWDK]36434/,IZW\QH1N$=V\E7 M9$S-Q8Q)R24U<]H8<^H<-?LU2C1S^H(]@)#R$37W.EE+F4^#SI3E8SA3XUM=F0-6 MWDV]TBH+"\6ZR%JNIOHK96.8D%0#3"*3T%*E.*&<6*CD;`#&^G)SBT#.(;1A M8\5E5*5BJT[ M,M\$@,.;>,2)?-9!YCDCO>\'/C%19H]8**U:8"-` M:K[X.+[8JU&R+E^4B+-YXGN8YL8S96=_$SYI?-JJTSVT&:"%?E3T@7(QA\6R M&#@3#)FA4X@A\:1^3NZ&2>#/::AH4^%N)0RE*JZ$Y9NI^PS7)C"=SHM5]RGR M;$A!EVC%(#YF0;=X\V*84:.DC:&4)9AYB6ZF+?-]46%;(L9)ZE$ASN' M)\?@*.7ZI"AV7H=WY+]>26`C5&B!K>9(6^5(W1HEQ@.97\,7*\MIA;)PMHK' M?4CGB^F#9EDH@V'KD8WN4:=Q:+B6S1BZ1G13EC6I.FDG864!83P26&<[,)FU M5093KJ6"[=\S+*B"<2Y8?U<&NNB<&7M@DZNK9;5%*>`RRUVE9BN8QW&<`2L0 M5@OLXI+G>*$71<:_!3]R81IB:P1$F;7U6&>E_`_),+DQ3V$86C\-HHUFEF73 MMIO=HW&:^#>SAMH?"\5417IIQ$B?!\@Q.52F7P%,/`")I+R2"^<8'#2ZOAVS?R MK,'T*%.]$S`;E<'PI4R#8WX5W.A'(*9N,-3RDFW858JP5:"3YK*2"]GFSO/Q MK](=K@+YN!ZE9U5%\>:A230TJ81&ZI7P>$8]D'UFE79;.QV663#-X0[MWC2W MCN&?(*PYW:XX7>.D1HGF=)^]NU497>/$9G2J%PK9S<^DYL>GQCG3W7XDC^LU M>M4*9>-$\P?24]@,5:ZVQ?88VC0:LK/;*3T$SX7D)O2Y M>A25*FF:YU#ZM#E]'O?/13ATJ3WN\J.&(%5/<0_@8",XFW1$N6:*]E4?B./K M8W0FRCH[UA`4W.#9HQX>%[!F,S1V0&^;J?6X>2WJYAEZ98L12U;,F#8X5G&Z MQLFQ(<1QS4*)F/HEV))P[65F$E2P1]]9".*(AM<#HQ//0R]-!ZC5]^ M4"VGU>/M7H,?_ZHM[5BU1:J-+`!>&!&`NCB8JBX(S'OJJ^QQE80SDT?'8N0' M=@I4\N@!^Q`Y_$8VM%;!1K"WBC[*+,\YFXC15E0S!E7`4[);H0LWR M;D48DG`WE1JJ%@C5FVI5%`);/9(V]3&[=B8B9$T6:Z(=%Q:W+=E0:;3)`H:Z MS*T`8*WJ5KA/'%1`U")A55Z>REG&8"FL]Y)3.#SWH4)#KO0>L1UW*ANCJBX% MI@E<)D:3B))V1G&2L.-)!T-:[JPPP.A`[JR=%`PE6+1-11";*"J=):^BN@NE M\^26X`2,_@W,`/@J7Z=NE/& MF1;^6BS]==P%M,IA/MBHA-I^4/(%]L&$0X,!G=B0@!W`)N9XCMPMUHSF3E96 M_I&'=TZ;(EHT2X8_529`243\ZT]Y>G3M>;.?KTQ%"6.MN8SA!,-!_0;+?1?& MHS___O_^/P[\\U?UEKF%+\:V^>/1P7$?Z1?17CO[TY M!_!E/`[\+XOY\\E1N_'F[X6-T_LPR]ZL1'QKO["!^@=#_/`%+=C-YKRI[$(6 MT4)`AJ^T+,)%)(FU\!J=EMFMQ4DI/*%"11=RU_7%)`A328KFU/PL?1WX[C5-9T$:FQ;A1[& M,3:T(;V%2U'G4WB3.G.9."CE_M>XMEM%F+/'GCZK#AO9D_3!6RCD63T4I.:* MGDN5<*]+%H*PITLW\C'U"KG:?$KMFO&Z*-#35\UKK;[GO!&8`I_.*-_C;V\: M;^CO&>:MR+_GX';.`(1A$KC.;R*\$5C_#H#UHO1(0GP;^-GD9VI:](LSI(*9 M1Y0"-$O%SX[Z],8`A+`D:B)J_P'BB5KH,,ZR>&J>1C&"WJ">[`!Y]+TB$D<3:ET"4#6[?ZG"3^8OG:'9TE/(%3%<`%_H`64TC[N`&[3/4#`-(C9"BPO)8NBM""%`N?"G):2@(#CZC^JERHAV`2R^L\`5Q^8>^O6 MULMQ11^3M2@62!\6>YV`1.PC^+\5-B5Q\]ZR=?*P=O#!Y\A:Q8(*-TL4#0.CN)6U^ MH?S-W5+F)MA[39HOGC1_ETW:=DN3?A53;G>TVVF57Q_C_3X%XQTO M^@"MJ&E].^T%"]@X##4+>#9"8BTCUJ=PWV3$]=3:IZ>$WIK%[/?^[!WYOT`64Y^!-;%;(1C]1![QPE?;"*-:PT6_J<`R MC,`HA#!02SH,<%+A$Q&@SIG"+!-*@1:^B6X@:%2$`Y6>264X1[J#>(>'1+,\ M^\B&?>`WVIW_#$(?=JO<53KBG.=TESR+O7U2(X7S-%8*YW&&@_VT#$BVV6O] M92L$JPWZIELU+.^X4NJ_7S" MW7XPDA8H5;`>+&\:BKU0+%&+Z1 M9M\PFZN"\RK??%V+QD#TO%(*3OXU2Z\KXA(EYZA8S:D5D[,E^D MLZMV9+[!?P#O_;&\<4H MF'IA^K>9@PK%3Q#80![Y#/N MVGYJ:`$A['6I:;;(J>C*8.X=OTK4HJDA+I9$63\9$M]YT_]NNFLP: MJ7R$3WWN30H/>8'_,3KS9D%&_8)68"K?K][;R(;Y![U^HV$=VP7#/P**>1XR M#T5W,&AU.H.UP;CRB&DC47#M,,G!TX\I5JO_&'W#[HL>M5%:=4ONIGJ="&H;]YED:/7(;W!\/K\_BY,9 M?W__VEO-3FO0[6]\\>3[!*JG=U>F(O7"')@HC%3"6)AG`_`H3'[Z]KN7H.M@ M#I'+P6QW=@KFU8/`;!XO(/=-@KDYTEV.\?[VEV)C?.^6@D_PV7R?)]AXBJZ: M?WEA+DY'W"R;ROVOS2WGN7JS6^:4*TZ^2:`[%M"=:J!_I,'/41#^[4V6Y(#G MGS:,L]Y1JZ-P!I][:M__&:'F@[T#O9D``AFE'Z-1%0F4T'K2W0Q6S[QT@DV; M;H!THBP]SG@T.GIX'.[^8<F MJR___OKS[W'R)_"@1RH4K4ZOU05JK1BRC*6/T0W0#RBXYT$4I!/A_TI-WE<_ M)O=MP^H3K+2R7J_7M83;ZM'GND?F`K%>8CR/Y`B]1M_2!)9-\5AP5I(V^MU. MJ_4P>.XU`))*UW=O:[N7E=WK]O(5M7=Z_9A@J=N_["?+<+J[G5[,$%-FGN7*[?;2>ON M=34+J)L3O6H64'>OVX,)ZE.X+S)BW;VN)LWZ@MB3"V(?3F#XG',^7F5;G?T= MH2DXKKO7U2QF+T>H64Q]!EY#`MFCXT?FLV^^BNL@S3"8^XLW73VV\NHN M$LGUG7/VVYF#,H[*?V_\XDCD.(0=QT9/29]ZRC";G3:@7!Q9=1$YI[,D")T6 MU[=S[>`GYUK6KD)0/!54A3%/LSP938`G.?HB7"]\RG5N,"3SV*#$MY$$9'CG?$Z.G7^@#>1KG,)R*9S4T?&DC@PH+<%R M7.^YWO.+41;;90V+VSZ,DR2^E>A^VY0;G$U`H;^>.)X#^S4-TA2S0R,\?4/A M89:`$Z!U0:09[FJS\1?G-LCP<=C9/,'ZP#XFK\*FE&;O.F,8$!X1#KT0"P\1C;QMU+LK=_>T*IK5A0WL=]U.JX7H(D#\ M7"P[[NOO(AQ/&&L,Z\`?/#[`B1B)X`:%\7J##-?_AQ?E'C#M5LOF>`J/9!N6 M3!]9'N`296=')QDR/^I*""D$`Y.*P)QR*<'*[/5F^S5.-J MB2+(4N=V$H>AX@5I/DP#/P!:74@BMJ=GU;LU/8&=S)O.]2 MGK"P6.MZ$XAHD+K2X/:>K<*>> MY&[/[0W:SQ`]SP7!G;Y[TNR]"(EA"]CY[$7Y&-.%$I'4AW1Q3$[[I.EV^JUG MB*'G@N-UA:17)O$T-A$&SXOV=G0ZNR\K7&[O$/P,CN83]7W()C*):I>$ M]YIZCS1/&FZSTWR&A_M5[5+7'71/]I]+/,4%CB^3K^@;QGO02HSKZ,G9QO:[ MA.CUOWWPVO>G<8A>3-/M==MNZZ3WA!M:D\1>D42_X_8ZK9W00P4[W%Q^P`/C M",KA".^\-$@OQG(TK/0,-]+HCO__U48?Y/B!4(/.[,M$I"+**.V"0,J?`KA] M#2K`J,X\\G(_0-\_$`K`E_(GDFX\%3\^#B(O&@4P:0JXI-"@U`FB49C[@@(& M=*A!*;X/(PY,A-!1.4+HV#D-84P`+!B#@`$,@L*057"A#-=,90R[[V16P(XS M\6XP?%E$C@B#*4#(\;X6]/!890S0:B>G?-Z^I^)B_`&PA]'NJ_=T>4GGZCN' M<&DDU$>JZDC-$C'S$B(_=1Y6/5'X((;#8L0]Q=Y]/[XZ=GX]/;UT$O'?/,#0 M=0#,N^;PO"R&O_X4CM!422$^:9I/9:7+;()9&N.Q&&6R?BYV>%)I(5-]:#D0 MCUZW(H-<^L+7=Q$^B70/1P:GMV.(/!Y?I0E0%%'5&DTAWVI`!*93I3"@;S(` M$MV6:D;-#(!M9G@6\Q#AA'4F'*&<3>+4PDLE&R@>Z*J&"'`UE_HB MU+=K]@NBA/:1/EC(J=G!LKP)BK(#F1K.`%QZ(\0=,(B)"H.DJS*".R_Z$Z;@ MRY4J7ZNK%7^,XS^=&-1Q/_'&F3.+93,/UQFABHYW:,;)%[Z@'VF;8C2B.1,0 M?.$*#@/8+YSI!@X''TED-`2"3/8)5'Y,(G3B39PXH<#`_ML)7+@JGM=WD04- M!:^&2FCC!V%(8G&>1D%.F'B,A"B>'Z'JZ*YT."LZ(`#_R.XPOS:#M_'-&?4' MK`_U+S*;-?@_?6^=!S]`H#JEBZ$^V4M/ML(=C"FL=&""1.5+8.:E)$`Z*4)1 MGXL"\7_H@L8(?)!D@VD^=9(\%"[?WR3I>DZ>BG$>PJT[%LYU(F!4C*['W,Y( M.'?"2S#>_F?GH'FHKG-]3ADI!ZU#@"](Z2J5C["`D-`E"SH^'NE@"H#><*-V M/*1Z7F`9MM3](Z-TO%_PN8/V(;$U.%HP0B*NO<1'AL$20YKAE6V:#Q$T\$L$ M&\!P@*0AF_REK@+%"`P2(O[B@/D9K1RG.Z0)<$DT(7V/8-N(I$0C.0%+3:AH MH'@B-/-%J2U(:+`B`X8=QJ+_J+I,O?_`8JVW'8\[P+*P!&B4\@M*83@&I8-7 MLK!5N=%\^OB-B'+Q58QB4)NH7D#-OGZ16'$LM-0\JXPMA:0@Q20[Q-/_LA@(^V1EB5Z?OK/0PYTM\#"`W7:=B.W">8,C#PZ8XOL`RTYHC-2:@R`D\'<3G%,B-&9X>+6]R@ M38J4SUAC>"Q;*Q$DU]A?J4XWG&(9(DAFR3&I'GA$$JV M^"D-XZR0MKX@8_">"[=\0W]+/!^M^A2\H(S]7W56,[_]*F]IG0-H2<33K@6P70\3;7,0,$=TS1!$MBH"IPQ>0/Z4TCVHCA:EXJ+?+D-1WJN8 M8HAZ`B?3PGS7@MF=J9T01#\![&5 MC&0EOC#?+W`$%_TW[\>+E_*+K(+7[<#"=^MFV#MV8)_N/`O8RF`$:2.@$SA7 M>%Q!]TZ==S'\QRYL8XGMYZ=7!;G=DO+-`&>QSQ9%/"C6RZ=79_:[_4X#.X2V MNJYCGK%WSS5/LW8Q"4!TT^X,%K6,FD#&2[BL$[29>#\6>"9T:0'4MT?(!>39 MQ5?0T@K#HS[`/H4;,AQH6PJ!04Q$^C!)"5KHLL"98%0ILAP[5*^/:PY,!4BP MOKL2Q,A*E#*ARF'9/)?=%Z3$#$5VB^!1%1L8<:C\V8N&9J=*D%@+,$X3Y5W1 MLXG(&RE!#(`Q>-PO0=+Y@]2LC]1L2/95DO=L*009KWL@A]JNT@(VGW M4OXG[P<-$Q!Q`,=U]%W!1AC-4Z6"FN#.D%@?9/B=H:]I#%,05[\[0H//$0C\ MALRDZE&Q*\YM`%<,/(Q&:[AI\#3Y.Q#?]YJKL&!!-VD!9;PIA#95[8-D^1D^ M3?8VT)F<$?8)/X+C>`MH+>*ACBDT`2@V2Q<$"BR[@\D7] MP4NP&5%Z*1(J\/GB[^L5Y/TOL!$*+\[!)]B(0P?P@]N(-=8(3[4"L-QI.)WE MR(:%0B.64Z,B=@0,MZB%*QF="%D\"T9.JX<7LFL0CQ@G5!\[&/DR,F,=A+0E M>DADLG)&,IWXP4W@ZSI\(I.L6[WG96Q](3U.VF4XVL&4T)O$(?D\#VB(?(JG M,DX.I6'&N96]*!R/VT/@(T.N$V8J]16:]]HZ"0T*NQ=3^`\,RQ:[Q9$#<'N_ M#T):'K&%A2N'A:(BHL:QYK@'"%U*'*E@M!A[-12X0)J=+LM" MD==\9Z+5S\;#0:ZA,_=BAD#G"?-,>LZZ%5E8.72!N4I/"4H,@B]G&!!XK M'LB%1SXB+;@12\KN.95%1MF,6U%HM+`6E#UNR6;+YDU=+ZKM=@<=M]\]6?3F MK<"H%(/$2A9^#VLN<_)S+TC^A25./Q,RA7'*U#P]^P6QXQ!Z'`L_M8ZF./:4 MD9+:H5.LYK"9$=%'!727R/-2.?)U=$62!%QPUWJ]X+?A:#&\!P8M.)$+-DG7 MW#+AQ1BAP6^A[`>:26K-X1;M2<"AO*FXC9,_2?WBE1+GLMX@WW8T(7NN#>[4 MP,%<6H-0F\^5Y8\VHENQ$>BD81]0('UT=)OV/$?WAG1]EJ312@_Q,&PJ*/P2B8(:-F]8#-8=;F M4@C@L?,[JFU*W547534YL#)_WU'`->!@6:;/A=(1%20V&6:3JL@KB<,(EQ#B MD-,82Q[[Z.>!.SS.4[52K=P&"LT*+=()J(.Y3+2EV9@*=,E1\E0Y+V$K%5[T M+NDM<=G!14$$$]2K,R<)TC]=LW]8K!F&D/X."F"`!W1D11Q)GQ\>1'7&N^7S M;/9C$H`4`[?N'+]#@D#)O.50"H)S1KV.16UVRJ_ M^80X=)K.D?._>4PU7;G].1Y'=*=3TI^Q`J0VA0;DF^/P%R'IG60W/C6W0D8M MC;!Y@[.(3=0[8>]$"W;B(U.S%>/T7WMO='P&X%YMGW:T6T=+F4>K.(L(:'`? MSO7GZ1GLJB;>RA0%FN*B$%B#N-;[%!`K%]S?B9_>-A.(Y*&B&IYH]ZR M>XK*%MLU("AHKC6^"QU-@TY<0>$V3O4-(;%>4ETJE?25M>YY#RFZ=^+DY6OG M90^I7/>K5KTU%E058Z+IQ+O%UB4PBA>FK@P)F`(?T2'%*HK+X0@NYUNU=R'0 MPR.'R=A+DFENE*CX9N?@_./Y!7\D;]TA:1;?,RZY!-TYXS#-!L#E!/8U^$KBXTKCH+%*=TS'1:5KCZ<+8D M$IGCC?LNNS?D[E]Z=W3+.WQ(CI2B33!H@P+-S0($3,O)42H1`S4:2ZUG_F$2 M`K0AQKF)0R]C$XIT/9(_)KS#Q[B#$.*MXN94^G`PY=@B:Z0@+3C/AYB#);T] MB1B'$CYX5QH9,&^;,R<<2KZ@>QF$5N%*;X,5GCP4Y;$]-/%@[!6J`"-R<,@X M5_V@@4T9.")`&"PO0?W0^IFYJ)E`8,2QQB-IY93CZH6C/&3G+(5PJ,C0$DTA M$(3$(Y8#1_:Q)FG\E@)5C".D2&]&@J2(ZLP+0OAL00XJJ.=XPQAH0,`^Q'=8 M1U4S?VQ+10T8*5[Y)H@3U\&D.=I;V>)1T@:9>H6739315QG6@+B'6AJB8&KE M%W)5J+)MZRT<,!/9$B=C$7!D&OY(.7T1[*8.B^?(.\X\D?H*QE5+GXF]X[B` MBK-\%<8`1@&+W('.U8CT98I@A$7Y,4C^=\0MT/^- MD-XZV4?*;*2FE3AB3N&3X8KB/Q(RD_IF*5;KF7E*4CM<9%65=_,#[MSRM0T, MVBHOD,11C!$-4Y.E^.*%U962=A"1-F&!_Y?4:U"@J!C=_+R4P2URYP;MD>\[C.W4]%:K12/GJO1AFSD>`E;QX9YA\R->H!T?`UW4AR#:" MNV_$%^"R/KXN5\HV)`R4/@F4OOLX#WP1< M5RQ'`HB;G&,<_E[HXX/$C.17!:B2W61@.F(+PU.3.)U)V$D'==G^ M5KFS&!;KH7LKHB`?K*;!$)?)`A6$_W"@/2%=_(@ MDB\Y)?9`36PQ^I33VIT,8!=D64)53>5\%NI8%=D?MWT@ORQ:696K&,M@J=:, M,D43IE;?&MX_BI-9S"&ODFFIJ#,91YMF23XR)0P.J,E5AME'YBJ)AX!A-4;I M`6K%5WB`N'F<9-?>M3@:,H=`\AUC^T@)@O0`%'%BY1HA5DRP M7YQ<>Y%<3*'$@:5J\;ODC)>^-G$'O)$T9JMZ2G8[DBG36HFK#I(NT4\ MC!-.Q=`F$IE0H`0H*:\<43]10^;+IS:\7\HN4@BC?K(W7A)(!Y[\6D8P6++> MOSY^*/8U1<5TXD77.'AQPSB7C"U42&9U3GL)078-&&EE-VI`PK"YQ.$;:^.!A#!`9!66& MG`Z[*53%T`]0[%`1#M3L.<@K)I&,+1"\^^H],O;I.PI/@2QSHNSV5F2J3+N6 MA*;*'KFZ_A>J^!SO3V;$A(L(C]Y.]4[@(UC[+>-S.:47C')OD5&5-S,6-231V:*@L+A?S( M&CVFJ@_E\9K(7`,,B-E#%-)3I3BAG*CES2+`F.D_MPCD'$(;-E9<1E6"D2.% M+Y,82U*E`/HZ4G#Q,FAUJ$.,J\=/M7D'X8AL0\V"(66U."&+&RCS30`XO(DI M@_?8L0Z:<^O9?#NVZ*TYX#:PTO8TSQGI?3_PB8DR>\3B$]4"&P%2\\7'\<5> MC9)U^:)$G,T3W\,T-YXI)_2;\$GCTU:=[J'-`"WTHZ(/E(NI/);%P)E@P`^= M0LP,(/5SK!AFY"AI8PAE>2U>H@L_)5SI1$>N\I4$-D*%%MAJCK15CM2M46(\D/DU?+&RG%:HE6*K>%QW=[Y( M(FB6O\9X%DG72R);CVQTCSJ-0\.U;,;0-:*;LJQ)U4D["2M+.>&1P/II@;08 M+S"82068`76A&Y<'S5A'(F7(N*<+S#4Y4*I7!4XPX(V@N)8/X MQE5_+DW>H_.-/&LP/2;>X\G]5U(]4Q@URD2=>`(`EO#II$0Y-*:*1>"8]G5//;9U9IS6PB M0`NF.=RAW9OFUC'\$X0UI]L5IVN@J;H3B2V3;&HSV'TC4Y-@F/:JJ*P12F-@6D M[21_2F[!/:HA\<%K-D,C1W0VV9J/1+?2#?/ MT"M;C%BR8L:TP;&*TS5.CIT+%:K8M//LB/9N8JM'!,(('ZD6&X>":Q9N]U?" M8`%9#WTN>DX'$0SO='N(FB/.<<1!C9+Y*-J5>.)@;156LD305P_IB*H&&*Y# M+3#XW.HN&.KQ=J_!CW_5EG8L7B/51A8`+XP(@$]:Q6T0&/@33I3'Q2+.3!8@ MBY$?V"E0R:,'[$-,90DP3!G4P4:W,L)#Z'@MXH^HE,K93)RF*A8BN""0@MT2 M7:@)PJT(0Q+NIE)#U0*A>E.MBD)@JT?2ICYFU\Y$A*S)8CGUX\+BMB4;*HTV M6([;C4I4< M2N?GTKVFN'\F1I.(\H-&<9((V9I3!D-:[JPPP.A`RC!"NK`,)=C+0440FR@J MG0"HHKH+]63G-(9@.O.81!94"37-3==6)UC**-&/219:-]-GKMH3.Y/0PQE']C*ZL/L/]U^D\)9UJ`;+$$V7$7T#N'"F$%<*JG30DE?'-G-GL+49ZGXV5&?WAB`$)9$342%5X%BU3J'<0;JM7GZ<>WE-SX" M+`>P%_WM34NC2BZ9`8<%A!Z`79P$,,`NBOF(;EI(- MO3Q?7X86@F/HX[4MO+QLS%HSM6WL^NNRH`?NP(:X$>BSF7C`I?X8-!D+ MU'.Z!N4(NZ&D9K_EGK1[SQ`_SP7#1R]"4M@"8LX+9>&>(07NBM?WW%[W60GR MSPS#S^"$/L7M^=6[=3ZKPHX[)[_[-;]=S+$;`FQWW4[C.=[!KVF3G@&7>)I[ M'%\>XH=O<4:I!7:MW*%>WY,SC]9Q"XD&PZ9#L142T9AX^^"UKP+Y;NA=+Z9S M?=;JNZULHN.16;0Y$Y MIY&OPW*^IV*OW%^ MI,'/41""NI'DXHWSTUR[416YH_N3?@6Q^*O`Y!F8FT(8V+/^,7HOF[K"0PS@ MOU3=I%/=F'7%W3107N8)P.6+40`DG?[MS<YN%L8P"["(: M9!1I`?MT1L%0UP*&YMZ)941+(E@7T6O.\L#M7$AU"ZCF@8M9=YH%JS&[#N>[ MW6MV5C@^,$,9FE_CV*="1YM;X+(A5UE,ZZ3=;0_:9CUJP/FN$QE6BP(FRN0* MR_OP0Q9'VL*Z'CK=2FON=T_@4;LWP?V3E0'\'GE8WPW+OV%)4U71](,L2KTY M3*P_T2HX:)X,.JT3@X+ELY1A^A1'UYB;A(_*^W6#*UYQ]%66V>\V&C:'KAAZ MT>Q?XDRDE]X=AVML?''W#;_*ZKJ-3K_9'\POSQY\#@!S67^!>VGSN[?J^"NM ML']26F'5Z$M`6&-AQ?,Q:#8ZK()63"\@N+JR[^__BRY0@K<,AX%F*/W>Y!-/F$1S+7%JGF(.@S0/3/- M`83!LA\H.23=!!3-=J-1`L2:80.S_\$93'^<8]7/3:W7*J.EM8#L3*9VT->?K`J[#V,^ M):@>,'6!.'[GGNH?*8S_6WPIVZI?C,^HASKG9J]-UY2CG<[I?NWNH`.2I-SK M5:8NP'HI$@R5\Z[A&9Y!OH.7]G=LJW-ZG0BNBK@8O8I>/WV3`,Q1::7>VCAN M=27@:\`QIUW)A/5O\2G7%U/[)])?$ZRGNPD64I+@[IMS$S`632D/TV\W@YK' ML:->H[%[Y`'D@Z-F7ZT"/@_4*BA[.!CFQ/(44?$ZU"._>9'_^?U9G,Q66-]) M_T&K([)GL4;*R$3FZLA6'[MM[5&G:U^1*T#U5*M0#\@*LM]N86SX__C;),Y3 MV+6KX$;>4:NCU@R?>VI)_XS0\H]I<=Y,P'D<@6PR M6F$9K"T\BW7HW3!>E5R?W3:?A3$6DW@/ M.N(6=W61Q1##Z#+Q*;@1_BON26JPXC!:")PZH]'"%78B5(7E.-U]%&-'A:'N MJAEH))HL^U0FI,OV"E19"5LL4$D3F77,-7$YBS=(1OD42V*,5.FF6]8.L'X& M-294/00I!S@G3Y\34IE0*HN"'<:Y/Z:L\T3?3&=>D-#Q%3\":MQE[;@$5#,"/T"O-K9P`0'@;B@O_`])W+N M".O57"2J9,+%&"VH]!*/4G0RX<8B@VK7D#M1U M*H*Y(Q/+\I*>*C1!!8YPD52!0_#!Y*H\J,RDQ5YTA:Z?80D2!X/39MS9ADL< MJ+:WJ6S'6SC2Q%IT$SW55T<]8GKD+&B&Y\W/#T<9RQEH/B?9&HU"G65D?Z(\ M4OWQL/.M+F%1J(/`90M,.S[L,(,@$N?#4I5!B.L-QCY>,Y*9T7UZK90YR6! M[#SL46.C`)OV)I+DX5LZ=70B:%G<_-B<78FL^5LV.=3L1 M3W(Q.F!>Q@([05'5Y#YU/#V67=B/AE.UB61_E3OKG'*/IC2K>%[K"4YQPGGF M&6&=6BUY50IB>EEF22DEQB$]5K*#E8]RF0><^I11@"8+ZH%<*QI`WP8GCG3\ MUTR@JE".:BGP$/MXBT^C4N5\2R\RM;1I*!@\(Q_[%QA-U734EI* MA=2PXUI$U.V11\'&E"2(H00EYU9M/9"O$%"RH#T7'^,+VS07Q?!S71^Q4'RL M\G3=$N3Y].OMY'WG3WJ'ZPNKGVN)28\X!WL96 MFPIVBQ$\Z!LK-('.;%F"8M-\Z5*(G(6[5YI@_@EK"GNK';W-!(S>:E`ZX%(* MO5ODCU6]VQF^TK17(@Q%4EC-OX+,=-4F0OH M*WN492$KCN/<.T:_KMUS(CDMENF/K<8JG/![9YZQL:"@;6M1)T29=]H#.$MG`&@BDTK#"%<9M MO7`D6U<4[$!\*"14=,*44;1@4AD[E<=:5W>?SD*!``SOG'))QBY#8@',:JB> M4IWI$DR/P$\U1L@VELH2L6E=('8[!6(?6`"#<..CD8UHXF>'3BQ>9F!+8%54`]A*,25)KOT3H%9)^$>A&,M=WPJ=G"K9Y"MPM>"& MG-7K4JEL[C$8ZO7= M9K.]1?3LBEGNC*(R0=HA*FJJ\D%-78O*NJ+"A__N/X'M#]/Z$D='J&&(3'`G MY!2UNIK$JK'5?2;TM2\,#*D+G9&C(%/J>DUB+X/$]H>%S07%'YU5AB?6)+?P MXCSIP.79?@94MR^,K1`U5]-4%4WU3P9NH]/??YK:8P.:59>&5EM;T6KV@R]K MRYG,HGS1)/$81!T,3IJ;LSD\!I+#A2"\.($,J#/!KL&JFM3.J?,UE6@_0-FM MT]E0)?V]IO"'-H1X#56WUW4O[$^)[=[3F.WVHJ3V'H1Z5*K*''L1&=N@#FY7 MWU=;=;"#>QABU(*5'%SWG((^\W,<(Q4,=.4-T@@VCA3\7#=/19`I_M%V* MYYY/89IX`-%(QIS')J:3Q\#7L&3"+F-97GK8RM[>V;K[;F^_N^_NEQ%E_[=S M#YLI;[E_\FO#Y3.((EB]%W6OM9V8HZ^""A2OB:I7$%35VUE05;/E]DZZ;NMD MW6:6=2/JO=W2AMMKG;C-_HYZBS^Q]>0QJ,*V+P$UYW$.L)+,8A/1'MZ`NS54 M-P=MM[,V2>W4C/?:]^BDW7);C77#8_?93K7'=H^$91=5["+"=; MCH7@K["P4B)208E/UUC-NC9-659#WA2RV>A]PL)PLO$"`:*,3W:6I#8^P7]& M8LXR0Y:GLJU)VX!,G0NGNL9%T81$0"BK480)G5/`QD39CG397J?=D+F\9/>9 MS9+X!UDIPSOG;=^%']Q^K\W9B0=MM]'KN]U>_]!%P]5,96[N@#KVCA!P@A4R MS[F8,(%D5Q1V,/]W+_/.GQ:KF&2>`[&V>@_(,/\B\L2[%I&#%?V/"ZG>(_A& MAJ\X!V8X]48YAQC+`=Y.8BP)%]]&>,KR81KX@9?7D=8)E(1&LG\#.%./, M40NNY\R+/(`B6K0>26U6UCA!MTKFN$:>21O'1[\?7QVS4%%(X\;Z=U$49-8>Y%R-*E M8"U4K9*+W3QN%7.Q"9*#X-!YVY()THOSL0\"^[F%B=1(K)*%]N@E?*O?F'L+ M5O_?W$N`Q`!YPY#KDYT,!1P,O#VT(5?U./(L/'[>8Y]B/5>X=3)305$ M>/@\K;SE=F%^@+/[%_R"=A%KDJ5>*+B$H<3%S:'3JG@$O]$4@;CN-=0%@O5C MA3>&J63V+3?"P#=2+.ZD;D<0(E+N^X,;[O$?6&0AD(V)X`,!H>033U:OI.BR MS/L3[U)5>H!R/VQ*/T-3?(8U;6RJF)4(_4K-:1$Z:((`I?+4`8T*3Q6/0J$( MR[&)8,;EWRC]6BXP+=.4I6[6DM@>DLB_LIT[=6M4CWL4HSA&JM[3.$:ISA/;((EKG".W]'NU%CM"Z M.OV\#6-%:\0*QHQ4O2\%C2H#1LP1-?AG4GG> M.'D4\"C?K]Z_<7PQ"D"M3E&E_7NS!1B>,;SD!@_K''YQ_/+_@CT,/X#C$?`QN MGEVG4UIY`2,O2:B3-P5](_J"\@[*_`P9=LYF9WBCC@A_K=;H/32YS2=H/2;]EGNRU4#S_1UA-Q@^>A&2PA80Z*U_?<7O=9"?+/#,//X(0^Q>WYU;MU/BMKU<[)[S7%H;>[;J?Q'._@ MU[1)SX!+/,T]CB^3\9]+S@0+O`)/SCRVGTB@,?'VP6O?G]P"O9C.R8G;Z0R> M<#MK@M@K@K"L#]NFAPK&N!?))T_KL3HE;Z+*B&BUV-3O6CZK6X^+-LU"X5]S MU:BJFGZFOM6GV(OLDH&IH.8SPFGNHE;8(W)^EOGIE4__ZLN_OYH'V2I]*6L% MVJ[\T_1B;`(LEL89M'IP!/[ZTY*1'SBYBAU8.GFGTVT^8')C#UMCV3_2X._!#^*55A.HU\TW^:OZH#-9RN M':A!V%+%US#,P"",8#LUY:SJ*(XY/EM5IS@R*6T$BO(*NLZ8<.T97`?EYN@F MH,"I@PGJ8(*]=7G7P02O-)C@.9V6?5`NG_.*=F=Y4K$F6\JBNU0%FJD-PG_S M8$:5S=<[6*\@2*&YLR"%CMOH["A&82\&>]F[N:[Y^_5%FWS"MBK>:)1/<^Y1 MX(M9`AHN)>SLAPG\A;IF#CKMO:[A5.]Q[7[CP79414[;@LXM:X2+K35V8K6O M?3!;]\&TW5YS-RZ8FAR>`3D<[804*OCDWC5'K,V2+]QX5ILE:[/DWN_I/ERP MSWE%NY/(MVR6I.:K8^Z]BDWGJ%D;=LQ3#>7VVT#VLFU:32R=^X#RN;65ACW/A"&D^_(\84;]*;QH#[/_W-!;+YY(NTG(;'>`98*^A<;GE]KLG;JO1?,(-K4EBKTBB]C?L)`#]O15!0H%MMK1'W=FCE$/X5=.5 M"-#K3`&4B6J]LB!\G9JPW'JI\[8U:+FM;H^^?0N/)"+%KN_!C0COCIWU0<@F MB5@7AF:C[<*_"V`XC2(TF57-[&`C46?($+SM-`;`IWK.#&;"]C,(2YQ?3V"F M5L/*8Y)9)BMFD10R3Z[R*6SL M_9)[OZ?[((@_YQ7MSG98ITN\,M=5G2[QDG:S=D36Z1+[:N&NTR5>_AX_`R]& MG2Y1VZOK=(F:'&KWQ1.Z+VJSY`LWGM5FR=HLN?=[N@\7['->T>XD\CI=XO7: MM.ITB9>VH[65LDZ7J-,EGC^.7X:UKTZ7>$$&Z#I=XG7L\S-@/76Z1&U1=JKYAZGEK1V,7XOQB))A'\V`4!$NFIH_;*F M$YW&H-7HF6XB2RV=CEGY\CGF M-L:(U':""'P.!7Z``6Q4+AQ\@TC:)D@KH;/=L.AH0\"4%XD]4S/Q*;@1Q MR:.X_D0K(03$*GAT)8S`-&6@WHMA5M$CZC4E:&EYA%H$#>P60?A-ZEQZ=R0O M%*65O4BP4J"71)\G@9(@NH@J.K!A>AJVK/*B.X<\S\(G:(((S<7<90TC[J_$ M*$^"[,ZT7'.=69ZD.?!_M"R#RCJ:5+9L.WCG)4//C]-#YV,T.G8.)$(Z_5_X MG.V=/W M+H<7T5)7:#N'ZV:,#867I.0/3$2:X5R>DP"WPZ%!)-;IGK^@F_`F\(7O.A,` MZT8DN"7P?#Z#%>+<,;!*$.FB$;Y,,,#XF/\`>P&0`#,@NP*JYNK;,0B!"/KP MKK"]N*S,"84'$+UM&D0R$6A@"4Y*4O7ADL>M:+8-Q,<$PD>]LM$(.&KJ_!?( M"KX*.3TC2)T9'TP8UO$`?$0'+.BSE\!V8/C!/_)(4("''>Y1R+N$Q_!MX<$; M.+,+6`42CV!E!$-A."3F8^<4@([S+`76BN810&X0C8(99N)B'C#!ZM/G/)IY M@6\6#1#[N7`DSF&V,,"O8?&$?\2="."G1!TA`J'%`2I]UY$4Y"/N:/^8M+'# MH1-D,#CP\80$*1?A$*%`-*?V_BC:[?T"J!K"\:4KD>'"LPBHP!9S"(HOQEX> M9GO4Y_!IL\X_DLP28?XU[.`M;)1N$5G@<,S9TA2IX!;(TL/N?[1=MT`&#DB] MJ(EC/"V<5Q^N7]HWXAUXA&$KX?X.D)RN@4]=XV;?>&%.Q_IMV^T`0^TV.Q5, M03\%P,CD<@EQSG54RXRGQ'$@!W\&CYHR#".`KPC[T0$H?,92# M3L-MMUK,2!:D/]=TM>J-R;3$R'0:?T%N/H7OL*$I[3]MB<6%^!["?6BZ70Y- MP&?*Q(N=35$J="YS8'`>7$D+&IT2<>$?!,*$Z';J97Q3^_+"T4O0W(HF>=OO M,@#`7(9P^2$_!`"`DPT%W(BB_![76T!QP/<#A!465!R#@+AWG'Y-7A9YX378 MZE70EJM*03#30D8QB4.X8./;"%A!F@_3P`\`KR[`D"?>M8C@U616$+#4+P6Y M2#+`-0GVA'=:"H<;(%G@7"AC"2SH<1\E*F$!R="50I`/U->8>P]`,[)($($H M$(93ZO)ZH,4' M&<;P0ELZMP5^1(=2"@@82S%@J5L6.H%]1ID38"29%BY9$3>($[^COB,"K#(;Y7=[A:`5+W]U]^"&249"*RR08B:^@ MWK].I?V;7?'$X7C]E,SJ@#T6>97PPP?)DMB1'O$!H!F*?I@A*E.MH:6T%:JL M2H7@/(JG<(Y@=8CS2IIY^A(LK5>4[*`#C=L:S#6"W=<*96[N8<2]-@(I3N%< M&&)_"F^KQE;_.2!+,M0*"U\5LG85?&'%E.XB;D8%V396FF_7>Z7NO"7[,TR< MGPJ[\OA9+_E:.'A[^.!#9.WBACG2$TRP4;IX``C=O:3-+SG5;]LI96Z"O]>D M^>))\W<:5OB[)=A"].>P5N)Q[E8GX+QCA=]\&]T M>=2WTUZP@(W#4+.`9R,DUC)B?0KW349<3ZU]>LJI2;.^(%[L!;$/)S!\SAF+ MZR:-[R:3H7'Y7!(3A!CA\( M'XY$"(&2/P50^QH;^*TZOB6/O-P/,#(&:,;'?E(S4`>N)P(`EY5)9$2<9_HBA<%_(\ MX:R+H4RKX-`O%60[\3CLM%!Y?1R,@JP0X4,@Z,@P#";KN,U&U^VT3^;'NXV3 M/VF)WBS`(#1\O-7IN:UNRUD8%DVC\"KN2C%(B#;$3Q#E0L56E]!(.09B)HC2 M5*:!SLT89NPD<3P?(PXSH4&#D<>@Y#D8I.=1H'<8`Y:1%K(@=``+(D6>&*03 M@9,FF"8@H4@SV*,I;<=0C&(DRED2CP/BH:)0\>TPF,^;&`8SV@K\=1@^!P< M$0[@E[LK8TN]T22`+RAF5VVK$^+[^*S9CL(V4UQF)##GR)O&`$-,B2W9!"-" M972M"?%6^PZW(0$!A_.S%WG7Q%9LUC3#^_">9<+)'X6Y#ZS#"U*F]KF)[+!G MSM92@8$Z=-:.\CMV?E.)4U,-%PP617&FLJL<7#:PICS!6%*9\C&'DB&&*8[@ M]W2#&#V!3/,]+9P MUA[1G2_241(,A:\N%\QA%YP%YB7>=>+-,$B=;TM*I,H]'(SCI^41D!2.*Y!W MJ*0\+R-F:!TRB]7QM4!`P7KQE8I;VK%O:`*B\I;V8XR-U\>$Z-9'1///1+A3 MRK$$:HT$(@53*X(EC'S)<9QO,+E$2BVG)QL)^G1$>4:I3,;%4@&<:O?)W/FZ M;,:KDW@?TF32DQC5:91V_J(M2=6M)OIX+ M@I_!T7R:V_,"+>H[)[S7U,B@>=)PFYWF,SS'^.$; M5@*BE0SUFIZ<;=2]`QZVF*;;Z[;=UDGO"3>T)HF](HE^Q^UU6CNAAPIV^/B0 MT4WXO)7_W!?!S]\2#]V:5W?381RN[`Q'#_U??YI[OUC,S`Y1?175PXN41H7" MFRV[4CBAQ%$X*1'A5AWD>QFF4Y=FJTNSU:79#,>H2[,]!%EU:391EV:K2[-M M@@Y?8_VKNC3;'DQ0D^8K+[M1EV:K64!=>>=5LX"Z--L>3%"?PGV1$>O2;#5I MUA?$GEP0^W`"P^<<@_,J:\;L[PAUW:27@N.Z-%O-8O9RA)K%U&=@;TJSA=N) MI5C#2;^I\))O)C#"\499<(-U253DPY(^O02(+O@0I%B#@^,OTCK8H2[0L,<. M_MVJ>Y9KSK%F+F+UF=PSSV.;7Y\!PWF<3>'5&`WLL^AESBX+C#QOJ5B%G#:? M%;MZ;6+Q3G9I0PQ@U7BW?FL[14=^15%`7A(/LK[N:8F6LF%X>]0V<)O]$_>D MLVZ1A?W'X3/=D,;QVK7'GK9&S=,(`4IH6O?L[\-5MAM".NBXW9.NVQRL6_)H M"[`J/V MDW'LA9U@#TJ\/E'*]KIZ[O[D9S]G/UZ]V;4_L)1;'4J++\UM/A7:/MV3'K^X MR#V].8E#V,WTPW_S(+O#5',UU$7R%;&4OO0\^]H16CM"7XF'K':$OHIMKAVA MM8)3.T*?G^Y<.T*?PRYMB`'4CM#G[G>K':%[MB&U([1VA-:.T%>S2[4CM':$ MOCK_6KU1SV2CGK6(4#M"G[UOK':$OJ+-?GI'Z+J^O*H"Y&OZ(PM%PG\5D4B\ M4-8P![YU&8>%7M\OSWNYN"8V3I"3D8>Q0D#D3P'./E<-+_2W7[>KO;=*"W1M M5Z=OE4\YFR2"VY\O\2Z;FQ9!P(=YG$0X>>3E/J@3_K$#RTBM+Q:LPJEX3,( M-KV/"_P>$3!7.%?J'*B*Z?U??CT]O51_#7XY)(P$Z!`+IA:,033&;<8N:-PD M'M8,(*;H.L,Y&",E.+F,.S"-1"X/=N`SQF`KSZN?C\'5P)3A1G\-XHS'T@@#"4XQ27.X[C#)X#(.5Z?&=X5X5MLS6. MV1:F6%3Y@+9#D8G*S3]V/O)6Q;,@PHD!0W"0O&OZV278/!\/#"/S`,DI2&DN M>%0>PP3QF9",B(TBO#`])+H+@('+LQ/!24A3+^&("L\9>T&B-I.7;,A0(@;( M^F(&:Z7)X,D\S-)'G1T@'\2[`B4`'`(_`O$["V!J21MJHFP"\N[4NP.0'/%C M)D9T?N3LXR`%H=VY$UZ"I4-ICB2!L,ZQ3"=Q'OHX?2(\.E+PSG_R MB`C-4)]UXN\9T)-]#\8%)J36(!9S*T6&V/5,`'&K_5''O*(APFD48074KV(6 M)YD#\*H#\4^`+938T&N`TW5L2P2K7>2%:_^]&&8?Z2#B8D]]0`J@R0L_(E<1 M:?85T$!\R+\4"3K?@<0+DL!I>C&V;G_8N(!_N,P3\<;QQ2@`4D__]N;CE_,W M?V\<-[H2SH?,O"W0>T>MWA\C.*WQ](]_1B@E`0TFWDSDH&6F'Z/19]K@^U?7 M;&QJ==]$,KT8OP>>D03#'%\^O8:CBZ.M+(E=-KO_EO`L&:XP[<4,?_L6P_J` MN:<@5)Y1CPYNF++2QE]1UX\YY#39V"CA63I/`2(EOFX#IC:H>*#A29CNF:D` MU;L\!?Z9IJ'S0/9.6JVCMI-17;GWBB+ MDR]YEM!@G[QA^NG3V1S=?;]Z;Z\"-KEUTNJU>VH-Z\&UX25)O*]WDN97U!TT MNIWMKN=C=`.4'\.UNL6=Z?6;S?8*Z]#`;`;\#>U"J]$Y:76W!'XFPE!0M6_X M#H25;*L;460]ZT*V\K*^Q!%>Z2`SPC&#DV"6;I4N3SK-1GM%NKP?U)47 M_FL<^[=!&&YU;?V30:/37V%M"IJ-@+\AY@>,N]]N][8!?:E+X#;W8'#27.T& M*L&TR;5L2B8`>EKE,GK$2K!3XP?06$'/W.JIAT/?Z:Q"6B68-KF631V3SJ#; M6H5_/70IU`38:I^Y57%M92FA#-5&E[.IK6D]=C7*OZ#ENZ_>[61 M78R_BE0D-TN7L13&=K?3Z!E'QOT3E4%#]\8*C+0,Q(\T^#D*PK^]`?48#YWLL29RT$:C50#).)="NXNLH^#_A?T0?1#`.A,]""!%3 M`G]%=H=;^"V?"K_8Z'9%D\5*9_@E.)C0Q#E+1!A,@PB-NUX(6&)[KK2GSJ0) M0GD-1L+)8K9<$O(=3V*?C(VAQ5,\W@!GZ*'!-&9;HX"YIVSC1`ORC1?F\.B> M)=V]S)R[!T:E$&[@_,8)T<7/<+(!&O0Z;RW[B3RLS`EL#: M5="C2G$X`6J5A'\4BK'<]:W0B1*P'6-U6Y-"=AQQO\N`%@7-8&8>@Z%>WVTVV_L?Z'DOL]P911D3LJ-LR#5U+XSH:]]86!(7:GE6*E)[,60 MV/ZP,./0DO:,(^72'$"F?30.\I%OW/J?$T)U`M]=?3$JX^>Z`[<1G?=PA]UZ$0=.K%B M<$ZCXYZTMEGKZ869R&H+_;T6^F:[[[;;&[(&^A?HH&^Z;9J`WV%@=X7 MP<\?8)#L[@S&2K`@DR]^_%/9)@::C(_Q)'(_YCC1S68NIRQ\[K7'&R#<*X4K)OHY@0^T`HT>H@ MJ^I]C$['8]ATK))XE0_3P`^\A`D@'M&W,-(_XB#*_@6/Y\G2]/%U6(@58.O,VG'FK2SPJ2M?F?P MN!EA:?UUEMEN#IJ]5OO1R^S?L\S[J/$L3K.+,9I/TJLX]#>Q@^UFH]WJ=,S2 M2G,\`(1U][/9&W0W.?^ZN]OL]$Y.FHT-H^"Q>_UK$J=8O&$Q+QK[VN_"?_;R-0;V,\K$8+4=0W<^;.7_"FP9*?4 M\3:QO:U6:]!I6FQQ\72/`VR%S=\X)M;:]0$(-DWNPT M^IVN1>;WS+D!$-?E=OU!?[!;"-<](?U&;V`7Y-D)#N\[*Z5M;K7:#X?PO9@E M`H5AK'\+[TQCT#O^CR.'-L%K!ZU6UX)NR72/A&P#S'9]7*QWQS90@-P1+A[+ M;W6]],J::0\5H$]`.6BW#`KF9GD0&(]E.YN!8FURZ+4ZW<[)%I#Q*/ZQ.A0? MHU$\%9]`&-P(IT!\M"O@,-,\$))UR>.H/^A1:<7-@[*V@-9O]CI;PLE:5'*T MD$P6@Z(*NV]0INDU6XV3CFWL*4SQ``@V<&VLMLZU]KW5;)TT-KW.QUX)QK+& M>V[?0E1(GUS%F]CFHU:WWVV>M*JL>LOFWAS$&R&+1Z!K+6J!WSN@OC\IMAY+ M7-@=0IJ^J7<.P7$NR$1+G2/2-,?6/&A0VLA]TVPTFXVN+8VM`<#&H=^(]/IX M#*YGZ>WWN^T-(?`".\)\B:.X>*UL\.HX:K<&`Q!`K2MLZ9R/AW`#>_H@M*S' M.[K=3K_?V2E6'LLKOHALL[(G_-YO-6U/26&*M>=_M,3YN.G7IH%.K]^SC?J/ M7OWC9,NETW_PD@CH++T4";6P>>>EP0A93!#FLGO5VN2@QIKKAG/$W9E6G'L# MH-Y+.4M!;>X2U'NI;']`O9#"HOU/4B/!/;X`[7HLO.1J4+\;TJM4/ M^=$DO*"74Z_?:+<+^M+#`-K>LI:3^\*V68-!MU$PG>S;NI:?C47;-6B<]/JV M/V;?EK7\'"U:5J-STFPW-DZ%1?7DG/L41ME0[0,E"VMZ!U=^*D;PM(FUG-%Y&=>>F$ M^ACZPG]W]QUN$^1]CV=CK+@9F-;@B),NV@%67'VS<*]MO6H?3+HV);8AP,. MFT.1T]]BF4B@JK5?AAY%H7^`;V?K=%Q>&F?9Z%@DL_KVCJ0J]5$%46S?48F-:^;UJ#S@-`NM1/;<6KV#HYZ;:;\Z>R M8KI'0K8)MF4==!M_5@K2'<*R&=6F>](NL/L5)]\DT)ME];$_UIH&\Z&65,% M#2V9J%^W8R[[H\9^[.O6_2%6^)+1%1I]\?]%KW M7V\K$-3C`%\7SYU&O]F[7Q)?`6Y\#01`_`\*@3=>B,?B4B1![)=UE(WH$*U. MP9.ZSOR;AGU=K`_ZC?XV(3^%34R2.]BO?V&UR(=F]K;;@_N@+,VT0?!6L9J< MM.]%X[8`7)%$3SI/AL+V*CO<:M][A.Z!3T5$7GK!1E(_%P6>XOCKSKT9@W0\ M%=^\'RCG!C[PQRU=JZM-M($5G<6@*24I&?;IZCR=HKF(OP:YKKD9-U[Q_KYW MTHU`N:'8/C.WGNYCE,(+*.DQ'!M!4KO3[':;%JVO.ODF@=X`SN;K7VP$/2?M M=JO;M6(/*N9Y("AK7]B=AJT"+P&$G('SO]LZTX92#AOM9EEWFA;?O1-P;&VUZF-#.#!(!36H)48LKR2LPHX9)[@N-O`V;KS MK5UQQ"+R97,5@#+*,P<1*>19(0M;)J7'0[`VHKH&4>O-/A='XV%1**(ZT,]& M<.B]:_CBXC:"JW<2S$['()#>C[\E&?/S;*4J9_XL3F9S2?-`__-AE8UC.W9@ M7?@+&_<'9!V<78%]OU6K"%42:Q$]OO<2_F%$WU5_A0:P2QD8M*FNS MXM6B]H5X%H^&ON:YPZ9"8A\6F+GQE<"UU`;HU14%_VNM$FY=X@];`/;I\-&Q MKFS$QQ\2A#_.)H$8?_@A1CE6S[@8CX%U)`LW>!]PAK1(SPG_?9X`,^&'R3Y& M@P]7#+5])$XJJX`4L;$^J%7&!6-)4":WK\#\KC)2'*OE@87\:,%MWBQEB*XV MY6:!!<;<`,:\YBXL6E!C\POZ[&6PB=G=HIN/%J!):O7%\"U'SR\"VIYZ;?L3 M'U[6H1]@&UIP]COEJIYK@5&4*3A"SH@'F$X+N_(90)T\^)ZU](ZE$RR+YMA& MB,"":([[`@(^Q='U-Y%,Y\`HXN2/%3K!+9>2._UFW_*;V//.Y:A-9V%\)X2$ MW3)OG3VNK&VS,;##P^^=9R.`/=!W((D+*P6*%&G?"Y&\'HF!3O^D:04E+Y_D M\2"M0KC=7F_07A;Z-`KH2!D]@0>4B M#`^!=)5W'LEJ^IU>IU4XUZO.N&%@5RLGUFVW3GH;`=>^VLZ]('E4O$&OK`M5 MCKYC.$FQ["`[`ZUA3AZ#`;+@#X"AM4U@,='(2V2]-NK M2/J+0GF(Q=D9=O,T\-`0J4ZCW5*7QMP,5;;M5)HB%X/5?12J2&^&?Q\EYCJJ.\MPN"1=5P#,5 M`-$#&,&-0(>!Q6RQ_L-YG">&XZY@9NYVI1?YP7"O;7E/[[%4?_@!B`Y2H8W5 MI6H?ZO=+:D&_67=+H9+/HWTN6U_I$]E-\*Q+^%$Q7[N;Q(/IX`$HWLZA]1*`2YG[WD&JR-3'7 M[KP`S*DR1-;E((_'"G?7JH[@A_D)-[ZB/43D?12X`(/M[J#3MTU?3XG!.:_E M`Z>=GZ[$D+^*J1=$5#D*F^Q1E`2:5%H;89A_OVS_N_>YA-*G7]LS1WDU@?_] M\N3?[<^MWOL:W8M%CG?B.H@B*@D7HM#:W`!'7E,6V).%/]=-V;!\L261%#&[JF,Q/M^R8/&/NO.9"GPO2]Y3[;@+;CXBI MM)@_GZLGYZN/@/U)D".=Z,\/.@V3\YL2M=[VI=N\/GOX@R=H3/H_F8B!TM;'<(E6Q\>SA=&IW]X'7)65>] MXW?)NN]7H_=ZZ<]V?U:]%%82%AZW^C79YR8DI<=1I:[6LP]+7F\/%DKCB@2W M$HKT.'2SJ4.'/^]XC3NB<4M!V#G&*X[U7W_Z,4S"X&?\?_CS_P=02P,$%``` M``@`KSUP1^?/>PDM$0``/]H``!4`'`!S;GER+3(P,34P.3,P7V-A;"YX;6Q5 M5`D``^G/25;ISTE6=7@+``$$)0X```0Y`0``[5UM<]NX$?[>F?X'U#=MW"0. MC5WN[@/L+H`%^//?7Q8!>$*481)^W)N\'>\!%'K$Q^'\X][7N]')W>GEY1Y@ M$0Q]&)`0?=P+R=[?__;'/P#^W\]_&HW`!4:!?PS.B#>Z#&?D)W`-%^@8?$8A MHC`B]"?P*PQB\81)C?GY[8+/A'YC;SVBQ^Z.Q-1#&:^[Z]]NP9\/SL#!>/)N_.%P M#";C7\`OA^#LXOKMRXSK<@8CWD[\FC>;3,0?1_?C=\?O^/]'FN^,8!2S[)WC ME_?C\>%X/)ZLR7\.:)"^XW`_%2?CS'^+%>US MDC!\S*1X5\2#D>QGK:\!C2W$OT9ILY%X-)H80N>6=9[(M6^QRI>('"Z"3TS\,(1RL!&UU(J;DF MDNTC1;./>RQV M1W%N(.6V>$01]F!@(ELMX8X%%0,0":S8=#9="B_%,6)M4JJI>A3Q%++'BX`\ M&TE8(=JQ@-?IPA=M0E3:;AC M02[P"_*EQHQ[VPI#!CTM9]-& MM^L^M^[<[`:NH#!)Z/,G-$;^%88/.,"1QJ`QX;%K9T0BE+ZWU1'5M-VY\R;> MMT<2^#R]/4/#6\*P@V;%P//M>X$A&B5,B_1E/^#7@;:/KPX;3I69DKK;M M0YQ_0S37I+?B?4V5V8YK MG][85!,MXCX%'J4_W%#LH9,@2-:>$D?G_2?&E+N],.\@^._B!?*GX3F+\$*D MWQ<04[E*EQK=2.^>9>C7?)1SK(FF:ENP'#0#,!VVW;@-JM(HK\6L&6C
&=)KK>I_>W]SC&H9Q%J1!V_\:AW&ZH\^BQVR]D]0MM#V*NW%, MR8-I',G=61YZ/JUDIG'+_132'"8[8#V(LOFG)]R%/>%(-UAW9MCG/&PC2/ID M!SANRWP8A0N/NV#9C:5*.0\&7AS(Y/R*_[M`@5XB%/K(3_D(U7:UE\P?"V;C M]7\3,`(I5?Y'CAM8LP`%'OWK4+MI7)#Y@`N:;3ORGT\)?T_(D"]^8GS&ZHOT M`R2,P)I3(GY`5`3$;S2%<[HL^LH_XM")] M(GO-:#Q)"@.^2Q[_OD[=3F,J-IG3%P3P`07RM;\G[4K-]NT)++9Q>0\2?YWS M^=(3#,0"_$E4F&TT*Z))7E8PUY=.J`<(Y2'ZX]XD?0^D7J$'5:LTDA;[3(Q0 MP6:$>1=)Z6>4+%3V3FQ+NJB2QX5+L0>>$9X_1E)ZBSBF^>4M\A"7G>=IURAJ M[X=**CW4#JRBIJ.W`ZMPJ/4U#E6<\<]B=,&5RRTH\"EQZ]A04^F!\\XJ.#IZ.P=6L::E*<%Q M)?`WQ8Y:=%PS]0TE2T2CU4T`U\D^3TZ6(AM6.BDUE1N1O3%FM"OL'$J?"?&? M<1`T([)IX4;@;K!^61'G+%U>)^>]XOS%"V*Q]M".@AZU&T&],9KK&\`Y]+Z& M<$%XB/LO\L_00W3)6"PF[DF"V(Q;&YT;D;X!,3VEG<-*I(UL79%W&9[,9CC` M/$5A=_$#PSZ&=+V=3#SYE#OJ?Q(<1K_RYC%%BMQ@2[9Z2/]@:VSNP&3.=83< M'E5K0E[7UH%U$=6^F_8RB183VREOLV(-2R<&IG&N9^8W)DLSJ``RAF<8^:WP M&C&QG3IKP]O!-,[!>T7"^3VB"Q$UVSU/76/;N;8V7`I5G8/E+$;WI';!@CN1 M:Q)Z&JLV>@QL)^+:\!F:Q#E(>0ACB<,SX5C1>Q M3*=*QU6K^.C0VA[XVHCI&$Y#'.=[>X14B16O3R*'Y#_*8Z^AIBQ&/G)PW5A MY*9J0VOT=>!J>_[79:1V-EY-CQA9WB?V?7D"!P8W$/N7X2E<7_/6B5 M-2V=3$RTE-+KJBXN(:MOKB\LM;[KLM0J>`+)U)&E5G$*GLO$<^(GS.WU M:?65:W`99OTRN<1$60MDPN/_7L1\P!D"5"X(K!VQ[@5U.VL&O7K*[8![C8L) MQ53R`H<\N^"ZROQ"Y!Q);JDZ$:[-P79&MC7`IL9R#FU9@/(),IE=BN#>,EZ; MVMNNV=@:2;4AG,.M-.'C$X&TK]U0M,#Q0G=XUI+:/F*[XW&I,(]SP/)`3Y&\ MZ7K]]V58O?=(M>BA0VW[7.W6$H8R;VY<%7Z]-8>98[>0J8'ZH^O"=0:L[P& M-$V^7F0RA-7\]/!__YKP-_\,E-..O'A#FDD/*%/J8?WA-6%=;YQ=#O>:*V"O M?[O]_3/$(1,3:\2F8>Y+`C7XB/;-S367&<8.HJ)6S-$!UJ#N>FMDNW6O6AXV M+P:#*[G^>$^23WTT7IS5K*H)#T=7S!30EB\6,S:8>XE%JL,%H5QZ#R&?B=L# MY=*\42SH=H\YKAHF<@_??&C0\[+-%(YN]>@CV68,]^#+QX74HTQGN5L!]*)E`ZFC MFSO=PJ;2/,[%S_KORMP@BHE?7O%LQMB,B^V5=_IC!;OK%?CEK^JG@F;*$2]0?QD3;,O(`PWIK_8TTFZDVC1P0VQ`/< M5:#UY?!Z-7XLJY$P$WKDV($-/[!AV+]JA<](UVOPOJR!I`$;HOZES#[A4R_A MA[*$N?;]"Z?^U'&MQ)-Q66+)9&U9)C])N.$#RI^3Z4^5IN\9URLQ*2N1D`-) M#XH,!NC*)EOC!44.*CT\80427A*1A!NH+3'HT5O6)?`%\0\KGE*0@,I\IL\# M!I5O#=>+>E3QACG*OX+*A77]B;PY.<1.B?2[*&STXI-W9;ESY.`O<+'\"92X M#&3TY!N[]5)70J@D`1G-0#*FGXZM%[(:(*60&R)7XKLRSD\J45(_SH,WZ4^# MW+Q4"/GWPD4TJ%0)J\7`#]ZLB0<1.HOH"H$/*E$UHQI45G5"H%*@$E';TX)! M-=,)L2K].@?:0;7,.U:5-I6X6W"OPXNJI6X[=!3+&C?B&XZ&E920#*8<8!34;I M#S<4>^@DD"NF8N5H[>77M18^]X?Y.RD9BQ?(GX;G+,(+,3&Z@)C*BZA3_.L- MTC+AY@\V/TMYP$:@-"JD(DF'FG>DB52`-\WD`D(PL)8L,W>W\[L-%:7IJ,P5 M48H;:RX(7)BQV&4YK.K-I8C80?8*!VO+U^96+JY2&FNZ\SV+ M;@"*9$-QY9^&6D4.UA;=!P"PSE;6`6P_"Z;;-9VX/'VH<=COP;`.4%:6>0T0 MK%GR';P2HV_@JLO@MO&*4!`@+XIAD%:3=X*NCHVU*HS^46RVFF5`KTDHCWI' M2.XQLN8S/\9_<&,&](K1V<[1O)LG5: MP+)4#%-:9DIDOT4L#D3Y9DXQY9I1VU[-"'#68"9X@X2Y6$7,L<\M_`RYGS.Z M\QZ1'P>BGA%2NL+A7"Y$36=9$Y7BAXH]GQ%(>:\OJ5MS7Z]SB2>YW:&MUKQV M=[FKE.8:M5SANFEE^2Y:*Y%23-M[1=7:IMWJIZ MSM6,9[+>PN M=JJ%L+-5J%9WE&T)K]LU&J3>#I6:"0T[%':*U^W5!K.9^#3>0Z%,A-14-J\A MS'^R=G/7*?\Y0-+%%"\][7!MR>[>8#OYTH&^?(WACLWKY%FX>I';KK=HH;.= M`78`6\\4SB4P8IX0H2L>?BJN7NG3VNC<5*FE6[93VO9">G"5NJ:N05Y3Y\SY M5KVKRKOPLNV&=HUVB]$&6"(VV(;=9JNUO\FK&23->C@\(VHZ6:4W%ZI4&C>? MM+)6+JE1&IY;Z]5IKIP650J9M4O)B\O"^A7H#DR5=*QV&E/:-GW09V(Q4)TO ME@%9(93T=1,5-4AM)QT=H"S%)&W[.)>"))J*3U8B)O;482`^WZ73[X]N`A>UT97N8C>W5__['%QC&,YY#\&!*F9:O%62M5+;7 MVK?`2DN_H>#A'F%!9(*GC8V:Q/8E5UL"HV,/)R<"^>/\>LE_]NK4'THO7P%@5:WD!*>>/@WGU[-3H/;UV&Q`)0^F<<3X--O'X?S32IX@ MN^63;J2<;U7/MQ?4+.PXI0]S[P$/J^2LFGS5L,5&]<;(/TUN3E*7&E5JK!0F M*/XJ96]![?1D[T;O]$F'7G!4J;8J'1\NV"![ZE0_J!JD\%BG)QQ5]J959BC] MKJDO)/%(_/$`&>)/_@=02P,$%`````@`KSUP1W[;5]Y4(0``1U`"`!4`'`!S M;GER+3(P,34P.3,P7V1E9BYX;6Q55`D``^G/25;ISTE6=7@+``$$)0X```0Y M`0``[5WK<]LXDO]^5?<_\+QUM[,?'%N)DSC9R6WYF?6L8WEM9>;VDXHF(0DU M%*'EP[;FKS^`#XD4V2!(@P3H<&HJ<62@U=T_``WT`_CY;\]+QWA$GH^)^V5O M].9PST"N16SLSK_L?;_?/[D_N[K:,_S`=&W3(2[ZLN>2O;_][W_^AT'_^_F_ M]O>-2XP<^[-Q3JS]*W=&_FK]W M_XU%Q,C=D]"ST(;6_'H[C[SPYV M?__,_G@P?610@%S_\[./O^QE)'UZ]X9X\X.WM-?!_WV[OK<6:&GN8YC4M9O].G3IX/HMVG30LOG!\])O^/=0RE.D;(]XJ`[ M-#/8WW1H;;[57],Q/%_[@8=7OD6\%1U7RP/6ZH""&BZ1&YRX]H4;X&#-$/:6 M$==4DHCLPD.S+WN^N_;VT_'$OOM/(GV#]8K.-1^SJ;)G'+R4W5/383J^7R`4 M5+%7UK9%=FY-C^IB@0)LF4X=WDH[2F:4S57$L/+'L_&*+6@4([^*2WZO%ED\ M,_W%I4.>:G%8Z"29P1NZW'EH/#L-?>PBOY(WJ+ULO87+I>FMQ[-[/'?QC`XB M.B,MBX1T2KKS6^)@"Z-J1=:B(EF$$]^GTX!:L$6\-',Y+6TLF:$K]Y&.*>*M MJY@I-)3,R"5^1G8DL4]7V2N76I@Y?G!0_%$5=V*]);-\AQPZ)VVZJ@7KB6>Z MOFD)+395_62/N7AP^[?FVF0J<6WZB14#5YIG3A?)S-&-^A('D94X(]%Z1L\&`O!6]6M# MA^.5H&4NMFV#G=],CT[%ZI6FM+$20R?7X'5I^"9L?E:O.7"7MHR@&&-`\TX- MHABG=6@HL#J"XZ`VI1:7*S&6X1YM+ETU>"OOTO(QXAP%)G;\&_;=`7ZLMN:" M_96LOG6%>1G5-E?CNI((=6Z3X?WTAUL/6^C$<1+?4[+06?\.L4>7/3>[0-#? MA4MDC]T+/\!+MOV^-+$7.?12I=>2NV4>VE6?1RZ9]^H.^:'#_`D1NSYF_#?3 MA3C!MBSW/G.HVJ&#F'?$\]9T3D6*'<\V301%>P')3G<`=:=M,VJ=BK2_623C M=B";+Y.U]M=TY#>HBVA=.@IV>)DY)-)<=/5I_9M;]&'4W@4)]&W?QU%[NR-. MHL7=>B.N*_JVR.YV84H^&(=!%,BEIN=T'>TT[N@ZA02GB032G0B;_?2$+F&/ M.!`UUHT)MGD.VS*2?B(!QY<2[T;@W,=-L&Q&DB>DT/LXB MTN\C5A>4A&>%#VC?QDOD^E$8./FBK`(W5+`;'-"F!TF;@U("[?.]^;)]FRQ- M7)/I8N\..(Z^:7^)E@_(J\ENOFO[O)J.4X_#J$/[?+DD.*G+6MJGTS&)9B8] M/S8>E&GW/,_T8^Q&1]%K^L\GDO M.2D^[DJ1$&-B9,@96WK&EF#KDI7GR>0$.-X5(.IC;#NUSF0Q?R;'X*==!C/M M6^=-,'LFR_#H<)?AB$BL5S^R:ULZ1DJH=4DJ4VMR,HQV94BZ&U%_(T^@_6%< M)\O[9V/1MG>/*?)TVAL_ MQ9W_DM84I#P[Q,HQ&@5UB5=ZL(T.I#/3?XA.I:&_/S?-U0%S:!T@)_#33R(7 MU_[A**EB^%/R\72SB:7:05?TQXTHCOF`G.B[ITGCLK8'&K`^R:[I'+8G^76\ M.$).O)3YY%0OZ#J)70F?+;IXT3%UX43?]F7/1W/V0\K9S"/+2GTFNB-<";(* MIHSL&<2C*_^7O='AEA01.)+_?%#B0^PL0L=Q+;XMA+TVO;9>1=4!.Q[_A9!7==BN2\$:U/KE MQ&L<">M22$YU8$Z80F`L%P+IG&.@9C#'K!G`"%6%EYOH;Q M4T+.V-`;H@E#-.'U1Q,NJ)T/UNQ"..*R^+%@1*&\F]Y^'2&9=8LL[/!:Y2L` MFBN.+W`53D0$T-2-(P,=G9TYTA#LU(5S/TGV)URWS4XK5:X:_H`G?'ZE>V@` MC5X+:72GU;0,5YTT6L8O.$;5FH$)V]2R0G4;/V([-!V^G0::ZVV?N3+J%F(I M,/L;#A:1VY6=Y19X-2%Q'4B53:A-2(TMYX-3`:28;K2S[JHPUGE'T.(XZ#8O M@5BA'\?K4Q\`/RD!:J_*I=MTDA%1F2`DCA2G6GDH$I%=`\XW@L66>ML_2+*2 MR:`4@?-X";G$KNE:V'2V]5N,JLQKRH[33_T"0E`B")E/DI&Y1ZL@^M8"3Y=X5@F/8&]J'OL% M4BVYX%B?/IF_0R:WC$SN(VWP'#*Y=3Q/#9G^9G)_Y*C\H^),[G01 M_XK(G+*^8-LNQ6K6^<+HHS4$"E$U$!-#4_ M,E'2V1A)0[)3$_3]GFMOTE]/1XK*6JO'.X&X!4]`([71B>BNW(H#SK:)WC:C M($N)N\FM?`HYWU6@XDW\QGO`R75:#D MFBE;Z\O&.*GB$U[EU?I%)O0+QK,3EKTWC\9<13Y<>7.]5W^NC"5G.:6`9-AD M)6PWQ#6WGV2]!U63I38A1?EP7'#(RT32U`*IPEAG2];B..CTI,(NC/3P0Q@I M=.ZAB"=^>!3N,1TI2HIK.M-(#;%`D]@X,0Y*NL<6NRU;#(WRQM.1(K>E!"!X M$H$8-'9HPM."/8&'W;GPI"AO/QTI2AZ0,R5X0H%@',OP+OO(>C,GCPH[GIQ!FOP%Z0MBHTTG0'6,8JI.;C#I5Y.FRBM5>"H MC0`M6FZ':JN^T]W-WTW7_G9^1KP5=_7>;38==9T5"8U/4L4DN`C+ M3G.,O[[J#L>=5MU;/V%%[O`(&S.UB3W7Q)U/D+<\1P_!YI5A^(15VGSZ5E%* MEO"5"ARV06`49],_!%>N'WC1\T^7")TLV?4T,#!`!_VAX3(.6E'%<\9DMU=9 MR&=IL)1EWGS9::H_(`#+H$F5:P8NGE?L=,9N?B,69BDJK/Z,\018!+B#QJH6 M81Q2N%H'>7ZZ7M%=G(?\X(ZR'TEMW]*3"OV%.>=,"G$:&D/84!8(5;4Y.7DI MZ+G\$7D!N]HM?=`^7I3'L\D"[5R#(`IS+:)]P[V!<-!`4!MXAX?SE6MYR/31 M.8K_;C*]=VGT#>9J660'T3A6TJ*KR\4C=HY2%FH9F.7)M.;#K3_\@]X@HIOB:YOB#42"P(RD^*\QRM MT$,VF^?PBI9II#%$$+/@"5>/NY*I77S`;C10-J_+,8/J8SMYBC:]?G4-(]2` MF/Y(-A8*1%SQ%1OF"@>F$QU\;,RN2V7E!*%'1^MI&-R0X%_LJ69LPS"+4M`? MVWJ2@(!*=L+FMSLGMAUIRW1JGO,8K2:D-(;M92*!^*G-:8XN7;[R_9":B]!C M#T$B#Q/[?F%2<3)7M7/K9@1):(QM,U%`3-4Z:.Y-=GU3),NMARU$A8@DX$`( M].@!8ES.X="5W$4SN>PQ'CD3DKX>.IZQYW.)&[$'+)(B736&H9X((!Y-71X` M'MO%EXZ-:/(F3+&,B.\N_24C&D'IE*^:50(]-0:CE@0@&$V= M'1`8Z=>R*T@@M6?;Z*[@(J]@"%AQ?>QVZW$3,LG3]34VA%=N)@52:.M5245C MZ!I+`X*K^/Z`S+XR8T#'3R[RV!6H)S-ZX*L+L!"E7H%<0R(0:,D.C#NR-IU@ M7>F=*+336/$'@,0RB(#DI(>=KH(QP-5QP3N0Z:*QI$<9!C(8MTPV29TI9 M<((XV,)(\+G*#X7W-F/B[+W*#'EC2]](OV!XPG)XPK)^**V_3UC^8!<]J?6T M#!<]Z:MK+>M!Z^.A]45/5)[*J1X07?0M[,0IXV<+MKQ< MN>=HAE@2)&UTXOLH\-G8C)/*'8<\F:[%@5KR%VD_+-J0%[24. M/+IG978NMEQIM0M&=`^[NI?C);%"_]*T:/NTP()[%2'8?JIF!]ETCA%!D?1< M=:&'UTN<]X66>AL_\$EYS;R[==[%+3N8B?168^%`!'9/9#4>!M;-HK6/GLZV M2R+"G=JJ7TPW-+WUY(GR4/L9=)&^JH+,C5]"%Q8*-&.2*U%`CEBN:'.0\KVG M9:M''V$J$0M<,&4#%;JH\#2[T$2J[#CM^IKOE\(C)A$8+)&,S#U:!=&W%GBZ MQ+-*>`1[3S_T"Z,Z8H&1$;4[QOH/@/.?/*^BH?<^O\%SZ-*"\_+QK/]4O;*4 M3OG/T&N[RW\90CKOX%M`L=.=_#]A`K-L,U4+O4"!68%-<(E7NRUM\;K*4>]N7"B5``).\MZFW=LJ]<6B ME@1@2.QU%_WIBUY=(<#]@`ZO#NFK9I!;V6YVS5\=Z@E"C<32U&W5]`8R?:'B M,2S[:-C!!63Z*EJ$<4CA:N_=:^'^,7UA$N8>/,+H5**UG_X0O;/!*L:M>,V- M:M`2T6RZ`F?+T7P_7")[[%[X`5ZR`-&F/"V]M6PC?:[2Z[BBTFO?V/X<\6-L M&8K;^D;*DF&ZMI%ARDBX,FC3#5\&8\R(.=O4D0W58T/UV*NM'AM2<&2GX"B^ M1VU(P=$\!CJDX.B:@A,7/-V$=`\4;:#,!__Z^HQ?^\7IHJC\2RP'IXIQV:M; M)UE/JB[$>W'64RM7Y`$J3[WPV8<,;SUR2;REF=SZ2\_M%L*/P+Z-4:E'9%HV M4[4XG#64I:/9P>.,'1]=2JCL+>0JJ39]^PM,7H2._-Y\A@+D.,@*0M-)_?6- MH"F2Z3-*@#0=.=9YO-VP1[27*Q0@^LDCSAX>:N!50J6_<$'"R/:=-T/K/KJ' M/HB\.R^$K)14KW&#)>K(YUZQ#)CN'%/K&3OESD(_($OD92\E@**(+Z;;7UC% MQ9/MYF^`\5="["?L0/?AB73M+U(Y"03\^%WMXY.5P!>5P!>5P!>5P!667,Y*W?ZY\`EV@L[ZGAYHR0/"I75"Y'E84Q$_K M7'.+MH1)]!K*HB0"\U').7`3)=R_MQ;(#MFBE'OKC*U121/>2?#=X>Y)<-.- M/:&;T&9GOY1ZG$3*/MFVW)X%MUII2_)+_(SL)"G7M7<]R4(/+;P;[0H=$4T3 M:UD^[99N^FG9XPNJI=W?/*`D24X/,$Q^#\&_\?@_]`'D,'_,?@_!O^'?OX/26\_+#":73PC*V1; MC?%LABWD55UUPNG43Z^)F%QZ+MA#&9+L,B1];G8>RI!T-)]#&9*N94AR:V(4 MO3SP\IH8[@,#BF\"7I@>.C7IX3-*EZ8C+-:EQRXN8V/S=+UMDA3^GSR9GAV_ M_NU_C9ZAOG)OD8>)77$16`M?INP&3V%G0$LRZ[GYB5X?CUA&]GGH87<>\QVY MD",Y'W95P?,$U2:F_W!H*).>>Z-;CU@(V?XEU<<-"1`G2S?I`O70'C@NXZ`] M5?P.VD-PY?J!%S(!TSNF[JC`D=3V]L8=&"]Q&MHC6%,4"%.UMVSEA?AF!G0- MH=L2RK\HAMD^/<.LP#JXJ5*.T1EQ'Y''#@'Q3W1\;>6(UGG_RO=#9(_XN(G3 MZ066-<6!\)5<#)2D[5.66.(SM&\]RAS(ZL'@G?KB7OCB),@\A=:QV!0P1VR=E.,;(/PL]K_QNXG2! MX/32'JE*YB&DFE9JR4'JFKCS"?*6_#F4;:4]$@5F>?%WA:H7.S#UZI`D?#!2 M7U:5KZ5D]^S&5C%3&);)M!-ISLV\.BK47R44C81DE%25$,U=[IA/RA/NUF4V M5A9VL0RL][OJB$ALA!J2KH:DJR'I"@)K2+IZK0DY0]+5Z\=8YWAS[Y*N6B\Z M*QND^N=/57;P2++?6V?Y!DNH7TSN,EY!*[IFMAT]D( MYS/.JS(1Q7JK,7(@`KMN:G$%:&?4VD=/9_,E$>%.S=4OIAN:WGKR1'F@?Y+) M@H0^/=C?8WH@1R[7=`GU567&:LTETD0H,8G`(*MD9.[1*HB^M<#3)9Y5PB/86Y6+ MO"E&=<0"H[+Z),@/!0\R"AX4O^4^%#QH[KH:"AY^C(*'H[X6/!SQ\B=59Z@G MB_A71.:4]06VJN(MG"YZVZ)*677+;KV/EX+&D-4K70B*H"FYD2RAKJYU7LIKX*'S[2#?S&>\#)=5H.2:J5KH MRX8XJ6`37.+5;DNS&<6;][YA]96-"?:-]P;"`=N M0#0:"-GA?.5:'C)]=([BOYM,[UT:?8.Y6A8]HPN55:#Q8'U)66Q"H1^(BDLB MVV4'^`\84ZPT@WTSM-%A#0OM--8WAU\]S[G1-2%Q)73AEI#L/>8\I[48!8U1 M:R0)A*?LDO%H9B;U2M]=^A7I4UHG<+A!G$WC3D.-4>$Q#)ZIY4Z([>%B/&-\L`=-%:T"..0PM46>B=7 MB_D3$JV9'F*/.?A!]!D\!7B]-(9)F'OP""PY*),=,[$INZ528=\GWIJ5O@K, MD;)N&D,@SCZ(@5H_1(/R?'W1`+D%E9\Y^RLIT(]V?0OB4&[\PH%8:?F' MW=+R+*4_&PFMH<1\*#&O?Q#I<8DY_8+Q+'/M:$6)>7ESO:/77!EUW,PK3@]5A5]-)QH1EPK$0\;RZR/KS9P\'M@(LUEYQ'Y@6!UE)B/] M:'J-YJ83%\P#=H^V*C32U-J5L=IF!$]4R647$N0U?*'RJA..V@C`8:MFI1VU M:KGTUU9]IROYWTW7_G9^1D^?W.5[MUGG:S8T/$D%CZ`>U8;W-XO<3DJ"+UB, M4=Y-TS5;C'D0*:5`[?!:E>H/-%=LQ60#4)3\2N!0XUCU\H>:ARU MU+7.EN:UU#A278K4.&:;*7L:MKK&L<`FN.BH=<W=+25FZYDW3A M,5DNB1NE*,7/GYV$P8)X^(]MQE3)W<=P)V77.H@FT53Q#N&D^%[J+=<5Q;^[ M+?L$R);A-N.)4E"X-;VQ%Y>U1ES?(B\:3D+`0)W[A!57!CT#"=E$S-CGR/)1 M[U?8);-9)MN`%_P1HZ`]D+4$T=.AQTH?QK-(D)N0:87^(_.`YY4KAF@-*OJC M6E<8/0^@&3%N/6P)K*U0CSXA5F0[!X?$/0J'W'ML#Q.`S\P'1M.M)JX)/IU3^0=IF'D&I: MWBA0,9=AX9I(,[WK''JKC4VGR8BQ@^G*9=L+:DD9)YEW9ECASR4)O.J2F:K9;0&3 M@+Q,$#U7L,QF/=DGQGOV.^0C[Q%1.;S+,*`;+';2,JG`0H<6,5*J:M::G&1J M2*0GT!'GIR;=K;`T7;IJF;&.-\5ZI^MMD^3:DY,GEFX4;ZB_LJQ=_\J-W2-? M/>+SMK#ROTS[P=*6S'H&TBJE]2O$O7BFVT7LHXW$OR'V&@RR3QZ11X^PZ>\C MI^H+1II4/OH_".6K0R!2J-RCL'\?+I>FMQ[/D@\R[I'3=21+E!&2^`S*'0[' M?(<#_7?\)0:9;3[,?(_QL#:B;S*BK]HX*`:WQ."6&-P2@UM"^?%X<$L,;HE^ MN24R)IYQP:^4+&NKK8,!Y%;/!:=\V[F;G1E=]+LCF9_;4$8[HVORA+SX)[S$ MO-MU6_S6GN[T)0H/C33%+P?*%#M-LT>##F;@QQI_%7K0>-%[D*2! MHN0[!^\[Q.!CX7QV799I!:'IL+>6WE8,5?4,]F,H:Z(GC;U]G6DHU^44S;'+ MU'5J.LS%SGG612.](#-!05ETO( MG+%%R7DSMJM%MR97_1BT*I4#C>3W6@9GLI^>6`%^9/=A\$(RGVJ$9/*_2LD/ M89@A##.$888PC#[A@"$,,X1AAC#,$(91D..7.<;')Z3V,OP*7S75_>6K=B1^ MG0-)>;+H:Q],D,R:NH]Y-=;90U]Z@N64+M>GI?]@:"92GQRFXB/[DG@SA%E2 M/2NCN'A>82^^(S,=[.TM))5?K?](ZD0#&KM'Y=CGEE+1Y3#PZ@=A'3U`0U'Q M^^`OS<+/FW=%E1'B3/1_2$K6!30LU=Y%\H/6[+SZP5E?'=#X5/O`?.N[%S5V M_45L]7_TMJX=7B!&?9`S>>\F$^5,/VE0@W9T6![P3$GF(YZ;3X3H&2"%&]5R-AA(U38X&0XG:4*+6 MP_$WE*@-)6JO))%\*%$;2M1^N.J)H41M*%'KXWYC*%$;2M1ZL\B^NA*U8O0F M][%(D=K1J$[,9N=W0YG:$*<9XC1#G$:_>,$0IQGB-$.<9HC3='.:%<@G2M]D MH'NY,,J:&P<+Y$T6IIML16^(^XA\NA=MK;:M+@NO-[FKD29^M`&93RI6,1[S M'/S`P[%$$1J[N5M1P:_1=%0Y&O,<_,"CL401?7(]RU!!DA:L=D`6F/B!QV2Y M+F2[H:$;)IJ*59)KS?-(2MA#1M=&:,JNOL-7>ZU!`[UIH:'L@5YSAU.S$N9% M\$AD[94.8-D:@@9KT_+#IH,5+%Q+9^Q+"PJ%M"Z7BYX/P1:4`8TVR<^YM[ZU M825H6JV+@GSU?$1VHAY>%*PJRIQ\SOY@<7+ZR?\#4$L#!!0````(`*\]<$=` MS0(E+$L``/]"!``5`!P`&UL550)``/ISTE6 MZ<])5G5X"P`!!"4.```$.0$``.5]^W,DMY'F[Q=Q_P-.>W>6(H::&8WL7!C.*;-(;DDQSZ'8D-1K$*39557M>O!(?W7'Q[UQKO8#62/-KP2U9V)_@!\ M2"2`1.+?__-IG:%'7%9ID?_AJ[??OOD*X3PNDC2__\-7GVX.#F^.S\Z^0E4= MY4F4%3G^PU=Y\=5__L?__!^(_-^__Z^#`W2:XBSY$9T4\<%9OBI^CRZB-?X1 M?<`Y+J.Z*'^/_A)E#?VD.$TS7*+C8KW)<(W)%_R'?T3??_MO$3HXL"CV+SA/ MBO+3]5E?[$-=;WY\_?KSY\_?YL5C]+DH?ZF^C0N[XFZ*IHQQ7];-Q=^NT?_Y M[@1]]^;M;]_\\.X->OOFO]!_O4,GIQ??/JU(74ZBFLC1KXG8V[?T']_?OOGM MC[\E__O>\C?KJ&ZJ_C??//W;FS?OWKQY\Y:K_WN6YK_\2/]Q%U48D0[*JQ^? MJO0/7XUJ^OG=MT5Y__H[HO7Z_WT\OXD?\#HZ2'/:43'^JM.BI=J"#Y=%=FW6^\>]W!Z4LFWZ8:^1&2*OVQ8O#.BSBJ&<^,/X.4$O2_#CJQ M`_K1P=OO#MZ]_?:I2K[J&I^U8%ED^!JO$*OFC_7SAG"W2BGUOFH_>RCQ2@XF M*\O75/]UCN])AR?TAWZ@/_3V=_2'_J7]^#RZP]E7B$H21BKK]<.DK%;IM6^P M5[A,B^1]O@SU7#L0?#)VROH%%1CK>Z_";5%'V2+P8TWOL"_PLA8?]/RW-)E8 M\+*6'FGN!'8M0G9N7GF[9O3#<_+7!")^JLF4B9,.)"U"8X'9+[")H2V[+[V( M)^5FU)H7Y;3N5?Y<'G1S)ZL=G5%_OGDFOL#]\T?R#US>-'=G>?P1K^]PK\V@ M_^$KD_#K.2:J=EAVP*(R-M2NE7@=%V1NVM0'&6]'KKXJB[490]L&A4GRY^RN M+YFW&/EQ114F8B6NF%/BU&'C>E@U9@MOG1%QZNOA_.#3S5?_TN]-___GKXA27\:&O!:K"*JCM6C:8ZN(^BS6O*F]`K1$6A&J`.I8WQFMD($;FXCQ]\&IH0$U)P7C`94!Y7B\7V^RXAGC$;VU M_H=&WB=)C+#'C%$*@Z&/">&<2YT\FE@:6$;F\'-4)K?D5S169B;CDT%2>&/6 M3`3`,$6&:LX.)H.HT&Z=C_?_:-+Z^8PT=5ZGCY@:N-O/Q>U#T511GE2'>7)* MZEYCK/%+W,OPYK(LK5[OS;@6$)QD+T$MF"A6#.K+X7X0(='WP.S444%&R^7J M)"UQ3'ZB.GZ(TG)M6(:;E+SN)UM58+*MK-4(3D,GF,(F,U6BFSR]&C"^W:9U MAB]79WF2/J9)$V6:^5$AZY-=6KAC4DD%P7!)AVY.(29+*31(@_+9/T9/Z;I9 M:PW43,8G8Z3PQDR9"(!AB`S5G!FM##"+2#`&G.@_Q),_\\1 MS?N>?0_+#J2YV0Y,9;S:`1F\B1T8"X#A@0R58`>X##`[<)8_XHJ4K27$7,@G M(^0`QY282H#AA!36G!2=$#!67..,Q3Q&9?U\6T9Y%<5TMZ@Z>AY_HYL^'`KP M.K\X5VPR`5EK@V&A,V1A"N-BB,GM=F^(!XT=WI>8'9BI-X`4@MYV>;1`^ZT< MJ51P8ABA"?,6#^7KA8&9*KIE>;DZ+$OJ:E%\NJ6Q7-;KTE@'=[(TE@D&9X\- M.F%I3#>5R!U&E@[,@@BWBBA`-?3 M8/8]C*Z7@YIW]_9/*Q4=?$4JER;4R\^3[D?5?:V3]M;M9L@]`]2B,,A@Q"=$ M#78*B&CT9]J[)LGHBLYM<83/JJK!B9HE6G%O-+$`W?-$(PN#*&:`VNM2MP4Z MPHAK[7S*:/*'-,M.TJHNT[N&^LH?RJ+9:&80@X:_"<4*^C"_:,5A$,<*HS#[ M<"4TUD),#=@:Y_@AQ:OW3SAN:$S9Y8JXSUA_WJ75\'IKTPQ]3(\"7&]K9M\'[W,-J'DGG]^B M5FS7/7Q:Q$UU&E&7J+M<054)\(8,?T M^%.4-U'Y?/N9^,_/HR#FF_1)'Y5NJ>B--DX5Z2EDI06#3BY0Y]1J==%W;U[1 M^/+?07-92LQ2G=%L<9I#)E',JW.B`#GQ2&8RP9EC`"9&/VR*LF99^W8;^Z`D M,WXDGRPS/'/5\*9'7AFS\9GJ!2?1`K`&`_2OP`R0S@E6R/@T/4HW6"H0G"\Z M5'-B>/*"_YRG]P_U[0,NHPTF2[&X.HK*NR@I*FUR-2LU;W;&H1*]C;'0"UA0:81AL,0"H;"L MX@NJ7@=1I5>(J.W\3-F\N2*(^#L[-FRNW$#<7)&#$LZ%O6VNB$;+<3J!,8VX M3!_@IPW+Z6*LLM6DG:H53Y/CVX>T=-QEL=#RM\ZQKL*PQ#&JP*"1-4YA84,4 MT;MM;ZNH)A32.^P'!*BGZ4I/)&M5?Q.06V6&BGJ&9=^.G;V^`[7?TP>0?<'%/IL&'--8F6=#( M!PGM5\&6AO7/A8-SQA;AG$=CL=UNSQYG197F]W0?6!/2)`KY"V12`1S"E^82 MP;M="TM,Q,ODVJWX78>RY7U(B\5U1*VXQU`V(^A1*)M2%@@KC`#%4+9!8P>7 M%15,^2-Q7#Z>'!>E)G)-E/'&"16\G@AS`1B]KT`U[W(JACXFB`KNQ)^HY_7J?1.O%3"!P4TT"@!)%\'[WXU M)B%@B$HA+K;;N?\\C7%>88N)0"7I+T!,"W6($Y.*!>]\,S:!!%S8G[TGLTS5 M9#5Q1.S\`I6P3Z]`#WCL$\@E8?#"!$_B#[3ROKT![2F8(.+9%U"?=DPK6&5I7=G6K=BY$V<35:_2">)@=TC>_II8LHKVEN>(D+)1?SY7/J M0':.ITPF.'<,P(1L$IP=@RQ+U1^.%L>$MF64G>4)?OHS?E963I#S2PP%S"DS M9D*`J"%'IN!&*XR8-"+B(=C1F32:B$=2K>G7OK@@`]518/P=B)Z7`%+.&U0F M9"_W+RW3G5)-769ROOM="G-.@(D0*";(D"DIP86)-Y&P[>L0[#@D0!(*YC2+ M[B7UFGWOBPU26!T+)E^"Z'T9(B%72R>#J%"(OCYNRI)B3*LXROZ&HU)M#-2B MOAA@`MN1024'@A<&<,+>!!='7!Y1A:#&@3LKIVF&RV,"X;XHU<[C3,JOZRB% M.'4<)R(@R*'&I7`:F2CJ9`.N)X9\$C5YI6%1@ MMNS0:``BDP5,U8)DE/'C%>+*:*0=@FVW941_^N9Y?5?(ZCS[WA>'I+`ZNDR^ M!,$,&2(A%2N705PHY"J%3WW<,6;WO#6^MD36]VI%"7>^8A$$07##A$ZY4+_1;/;/T89ICGPZ^.H+)^)K_^7*&OF.W^.NEZ3 MRKA49Y)IQD81#.UFST3E6**SV[]"H^V64#?LPNG3P8 M=EF`%!-H=:1"M(%0V3XGMJ'/B<'@V56)-U&:O'_:T%AB/<$4LCZ9I84[II14 M$`R7=.@D">5`7=92=VZ[,5.<9M!`T79?!(,9566PPF>*N M"%X6ADR\_`W=F%(;"[V*WRG&#'XZTZCEP1@7"Y!"IJSTB;@J$:/5*Y3C&@:W M^*/!%'IUEA^N5FF6$I^JNFGNJC1)HY(X960H%#'[E-3T3T6:UW\AX@UI4XWI M?4&9_E^$?F'UQ0>D%Q8(AM_;J(7\>6JVGY[FJ+MF0^_;?@MC*'PHBN1SFJG: M9/C:)T'GH,9;0NRCK])TY.\%U-'TV*2(>WJUE% M6YB4?)+/K@)CVNDUP!#."J80PT`D4=J*HKBH:D!,!7($ M+.:TZ-41=;C'!?P&M2^8?]V^`OP-.-+:!3#H%`(1TR*402T-D7QN00TC12"1 M#=W!Y%7T3,^/R%@BGY0-3L0Z&DY#K4H(!', M.D:\$)0-I9'?W^)R31=#>F9*);U.VVJHD_E:%`/#*#4VU0Q-7R*C,ERK-XGEL5,'0T0VO M,T5A&CQ;/S*TNVCG%09V_HP;,=:.WO14_QR:9S<"-`P,^_6N3"<0F=3P%;P2 M%<`8,!N4PE9+;Z/@K7[''J>%4QIN!6!R\<$P1`)*YJ1W/CH,&G1NH@4=Y*(A MW'(3/61R8&BB`:>C"SLPHHX/=7=0DE9LLP*ZWV/TRQ6RP29,8KITGL-MJ\>CW5@4,SY+!S*Z;?;>?<>G'`[GVGKS["!K+A& M2;6TEZ8%,=_&2@9R;J'&,F!XHP`FLT5%CBJ>H^Q_O_GV#?F_M]2#1H]4[??H MW9LWK][P_T<5SV%&C=:__K;_-&KJAZ*D46#4!:\V.*[31YP]_Q[][H=7W[W[ MMU=OOO^>Z?SNNU=OIR71.#`:]D^^+(;$:--BP#&697*CL=YQF=[AY*BI/^6\ M(NV'&[HQ.[H7;.ZB!44&&@F+*Z\8-<[E^1EA/_`1EN-[NJ+4N9%;J(MN4**Z M0'>X'2@PAL)ADK`,/U%V%:7)67X<;5+B**N"$5327H-`])`G`1]R43"&78]/ M".3HI1&[UIOF*.8*,+ATC>LHS7'R/BIS8OFKPSANU@W;QFE=%D4SV"CZ9)A] M1<9D,VN!X9TU5$DL42>($BX)@WNB:VWM@X=>U-@M9F#MMRCQR;==JLDZ!K?K MF`1J+*XT_-B\\Z10@Q0P;MC4D^K`8IXE6N/VW][$B(]\TJNHO"Q9JL:$K0.O M<,G<5+,WJ]8,M/0P546QPE"I@9E9[;'J5^_]HAT<"7GN\\-^G\!R*371"+G> ME4#7+6='XA!)IL"H)U>W]=-K`279&5LHVS9")QV47%/(6F)Q4;BDFN"S(A2D MC0V'1SCL5(+22O$`AXT\7(*9']^0LJS8S:L;+\FN$!=KW*?0-IRN*:7]YE#0 M0IZF39"*@J&5'I^8'(%*HR'?.;3,YM?X$>>-\O1_^-KOAM@4U'3;BW\'AA`S M0&)F3?8UC-X^+JKZE0W9!FJM)PS*;]SD13B=/J9B(!A@AR7.,E4+`"Q MBC(H(1L?RJ*JKLIBI=PRGTAX3=(D0IOD:1J^AK5O)`(34C91";1A(C!H<+G! M943#B=HL+*8'+S3R/BEBA#TFC%(8C!4Q(9SSJ)<'EG?W!F>DS/O#//D8E;_@ M48U4F_P:!:]')D;@DZ,3I3081ADA"G%@7('M6:\[%1BL^H!S0O>,YB5(UFF> MTJ%!8WWTU#)J>9W2[*HPF>;T*F"89H=3F`FY%D\4,=&#P;D3O"DQ3.)R]A_*MI!J^'U:K09^N0ZM%H<#,?,&,6T<8,&)]E(!P;%A$G?UCD([&I9 MN5BP/',5//D1;@'4N^IKP7>8SLE:PE3?L600THA0I;09Q(`21P"HV/7[.B,B MW_`'55H>%3D4_M0/N.0X:9)URP6?04[R+(,XR^<\%H$62RZ')TG6S*2ZV0P*0;K\]2WO M1_[9Y>JDO:2MK+B=T?"PI5\&,RD:;_:=$O# MU"M.#Q)40Z#R,Q!N"CR M8NK$ZJ=DDY)W?\]8`<'?4VH`6UO88%6L4)GK!VMU>H%KX[IT)N,U+Y(,WB0Q MTE@`%E-DT(2$-[A&]&L89.AN_70!R4=1E<;4Q*994ROC+8U:/@EC684QA0PJ M8#PX.YPRAF7L_)K8'A8HAP[0'55E&ZP)5X;!O[_B]/Z!H#E\)+;U'E\TZSM< M7JY8;49@H6/KW ML8>7*_HD_6E6?#;M\^E5_%Y?-(.?7F14RX.AI05(,3-+%T!*UAA4"3$M<.&D M]!E[@NZJ+![3!"='SY\JG)SE_=;Y(4W,P6_3Z2FXI"#/+N3"BL[\3,=2P)!X M,70A'G)@,SLI&>*9AB)TY(:S3O@.4N=(<*F<.!BFXS#Y>],^C$I3G-/N23,\ MJ--&F_3UT]XR^;LA/HC3_9A2*$/4_"R0GVW3;_S3-(U*[_)YMG#+'FN_I M*U]'M%;W.L8<*S49-Y:Z<,:"&^!]W0;OMCC8CC_=,=5%\:F$O2Z`M(`G2Q^I M)!B":>%)$U'2!36F*4X'\6T=6U?Y<\DH\N:'=V\806XN_G;]\XPY@%XKV6F)C.$\S_ M/?)7VX1_YBOCU@5XOD7N6+'9Q7)+[>!F<3%D86_E@?P7S921CUNG6I8PJHKHZ>JJ`]&"O`))X(5PU^Y!)#$X&(5B/-!<^V:(J5-:F%9)J^$GFA3'?A< MD^*=TZT5@A9LK3+4NC>_G:V^OC`8L[!-A>WF95U)T)8^+ZK%GK_V;GUH^>)3 M3ZC'T2\[A@87"^F&6W8"ZGCB`IK(_#K&%N(LM`4!(+9%12T(KBD%S![`8NBF M.(N^!,LX"W_D)M-0>RC+=H-+3"I/1F+]?$4J1!\ZIYFS-VOU:Y@N!?@DLWO% MQB2VUX;F/CLC%QSIM@"T*LKQQC_=@5VE3S0HDVUJP>+O:5&2BL88)]4IX4%[ ML5<8MX9&LRXE!),=JRBCLV414#GM!M^%V*?$EI-/+YJZY)\1.,`8W@_HHZ9* M*UI21R,O*+.,/G[ MW1+61QOYPWNQWK,WM_UZKUWBD?]U3O"> MK/#ZR*R7KO"T!0&@LD5%+2BM*07Z"L\,W;3"ZTN`M\(;>4P718V[G4?5+*84 M]^HO&$!/_`2%+!C2&0"*)QENS7*XL&*46]YOG7@]Z MFO=>+@O-XS3@%-/CM^)TQ0.05U=]96S3O6@U0JQO--!E2QN).#2.F:$J%C20 M0]/'%GD\B-H,-5=163_3ZEH8=+UZJ#G3IE*J.52G"W).M0`\Y^C7@PZJBV]0 ME#Q2BK9S;LD+H2_UU<_,4@*A[;`/]D>05-K!MK4-%5%L9&I4H-J M0,V0A2P(45E&.3QZL`T&$^T7\R_>#8"Z3?.R[9F]V'&TMY?2")-5OS$#;=>1 M5O8P3^B_Z)GL8Y31:>(*EVF1S./&%$WF5H37I\465&[R[IB#/BP:+T`N(W+: MBM*=$B&;UD^DZ'&WL2V[]69HN?<'AO6,SGQ.GZSV60LKU64=:FPSO)54:[Y\RZ&-&6VVEXO[+M5:7*#WTX5C#_OAE>X MXS_21O3R;59438DG"<[0J+@77U!47/IG_EV4)B=-2487GQ,5Q+.0]W;YWP9V MGP!`)QR<3K8(I::.W:])F!*J'W!KW6C<"I@+K?S%!5HYQ3B:BH1X]F(,3O;F M!?T^.$\TH%3/7$"A`$TG=1L]T<.P-"&>M+)FHJ#_9]IE0,47VL=2@*BA@*9X MH:FFDC!(-7*LUV36R509#0%?$#DX1 M*?J`K;6'BQO4SY<%^0"9^HX+@K2L6(85MK][N*9W!?G'-4[>JE9`9CV_+]); M5F/Z1KU!"0QE;9&*[]@/>^]L4QXSMPM5N*XS/#YMA\%&>O(ZU+6OWEE.!F1# MX?)ZJTAIK^[[`1^72LW?[K'1!<-41\!SPA[A'*_2."66->Y+02LM-=X!E=?T=1Q2(WZ,>*^Q0[VMX0P8_#461+<9.&MRT..^C])H=>/#B;[#%N MDU7[<$N'>1UGS.:.MW_81OW>_+%6Z5FKYB8:<;G-,+`0MGBT6- MNTEW3&EZIQ=M"-`'>N@8W9>8^96[V@@>`E%X50XK.BIIA$I>E^E=PS:U.Q#2 M34S'$OQM%B^JVK!][*0>G)7+,=NL<48$C4=%[9Z>-.@IR]J,I:/J=16[:@?* M[6#]Y3OM2\KQ>*ZQO)JC\P[W0H#0=CER\7QD*&H>+#=F<6]@=^^,]IM5[-8\ M2XY&5F]-29'*6D,O[XV3-K![[NF$87#,`N&<2\,N(]WBV;1Y[=).:T=T&8)$ M6?;XJAL#(Y?"8.Q<2_!&J655ZTGFI@Z#=HLP"PI5YIIP'.&MVD]WFZ2F.:YTZHWRU^JH\R]?4T6V6O^YI. M%9KL:EII@J&C$UPQCF.]CLIG:O)&Y2`)8V'0M+/)Q\7ZCDSRS)@;[*!>Q2K@L8ZX"RBI&)#H)/)(MHJ!Z:?ID(&(DHT(5-2#5=R MB(EKU.U>PJ!B_QS(4`WCTU@:#;^AND;HTYA=I3@8>IDQ*I]S&8=*0K-WDFJ9 MK)Q>)3#-M!9-)P_O'0PCUIV]'Z0\'WFB!Y4TE?5AGISE-?GQE+[(P3_2W$JR MU?1X9N)2E='IB8U:<)OECE4\4:%IR[DH(NIHT&\_#<(QE6ER4P7",JFI):69'O4YP$CH"%5,\\LQE M3`^-%<'Y:JH:VKMN3B5`8*:E8^>@#IZO]OZ>FKHP^-KF5JVZ%]NBS&0NM1J> MD^V9H,^2[*G$P?#-C%&2EI1IL'FYTP%G%6V>![2WD(M+"W"XMK3*DI,WUZ+` ML/IE^)7O15Z-WHML"T3GT-Z+I#?.K/<&5<*^[P/:[0C*)<&P3@MO3BHJ#'D+ M<%H9DX%42H)5/QNLSUS()UGD`,<7DEK'H>:)_3:59K?XSR>^(L&J^98AM^T(`NJ-TT1XE`` M&,(N02V[5M>6P7-5CDN![,A95=YD>%T+`4=JK0EV*V&_:&TRQF->_]]HO?G] ME-DP.#Q4A]TOW."\8J$\[5XG>T6'7="YBRJZ>?IL<__DI85Z7=ILI0$F*Z`7 ME0AF#&RE&L+:?)K9=50LZG;76<&O$"OZ@)6-^@=HH1V3);&SUKF M6"AYHXYU!7KN@V!A;F'/:M'HP7"TR1Z8530\PN7SUS/]IO"ABJ>SUHHA3 MA2871:PT@W-O$5SA%A-5IFN%\>US&(S\5!&_[GU5IVOBS:FNE<^%?#),#G#, MI*D$&,9(8KC%Y=SA,*<$,7FG:']"QJ\;L51V]$A@BVB*5O+\# M\8K)V7H3I24=2)8+*CMAZX)RX!!X M.?@YIZG204:U0''Z0U$DG],LD]P,Z[[2&E0'?9_L=:[6F++6RE"V^I8"%_9O M6B$8U+S&CSAO\#6.B_N<)66TLZT6>GYO3EE68WI?RJ`$QD3:(A7O1C$]-%*$ M0;O;,DKH-87+^@&7W7T#@A*391H93EIK:*GKDWY.U1E3T$H1F@5T`:V\6S+( MPV#D84)?*DJK-+]G1\!V9M"HY?5"E%T5)A>?]"I@#*`=3H%L@Q9Z_T1/^H&0 M[1I7F+0DW=TZ(28Z*]C.00M1:_RL-/W.O-95FC+*KPN2FE%X%#+WL<`JWZW"-.DWT]7E15=\@4@)J']IA)>TJ6J5@$SSI ML]*P#C6+^XM0,8,>8E/4LL%98PE0W,^@[E6K`L,JG49IR=XU^X@C&HDU',O8 MV2<'?9^6RKE:8YMEK1R2 MRT+;S##@W%EVR2U=,.X#U<>A[#P,G6U0QP1M^HCI*76E75@N*LGKI>/E59U< M/W8O!HQ%7(Y=&GM\P(J:W/>!P>H+_'D4EU@6.?DSYM;;91IW+\;KTS(+*SEY M>,:Q##!,7@A'4J)>`F?N/H>S#T MD8`2`JP>R']AE.:("Z._X:A$[_,$!B?ZQ[ENZ1&(RM[/A/SF^)`!G";R&$N` MX884ECC_M4+H)R8&Y.9J#^L\S?$9^5/]GKHH&(0=`E`I0WHI>"R90],PA8HB M)@N%+O$#3IH,7Z[:`_Y_XN0LH3[@*NVS4=/G-DOR7_DX&2#YKEGCA''?F(1H MV[_BE:B[::()R[?[$W"&R$[J):17[5ZVOBK3&*/#C(T7&A/=Y=UO?X*=H8U^ M!+6_@HAH=]TD0<.F#Q#G[ZA]D&?T@B[Q44^+6+(L`,T:6X1;&0%D@)HRN<=404M'[`*,B83!YL`?])MAQ4Y:=IV4_ MC9C4P\P/=I62&WZ]+ABV.@(67*%6G26)BX)*='?%#)W;0=/3\_@F7<5IAMH2[ MIONN]H-H=S\<9JCMNB'E`W)7OPIPV.ZXJIK9KLWNABZ;NB*S74+=W[OG=N." M%;8GHWIH%K)PK=/'M'YVG/J6%PQJ5%HWA-.H,Y:Z/Z/*MBJZ*7&2&A%UQ7A> M);XX+R&8U:(%1GVF.<1Z<&>9"A<;Z@Z?LU/A\7?]K4\]-N/`?`\_&MSV^:ZI MQJ'H1^0>>132MS"ZBER6U^G]@SF7\@O*"^0_+*NVPFUP*RSXB-E6#F*1E+(^J2M%NZ8DE)!,'33H1,3OT0YBM9TZP4& M92CHLYSX90V-'3G%^)"!4U15*>W[.3D-Y/ES;!50 MU&N@ST0%U0\8G6^!)KN8D<[R&I-FJZ\)7!;BF%R1A0Q-Y7RO,C(N!82;MVPJ MII[*=-K!Z;D8LO0MWK0O@?S)BT`E44>;7ATB<8^+G"5UNT# MYHL1NI(O'>H3<:DUGE M/4LE.+^0(A?QZG=*P$V!-B:EWR^\:$RM+3";/7JZMHW-9_KFSL+HBR1P+`L;&9>@M:/O^ MZ.SVY!#&7'J#XZ;$"37$JEWNL837TP81VN3\8/@Z.''4F(0]?B[!IZOB+DOO M`>49Z&YO$,[>M7M__6/`U+6LT@27[.,NCD,Q8,BZ M'/N[IFCL?JJ"[0'5E'1RF0R^;M8R-LHRI):S(@B96/ MZO[O<1)+=*3=]!LM,%PUU'P(K79MB4W.GOR(F< M+G$.DX3=8(LRAPW'%Y3CS7E\235[QW%)(<$I^5+D8I+F3ID8S:C<[IIV6VD9 MBOB7LZIJB*O3T'TAGGFD#1(:[FFJLS58Z_M-XN!8K6EN!TOEX(1=BEC(B]JL M[W!)@U4JIH)25A8[#;QK?0L4@;NU&_4!.RRLK,L%JVHDI;A79AI`3XBHD(7# M.SU`\3B11Q2B#8L")'2+>>+=BI:PHUF[#;SBH^.VZ)(R7*YXTE\&7C8/V.EY MFY5=JM'/PC9*P"JG[6,;YT!U%H.*S5O%L.A$KVEL-`)3BQ'H`*MF";:M)>FN1WH&69E#%[" MK*[\$T)L:<6F`O[8(@,V\&+\+1`&2""))J2500F<%?[@H_-E7C?%<5_K++\E MWE,5Q9+CSF5%!%I-65=.L<(RZ@>GX0M`2XXR>Z^X\U9(<]=E>M?0<\VHHK%R MV[-.VU_PCSRVR\\Y+JN'='.XJG'I1&?+8D)M$+A44K5Q8%,&1&J[`-=[XT6G MC6JJN<(E?O'IE6*ZO2Z>HZQ^UN__2X2\3;M*@/W4*T@$)X<6EI`WG?(Q*G_!]'R^ MO6$ACXI12KFGUFN^D]4?%I4&S`:T\61O+!.>8`4IB? M"AJ5MFD5*=DBKDKOTH))(GL<50_T*MDC&0@TW5;=7373Y0$Q*?D-E;2IP#1` M4J/5;)6P],DRW@<*?V"C5,$65$$P8AWZ]6F&9APOTC M]32HDSX%D\=IQJ\$\>N(9_D)7F$:BTR$>/9O.O[XI:$L*SY'>:PB[]9_Q>O3 M\;MIHLE3\]O]"3`#:#?UTCNRCYT:BCJ]':UW>+)3AS@Z@X*W58\5\'[AHY4. M3C5KB'/6<)T`,7)=^COW`$RUBN_82Q/X>=BE2AX&?>Q`*H(MJZ44VN4!!JZC M-!]N^Q[&<;-NV`8R,;-IG$IWM\Q:OG;;?^`=EK,8M$2WV^Z`6=AU'T11PF5W M->*+\A<"KKV?)67@3,+?>)9"&X;OY&L@HU6&29;%C1Z@Q.V=N"UU\+92O91D M64K](N[IC!]5'))@JK?)'?3])GIQK-8TSXNE.&+9ADYQE'% M[M)'-5K19RZI/ZOU8'<6EKBC(%8P)[;.B*WB66E+A_;G:+NS8*#T'RPFC5/3':/39%ELV8&!SQ(?E%)7CS,)95 MK;H-K3#YY)-_*L]PY%P&"AIK*6;%0H@^?A&K00C!4D1_$7!1M.MDP'+PI,KHW M$;7ORB\FHJ(<*&S45M.6DM)"]H*7.N0R[/0F0&>TZS[.N"^3;NWN'2'H%<'02I%I9RV:UI= M*$>)"W$K-VI:L3",HR_0=T_5+*CG5!T*XV25LF7<6'>?&"?!+6$9?PN?>Q>XYK&OYZ-T8@[-,-.'PD-IM6S9.%$. MOLI=BEAVNS)E0NCKC(A]`X.3U25K%!%=3XL.[JBZC6!5=I-7P24`+Z&/* M:<3!D,R,4=PG890B*FC003]U6O^](Z>O/Q]\G^/R_ID,A*01&*.5].;(Z:'V M+IM<+#@SS-B$U,%,AFX)4Z%=]W__KI[4MY>*^>]Y$:38[8,,L#X7@,D>6^(" M4*:4%OEIFJ?5`T[H)IO*N5$)^YU(=("GA6=%(E;\J5;&'P]$SCDH8G%,&?4_RM\^:Q*0$(HV" M.@&]5@,,[ZQ@VN5-@$&UR=7"X<%4\G>&V37UZ\S%TSE^H&E]N'7X$VCTDA8.FDX?FL%EA%1=G3RRW.(U\>K6- M?&O*?1R[6/O`\?16,?-PX^(=8M]/+X\_W:RBF'0@>P2QCX/?;"D.?CN3'=T\ MJ/%Y^DB3Z$^C_'2>E5G-Y^1D6XFQY3'I!"><(U!CW"6JFKN_$P[2-!9CAQ\\ M#T?3Z'BZ=&\N94%`N&JHJ"5[%:5`]N2TFXZ>LV1U&%$W9)*J]X>C6:QNB>92DX>AY$VD2OAY^C,N&Y MLLB\0O,=G>7\25V='["37_*:#'QW335)*+[]GP'CH.RN;O)4;A6Z;.J*C+XD MS>]?(:;^\M=MMC3R:#*P%M'X66J6(H:UPMV\H52MNJ0D[^^-+ZNJ\/*X6S%P MF+\8^YS93(,FE;OGI:&"4SW<-DZ,<5*=DD\OBAK+KH&89$$FCM$CE>Q2,P5$ M6XE-3]U?^S)6[ M-KSN6X!]WJ&T")3V951L9X:6@DHPCU=.J_DQJHEAJ9\E;YG:*/A-"V<"KF;B M6!J,>3="--)KW>H`>AN58CPNZ#5S_E=-%SX=ZO&[FF\U+>-2B&\:NE=P M3DW[$D#1U1FV9,H;3W+TA51>##65!^^[>L*9WW@C=:B:C#Z0=HK) M;(W+CT5>/\@VY@T*_IYXM@$^9%'420?GE35$U7W%N%="*Z+%(DK65`^&);S& MW5,U--:-[1U>124Q\&0<*8:87L7KTY46X*9'? MT\<5-2-_*N)SI,O`C;DS_A[,2):`$LYMBBBG6^9AWZI,5SQBW1F1TSWQF)F3DN<83(L*S"(K-1I@:&8%4\6Q#-]'&5M@ M[&@Q^C'*&QK(U91D96TT5'8JWA:DEN#[):E!/CAE'$#."3/1VM73R*3E"W9R M8T<4O;R_YY$M8`\/)&N$8?##`J',22J,1V[^)JO+^@&7LX1D-%Z<&SUU)J8% M^CZG,.=JC6$MEYV12P_XDK1B?8NB^_N2!;J:WVYZ@4M!?_.D M_4G9$^4J(6_.@Q)@[S$($L$-M!:6OM=WV==#",/EBI_3#9LW=*]'ZNP8=?RY MD9;P!U?2H`"#)Y8H]<\5ITP12!"1TZ[G.[^S,S'.]GN>[Q1MSX2ZN3=0(X]> MEA7,HDH&WIRI1"C)7M0_A[L=([G%D-R'(DL(L>B5S9J-V9M-FA>KU6T9Y544 MF^)PK=2]!]\Z5$J(N+70#6Y\%P(6;0JBA1-)3D85TTNORC>6C=I!%D3:2&+ET1B>+!IV1[C/K54#&H=4^WP_`6 M1^YN6Q\^6MID>,EI49XV]`BI&QEFM]FV')_^X^)J*A8O=H4$I^]+D6LGO=8B MEFT9S#2FK3X,(#AS8%K6?8U`]%F?X3 M)Y]RLN9FU>+-1%-?59.FN*8-?%Y\QB7_*UVGJE"JW?YD^&&^W<8S#^KM_![P M(;S52EKE$YB.VR]PM':[+Z-:MPWAHV=TO[ZW8]CF6FBC-[:^$[7D1#0>3<4$"JM M,"3AH<$R-&#:P\H0]86@ME0T*@V=IRM('HBWIIVH'.'[-*=-=!1E="]%E90` M%L0OUT39=4XX.Z7']RLU5E:-8F6QNH)[@]45C:Z^\`53^PT-*0JP8)+]^MXO MF-1-NO,%D_C3L$R#M_JJ1OU(H5\PC3X#--"W947%)M)942]^B#.DO?4[%C;^ MSOP,1SRPC$?81K"R*'OL1]CGMAUY3MR"+CV_^"[2[2BYQ@=[SOV#Y/]MKH5V$;V[KU_=ITG!LTAT-:C"1FO[7.@NB-0W[ M#WNS&GIIY.OT^9T0`=TN"$!9A>TW[59#N>U_?G_"9:7Y\J\W?=DDM*BX'1_= MKCKM2[38EWF1!B:E`36,'>5?=JGFBQD">WY1XU<^&"Q;QVY$O"#8^^K M^<]_&6-?WJA^AO[TM_?_^&Q9A56CW2HHY$L8UW]A%C#8N)[__);OFXW4M(BB^PVP9U?/"G2/@6+T]*P*W"0:C`AHH MI-VK?6BHK9PS[F`K;-OFS'%GP"'J'!`N^&9J!]WP-:V\'MOO[P=?=`2L=[O::=_]@="4'CG-@ M#0K.X/?5`1[<`DM$OQ*?P*TU]O!V&NCEW/XLT`'M$.Y'0VUIB1[TNAQKZ<,X M+AO:S'G59#4!/P@$UDK_G!2Q-PZ1WV(]QH@AHY`-U'DOMCIH M4$)4"Q$UQ/2^#=%%QU'UUL<89X^\R.6VGZ-++!^,0)5/,W+W^2\+=`11EP+_<3U M_CM$YYP0UR0F:Y1*T2&S[V%U@AS?B]J%H*D(KFI/DE#1@C7&N MZ#C7`F!UY4+T\\[EQ:"^'$0+0J0DU!>%2%FH*RQHEY]&U+I?-(2&M%G(9($^Z[=FL&13>H M16'UA1'GO$-Z!3:]=RI!N^7&8()N()L@.;AYJ]_`,$$W#^EF'>4G:;0N\N2J M+/Y.>E_5ZFI98#U@!"KT!M=`K0IJ=<)VS?3RN*I39%+`ND,#4>@(ME7&A?D* M)&@7/.=DMGKF4]9-X$K:':/OX?6!"$YR M;+*)\N??5`BW\@ASA;`M'I4T:)RL[FM,6J>^C9YP=8(WQ&%.^69WGARNB[). M_SEI`+%K'`L"VH?+:B$;9;R+V_)0VA:(:EHB2D9%LG.":%1H$$*TCCL_RKLM MKD@3/T05OER-3@C%:@+X'V8L7*Z#J6%H(: M6@J;'J.NJ"#]>TK:HN([XT=-E>:X4IUU*R5A]9T)IG`J0.51>S;0:01UVLE, MT.3U5?3@">=Z)K2[Z[KM7Z+LW;W\7=,`I*T)=Z25]-M7;DUZ3 M@C;TV[\&[;?.6A_&_VC2BIWI5E=E<4IC8@[CF)J)ZAK'.'VDED+H/C=U6+VX M"/N\,_O9+AJ50C=T$0LK(A_S@E#9EQ3$HNHJ>Y93VA;ELU/W]EK[TZMSR':= MN>D[,^WT`79AC;,,LVSOY+,-+FO7WA0+V*>.5:)W[^.A*/HQ*PM M=;NN!@OZ_J`:E0>8`,2\D9JEQ'X M/]1PJ8XK3X:RZ>ZX. MKO>Z%4B[O;-HY=7J[D]?RH&[=FF_YFKWMR#V+;W?V)WXNO;M6'>O^E8"?$'? MLJNAN"T&7-_>%G64G:?179J1+QP[=ZZ\/[VK0.[:O34M!F5#.4'ZM]\G>,_B MD4@=DT9R=TXN!JO/M!CGO=,+(\P#L39D=.L`.H>&&2`-K\`4-WV M<2\:YC0S?<()=Z,/\V3N6=_BI_HHDT4<6.K!ZA\WT,*Y)]5N5P4L5B2=KQ70 M3[0,Q`H)$U/:K-=1^7RYXC65U)%Z2!3DG;17'?5A]>XR\$)4*B^%!B&L>(=+ M>[IF1ZDU[6Y66I#!^S'*FQ5]]+/$936:CH^;LI2=>1OD876G'5CA!M"@58T] M"Q1SM3`A0>3/@CD_%IVD$X;50Q9(Q?M`G0J8SCG!=_5)6K%%Y%^BK!$7WX($ MK&Y0P1-NV!,YE+2"Z)%*!FGPF_@!)TW618HY/-79Y7MB[QT>/8LO'JK]%1\_ M"HL6'FNLF4,_=RFZBB%%%[JC:PU2&&*9Q8*0\$/!7^&.<9E?T7.!9S5W-+*P MNMP,=-Y33`/%7`5MF$YHKV;"06K8LJ(BT[EF;!L48'62)5KYY;4^X]V@&'[1 M`31MH,@3H$"!\1-V*XFW:PD6Q,"@,6`T0HR.GM%8KD6-&&PDRR)I2B*)^HPV M/7S$\"-:@?:.:87Z*K3O?^_5\/SB7RCX,H;=]EMD^T/,;K1PH$0*<:BF01C& M._F5Y?3?KT&RD\HO&0^5Y9S3X[&G/4C6_PJ3V>_7R/#4'*'FCA%*D-/&!WK& M&F5MR`M-O5QDAET'DP8L`MK"%78@N!X:%-%/K2H:+6P#Y0"GSROPJ+_)S>3# MZBHJZ\M5=P/OEG"YBF+IQ?PEA<#JVA?40,PE/A0UOZV-(AK#5=;T\_YF8CT4 M&>A\/">0:2+[HKPJ,4V#3BQ14])Z2`[%U<*PNM0"J7C\W:K0X!VTX4HH[;3" M1(U454-_O+MTWA%R%+.D&YINZK!ZK<0)P]?5]C2RL'C,#G7<,U:##+QEG0@][0__3C>)"=_<%K#:?H9HW M\*>;_A)V^`PQ48:O>0*J"VQ("#,1A=7B1IR&="]$!95;%3:^)\B+0FG$4>7Q(4*UQPFZ!TS,.65(4O3BLKK+"*KP^,HJJ;K50JX:8 M7IC3CRC-J_.BJG!UF8]VJ,1##X4@K)XQH!2..*@XXO*('GT-&J$?T.0FH-L[ M/"YRBZT7-W58/;<(N^+E37YHT=K"T;9I/"HJ\+Z-M%;*IU*5LM#ZT`14[+!1 MC\!X'.B/Q!G]>')\%0,?:0G_V789QROB^-=G-&M%=6K57IQ6/UAA56_/36^:AH' M?.?JAGS)[)^P#7V:KC0[[99ZL/K-#;00)MQIBQOOGGNNJ0[NHVCS]H,H,[;2C44IPRL MU%?M_:BA8'37U*@K^A6:%(Z&T@/QA(%^*+($EQ6_OR7K?5$*4)]JP$E3<[2B MO^GNJQW6_,B!YXDKZ.$K")-XF"=VO6/2`=17UE!UI^5TVXJ+!^JD#V51T0R[ MJU3J,HR^!M3T,E3"^3>505PH4-M>;G`9T7U@619NI1"@=E9C$R-W6TG4B89N M\[,\+M:8QC]H6WT0@]CN$G3JEN?"Z&LJ_DV@YN^N!+4LD#7]3`10LZN0R;9D MV:6E5C!06]-K66V4%77;TIINE9UB-AVQ*UOM/;OCHI)O=S@5`*B?EN&69J;L MHM2&34J`>LP>J^1)X%Z3'IFP`=8IHZ];]7!3 M5USBJ,(GF/_[+-<_3NJB!ZC[G."*,Q]70E]WZM^@-._2:`#8`Q!KUSUZH-B8 MTRJ`[C893LO^&JF"Z:;\B/8SK M]%')`7MM0/V^`/2\KTD1B):!ND)H9O*O:3FDR[]!PWI^*"M0_[8IT:K;@ET> M*7$7JD1SM->$X73GUL(ZDIYA5@YK_I]7U94 MX.YEV9B*&..D.B4";&EUQE((&\>P8Q$`.]H5N;*W:7ZJK[NB$&WI;]J4@7UQ MX4>TPGQ9]K:]-J".7@#:T6(#ZM]KXB9R/EZNZ,5:V=.N)EE`?6>$*%Q$Z17H M_@)3Z7RGP$:6[Y08MV0UXH#ZQ0:ETE!V&S\@=E9'T\`?<7*/^WR#UO.>2@U@ M=]F@U M4#]:P50_TPOIO:6MOX_U+G@ON>&4!N!I%$,%=!5%\CG-,LE3M-U7_)4VV;"R M5@8TQMPQB^_1<3%F+(V$W^5MU/[;_#C(7ZW^!!?*-?>04S/.@TS=,: MGZ>/6-A7&]5R7!$9B=Q+`427%X"7/&1'BCI@9Q' MIXZ!NG8@T0V5]V#I*[SM,[:CA&<7S3PWV,Y^!("CM_NZ21\F/KC3/TQ\USY, MW,I-'B9^U;T]3/X8?I6PC_WN_A/0]C5NSS_]99+5JL;>*`SK`?H7-[?QB?.+ M@L6-XF0'1M?UQ[\$?B^N\PX8KGP^OAX]'\^REG%$@0PX#X!8VN!=[(.E17G) M@``-].?O@P^>_6@?Z4`#"'BO1J&Q&UL550)``/ISTE6Z<])5G5X"P`!!"4.```$.0$``.U];7?;.)+N M]WO._@?>[+EW>S\XB9/T3*=G^N[Q:\:SCNVUG>D[G_K0(B1AFR(U(&E;\^L7 M`$F)X@M0H$BAJ'#.G.ZT`H"H>E`%H%`O?_Z/UX7O/!,6T3#XY?'LX.GDXN[IZXT2Q&WBN'P;DES=!^.8__M^__"^'_^_/__OHR+FD MQ/=^=L[#R=%5,`W_Y-RX"_*S\X4$A+EQR/[D_,WU$_%+>$E]PIRS<+'T24SX M7Z0?_MGY]/8GUSDZ`@S[-Q)X(?MV?[4>=A['RY_?O7MY>7D;A,_N2\A^C]Y. M0MAP#V'")F0]UL/-W^^=__/AW/GP_OC']Y\_OG>.W_^7\U\?G?/+F[>O4T[+ MN1OS=N*O>;/C8_&/3X_O?_SY1_[_3\!OQFZ<1.MOOG_]Z?W[C^_?OS].N__9 MI\'O/XM_/+D1<3A`0?3S:T1_>5.@].7CVY#-WGW@O=[]_Z_7#Y,Y6;A'-!!` M3?/G]_)O\V;5EJ^/C$__\;'=_ETUB/SOZ6*]H691/3G2$[O M.IRXL5QGVL\XC2W$?QWES8[$3T?''XX^'K]]C;PW.?,E!UGHDWLR=<2_^7I9 M?S5:\84Y6T4QH\MH$K(E7RR+=Z+5.XY4LB!!?!)X%T%,XY6`C2WDK#DE/5D@M01,7Z?^.\VW6ZIZXO>/PP)R363:^N;8_3 MN7,9Y\6Q5P'>8&7WR2?J3;G:PWAU/^9[X7"8]KM7BU2-S@\B=@)2- MKE_7:RY=W-&=NW(%2P*/_\(2XEU3]XGZ-`8(CP*3?WZ%-U&\H4W>0?"65<[05%!<'_+ED0[S:X MB&*Z$,?O2YEHK233=HW3W(U6 MX\_LR6Y@BJCI.!9.>`49@C2':I_>O]RC#^KD-ENV&5!&W9"3BIS5Y.K_F/VQU(:\Q"3SBY0,) MVKIZ3.8_B\'>I_\[=HZH>_X_#^) M/PA"/AV]/\Z>__^5__1;.H=[,J/BTT$L7"YJ9LZ;UK;47Z^E*0L7IJS,V!9J""ERET]A[Q"<<4*8 MZU]QT7G]3[)285!I"@3A&!\*#53;@"&GXY$/6\_][19`IG_`Q/0Z&FWR^HXP M&G(*/.$FIF9ZJ2F0^Q\Q&)&E[X[JV=_J0F0[9\PL;V62AOL M/DN8(/&21A/7_SMQF7+A-[<&@O`C)A!TM-O;>*63[1F?RJS@B5.W[98:`E'X M`R84%!1;//F$BT48R#O)PYQ37KQ]*8]!RGY`>/Z(#QX(/VR@](I M].N!*34!8O`3)@QJJ;1Y1DI59GIFN.2_1?6L5S0'PO`9$PQ:ZNU#(G8Q,""% MQN#;&EX\*J37H/'G=[6VHOX-2;6N^UN&HP_.D;-V_N9_/@OY=X*(>.)/4>A3 M3SP".=E`3CK2KHMLZD9/$K`D.IJY[E*LM!_?$3^.\E^DH:FPY+*??UM/5;RN M!7Q*E$M$F+X%*ZQ-67=8[YUEJ#UYV:.BEI!R.UNF)R.^;@M2`R7=:[1=TE.+AI(6IH;LV2U@(;)<4X0%D[\=T0 M!1;;K:R9T5I`4$]D?,3S5+<*90"I.YES=ICE3NCA1/[**?EK2(/X;[QYPDB=9:B@2G88UIX-R03E M3GB'8QE\"4/OA?IU=N^LR:8%%!R[M]\R13CX7'8;Y_K@XG7B)\(FK\<`UAN* M3\_W7:WPP#F!`[MO@;L(^97AG\0[)T_Q510EPGZ:G5B;4=/U@^+5\V57@Q>, M>AQ(;>=P:#HGPCG?\^45=#0\E#-A,;HM\(I._^*0%*_T-EGX"%!\>[M][6!$ M-^43#LDKS!IL8U?U@2+8VQW.&(9&%%$;XB$!3V"3+F@0*++=>T_`H:FW\QKP M"`>XQ7BPDNW3=Z.(3BGQM.`:#0(%M[=;NC&X+7B$`]SK,)@]$K80AS(MB+6- MP<]C:,!2T(P#E/.$/(:USPQ<:]R$P03PY@(;``I>;Y=Q8_`,>8,#4)-M<(?= M[D-O=W)S&8-L:D._@6R6F]$QM:X;%.'>[I+=G52;N8)#&.MR]JD/+'!X>GL+ MA?&W^5"""X)\!X9!4=\:"DEOM_,VD*@(1P)-'56&:@T.SCXNWG!P5*0?T+8% M0A..X3ZNV#MN28<"8B%MJO#RJ\N<6N/FJ.H$]I1#"C*`(SCT:AM3=0?&Z8_[ MN!*T`6XH)NE"O)G.G;C2$HI1;T]SK<2ICEIT6,C8/^$J,6'TB7BG2?PMH%&4 M$"_[,4W&LW&J!>'68E0HQKU=W';!N#47S3?2S^E&&I"9L-S8WTI//$^^H[G^ MG4N]J^#,7=+857A/-':`KH#>[H;&*T!#.PYAOQ<9EP+B7;@LX'MZ=#*9)(M$ MVOU*.>VK6$'Z0F'K\777$#8X1W`@6"70Y*@#1ZBW2V0'AYI#N7GH3GOM_2W@ M.`_@HJGD3:=K`$4`<7U]K:UHXH\MHHF='[8&_O;ARR`6]P[+>5U"@G23P/F?"YA-]^MCK9#E3N!KTF9B!%[4I> MP`P0RSO8#E3N$JUM)B!%2IV*J8FT-HF8>K00=8<9+!.3M8.+IN3FUJGE$^S4 MLAG2":?.9E#GAV^!F_!+-O%L'EZN`DX\64]2?UYI[#O!,@D3UP+%I8?FP MH>%WY3J_31@6)1=Q72!":**'T%=N0Z6&M@\+9MQOH!,'"%]8&$5W+)RJC%Q; MC6SO_6;,KZ%OZ`:23/D'LRRD"9"R2='%=EH,,SBUM..0J@?B\S%G)X'WU66_ MD\*$%3=X11_;^3'T;`_!M&#"Z0OA9SC7%Q$2WH(&,A&]*(BB!4O;T78Z#5/$ M@)S``=LYX>P4T>J"F7S&:;SG5H6*&D]U52?;&3A,X0)P``=4%<(,-BF+B6M; MPM)([<&<.=+M^IH?J@!`%AO;3H?2&LHJQ8,',YX3EI(E4K[`3Y&:?M;S;1B> M)4%LP*%&KX*8<&[&VH-)I:'U)!M`-E>2;M31.WQGH$TJGHPEA9W[=GI.(QFZ MJ$7UM]ZKHZ6L)MP!X=HBMC.+$IPXR)\2>0+?3$!B3`#*39-PV&L9P1IA6\K M7@U?Z"6O;L(@W#Y3:)6YKA]T$?1G%VBS"&#<&/HAZX;$D+-RJ9GU1#!F1ZA: M(H>.7.[TF+M>G+H1G0@%1?TD5CV7:SM:3R5BABZ0$3BVX5$GN5:9 MD9MD\438[51.O%A&%@IFV_&L9Q0QPW@WMF%]=!=9Z2_]\*7AS?W'-F_N8DQ' M#HKDS;W@4+&FU\A1L*:7W0U33.B.A<^4PW^Z^L8!N0K6=IBL/C*%6"K:C(7' M?;`1S>KNVY)C.%1VOT>DOH#:@>MFAR>K(4O_G60)@T4*G$D83*BL%K&9\&/8 MF;3V\S7;?@J=K9,^P<"QW*R]Y_67J;9/S`;Z%+AMS,M\0(.9M/7(HV5JW5.E MPP6/8-NK98_XF[(5QV+(+Y32$"@,/QII;VIOVS-FCT"K6;8KK%&P8A*L]Y\_ MOI=0B2J5OWUQ:1`)*DAT&YQ,_I'0U&.[!BG1OKFY;8>8?0"EY@`F\2L]K)"G M.-<3=XPL:+*`*N':KK:]::QI7P4C6UM%GPE["B-BWR[*F<<(5S_G)/UW@5U9 M6#_([1\\AFWGG\X.\.:,PZ$DJO.N5A`T@;JNMVVWH!;8Z,!M9M+P7S*KU.:U MV)2)P33=K%=1ZF$5U/#E$.'?KH9HL@+*/3%XCW6]".JYH1[/ MNG-;C]L'A)/#/U3"#UE=O/8@\(OK\OG`D'-#=\QHH#AU&NSFA5`YEG5WJ^[> M"`$\PW$'X5HPN\=+6PHCC15+F[$V&<.Z`]8.@(6MJ3Z4EKW_.M/ MK31P:?CK`(;D:%K8 M'6'E99I[6"^[M0,8(9!&3-C=DV6VC]U.8=@U]X!BMV^3@CEV.JX,?T^_6]-G M$)JG[&2]G%IWDJOGS0$L@()Z*B[W0IW'E2`?IL35(U@OY=:+4H=P#8>2+]QD M_T*\&:FA&V0!:.YLO3)4<>/_$G;P9]<7VN^.,!IZY3?9YM5B-HKU M"G@M+NEM^'28:^.$BPAC*RX-NNILL.[0U8#)9&/$F=;+8"E7%Y\>B[^/Q?#; M!P15%OM:#H*X3A;$18#@Z/B0+)>^9)/KYVRZ"J8A6[C`0BW0`1"4^S->$(;< MZ2EF11YE7.J=)XPOPG2O4@`C^JB[V*^[9\C7$$H9IN-[GO--S%;E*EAL9:^T M'IBW]8GMBD1B8;^(C7ET7X79EWK\2J#TUZRTM5=#KS44303C`$14AN=4;5Y- M`V]](;OBFAGRE`@?`@I?;Z_/;5X033F$`]BSD$^813)B3)I13A;"XS?].2;> ML>(XJ>\*#GWNS2IAC$JY7@:0/3C0%';OS937L[P*.)&)S,`DIZ\`%3X"%-O^ MDI_LB*TILW!`7"R[&45\GBH1K6T,!:Z_]_T=@5.PH*=3?/6+Q=>FAG.\KA,4 MA_[>ZMOB`*$.D\Q(S9W6UBN>R:1)H!`6KS#%PT>`HMK?&_R.TF7*K+XNSIN7 MG70R)Y%86>+))X@9?4HD0V>,D`:'>WD2-QP$"EY_K^2[B&0[EO5F^`@FQ/>S M9`2%J>63NDO89.Y&Y)&Y0<0I:D[DT6XH*);]O8?OA.4.[.L)T?7DI3>^#";E M9Z6$B9DV(*?N`D6HO\?I71""L*,G)#;OWUF1WVQ-%-2S7JI,!X&BU=\+\RYH MM6,9IIRR-VZ<,#[_/,9A/<>M=+)_<(X6RG M^):-;(VLP22I#\EBX;(55S5T%M`IG8@8QS227ARG.4,F1>^5+?G]8UE^L\&$ M`!>&L!+:;PJE`'R+2JZ&/SKJC"[)$OB5-?Z90'[6]92O6(E:^%1GS! M)(XG443B_+A<+W4_E:5.]G'6G>PMQWS#YC>`)ZXNI<[3RY:ZET7IJIG8AN\` MZ8+VMRQ=$-1*\F7&&4SRE6>76M7+UN>R;&W:VRU])N>PF1DD8:"BD^4Z;J5Y M`41)WJ::L\8B"=N[6VJ7ZIDJ^]#-&(&`9O:6_;Y,Y*QQ@Z694B-18WSWD#$0S[;ST.?,R\Z)U,ZH7&]E'RJV/X+ M/?_-R?O:6VHBL"I>Z:6DW,ZVZU?&PG1:0O48R8O!$)8EJ!Z?.O\N$XY@DJ5- MI?9(.#718$:"QL>TXQ_+`E7H[OQ?=['\D[,]BDT__/7,1!1C<58F^Y/A,%8# M#P`S!4BGZ3B61;05SI6@A#:LPR3&4@?=+A6&EXH?B^SBY'TL'K?6DY)N>>O: M9]DE7*:HDBY&3Z(Z6I[*!G"RW'%7,3=H>KZH^L5(?;#NU*'E?VLVFI>)AK9=/D1L?0*V-59FAFHG5/"M M^M(`I?Y0GO9@OF-*'[+CBC<+W(?,^2'_T[]_[^YD345("XO&5?I/B.,1L#^X?)QU$`T)PP3FMXB??2ZB MF"[XB4?A'5UN!TV2AP:<>D)Q@-"0C0TJ4,#NX#QU6"`S8@L.)!N+\8#!A(\` MS@B!!4]3YN"`M.R2*K]`;5?KA>Y-002S`PEZBZ5+F;`$:SM: M+U5O##V0%SC$]YYSD\]!W.;.N>+Q0WGLS^JGZX07U-EZF?D6&AC,$QP@KA-K MPH_+C3VL5WAO<>]14X\#HPN7!9PFD[2T8!*82W[1E?G8OA)7//%MS%%@T3$8PGJI>6,A M,N8/#EC7(:P&>U53#^NUXUOL56KJAW\3V'CE%/UV4IC>%NRRT<6%_2 M:.+Z:;Y4Q=:[UA%OY?AYE6%Z]GU0E,\EVUA_GA[2S34^H M`TO_LT[T]J@N<%UNIQ.2RB+L15):9/4I$U(TR6'`@0L=D;DS`5@4VN+`HWXU M-2%0F/[:SP<)"F>^&T5Y@8E7"@&CVF6(F%2I*/C'V?1M*LSK/%RXM"Z);N[P M4],6&19-ZZOLNE1#R<;GM-/D.EQCANPFX;NWW/K=I^CZ^NPK63P15L-IF7)& MV<6V9U_S@ME*FP,@&\=)MBFER.FJ^#=J764R!C*!42DO$[(*RPX)F#IM5M<6 M!SCF2U(!7+_J[3\#.IO'CW/"W"5)8CJ)KH*)4KLI>]CV@6U>/T7E!B`:AVY[ MF,R)E_CD=IHYDOR3>%>>,"--Z3JKF4@+S_A_!5ZUT(W4#I#$`5U_R'*`2/.M MH7R^ZX?#.)9/?@LL5`ZX8^&EJ']:*(-JD,L6/)#MV!(P_BU9A,F(M'Z-4!B0 M/E1R:JY[8;`='52.VXU*6<_P+&$L/ZL9:6/="(/+?6O*'$R"IDDEJI"^2FY. M?49;#&*IS7B;V^5[3&Z[CC).N=_`=[%NGA2^'\:CV`YPU>:U;@H(ZF<3TF<8K\\VI_=BVMR@[BPS,='1[69[<2;69 MU6?&76?_VFTW&T@:L-9J)I]7J\U!4K>73P\C'=D>44"G[FL3!^=TW;)[\?X# M*I'8?DAKRAV\2G:G$9^>+I<>/B>Q2_WH1M`@G*_KE78E^W)]*6+GAVPX9SV> MS5O)6)[XH'TX^ZQ./#I[VO;-&8*S9[H'B$-#&,A%!7/XK.\V1&SJ*<'A^%F: MF\Y;JJ$Y,E14*ZX0`$.A]?*Y'ZE M\5S:WX1];$Z7C^%%P"\K6F]8XX%P(*A.&%8K_TW=Q(]K M+JIBIHWBD[]3@'KC@*EIH56*`D)(ZD>!_=4-$I>M'E_XY_@_P\=YF$1NX#W0 MUYB00*G,@'UMIV0U66]%;6;$FIY.QXUS$"DEVP-4[FT[J6KG$-6SIR>0SOQ0 MI`94:B_1L*:=[2R8;1G?2')?TN%=6A!M+F4 M?R'AC$]V3BB"P[A,'O&JE)1,"S91(;,RM/3Z2M%%V3(-*VV,DC-!/6C MK+X]*#73YJ^MYY#6+H^B.BJ3A4/W2'BC:S+MAR;'-:9TC< M:H2#VY454L?HCNR!W7#ZJ_M*%\E"Q^M2,^O:I&:!E%A=2Q@./?+(/W`[/1&/ MRC,IFYI'V_KF.%8\[-&VGH*"4=)FG93-M$1XWTT8N)M?BG<5G8P8#X0#0>5J M+-=1,26QGU//61C$C#XEDE$S1N3GU99;50_[B>;;+<$M>ZZ>)7WY_]")*,(" MPZ&IL?V,T;M#H&9$7T\7?$J)+[(H@P6AJ;W]C-"=B(&:'5V>`"(R>3L+G]]Y MA(KMYI/X@X#H4V&7X3_]=DUFKI^Z7C3L]+Q5I1&.W4&]O]?-NV#0VAN'-5Y5 MO`DJ=ZDZME48NP_OI[^X@??U_"QD2Z72J#:S5^:CPIFJ$FBBJB<5G'Y.ET>V MTLJ>N@6S$&F26%%;]Y&PQ3EYBMS!)ZF2DDI3VP$/!A+2 M0&9/&C^K.RFRAH83*I[7A*NMF$6#\E=UL!T(H>>RC@),*WY;+*^"F'!VQO=\ MPI).[XXP4;G)G2E$P60,VT[?+?45A#$8`>7W.UG)E]]%SOCE<"4N>E+OWDX? MYZ04TP-%V'!0V^ZP+2%OQ3J,:Z"X=J^""2-N1,Y)^N\V0ET=P[8W;0="W<28 M'G?$"=]]-<3US6Y685N-K/L\P[/R5VG# MP?2:NFKB&86OHG2[C"AG89;1)LW4J:B+VFHPZW[1QJGU6_`*!]AG[I+&KB_O M,1X5"8&$BZ/(5NZ=)O%-&/^=Q'>)VLW MN+[A_4V,U6XH*&(6;1WMB<,DAC(KV544)7Q#2)@H_BKKN6;YZS9U.Y3^O.`A MH+!:-*Z8$X4*3G>=:DYF%.2SEE-6H-?8P[H;!APL#=4]:ZR'*Q-FA%6%=[KWI&6M"$#SU!L5&O64;.*)N%>"67R3?7_@<-B!B-``7& MHD7"F"9,:BS/AOP89N7!\N,NB;ZP,%)L1OJ>UEV;P&H-RH6>9"JU1F95$N1J MR25;)TN@GM;=FV`R9,"%OG#(OR-"8YLXOMT&_&IKF;=UE.'00(4CQ4TB7"YR M#9KN_#E>O'*ZVMH:8=E.>6#0F-%.*0FFQZ]T2^N#3+1+D=E/OV[_OU M%.+@_@/Q??$Z''A?7?8[$4;>S/U#]3;1W`>*"H*+O9;R`D*8.HJ,1)WN%L/*ZLP]T%M`IG;A!G)6K%$\0H4\GE`#+KORA4BLK M'5S472D,[VS&=_(/("O%4N4`H&JRH@^&=#F#+)JB!V*LA+(_-(9>">4[2M]B MN9K)F+YE7YS^2@-0^I;M9K:#K`#96^KHPG'"/7.CN?"6?^:G])HP M1%V_P<0CPAB``ZP[%BX)BU>B^F5\$GABWDM!Y+>(3!/_FDX5B($ZVY8E^-T$ MS@H*.3*")Q M)-9BBH'OAR]N,%'@W/F'!A,XV1.+>[+[I'6FS1R?-'V&$7P)(KQ?I[.HE;]9 M0OH.)>X0SPOPUYW-J M.`O(3`S7PVO.KR'[G4\Z<\QO$J]2(_P!BW6SQB0\YX3Q`ZW8"M/-+8]B$3:G M3=8-Y?N-P1#XXQ[-:<)GW993SA4WS(C]Q[(16X[AY(,@,U37!&4!3-7J7AC, MI(,T5D/`&,W5R$RGB,W58VE73";ML;3K6-K5GFUV+.WZO91VM5S!>BSM.I9V MW>?KQ5C:M:O2KKT])@R[M"N&NJ/X"B./94?W8A8=JXZ.54=-R2JH^EZJCE\LACU=$#J#K:WSOG6'04K6JI>JU;+F`\>JWOB].] M%AWMKY+ZD&N.(LAP9=V990/+N8#& M\@8J;7`1Q70A;-YKK_@\;\J:[BU/\Y\TGN9' MSN;/<4)N5DLW)XT_6\'#$Q)YW9VH^]G?=ZTP6GR,Q^ M>*GP;I>WBWW.`,-[Q+`\Y?<.D?I-8_2ZMV3Z1>QU/WHQ=.G%8#L/S>C%L%\O MAM2__";A)RUY3'.?HDH-^;+7O;*+;:,FS(\!0G9/%T$[?B/]90;"XC?2P.[\ MQ:!8D>F.A9Q+02P^WD[UB`T]JH($=?9@`]4 M5PA2QX1"7]MBMCNB%48,#LB8^#Z9Q(GKYV\3K3"M&V88=O^V[+&@6F]$M='% MDL3\IA@^\[]M?`\P'F48SP`MF6,'J@>9K#5EX8YX-0R%_U6@/6W6D.,R[P8S MRC?GU/YRED1QN""L&&?:]/39P;C#>(7HC($6`/X2AMX+]9N2"L&ZXG^*@-,R MR)-+?I;.?&AVN&.L1P!B:KDR7@NF(,SOI:&")<3+2LZTT;65$R]&WT^^,M715EN^%M1Y*-%5!IP8?F2/TK1+XK2UC^_+M[5U-U$5,1M;W,_R MT5.O7/'+IB6&^]JZ*LB&&OUU3=FIR_URS:L+"2E?9U[2Z!GH*7-*`15R;B/4.QSS2U MM^V#8H"+AA*4Z-R[+U_YKLFHZT=\Z[N=WG/VLN=:PV^9/D5?VZXE.Z"FY0@R M!)6!BMNM;#N1[(!*??S<@$WNE_25>%D$2>"5W^1!94`^'I=/<'+0/.Q*1%MM MQLU_Q54:)&.`OFYUJ9W5W-,FP=]9KRY"O/N2RGH,*@FF!Q+#79S9[32O!G@V M=]E,M:EINMD^'8(P`I&.Z2JKUH%'#\EBX;+5[31MUZ@EZY7CAQ;*D=][TV^* M2V[:7JU%1]UI%G3>E%Y%E]Q)TV\(&A1&.Q(E6BQ%N%'\_,\^J=D!&DE3+,K. MOC`,U=PQ0VUZ%?6L"I3W&74OV[:"W?1`7U><;HQKX#@4G+$F:FB:YXU)*PM[ M4DRN^96M$]WZ.ZN^)P9'SD$Z MU$)!&9UJD3ERCDZU>+`8G6I'IUJ+")_-*9E>O)))(K;XV^F43@C3U2E0=K)M M1=O1%1="(J:[X9B_K^D%)&,E&81DC_Z6K3),O$?/+B,N]V*1?<%]XPYL3=$49#3V/9[.5CMC=# M>#;W_EB-9"W%X>1W.4OBG2>,!K-TJM(379+V5*9>=?]K,9CM-R7X6FC/*AQ8 MW[%P0H@777(6W(0Q4:0.V3RE-?2P_=QD4G!&2?3P8Y#.R5-\%40Q2P0_\L(@ M]YP_DDG>IF""RGT./H;MERPP].:,.;3%\-6-N:+BAQY.+A3\[3ZVW[A:@EU' M.`XE+.9Y%@9\P8@T;^F?8O%$DT]=[B31510EQ#M6@V8RCNTSN!&0Y@SJJU9? MFG.(ST(D4^%;_B7A.PAA7\,@GC=!PPG2=$G,$*DZ0D.DL84[HQJGOA3U@'(N-0#A_783![ M)&RAEKSM5@-(3%<[;TRB!;O,M;K`V4P95SOO7F3%7EZX[7R5PDLYW7@+F?`* M:0@@S94Q&Y\J">2R$9UL2!F.D0VZ54IL.V,!N!N&.(YLCE'.+E=9/RRW&Z@Z M693UB\72#U>$9%M)@=?:O130U7*,>#(+T+Y M2`(&0-W%MDG:D/L0^G$HK=MX3ACDZ-&LOPR&L&U>-E=EQOS!`2MDQI"-"3Z( M;6-RJUW*E$>'X5%?O'3!O.A_+%\MY!#K"P(NQWEQAS=)9M;4'H-C]B"=Y-4` MC*[QR'P&1]=X/%B,KO&C:_RP\TWW=@7[?O)-GS&2)KC@"D.M\*HM<4@*2-=5 M)X_#(_V<3-W$CR]IX`83ZOIK8B(Q4UV@"*PW#IB:%EK%:P-"4C\*[*]ND+AL M]?C"/\?_&3[.PR1R`^^!\LL/"93*#-C7MF(S66]%;6;$FIX,?8US$,G@VP-4 M[FW;;M0Y1/7LZ0ND)""/<\K,!0C0T;;+4VMHP$SI"94'LHSE=RJSN*13+33@ MWK:]G=KB8\@>'">W,3*QR\C$CV-DXAB9V'MD8F\O$H<6F9A+^1<2SOADYW2B ML\3E\INB!#IFFUE4%J)J@?9?7M0:F9-G]M MW8]9MSJ*VJA,%0[52C:S+JP&]GFM,[$M=4(![*W*1Y%<23A7"YNIWR^XY(W1UO*K!!$38< MU+;;;DO(6[$.XQHHKEU^L67$C<@Y2?_=1JBK8]A^ONE`J)L8@P=09=!VNC)W MB6=?CV#[H:>[2/824VP&@#;<8',W/3'/IJ.0:%C3SK9I#1;GWD@@#KF2.8?2 M5`>5E$/%XLHJ^QITA,%DB#!E2E^Y(:3T9O[-WP+.G+N$3>9<-Y_,&"$-Y7ED M<@5(3]N/IL`\$7`F##^^_<'U2935L%<6$*@TM/W""I>M>A+[B@%;WU%NI^++ M2M[*H"E%!]MV#YC`Z$G&L?-DR0RCQU"J5$9$I=@HEK\U+WQUK^'D>H!0OP>9 M2#EWJ@VLZ8L*HRI:H$F MHG#Q/7=AJ`L8)3@"'LHS4WG2=S0'!DJJA57SCI83U`_6NCA M\5>YU:L/+Y56MM]?E6MD*XJKGCX<^FC,+H(IBF',+H(WNT@W")^&HGC6])PR M(E)P1&=SE[*%VQSHFG74];/MW-!-^4T8=W!HSC$@8Z^<'@,R]A&000-00,9V M,]NZ!Q"044<7#C72:PQ,;\Y3@XZ!X6?V11C(=\VTUM))$L]#1O^Y>6:M23.E MZC28H`H`Z>@PTH0H55L.)MZABQ(6*+MSV2U+0W8DD7>$R:4'0K2Y\V!" M'@Q8@4/TB@X?J9%#N,D\+&D03J>%EQB5M1(Z@NU7)S.?;`.F(('2%9; M1&S$_#\*U06O`AB<1J/8MLL9N0*;,F?XFKE`]1VC$X`Z;NYA^^#?!NI:H@\` MUOJ8D>R0MTLD3=T0MJ\?NX;2-+-E^"NAXV>0=!A/4H2$9QUY1M M$D>Q&WA\51J`L]4+?T@(B(QN8`+$&Q2^>N8N:>SZ#:^-NDX#B/2`D-'(>+M^ MZ[=+J9-A#NM_K'58=[(QD#FJ;R9Z.Q5/QX0?,,4\LSQY9V$41U)`GMQ(I,U+ MHW0`]5MV'!>#1\P@'>&[`71TG$?V!H;8MQN-2#.;T\=UT6Y'0ZVURV8!J;WZ^B5VLVN`G$DX?NP^&@AI;7P^KX,$Z9-^VT^C.WG MF?KU4SRHM64-NJM-=K1,#_GWG,WLF?"YL\M$E&$5]S*7$PFZ[T"'LHUNFTN0 M&9MPH"PG>RJ.,<6#3B%NXW2U:9*==$Y>A$-/>A3_(GP@HZL@-<%\86&D.C_T M\;'!/`SVR.J!K*5(0^'%*[_:THBLB?R5B!SBQ#MY)HS?=_._E^;>'999Q_,8 MS*NE'8"P6B*.'I+%PF6KVVGV0\&8O#B7!_CYX M?X"K+/'!-$Z?.J(Z"JQI5OZ/1$;@W`9$+E5 M^!$_<7U14..#9IUBF."PK'T8./;]KO.M+J=D1@/!H5/7%V9X159_7+,U,6+CTIU>J_EP):SYE>PGLS9&PDO&OF]V5%2':;L89C_&W-*"1`[[B2+T,V)53X^8NXCHO7)65IELQ\ MG0@"?'KA9M@<8#F/5V3PP_09_C45B/.V:^DX.31>!-_PC4X$]/85L=#6! MX22YV2\DW\G17Q?@LGT@M11^9#*)P:3SL0#-0/;X[SLJSGX:(^M1<0/-2=;[ M6=W.46+':0T@B10.1@U*1Q_(^=?@SF:SHOK^F=+35D>9?,AM3YGUK[W%.JN>`O.O*]Q;UB]JU;88'"&&Y;*B8.;HAH+2&6)T M0['%^=$-9?AN*-UP75<@,VO7KD*F)4>5^CGC/^J/@<6#"[K0!Q8?E%UE#$H^ ME(5K%)0\Y#6,)_K5=HSG&-#<9T#S*"-C,#0Z?SA4;#LHD1D#J?%[[.TCD'K( M:W@,PAZ#L#L(PNY"!+"]46T_)`!"N#\=F[Q,E?ZNHR#N\35J?(T:7Z/&UZCQ M-6I\C1I?H\;7J-X=S_+:0GQG2Z2/ZFT\)^QQ[@;94?(F#)Y)Q,^2O04&F4_! M]FKIW_.L+2S?2?A%:[9M.__;6,SE&0S+;K]'4`Y=L?Y-BJ_-I5B>P;",XGL$ MY="78N:!;W&/SP>#Z_L/["W7>6- M`=JY=M@UA!X$4M>SP!]`;X4MW1RC]ZY0"]'2J+0I>%X#"&Q'PJGA*M+Q4-WQ MA=)F%#UV%O9T^VSV9\K^1OQ#N'#Q7_X'4$L#!!0````(`*\]<$J7Y.Z6+,[^-1FYUC/F@C!Z MOE??K^U9F-K,(71POO>Y4[GH-&YN]JQ__?27/UOP[^ROE8K5(MAU3JTFLRLW MM,]^M.[0")]:UYABCCS&?[1^0:XO6UB+N)A;#38:N]C#T!&,=&H=[7]`5J52 M@.POF#J,?WZ\B<@./6]\6JV^O+SL4_:,7AA_$OLV*T:NPWQNXXA6Y^ZW1^MO M!TWKH%8_KITT^F'X<>3]OO;1NO3UX^WH]JG6CL8\DS80SQ" M%EB?BO.]F$9?#O<9'U0/@+OJK[?MCH+;"P!/)RZA3WG@]9.3DZKJU:`9R$F/ MNYKT855V]Y#`$67H)09X0H6'J)V`=[P((0Y\7`TZ$Z`D%_1]`$HTJ(-3<`+; M^P/V7(4.@*\?56KURF%=@_NB,D!H'*'TD>@ITF&'1#G.H'#F8I&+HWIRD"BC MU!_E:\?Q>-6;CG$5@"H`A3FQ([S%2$D$X$$VYW.G>G*XDU,H0A!36`0&4^%Q M,A8VXV.8F*.JGERPN+AXA*G78GS4Q'WDNV##/WSDDC[!SI[E(3[`GG1[,48V M+DI63R)$*8.Y!BM,V"+;QF,"DPD:_G0FO>Y4:KD+LECR`ZPK"P:14%68DK[D M^X(Z5]0CWE3.3SY20^U9Q#G?,T+(P8$5-;R#^X02Q6,M^`?+@*71XQ\1=:R` MEA4C=E9-DXD1]P5V[NE/ZO.88P%D%%(;&D+$$&0.DHU7PYFQDHL2-FBU M?YLA+I$KEX'.$&,O4'RBQ:SH`]"N7(MQJ.D&HPZFP*C\))A+'.ASK)"BI4CN MU*V5^X`XR#?$'@&NL[I/=IL-<;B"(:QWB1'^N=V&B;0G[OOW8QEWP;`BL,J< M/K-)CHJ99$;;8GUK1MUZ]YDBWR$`L[-,I/T&$L.6RUYR##/K,MOE>!6[2.*6 MHKZSB[;+'<3@'-_W+WU!*!:A23*M9FN\E\]G",==)@`-O@3X4N>P,%F:RG9K MNN./1HA/[_L=,J`0V-D(PB+;9C[$,G3P`#YK$ZRG1#%8LU5^2%LEI"K-$J-K MS0A;FO)V6^I""'AP0T(\5*F8-$BRR:SW#VF]*V1+8V^W;F_H,\C$^#30Z^RK M6:XT(_80I!FJQQD%OJ0IA425?,C)&O%Z&ZWC>Z8A[7: MPW`SWF+6^6$FU)2X6N';K=B.Q^RG(7,=S$43QK6)IS.L;(=9S4>9V#%&XA]6 M2&2[U=U@HQ'Q5'8)2:>,GS&=A?!S>\V*/TXK/D;'^CL:C7^T$N2VVP3**^_' MB2I/K,6LZDS6JG"M$'FGV*25"+%P:L=_K3EM?-$@6!KHP]1$ZE(.PPFR.3VR;K!=:[@,J6*SQ*^./* M3C<:%7V0R64C])V."U03XHHO!&FV1B:G75Q9V)FI<)*;6)**PYM-MG+"NS-< M)ER-&RBGW6R(3!:<"%UWVL[&L!EUISK,^LY/AZ-X=J?PW+W$)O80<<6=U))' MGG'^WF(&RFR*3(*C3.P="W:\H6'V63%FS3C3H;WF3860\=`Q9,\" MT(A!2W(8G/V>K04[CXO[`6?R-#%ZQ,)WY#&Y3P$TLR\LJF94P`.8 MI<[M6N$HXL3,=L]4;PK8/1&4!_!F!]ERMYAWOB=_6A>&-ALV4PV:?SIH-Y%7*:;& MGJ-%P)/QU>O1-WM%IF95N%B;?*07K_'NEH#T\:8Y%3`3A-FHV>I7_/C3;G87 M.!(UI\)5`-!LFOSC).DC4SL3F39%#+:9!V$VRIR#*-%&RJCO,(42!./.Z^A8#9E-E3*PE3)B)5W1@;T.I-P]J3&G/WM#(9 M/-YZ`9'C,_&F!0]0'MAVY#C/K31*:_HBSQ^!]'V)R-7@TC2ADMAE#^DM1$.K$D@;F>H M9"ZM`2)LC+E,[JJ:>4W`(YY$?X@-8\EQP*NJZQ#91;UE1084[+ZBK&U)?ZU" M@O1397Z0>6POC\1SHS399B8J6$Y)C3> M"DP8+XZ:PT4NCOQ0F2$7'=]X"Y5I_%S$*G8]H5LJ,U*K<).]06IU=A2M%?@I M<'E6$4^)8]X%B-)53J2KU-]_(S.K,;*(B_#JK2`6NOOM\?L,T0U:(8(1:*Y?@\O-\K)9>#>Z\LE@VL7CUCZLN#G#-9DLVK"_`= M#*-819R")XD;ZF&(GKPNFLB2/@1LTACRK`YU+D8P,\C7D,^4J,OC;ZQ.PKC_ M1@@?.UVF#XG<]^5;CXRJY"":@<5@EY`U+I08(E#F&D1ZP-R6$?$`..LHHB&G MDJO/U,'\8L"Q0M*2+8=2?.$)Y(,54';+$=8@'GB63[UPOT'QI@V1$:L8Z,;Z M9G1PY4HEW0^<.;X="3>W=^7GPNNNGQ&_\M99(*M>ZTR)DNC:4#D6O'B$)]ZE M&ULTBH,OO6X$UX^>>IK&&H1;>-!#O68@N>[%A5P>;2.$C?:\U9IW">N"(ST0 M8A,U=+`27OC>D''R%3MJ!4F4I1[`X\3E]&H"JQL)C[RJHF#&#;[36)N@UFLF MPU0&4Y%3=5Q^FM&&&603A$BH?E9+S-IU,=PFB!/<`>XFWIC(MTP!P$T0J(E[ MW@VL_SRXW-=Q5.T$N3HF?82L0MV]Z,QB&RWCBKCEACU=S$?W??`PCY.>0L^$ M.V:0%<-2W;H&$8(-LP5!]B*@9:VPYN`Z>FFO4*I@`"M9#OV66NS4N]!'[_5Y MJT=L8_(<7)(4B+4TUH;&<"8Y8O<#+A8Z#OPF9?6PZT)2[R/W(:A1%Q0[%^\- M:N".416&>1!0L6IOP=&8"18#MA627,PWV#FDBG+`U?>&R$N3K* M+`&'9"P*3HY"A-Z@CJX90#.4#:U0K]`"GFN6I?H M"PJ>0GF+@G>9A]S$)9V+)<_!V531KQ$,W&:P(HE[&I,E2OSF]V_JCDSV#>+X MZRQ:L(50&UO_C24,P9[#A9`\RTR"SL\"E\;:7/GE*&[PT$RD3UJBZ)*SV?M% MD196P]U87;0(A7$('<"Z\\#Q&!'GA@I@1AWDT*5F(\S&RB;=5`ZD]YZTB6*K M4(Z%E\;:6/D?V12YWC1;J,KK6+[XMM[=-[UPR)_?B_;94HVKEIH`>RT;3?.3 MVK>5N(:!E?Q!&=^5Q=@6Q@*\X196\F&D_`5`&RK;+:)^'^:FSS$7L6=TP^<\ M]C1;#+:I`1>XUXBI:'&^=`M@-E4T64"7>QTRW5'7+,0KZ^F.38T>$V<>D(L? ML3K!A^.\!6&>]"4B!.-3^49FG@QSX,K=UX@S&'O)(G7X;2%4 MN4+D[^E>R#V`@0*]G,Y`'M!4[3N](.[DO-'R!9/!$-*3BV?,0=[$?N\5A#;R M%RSUWI6X]X:8=X>(AB\CW3'ZC`5@W_FC'N;1+N7F\K>BX12[95INH:C72G$W M]$')8M+:-UMIO;RLNK)]-Y.(1=ZJ)5JO]M<^[,8K>F5_@P2TCXD,VD2YCE^< MD=*-$;Q9=PM_@*C?NZ'V+4ZLX0:`54]D.&R$R#JV]F/OWN^L.Z0^0*>=?*\7HOYW,,X)=`*>*7+&OA-E*DG!9K763K7G2$9 MCQ!M$@21OPQ=_PNY>\J[C""E2]`D'/AA7"2YSC:7SJE\DY(X6/U4NF8OR;01 MHG3^8T7>+KO$0;:3%,`,4KH$39\.@8GX"2Z%GW*=15"ER]'NAB%1DO%L<^F< MMICMBQ:2CJSW^9(\FP!*Y_YG1'W$I]T7:)W&GD`=,LD^M(H";ZY4LORRA%P9 M\-(E^TAE"-J%$!6-,:#;XA+Q'G*8R$1[Q4!+ERB8&7<^K$02MXUZHMUNI*:0 M&:9T&3KYJU6VN71.LTY1P&\VRE]^]BGN#@DOL%P5@2Q=G@X>>XJ9#*LMTL\* M51R\=,D^=Y*LQ[Z7SEO#9?`H'LC=QE1\E]-1/K=YYR[2<:D)I'0)_@T.>MML M,)Z*1'/:2^>U36QY"FV.HN?VEL[W;/]VOH_,!2B=^\`3,H_^;'/IG#8AH!\% M*>P5]5091_T4@)IZ0).CV2NVQ6!1^$G+M/(+X+`$T,%:SDV)X0,B3M.7!(-2 M=%JT!3!EBV!^:S8M3%'HC;-4\HZSE%1S.C=.B,3O=[S.K[^D5?-=ARQ1X6?5 MX*H9^/@_4$L!`AX#%`````@`KSUP1_T/Q727(M,C`Q-3`Y,S`N>&UL550%``/ISTE6=7@+``$$)0X```0Y M`0``4$L!`AX#%`````@`KSUP1^?/>PDM$0``/]H``!4`&````````0```*2! MYY@``'-N>7(M,C`Q-3`Y,S!?8V%L+GAM;%54!0`#Z<])5G5X"P`!!"4.```$ M.0$``%!+`0(>`Q0````(`*\]<$=^VU?>5"$``$=0`@`5`!@```````$```"D M@6.J``!S;GER+3(P,34P.3,P7V1E9BYX;6Q55`4``^G/259U>`L``00E#@`` M!#D!``!02P$"'@,4````"`"O/7!'0,T")2Q+``#_0@0`%0`8```````!```` MI($&S```&UL550%``/ISTE6=7@+``$$)0X` M``0Y`0``4$L!`AX#%`````@`KSUP1^YU%G]F,@``AWP#`!4`&````````0`` M`*2!@17(M,C`Q-3`Y,S!?<')E+GAM;%54!0`#Z<])5G5X"P`!!"4. M```$.0$``%!+`0(>`Q0````(`*\]<$ XML 22 R8.htm IDEA: XBRL DOCUMENT v3.3.0.814

Asset Purchase
9 Months Ended

Sep. 30, 2015

Business Combinations [Abstract]

Asset Purchase

Note 3 – Asset Purchases

Asset Purchase Agreement with Factor Nutrition Labs, LLC:

On January 22, 2015 (the “Closing Date”), the Company entered into an Asset Purchase Agreement (the “Purchase Agreement”) with Factor Nutrition Labs, LLC, a Delaware limited liability company (the “Seller”), Vita Partners, LLC, RPR Partners, LLC, and Thor Associates, Inc. (each a “Principal Owner”). Pursuant to the Purchase Agreement, the Company purchased all of the assets of the Seller’s line of business and products called FOCUS Factor (the product plus the business related to the product is collectively referred to as the “Focus Factor Business”) and assumed the accounts payable and contractual obligations of the Focus Factor Business for an aggregate purchase price of $6.0 million, with $4.5 million paid on the Closing Date, and $750,000 to be paid on or before January 20, 2016 and an additional $750,000 to be paid on or before January 20, 2017.

The Company has accounted for this transaction under the acquisition method of accounting. Under the acquisition method of accounting, the total acquisition consideration price is allocated to the assets acquired and liabilities assumed based on their preliminary estimated fair values. The Company expects the purchase price allocations for the acquisition of Focus Factor Business to be completed by December 31, 2015. The preliminary allocation of the purchase price to the assets acquired and liabilities assumed based on the estimated fair values is as follows:

Assets

Accounts Receivable $ 2,926,369

Inventory 67,113

Intellectual Property 1,000,000

Non-compete provision 50,000

Non-solicitation provision 50,000

Intangible assets-Customer relationships 1,941,030

Goodwill 1,798,047

Liabilities

Accounts Payable (891,113 )

Accrued Expenses (941,446 )

$ 6,000,000

The Customer relationships, the non-compete and the non-solicitation provisions will be amortized over their estimated useful lives of 5 years.

Pro forma Results of Operations. The historical operating results of the Focus Factor Business prior to its acquisition date have not been included in the Company’s historical consolidated operating results. Pro forma results of operations data (unaudited) for the years ended December 31, 2014 and 2013, as if the acquisition had occurred on January 1, 2013, are as follows:

December 31,

2014 2013

Revenue $ 12,695,295 $ 10,629,171

Net income (loss) (183,471 ) 932,209

Pro forma revenue amount above does not include adjustment/reductions relating to certain discounts, coupons and placement fees and is presented gross.

The amounts of revenue and earnings of the FOCUS Factor Business since the acquisition date included in the unaudited condensed consolidated statement of operations for the nine months ended September 30, 2015 are approximately $7,015,763 and $(3,067,567), respectively.

Asset Purchase Agreement with Knight Therapeutics Inc.:

On June 26, 2015 (the “Closing Date”), Neuragen Corp., a Delaware corporation (“Neuragen”) and our wholly owned subsidiary, entered into an Asset Purchase Agreement (the “Purchase Agreement”) with Knight Therapeutics Inc., a Canadian corporation (“Knight”). Pursuant to the Purchase Agreement, Neuragen purchased the U.S. rights related to an innovative OTC product that helps relieve pain caused by diabetic nerve damage (the “Purchased Assets”) for an aggregate purchase price of $1.2 million, with (i) $250,000 paid on the Closing Date, (ii) $250,000 to be paid on or before June 30, 2016, (iii) $700,000 to be paid in quarterly installments (beginning with the quarter ending September 30, 2015) equal to the greater of $12,500 or 5% of U.S. net sales, and (iv) 2% of U.S. net sales of Neuragen for 60 months thereafter. The payment of such amounts is secured by a security interest in certain assets, undertakings and property (“Collateral”) pursuant to the Security Agreement, which will be released upon receipt of total payments of $1.2 million (collectively, “Total Consideration”).

The Company has accounted for this transaction under the acquisition method of accounting. Under the acquisition method of accounting, the total acquisition consideration price is allocated to the assets acquired and liabilities assumed based on their preliminary estimated fair values. The Company expects the purchase price allocations for the acquisition of the Purchased Assets to be completed by December 31, 2015. The preliminary allocation of the purchase price to the assets acquired and liabilities assumed based on the estimated fair values is as follows:

Assets

Accounts Receivable $ 58,054

Inventory 204,925

Goodwill 1,137,336

Liabilities

Accounts Payable (51,795 )

Accrued Expenses (148,520 )

$ 1,200,000

X

- Definition
The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1497-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1490-128463

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1486-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1500-128463

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1524-128463

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7000-128479

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4922-128472

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4934-128472

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4926-128472

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1383-128463

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6996-128479

+ Details

Name: us-gaap_BusinessCombinationDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_BusinessCombinationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 23 R32.htm IDEA: XBRL DOCUMENT v3.3.0.814

Fixed Assets and Intangible Assets - Summary of Fixed and Intangible Assets (Details) - USD ($)

Sep. 30, 2015

Dec. 31, 2014

Assets

Property and equipment $ 4,044

Less accumulated depreciation (430)

Fixed assets, net 3,614

FOCUSfactor intellectual property 1,000,000

Intangible assets subject to amortization 2,041,030

Less accumulated amortization (281,829)

Intangible assets, net $ 2,759,201

X

- Definition
Intellectual property.
+ References
No definition available.
+ Details

Name: SNYR_IntellectualProperty

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.14)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_PropertyPlantAndEquipmentGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 7

+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 24 R40.htm IDEA: XBRL DOCUMENT v3.3.0.814

Stock Warrants - Summary of Warrants Outstanding by Price Range (Details) - Warrant [Member]
9 Months Ended

Sep. 30, 2015

$ / shares

shares

Warrants Outstanding, exercise prices $ 0.34

Warrants Outstanding, Number Outstanding | shares 3,584,759

Warrants Outstanding, Remaining Average Contractual Life 9 years 3 months 26 days

Warrants Outstanding, Weighted Average Exercise Price $ 0.34

Warrants Exercisable, Number Exercisable | shares 3,584,759

Warrants Exercisable, Weighted Average Exercise Price $ 0.34

X

- Definition
The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (g)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(iii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_PlanNameAxis=us-gaap_WarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 25 R2.htm IDEA: XBRL DOCUMENT v3.3.0.814

Condensed Consolidated Balance Sheet - USD ($)

Sep. 30, 2015

Dec. 31, 2014

Current Assets:

Cash $ 824,948 $ 338

Accounts Receivable 1,327,154 2,898

Receivable from related party 175,422 16,077

Prepaid expenses 122,576 10,000

Inventory 499,448 26,064

Total Current Assets 2,949,548 $ 55,376

Fixed assets, net 3,614

Investment in Hand MD Corp. 1,500,000

Goodwill 2,935,383

Intangible assets, net 2,759,201

Debt issuance cost, net 198,429

Total Assets 10,346,175 $ 55,376

Current Liabilities:

Accounts payable and accrued liabilities $ 1,653,296 74,642

Notes payable, related party $ 100,000

Current portion of long-term debt $ 750,000

Current portion of long-term debt, related party 300,000 $ 6,400

Total Current Liabilities 2,703,296 $ 181,042

Long-term Liabilities:

Note payable 750,000

Note payable, net of debt discount, related party 5,047,178

Total Long-term Liabilities 5,797,178

Total Liabilities $ 8,500,474 $ 181,042

Commitments and contingencies

Stockholders' Equity (Deficit):

Common stock, $0.00001 par value; 300,000,000 shares and 75,000,000 authorized, respectively; 69,238,044 and 62,100,000 shares issued and outstanding, respectively $ 692 $ 621

Common stock to be issued 68,000 40,000

Additional paid in capital 5,882,448 867,004

Accumulated deficit (4,105,439) (1,033,291)

Total stockholders' equity (deficit) 1,845,701 (125,666)

Total Liabilities and Stockholders' Equity (Deficit) $ 10,346,175 $ 55,376

X

- Definition
Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3-4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Subparagraph a(1)

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 4

-Article 5

+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.30(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 12

-Article 7

+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.9)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.(a),19)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.17)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CommitmentsAndContingencies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of subscription receivable from investors who have been allocated common stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3(a)(2))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Subparagraph 2

-Article 4

+ Details

Name: us-gaap_DueFromRelatedPartiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying amount as of the balance sheet date of obligations due all related parties.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.15(3),(4))

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.17)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

+ Details

Name: us-gaap_DueToRelatedPartiesCurrentAndNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph ((a)(1),(b))

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_IntangibleAssetsNetExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51655945&loc=d3e3927-108312

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Total investments in (A) an entity in which the entity has significant influence, but does not have control, (B) subsidiaries that are not required to be consolidated and are accounted for using the equity and or cost method, and (C) an entity in which the reporting entity shares control of the entity with another party or group. Includes long-term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.12)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19-26)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.32)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 25

-Article 7

+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.21)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of obligation due after one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22-26)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22, 23, 24, 25, 26, 27

-Article 5

+ Details

Name: us-gaap_LiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesNoncurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of long-term debt, after unamortized discount or premium, scheduled to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LongTermDebtCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LongTermNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 13, 16

-Article 9

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

+ Details

Name: us-gaap_NotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a)(5))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_NotesPayableRelatedPartiesClassifiedCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6787-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 340

-SubTopic 10

-Section 05

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=51662447&loc=d3e5879-108316

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Assets

-URI http://asc.fasb.org/extlink&oid=6509628

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (g)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_PrepaidExpenseCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 7

+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_UnamortizedDebtIssuanceExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 26 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814

Nature of the Business
9 Months Ended

Sep. 30, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Nature of the Business

Note 1 – Nature of the Business

Synergy CHC Corp. (“Synergy”, “we”, “us”, “our” or the “Company”) (formerly Synergy Strips Corp.) was incorporated on December 29, 2010 in Nevada under the name “Oro Capital Corporation.” On April 21, 2014, the Company changed its fiscal year end from July 31 to December 31. On April 28, 2014, the Company changed its name to “Synergy Strips Corp.”. On August 5, 2015, the Company changed its name to “Synergy CHC Corp.”

The Company is a consumer health care company that is in the process of building a portfolio of best-in-class consumer product brands. Synergy’s strategy is to grow its portfolio both organically and by further acquisition.

Synergy is the sole owner of a subsidiary, Neuragen Corp., and the results have been consolidated in these statements.

Loan and Warrants

On January 22, 2015, the Company entered into a Loan and Security Agreement (“Loan Agreement”) with Knight Therapeutics (Barbados) Inc. (“Knight”), pursuant to which Knight agreed to loan the Company $6.0 million (the “Loan”), and which amount was borrowed at closing (the “Financing”) for the purpose of acquiring the Focus Factor Business (defined below). At closing, the Company paid Knight an origination fee of $120,000 and a work fee of $60,000 and also paid $40,000 of Knight’s expenses associated with the Loan. The Loan bears interest at a rate of 15% per year; provided, however, that upon the occurrence of an equity or convertible equity offering by the Company of at least $1.0 million, the interest rate will drop to 13% per year. Interest accrues quarterly and is payable in arrears on March 31, June 30, September 30 and December 31 in each year, beginning on March 31, 2015.

All outstanding principal and accrued and unpaid interest is due on the earliest to occur of either January 20, 2017 (the “Maturity Date”), or the date that Knight, in its discretion, accelerates the Company’s obligations due to an event of default. The Company may extend the Maturity Date for two successive additional 12-month periods if at March 31, 2016 and March 31, 2017, respectively, the Company’s revenues exceed $13.0 million and its EBITDA exceeds $2.0 million for the respective 12-month period then ending. Principal payments under the Loan Agreement commenced on June 30, 2015 and continue quarterly as set forth on the Repayment Schedule to the Loan Agreement.

Subject to certain restrictions, the Company may prepay the outstanding principal of the Loan (in whole but not in part) at any time if the Company pays a concurrent prepayment fee equal to the greater of (i) the total unpaid annual interest that would have been payable during the year in which the prepayment is made if the prepayment is made prior to the first anniversary of the closing, and (ii) $300,000. The Company’s obligations under the Loan Agreement are secured by a first priority security interest in all present and future assets of the Company. The Company also agreed to not pledge or otherwise encumber its intellectual property assets, subject to certain customary exceptions.

The Loan Agreement includes customary representations, warranties, and affirmative and restrictive covenants, including covenants to attain and maintain certain financial metrics, and to not merge or dispose of assets, acquire other businesses (except for businesses substantially similar or complementary to the Company’s business and the aggregate consideration to be paid does not exceed $100,000) or make capital expenditures in excess of $100,000 over the Company’s annual business plan in any year. The Loan Agreement also includes customary events of default, including payment defaults, breaches of covenants, change of control and material adverse effect default. Upon the occurrence of an event of default and during the continuation thereof, the principal amount of the Loan will bear a default interest rate of an additional 5%.

In connection with the Loan Agreement, the Company issued to Knight a warrant that entitled Knight to purchase 4,595,187 shares of common stock of the Company (“Common Stock”) on or prior to close of business on January 30, 2015 (the “ST Warrant”). The aggregate exercise price of the Common Stock under the ST Warrant is $1.00. Knight exercised the ST Warrant on January 22, 2015. Also in connection with the Loan Agreement, the Company issued to Knight a warrant to purchase 3,584,759 shares of Common Stock on or prior to the close of business of January 22, 2025 (the “LT Warrant”). The exercise price per share of the Common Stock under the LT Warrant is $0.34. The LT Warrant provides for cashless exercise. The LT Warrant also provides that in the event the closing price of the Common Stock remains above $1.00 for six consecutive months, Knight will forfeit the difference between the number of shares acquired under the LT Warrant prior to 90 days after such six-month period, and 25% of the shares purchasable under the LT Warrant.

Asset Purchase Agreement with Factor Nutrition Labs, LLC

On January 22, 2015 (the “Closing Date”), the Company entered into an Asset Purchase Agreement (the “Purchase Agreement”) with Factor Nutrition Labs, LLC, a Delaware limited liability company (the “Seller”), Vita Partners, LLC, RPR Partners, LLC, and Thor Associates, Inc. (each a “Principal Owner”). Pursuant to the Purchase Agreement, the Company purchased all of the assets of the Seller’s line of business and products called FOCUS Factor (the product plus the business related to the product is collectively referred to as the “Focus Factor Business”) and assumed the accounts payable and contractual obligations of the Focus Factor Business for an aggregate purchase price of $6.0 million, with $4.5 million paid on the Closing Date, and $750,000 to be paid on or before January 20, 2016 and an additional $750,000 to be paid on or before January 20, 2017.

Distribution Agreement

On January 22, 2015, the Company and Knight entered into a Distribution, License and Supply Agreement (the “Distribution Agreement”), pursuant to which the Company granted to Knight an exclusive license to commercialize FOCUSFactor, FOCUSFactor Kids and Synergy Strip and all improvements thereto (together the “Licensed Products”) and appointed Knight as the exclusive distributor to offer to sell and sell the Licensed Products in Canada, and, at Knight’s election, one or more of Israel, Russia, and Sub-Saharan Africa. The Distribution Agreement provides that Knight may sublicense its rights or use sub-distributors under the Distribution Agreement on terms consistent with the terms of the Distribution Agreement. During the term of the Distribution Agreement, Knight agrees to obtain from the Company all its requirements for the Licensed Products and the Company agrees to supply the Licensed Products at its adjusted production cost plus a designated percentage and any applicable taxes.

In the event of a long term inability by the Company to supply Knight with the Licensed Products, Knight is entitled to require, among other remedies, the Company to grant a Knight-designated third party a non-exclusive license to use all relevant intellectual property to manufacture and supply Knight with the Licensed Products for commercialization in the Territory. The term of the Distribution Agreement runs until 15 years from the date of the first commercial sale of a Licensed Product in Canada, and the Distribution Agreement will automatically renew for successive 15-year periods unless either party provides the other with written notice of its intention not to renew (a “Non-Renewal Notice”). The Company agrees that in the event it issues a Non-Renewal Notice, the Company will pay to Knight a non-renewal fee equal to the net sales of the Licensed Products achieved by Knight in the Territory during the eight calendar quarters preceding the date of such notice, plus all applicable taxes.

Distribution Option Agreement

In connection with the Loan Agreement, the Company entered into a Product Distribution Option Agreement, dated January 22, 2015 (the “Option Agreement”), pursuant to which the Company granted Knight the exclusive right to negotiate the exclusive distribution rights of any one or more of the Company’s products, including products from the Focus Factor Business, for the territories of Canada, Russia, Sub-Saharan Africa and Israel (the “Option”), pursuant to designated parameters. The Option Agreement is effective upon the date of the Option Agreement, will run until January 31, 2045, and will automatically renew thereafter for successive five-year periods unless either party provides a notice of termination prior to the Option Agreement’s expiration. If Knight does not exercise the option then the Company is free to contract for distribution with other parties, but only on terms no less favorable than those offered by Knight pursuant to the Option Agreement.

Asset Purchase Agreement with Knight Therapeutics Inc.

On June 26, 2015 (the “Closing Date”), Neuragen Corp., a Delaware corporation (“Neuragen”) and our wholly owned subsidiary, entered into an Asset Purchase Agreement (the “Purchase Agreement”) with Knight Therapeutics Inc., a Canadian corporation (“Knight”). Pursuant to the Purchase Agreement, Neuragen purchased the U.S. rights related to an innovative OTC product that helps relieve pain caused by diabetic nerve damage (the “Purchased Assets”) for an aggregate purchase price of $1.2 million, with (i) $250,000 paid on the Closing Date, (ii) $250,000 to be paid on or before June 30, 2016, (iii) $700,000 to be paid in quarterly installments (beginning with the quarter ending September 30, 2015) equal to the greater of $12,500 or 5% of U.S. net sales, and (iv) 2% of U.S. net sales of Neuragen for 60 months thereafter. The payment of such amounts is secured by a security interest in certain assets, undertakings and property (“Collateral”) pursuant to the Security Agreement, which will be released upon receipt of total payments of $1.2 million (collectively, “Total Consideration”).

Security Agreement

On the Closing Date, Neuragen entered into a Security Agreement with Knight, pursuant to which Neuragen granted a lien and security interest to Knight in Collateral in connection with the Purchase Agreement.

The Security Agreement was made to secure the payment of all indebtedness, obligations and liabilities of Neuragen of the Purchase Agreement, including all expenses and charges, legal or otherwise, suffered or incurred by Knight in collecting or enforcing such indebtedness of the Purchase Agreement.

The Security Agreement includes customary events of default, including but not limited to: payment defaults; Neuragen becoming insolvent or entering into bankruptcy; or if any contemplated security ceases to be a valid and perfected first-priority security interest that is not remedied within fifteen business days by Neuragen. Upon the occurrence of an event of default and during the continuation thereof, the principal amount of the outstanding Total Consideration will bear a default interest rate of an additional 10% per annum.

Contribution Agreement

On August 18, 2015 (the “Closing Date”), we entered into a Contribution Agreement with Hand MD Corp., a Delaware corporation, whereby we contributed to Hand MD Corp. 2,142,857 shares of our common stock in exchange for 50% of Hand MD Corp.’s outstanding capital securities valued at $0.70 per share. Simultaneously, Hand MD, LLC, a California limited liability company, entered into a Contribution Agreement with Hand MD Corp., the principal owners of Hand MD, LLC, and us whereby Hand MD LLC contributed to Hand MD Corp. all of its right, title and interest in its intellectual property associated with skincare, nail care and nail polish products (the “Hand MD Business”) in exchange for the other 50% of Hand MD Corp.’s outstanding capital securities. In the Contribution Agreement among Hand MD Corp., Hand MD, LLC, the principal owners of Hand MD, LLC and us, Hand MD, LLC and its principal owners agreed to not compete or solicit customers or employees for five years. As part of the transaction, we also purchased from Hand MD Corp. all inventory related to the Hand MD Business for approximately $97,000.

We also entered into a license agreement with Hand MD Corp. on August 18, 2015, whereby we acquired the exclusive worldwide license to commercialize Hand MD Corp. skincare products and all improvements thereto. The license runs in perpetuity unless earlier terminated. We will pay Hand MD Corp. a royalty of 5% of the net sales price of product sold, transferred or otherwise disposed of by us, as well as 5% of any amount we receive from sublicensees, subject to a minimum royalty of $250,000 in the second year of the license and $500,000 in the third year of the license, after which the minimum royalty terminates. We are solely responsible for any regulatory and intellectual property filings, including those necessary to maintain regulatory approvals for the licensed products. Either we or Hand MD Corp. can terminate the agreement in the event of bankruptcy or insolvency of the other party, or the uncured material breach of the agreement by the other party. Upon termination we would be entitled to sell any inventory of licensed product in the normal course of business and consistent with sales of licensed product during the term of the agreement.

The Contribution Agreements and the License Agreement contain customary representations and warranties and covenants by the respective parties.

We also entered into a Consulting Agreement on August 18, 2015, with Kara Harshbarger, the co-founder of Hand MD, LLC, pursuant to which she will provide marketing and sales related services. We will pay Ms. Harshbarger $10,000 a month for one year unless the Consulting Agreement is terminated earlier by either party. If we terminate the Consulting Agreement without cause, we will be obligated to pay the remaining term of the Agreement. Ms. Harshbarger agreed not to compete with us in the United States in any marketing or sales of skincare, nail polish and nail care products during the term of the Consulting Agreement and for 12 months after its termination. Ms. Harshbarger also agreed not to solicit customers or employees for the same period.

X

- Definition
The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6003-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 2A

-URI http://asc.fasb.org/extlink&oid=51801978&loc=SL51803626-108592

+ Details

Name: us-gaap_NatureOfOperations

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 27 R35.htm IDEA: XBRL DOCUMENT v3.3.0.814

Notes Payable (Details Narrative) - USD ($)
9 Months Ended

Jun. 26, 2015

Sep. 30, 2015

Sep. 30, 2014

Dec. 31, 2014

Loan amount $ 6,000,000

Debt instrument interest rate percentage 15.00%

Convertible equity offering $ 1,000,000

Change in loan interest rate 13.00%

Debt discount aggregate value $ 3,415,514

Debt discount value 840,322

Note issued as part of asset purchase agreement 1,500,000

Notes payable 750,000

Knight Therapeutics Inc [Member]

Note issued as part of asset purchase agreement $ 950,000

Amount payable under the purchase agreement 1,200,000

Total payments of acquire assets $ 1,200,000

Percentage of issued promissory note 0.00%

Notes payable 937,500

Knight Therapeutics Inc [Member] | U.S [Member]

Percentage of sale revenue net 2.00%

June 30, 2016 [Member] | Knight Therapeutics Inc [Member]

Amount payable under the purchase agreement $ 250,000

September 30, 2015 [Member] | Knight Therapeutics Inc [Member]

Amount payable under the purchase agreement 700,000

September 30, 2015 [Member] | Knight Therapeutics Inc [Member] | U.S [Member] | Maximum [Member]

Net sales $ 12,500

Percentage of sale revenue net 5.00%

Focus Factor Business [Member]

Amount payable under the purchase agreement 4,500,000

Focus Factor Business [Member] | January 20, 2016 [Member]

Amount payable under the purchase agreement 750,000

Focus Factor Business [Member] | January 20, 2017 [Member]

Amount payable under the purchase agreement $ 750,000

X

- Definition
Amount payable under the purchase agreement.
+ References
No definition available.
+ Details

Name: SNYR_AmountPayableUnderPurchaseAgreement

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Debt discount value.
+ References
No definition available.
+ Details

Name: SNYR_DebtDiscountValue

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Percentage of issued promissory note.
+ References
No definition available.
+ Details

Name: SNYR_PercentageOfIssuedPromissoryNote

Namespace Prefix: SNYR_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Percentage of sale revenue net.
+ References
No definition available.
+ Details

Name: SNYR_PercentageOfSaleRevenueNet

Namespace Prefix: SNYR_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586

+ Details

Name: us-gaap_DebtConversionConvertedInstrumentAmount1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 20

-Section 50

-Paragraph 4

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6928298&loc=SL6031897-161870

+ Details

Name: us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Incremental percentage increase (decrease) in the stated rate on a debt instrument.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentInterestRateIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.
+ References
No definition available.
+ Details

Name: us-gaap_LongTermDebtFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 13, 16

-Article 9

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

+ Details

Name: us-gaap_NotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The cash outflow associated with the purchase of all investments (debt, security, other) during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_SalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Value of stock issued pursuant to acquisitions during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_StockIssuedDuringPeriodValueAcquisitions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_KnightTherapeuticsIncMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=SNYR_USMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreationDateAxis=SNYR_JuneThirtyTwoThousandSixteenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreationDateAxis=SNYR_SeptemberThirtyTwoThousandFifteenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TitleOfIndividualAxis=SNYR_FocusFactorBusinessMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreationDateAxis=SNYR_JanuaryTwentyTwoThousandSixteenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreationDateAxis=SNYR_JanuaryTwentyTwoThousandSeventeenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 28 R22.htm IDEA: XBRL DOCUMENT v3.3.0.814

Accounts Payable and Accrued Liabilities (Tables)
9 Months Ended

Sep. 30, 2015

Payables and Accruals [Abstract]

Schedule of Accounts Payable and Accrued Liabilities

As of September 30, 2015 and December 31, 2014, accounts payable and accrued liabilities consisted of the following:

September 30, 2015 December 31, 2014

Accrued payroll $ - $ 10,867

Accrued legal fees 56,683 47,916

Manufacturers 1,391,472 -

Promotions 15,000 -

Other 190,141 15,859

Total $ 1,653,296 $ 74,642

X

- References
No definition available.
+ Details

Name: us-gaap_PayablesAndAccrualsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 29 R36.htm IDEA: XBRL DOCUMENT v3.3.0.814

Stockholders' Deficit (Details Narrative) - USD ($)
9 Months Ended

Aug. 18, 2015

Sep. 30, 2015

Dec. 31, 2014

Common stock, shares authorized 300,000,000 75,000,000

Common stock value $ 692 $ 621

Common stock, par value $ 0.00001 $ 0.00001

Time of conversion $ 100,000

Sale of common stock, shares 400,000

Common stock purchase price per share $ 0.25

Issuance of common stock, shares for acquisition 4,595,187

Common stock, shares issued 69,238,044 62,100,000

Common stock, shares outstanding 69,238,044 62,100,000

Board of Directors [Member] | Minimum [Member]

Common stock, shares authorized 75,000,000

Board of Directors [Member] | Maximum [Member]

Common stock, shares authorized 300,000,000

ST Warrant [Member]

Common stock purchase price per share $ 1.00

Contribution Agreement [Member] | Hand Md Corp [Member]

Common stock value $ 2,142,857

Sale of common stock, shares 2,142,857

Common stock purchase price per share $ 0.70 $ 0.70

Percentage of outstanding capital 50.00%

X

- Definition
Percentage of outstanding capital.
+ References
No definition available.
+ Details

Name: SNYR_PercentageOfOutstandingCapital

Namespace Prefix: SNYR_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.
+ References
No definition available.
+ Details

Name: us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.
+ References
No definition available.
+ Details

Name: us-gaap_SaleOfStockPricePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of stock issued during the period pursuant to acquisitions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28,29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesAcquisitions

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The change in equity as a result of a spin-off transaction (a regular or reverse spin-off) which is based on the recorded amounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Spinoff

-URI http://asc.fasb.org/extlink&oid=6749415

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 60

-Section 25

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6406278&loc=d3e26268-112671

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Reverse Spinoff

-URI http://asc.fasb.org/extlink&oid=6524171

+ Details

Name: us-gaap_StockholdersEquityNoteSpinoffTransaction

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_TitleOfIndividualAxis=us-gaap_BoardOfDirectorsChairmanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=SNYR_STWarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TypeOfArrangementAxis=SNYR_ContributionAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=SNYR_HandMDCorpMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 30 R24.htm IDEA: XBRL DOCUMENT v3.3.0.814

Stock Warrants (Tables)
9 Months Ended

Sep. 30, 2015

Stock Warrants

Summary of Warrants Outstanding by Price Range

The following table summarizes the warrants outstanding and the related prices for the shares of the Company’s common stock at September 30, 2015:

Warrants Outstanding Warrants Exercisable

Exercise
Prices ($) Number
Outstanding Weighted
Average
Remaining
Contractual Life
(Years) Weighted
Average
Exercise
Price ($) Number
Exercisable Weighted
Average
Exercise
Price

$ 0.34 3,584,759 9.32 $ 0.34 3,584,759 $ 0.34

Schedule of Stock Warrants Activity

The warrant activity for the nine months ended September 30, 2015 is as follows:

Warrants
Outstanding Weighted
Average
Exercise Price

Outstanding at December 31, 2014 — $ —

Granted 8,179,946 0.15

Exercised (4,595,187 ) 0.00000022

Expired or canceled — —

Outstanding at September 30, 2015 $ 3,584,759 $ 0.34

X

- Definition
Summary of warrants outstanding by price range.
+ References
No definition available.
+ Details

Name: SNYR_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockWarrantsPlansByExercisePriceRangeTextBlock

Namespace Prefix: SNYR_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: SNYR_StockWarrantsAbstract

Namespace Prefix: SNYR_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51659978&loc=d3e25284-112666

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 28

-Article 5

+ Details

Name: us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 31 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 32 R7.htm IDEA: XBRL DOCUMENT v3.3.0.814

Summary of Significant Accounting Policies
9 Months Ended

Sep. 30, 2015

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2 – Summary of Significant Accounting Policies

General

The accompanying condensed consolidated financial statements as of September 30, 2015 and December 31, 2014 and for the three and nine months ended September 30, 2015 and 2014 are unaudited. These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and are presented in accordance with the requirements of Rule S-X of the Securities and Exchange Commission (the “SEC”) and with the instructions to Form 10-Q. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2015 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2015. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements as of and for the year ended December 31, 2014 and footnotes thereto included in the Company’s Annual Report on Form 10-K filed with the SEC.

Basis of Presentation

The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all cash on hand and in banks, including accounts in book overdraft positions, certificates of deposit and other highly-liquid investments with maturities of three months or less, when purchased, to be cash and cash equivalents. As of September 30, 2015 the Company had no cash equivalents.

Capitalization of Fixed Assets

The Company capitalizes expenditures related to property and equipment, subject to a minimum rule, that have a useful life greater than one year for: (1) assets purchased; (2) existing assets that are replaced, improved or the useful lives have been extended; or (3) all land, regardless of cost. Acquisitions of new assets, additions, replacements and improvements (other than land) costing less than the minimum rule in addition to maintenance and repair costs, including any planned major maintenance activities, are expensed as incurred.

Intangible Assets

We evaluate the recoverability of intangible assets periodically and take into account events or circumstances that warrant revised estimates of useful lives or that indicate that impairment exists. Intangible assets that are subject to amortization are amortized on a straight-line basis over their useful lives.

Long-lived Assets

Long-lived assets include equipment and intangible assets other than those with indefinite lives. We assess the carrying value of our long-lived asset groups when indicators of impairment exist and recognize and impairment loss when the carrying amount of a long-lived asset is not recoverable when compared to undiscounted cash flows expected to result from the use and eventual disposition of the asset.

Indicators of impairment include significant underperformance relative to historical or projected future operating results, significant changes in our use of the assets or in our business strategy, loss of or changes in customer relationships and significant negative industry or economic trends. When indications of impairment arise for a particular asset or group of assets, we assess the future recoverability of the carrying value of the asset (or asset group) based on an undiscounted cash flow analysis. If carrying value exceeds projected, net, undiscounted cash flows, an additional analysis is performed to determine the fair value of the asset (or asset group), typically a discounted cash flow analysis, and an impairment charge is recorded for the excess of carrying value over fair value.

Goodwill

An asset purchase is accounted for under the purchase method of accounting. Under that method, assets and liabilities of the business acquired are recorded at their estimated fair values as of the date of the acquisition, with any excess of the cost of the acquisition over the estimated fair value of the net tangible and intangible assets acquired recorded as goodwill.

Revenue Recognition

Revenue is recognized in accordance with Staff Accounting Bulletin (“SAB”) No. 101, Revenue Recognition in Financial Statements, as revised by SAB No. 104. We recognize revenue when persuasive evidence of an arrangement exists, delivery has occurred, the sales price is fixed or determinable and collectability is reasonably assured. Ownership of and title to our products pass to customers upon delivery of the products to customers. Certain of our distributors may also perform a separate function as a co-packer on our behalf. In such cases, ownership of and title to our products that are co-packed on our behalf by those co-packers who are also distributors, passes to such distributors when we are notified by them that they have taken transfer or possession of the relevant portion of our finished goods.

Revenue is presented net of estimated returns and allowances, discounts, sales incentives and promotions including, price reductions, coupons, rebate offers and placement/slotting fees.

Accounts receivable

Accounts receivable are generally unsecured. The Company establishes an allowance for doubtful accounts receivable based on the age of outstanding invoices and management’s evaluation of collectability. Accounts are written off after all reasonable collection efforts have been exhausted and management concludes that likelihood of collection is remote. Any future recoveries are applied against the allowance for doubtful accounts.

Advertising Expense

The Company expenses marketing, promotions and advertising costs as incurred. Such costs are included in general and administrative expense in the accompanying condensed consolidated statements of operations.

Research and Development

Costs incurred in connection with the development of new products and processing methods are charged to general and administrative expenses as incurred.

Income Taxes

The Company utilizes Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) 740-10-25, “Income Taxes,” which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the tax basis of assets and liabilities and their financial reporting amounts based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. A valuation allowance is recorded when it is “more likely-than-not” that a deferred tax asset will not be realized.

The Company generated a deferred tax asset through net operating loss carry-forward. However, a valuation allowance of 100% has been established due to the uncertainty of the Company’s realization of the net operating loss carry forward prior to its expiration.

Net Earnings (Loss) Per Common Share

The Company computes earnings per share under ASC subtopic 260-10, Earnings Per Share. Basic earnings (loss) per share is computed by dividing the net income (loss) attributable to the common stockholders (the numerator) by the weighted average number of shares of common stock outstanding (the denominator) during the reporting periods. Diluted loss per share is computed by increasing the denominator by the weighted average number of additional shares that could have been outstanding from securities convertible into common stock (using the “treasury stock” method), unless their effect on net loss per share is anti-dilutive. As of September 30, 2015, an option to purchase 1,000,000 shares of common stock and warrants to purchase 3,584,759 shares of common stock were outstanding.

Going Concern

The Company’s unaudited condensed consolidated financial statements are prepared using U.S. GAAP applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company had an accumulated deficit at September 30, 2015 of $4,105,439. The Company had working capital of $246,252 as of September 30, 2015. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it establishes a revenue stream and becomes profitable. If the Company is unable to obtain adequate capital it could be forced to cease operations.

In order to continue as a going concern and to develop a reliable source of revenues, and achieve a profitable level of operations the Company will need, among other things, additional capital resources. Management’s plans to continue as a going concern include raising additional capital through borrowing and sales of common stock. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans.

The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Fair Value Measurements

The Company measures and discloses the fair value of assets and liabilities required to be carried at fair value in accordance with ASC 820, Fair Value Measurements and Disclosures. ASC 820 defines fair value, establishes a framework for measuring fair value, and enhances fair value measurement disclosure.

ASC 825 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825 establishes three levels of inputs that may be used to measure fair value:

Level 1 - Quoted prices for identical assets or liabilities in active markets to which we have access at the measurement date.

Level 2 - Inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly.

Level 3 - Unobservable inputs for the asset or liability.

The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

As of September 30, 2015, the Company has determined that there were no assets or liabilities measured at fair value.

Inventory

Inventory consists of raw materials, components and finished goods. The Company’s inventory is stated at the lower of cost (FIFO cost basis) or market.

Stock-Based Compensation

The Company has adopted the provisions of ASC 718. We estimate the fair value of stock options using a binomial model, consistent with the provisions of ASC 718 and SEC Staff Accounting Bulletin No. 107, Share-Based Payment. Option-pricing models require the input of highly subjective assumptions, including the price volatility of the underlying stock. We determined that the use of implied volatility is expected to be more reflective of market conditions and, therefore, could reasonably be expected to be a better indicator of our expected volatility than historical volatility. The expected term assumption used in calculating the estimated fair value of our stock-based compensation awards using the binomial model is based on detailed historical data about employees’ exercise behavior, vesting schedules, and death and disability probabilities. In addition, we are required to estimate the expected forfeiture rate and only recognize expense for those shares expected to vest. We estimate the forfeiture rate based on historical experience of our stock-based awards that are granted, exercised and cancelled. We believe the resulting binomial calculation provides a more refined estimate of the fair value of our employee stock options.

Recent Accounting Pronouncements

ASU 2015-03

In April 2015, the FASB issued Accounting Standards Update (“ASU”) No. 2015-03, Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. The amendments in this ASU require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this ASU. The amendments are effective for financial statements issued for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. The amendments are to be applied on a retrospective basis, wherein the balance sheet of each individual period presented is adjusted to reflect the period-specific effects of applying the new guidance. The Company is evaluating the possible effect of this guidance on its financial statements.

ASU 2015-02

In February 2015, the FASB issued ASU No. 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis, which is intended to improve targeted areas of consolidation guidance for legal entities such as limited partnerships, limited liability corporations, and securitization structures (collateralized debt obligations, collateralized loan obligations, and mortgage-backed security transactions). The ASU focuses on the consolidation evaluation for reporting organizations that are required to evaluate whether they should consolidate certain legal entities. In addition to reducing the number of consolidation models from four to two, the new standard simplifies the FASB Accounting Standards Codification and improves current U.S. GAAP by placing more emphasis on risk of loss when determining a controlling financial interest, reducing the frequency of the application of related-party guidance when determining a controlling financial interest in a variable interest entity (“VIE”), and changing consolidation conclusions for companies in several industries that typically make use of limited partnerships or VIEs. The ASU will be effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. We do not expect the adoption of ASU 2015-02 to have a material effect on our financial position, results of operations or cash flows.

ASU 2015-01

In January 2015, the FASB issued ASU No. 2015-01, “Income Statement - Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items.” This ASU eliminates from U.S. GAAP the concept of extraordinary items. ASU 2015-01 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. A reporting entity may apply the amendments prospectively. We do not expect the adoption of ASU 2015-01 to have a material effect on our financial position, results of operations or cash flows.

ASU 2014-17

In November 2014, the FASB issued ASU No. 2014-17, “Business Combinations (Topic 805): Pushdown Accounting.” This ASU provides an acquired entity with an option to apply pushdown accounting in its separate financial statements upon occurrence of an event in which an acquirer obtains control of the acquired entity. An acquired entity may elect the option to apply pushdown accounting in the reporting period in which the change-in-control event occurs. If pushdown accounting is applied to an individual change-in-control event, that election is irrevocable. ASU 2014-17 was effective on November 18, 2014. The adoption of ASU 2014-17 did not have any effect on our financial position, results of operations or cash flows.

ASU 2014-16

In November 2014, the FASB issued ASU 2014-16, “Derivatives and Hedging (Topic 815).” ASU 2014-16 addresses whether the host contract in a hybrid financial instrument issued in the form of a share should be accounted for as debt or equity. ASU 2014-16 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. We do not currently have issued, nor are we investors in, hybrid financial instruments. Accordingly, we do not expect the adoption of ASU 2014-16 to have any effect on our financial position, results of operations or cash flows.

ASU 2014-15

In August 2014, the FASB issued ASU No. 2014-15, “Presentation of Financial Statements - Going Concern (Subtopic 205-40)”. ASU 2014-15 provides guidance related to management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosure. ASU 2014-15 is effective for annual periods ending after December 15, 2016, and for interim and annual periods thereafter. Early application is permitted. We do not expect the adoption of ASU 2014-15 to have a material effect on our financial position, results of operations or cash flows.

ASU 2014-12

In June 2014, the FASB issued ASU No. 2014-12, “Compensation – Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period.” This ASU requires that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. ASU 2014-12 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. We do not expect the adoption of ASU 2014-12 to have a material effect on our financial position, results of operations or cash flows.

ASU 2014-09

In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606).” ASU 2014-09 affects any entity using U.S. GAAP that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards (e.g., insurance contracts or lease contracts). ASU 2014-09 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. We are still evaluating the effect of the adoption of ASU 2014-09. On April 1, 2015, the FASB voted to propose to defer the effective date of the new revenue recognition standard by one year.

ASU 2014-08

In April 2014, the FASB issued ASU No. 2014-08, “Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360) and Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity.” ASU 2014-08 amends the definition for what types of asset disposals are to be considered discontinued operations, as well as amending the required disclosures for discontinued operations and assets held for sale. ASU 2014-08 is effective for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2014. The adoption of ASU 2014-08 did not have any effect on our financial position, results of operations or cash flows.

There were various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company’s condensed financial position, results of operations or cash flows.

Change in Fiscal Year End

On April 21, 2014, the Company’s board of directors approved a change to the Company’s fiscal year end from July 31 to December 31 of each year.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for all significant accounting policies of the reporting entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18861-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18726-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18743-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18854-107790

+ Details

Name: us-gaap_SignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 33 R3.htm IDEA: XBRL DOCUMENT v3.3.0.814

Condensed Consolidated Balance Sheet (Parenthetical) - $ / shares

Sep. 30, 2015

Dec. 31, 2014

Statement of Financial Position [Abstract]

Common stock, par value $ 0.00001 $ 0.00001

Common stock, shares authorized 300,000,000 75,000,000

Common stock, shares issued 69,238,044 62,100,000

Common stock, shares outstanding 69,238,044 62,100,000

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfFinancialPositionAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 34 R17.htm IDEA: XBRL DOCUMENT v3.3.0.814

Stock Warrants
9 Months Ended

Sep. 30, 2015

Stock Warrants

Stock Warrants

Note 12 – Stock Warrants

The following table summarizes the warrants outstanding and the related prices for the shares of the Company’s common stock at September 30, 2015:

Warrants Outstanding Warrants Exercisable

Exercise
Prices ($) Number
Outstanding Weighted
Average
Remaining
Contractual Life
(Years) Weighted
Average
Exercise
Price ($) Number
Exercisable Weighted
Average
Exercise
Price

$ 0.34 3,584,759 9.32 $ 0.34 3,584,759 $ 0.34

The warrant activity for the nine months ended September 30, 2015 is as follows:

Warrants
Outstanding Weighted
Average
Exercise Price

Outstanding at December 31, 2014 — $ —

Granted 8,179,946 0.15

Exercised (4,595,187 ) 0.00000022

Expired or canceled — —

Outstanding at September 30, 2015 $ 3,584,759 $ 0.34

X

- References
No definition available.
+ Details

Name: SNYR_StockWarrantsAbstract

Namespace Prefix: SNYR_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Stock Warrants Disclosure [Text Block]
+ References
No definition available.
+ Details

Name: SNYR_StockWarrantsDisclosureTextBlock

Namespace Prefix: SNYR_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 35 R1.htm IDEA: XBRL DOCUMENT v3.3.0.814

Document and Entity Information - shares
9 Months Ended

Sep. 30, 2015

Nov. 03, 2015

Document And Entity Information [Abstract]

Entity Registrant Name Synergy CHC Corp.

Entity Central Index Key 0001562733

Document Type 10-Q

Document Period End Date Sep. 30, 2015

Amendment Flag false

Current Fiscal Year End Date --12-31

Entity Filer Category Smaller Reporting Company

Entity Common Stock, Shares Outstanding 69,238,044

Trading Symbol SNYR

Document Fiscal Period Focus Q3

Document Fiscal Year Focus 2015

X

- Definition
Document and Entity Information [Abstract]
+ References
No definition available.
+ Details

Name: SNYR_DocumentAndEntityInformationAbstract

Namespace Prefix: SNYR_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
If the value is true, then the document is an amendment to previously-filed/accepted document.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details

Name: dei_TradingSymbol

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

XML 36 R18.htm IDEA: XBRL DOCUMENT v3.3.0.814

Summary of Significant Accounting Policies (Policies)
9 Months Ended

Sep. 30, 2015

Accounting Policies [Abstract]

General

General

The accompanying condensed consolidated financial statements as of September 30, 2015 and December 31, 2014 and for the three and nine months ended September 30, 2015 and 2014 are unaudited. These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and are presented in accordance with the requirements of Rule S-X of the Securities and Exchange Commission (the “SEC”) and with the instructions to Form 10-Q. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2015 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2015. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements as of and for the year ended December 31, 2014 and footnotes thereto included in the Company’s Annual Report on Form 10-K filed with the SEC.

Basis of Presentation

Basis of Presentation

The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.

Use of Estimates

Use of Estimates

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all cash on hand and in banks, including accounts in book overdraft positions, certificates of deposit and other highly-liquid investments with maturities of three months or less, when purchased, to be cash and cash equivalents. As of September 30, 2015 the Company had no cash equivalents.

Capitalization of Fixed Assets

Capitalization of Fixed Assets

The Company capitalizes expenditures related to property and equipment, subject to a minimum rule, that have a useful life greater than one year for: (1) assets purchased; (2) existing assets that are replaced, improved or the useful lives have been extended; or (3) all land, regardless of cost. Acquisitions of new assets, additions, replacements and improvements (other than land) costing less than the minimum rule in addition to maintenance and repair costs, including any planned major maintenance activities, are expensed as incurred.

Intangible Assets

Intangible Assets

We evaluate the recoverability of intangible assets periodically and take into account events or circumstances that warrant revised estimates of useful lives or that indicate that impairment exists. Intangible assets that are subject to amortization are amortized on a straight-line basis over their useful lives.

Long-lived Assets

Long-lived Assets

Long-lived assets include equipment and intangible assets other than those with indefinite lives. We assess the carrying value of our long-lived asset groups when indicators of impairment exist and recognize and impairment loss when the carrying amount of a long-lived asset is not recoverable when compared to undiscounted cash flows expected to result from the use and eventual disposition of the asset.

Indicators of impairment include significant underperformance relative to historical or projected future operating results, significant changes in our use of the assets or in our business strategy, loss of or changes in customer relationships and significant negative industry or economic trends. When indications of impairment arise for a particular asset or group of assets, we assess the future recoverability of the carrying value of the asset (or asset group) based on an undiscounted cash flow analysis. If carrying value exceeds projected, net, undiscounted cash flows, an additional analysis is performed to determine the fair value of the asset (or asset group), typically a discounted cash flow analysis, and an impairment charge is recorded for the excess of carrying value over fair value.

Goodwill

Goodwill

An asset purchase is accounted for under the purchase method of accounting. Under that method, assets and liabilities of the business acquired are recorded at their estimated fair values as of the date of the acquisition, with any excess of the cost of the acquisition over the estimated fair value of the net tangible and intangible assets acquired recorded as goodwill.

Revenue Recognition

Revenue Recognition

Revenue is recognized in accordance with Staff Accounting Bulletin (“SAB”) No. 101, Revenue Recognition in Financial Statements, as revised by SAB No. 104. We recognize revenue when persuasive evidence of an arrangement exists, delivery has occurred, the sales price is fixed or determinable and collectability is reasonably assured. Ownership of and title to our products pass to customers upon delivery of the products to customers. Certain of our distributors may also perform a separate function as a co-packer on our behalf. In such cases, ownership of and title to our products that are co-packed on our behalf by those co-packers who are also distributors, passes to such distributors when we are notified by them that they have taken transfer or possession of the relevant portion of our finished goods.

Revenue is presented net of estimated returns and allowances, discounts, sales incentives and promotions including, price reductions, coupons, rebate offers and placement/slotting fees.

Accounts Receivable

Accounts receivable

Accounts receivable are generally unsecured. The Company establishes an allowance for doubtful accounts receivable based on the age of outstanding invoices and management’s evaluation of collectability. Accounts are written off after all reasonable collection efforts have been exhausted and management concludes that likelihood of collection is remote. Any future recoveries are applied against the allowance for doubtful accounts.

Advertising Expense

Advertising Expense

The Company expenses marketing, promotions and advertising costs as incurred. Such costs are included in general and administrative expense in the accompanying condensed consolidated statements of operations.

Research and Development

Research and Development

Costs incurred in connection with the development of new products and processing methods are charged to general and administrative expenses as incurred.

Income Taxes

Income Taxes

The Company utilizes Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) 740-10-25, “Income Taxes,” which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the tax basis of assets and liabilities and their financial reporting amounts based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. A valuation allowance is recorded when it is “more likely-than-not” that a deferred tax asset will not be realized.

The Company generated a deferred tax asset through net operating loss carry-forward. However, a valuation allowance of 100% has been established due to the uncertainty of the Company’s realization of the net operating loss carry forward prior to its expiration.

Net Earnings (Loss) Per Common Share

Net Earnings (Loss) Per Common Share

The Company computes earnings per share under ASC subtopic 260-10, Earnings Per Share. Basic earnings (loss) per share is computed by dividing the net income (loss) attributable to the common stockholders (the numerator) by the weighted average number of shares of common stock outstanding (the denominator) during the reporting periods. Diluted loss per share is computed by increasing the denominator by the weighted average number of additional shares that could have been outstanding from securities convertible into common stock (using the “treasury stock” method), unless their effect on net loss per share is anti-dilutive. As of September 30, 2015, an option to purchase 1,000,000 shares of common stock and warrants to purchase 3,584,759 shares of common stock were outstanding.

Going Concern

Going Concern

The Company’s unaudited condensed consolidated financial statements are prepared using U.S. GAAP applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company had an accumulated deficit at September 30, 2015 of $4,105,439. The Company had working capital of $246,252 as of September 30, 2015. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it establishes a revenue stream and becomes profitable. If the Company is unable to obtain adequate capital it could be forced to cease operations.

In order to continue as a going concern and to develop a reliable source of revenues, and achieve a profitable level of operations the Company will need, among other things, additional capital resources. Management’s plans to continue as a going concern include raising additional capital through borrowing and sales of common stock. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans.

The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Fair Value Measurements

Fair Value Measurements

The Company measures and discloses the fair value of assets and liabilities required to be carried at fair value in accordance with ASC 820, Fair Value Measurements and Disclosures. ASC 820 defines fair value, establishes a framework for measuring fair value, and enhances fair value measurement disclosure.

ASC 825 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825 establishes three levels of inputs that may be used to measure fair value:

Level 1 - Quoted prices for identical assets or liabilities in active markets to which we have access at the measurement date.

Level 2 - Inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly.

Level 3 - Unobservable inputs for the asset or liability.

The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

As of September 30, 2015, the Company has determined that there were no assets or liabilities measured at fair value.

Inventory

Inventory

Inventory consists of raw materials, components and finished goods. The Company’s inventory is stated at the lower of cost (FIFO cost basis) or market.

Stock-Based Compensation

Stock-Based Compensation

The Company has adopted the provisions of ASC 718. We estimate the fair value of stock options using a binomial model, consistent with the provisions of ASC 718 and SEC Staff Accounting Bulletin No. 107, Share-Based Payment. Option-pricing models require the input of highly subjective assumptions, including the price volatility of the underlying stock. We determined that the use of implied volatility is expected to be more reflective of market conditions and, therefore, could reasonably be expected to be a better indicator of our expected volatility than historical volatility. The expected term assumption used in calculating the estimated fair value of our stock-based compensation awards using the binomial model is based on detailed historical data about employees’ exercise behavior, vesting schedules, and death and disability probabilities. In addition, we are required to estimate the expected forfeiture rate and only recognize expense for those shares expected to vest. We estimate the forfeiture rate based on historical experience of our stock-based awards that are granted, exercised and cancelled. We believe the resulting binomial calculation provides a more refined estimate of the fair value of our employee stock options.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

ASU 2015-03

In April 2015, the FASB issued Accounting Standards Update (“ASU”) No. 2015-03, Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. The amendments in this ASU require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this ASU. The amendments are effective for financial statements issued for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. The amendments are to be applied on a retrospective basis, wherein the balance sheet of each individual period presented is adjusted to reflect the period-specific effects of applying the new guidance. The Company is evaluating the possible effect of this guidance on its financial statements.

ASU 2015-02

In February 2015, the FASB issued ASU No. 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis, which is intended to improve targeted areas of consolidation guidance for legal entities such as limited partnerships, limited liability corporations, and securitization structures (collateralized debt obligations, collateralized loan obligations, and mortgage-backed security transactions). The ASU focuses on the consolidation evaluation for reporting organizations that are required to evaluate whether they should consolidate certain legal entities. In addition to reducing the number of consolidation models from four to two, the new standard simplifies the FASB Accounting Standards Codification and improves current U.S. GAAP by placing more emphasis on risk of loss when determining a controlling financial interest, reducing the frequency of the application of related-party guidance when determining a controlling financial interest in a variable interest entity (“VIE”), and changing consolidation conclusions for companies in several industries that typically make use of limited partnerships or VIEs. The ASU will be effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. We do not expect the adoption of ASU 2015-02 to have a material effect on our financial position, results of operations or cash flows.

ASU 2015-01

In January 2015, the FASB issued ASU No. 2015-01, “Income Statement - Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items.” This ASU eliminates from U.S. GAAP the concept of extraordinary items. ASU 2015-01 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. A reporting entity may apply the amendments prospectively. We do not expect the adoption of ASU 2015-01 to have a material effect on our financial position, results of operations or cash flows.

ASU 2014-17

In November 2014, the FASB issued ASU No. 2014-17, “Business Combinations (Topic 805): Pushdown Accounting.” This ASU provides an acquired entity with an option to apply pushdown accounting in its separate financial statements upon occurrence of an event in which an acquirer obtains control of the acquired entity. An acquired entity may elect the option to apply pushdown accounting in the reporting period in which the change-in-control event occurs. If pushdown accounting is applied to an individual change-in-control event, that election is irrevocable. ASU 2014-17 was effective on November 18, 2014. The adoption of ASU 2014-17 did not have any effect on our financial position, results of operations or cash flows.

ASU 2014-16

In November 2014, the FASB issued ASU 2014-16, “Derivatives and Hedging (Topic 815).” ASU 2014-16 addresses whether the host contract in a hybrid financial instrument issued in the form of a share should be accounted for as debt or equity. ASU 2014-16 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. We do not currently have issued, nor are we investors in, hybrid financial instruments. Accordingly, we do not expect the adoption of ASU 2014-16 to have any effect on our financial position, results of operations or cash flows.

ASU 2014-15

In August 2014, the FASB issued ASU No. 2014-15, “Presentation of Financial Statements - Going Concern (Subtopic 205-40)”. ASU 2014-15 provides guidance related to management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosure. ASU 2014-15 is effective for annual periods ending after December 15, 2016, and for interim and annual periods thereafter. Early application is permitted. We do not expect the adoption of ASU 2014-15 to have a material effect on our financial position, results of operations or cash flows.

ASU 2014-12

In June 2014, the FASB issued ASU No. 2014-12, “Compensation – Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period.” This ASU requires that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. ASU 2014-12 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. We do not expect the adoption of ASU 2014-12 to have a material effect on our financial position, results of operations or cash flows.

ASU 2014-09

In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606).” ASU 2014-09 affects any entity using U.S. GAAP that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards (e.g., insurance contracts or lease contracts). ASU 2014-09 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. We are still evaluating the effect of the adoption of ASU 2014-09. On April 1, 2015, the FASB voted to propose to defer the effective date of the new revenue recognition standard by one year.

ASU 2014-08

In April 2014, the FASB issued ASU No. 2014-08, “Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360) and Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity.” ASU 2014-08 amends the definition for what types of asset disposals are to be considered discontinued operations, as well as amending the required disclosures for discontinued operations and assets held for sale. ASU 2014-08 is effective for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2014. The adoption of ASU 2014-08 did not have any effect on our financial position, results of operations or cash flows.

There were various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company’s condensed financial position, results of operations or cash flows.

Change in Fiscal Year End

Change in Fiscal Year End

On April 21, 2014, the Company’s board of directors approved a change to the Company’s fiscal year end from July 31 to December 31 of each year.

X

- Definition
General Accounting [Pollicy Text Block].
+ References
No definition available.
+ Details

Name: SNYR_GeneralAccountingPollicyTextBlock

Namespace Prefix: SNYR_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Going concern policy text block.
+ References
No definition available.
+ Details

Name: SNYR_GoingConcernPolicyTextBlock

Namespace Prefix: SNYR_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for advertising costs. For those costs that cannot be capitalized, discloses whether such costs are expensed as incurred or the first period in which the advertising takes place. For direct response advertising costs that are capitalized, describes those assets and the accounting policy used, including a description of the qualifying activity, the types of costs capitalized and the related amortization period. An entity also may disclose its accounting policy for cooperative advertising arrangements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 340

-SubTopic 20

-Section 55

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51677389&loc=d3e8384-108330

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 340

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=51662920&loc=d3e8275-108329

+ Details

Name: us-gaap_AdvertisingCostsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
No definition available.
+ Details

Name: us-gaap_BasisOfAccountingPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 305

-SubTopic 10

-Section 05

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6375392&loc=d3e26790-107797

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4273-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Financial Reporting Release (FRR)

-Number 203

-Paragraph 02-03

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

+ Details

Name: us-gaap_CashAndCashEquivalentsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

+ Details

Name: us-gaap_EarningsPerSharePolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.
+ References
No definition available.
+ Details

Name: us-gaap_FairValueMeasurementPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=51664549&loc=d3e5291-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section S99

-Paragraph 3

-Subparagraph (SX 210.3A-03.(b))

-URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355100-122828

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.3A-02.(b))

-URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355033-122828

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph k

-Article 1

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 06

-Article 3

+ Details

Name: us-gaap_FiscalPeriod

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 05

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51717228&loc=d3e202-110218

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section CC

-Subsection 3

+ Details

Name: us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32840-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 30

-Section 05

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6423966&loc=d3e40913-109327

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 740

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 17

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32809-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e32247-109318

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e32280-109318

+ Details

Name: us-gaap_IncomeTaxPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_IntangibleAssetsFiniteLivedPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for major classes of inventories, bases of stating inventories (for example, lower of cost or market), methods by which amounts are added and removed from inventory classes (for example, FIFO, LIFO, or average cost), loss recognition on impairment of inventories, and situations in which inventories are stated above cost. If inventory is carried at cost, this disclosure includes the nature of the cost elements included in inventory.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28360613&loc=d3e4492-108314

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(b))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=28360613&loc=d3e4556-108314

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Financial Reporting Release (FRR)

-Number 206

-Paragraph b

-Subparagraph i, ii

-Chapter 2

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 6

-Subparagraph a

-Article 5

+ Details

Name: us-gaap_InventoryPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_PropertyPlantAndEquipmentPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 730

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Research and Development

-URI http://asc.fasb.org/extlink&oid=6523717

+ Details

Name: us-gaap_ResearchAndDevelopmentExpensePolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18823-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18726-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.B.Q1)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section B

-Paragraph Question 1

+ Details

Name: us-gaap_RevenueRecognitionPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (b),(f)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for trade and other accounts receivables. This disclosure may include the basis at which such receivables are carried in the entity's statements of financial position (for example, net realizable value), how the entity determines the level of its allowance for doubtful accounts, when impairments, charge-offs or recoveries are recognized, and the entity's income recognition policies for such receivables, including its treatment of related fees and costs, its treatment of premiums, discounts or unearned income, when accrual of interest is discontinued, how the entity records payments received on nonaccrual receivables and its policy for resuming accrual of interest on such receivables. If the enterprise holds a large number of similar loans, disclosure may include the accounting policy for the anticipation of prepayments and significant assumptions underlying prepayment estimates for amortization of premiums, discounts, and nonrefundable fees and costs.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6378556&loc=d3e10133-111534

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section 50

-Paragraph 15

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=49124121&loc=d3e5212-111524

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=49124121&loc=d3e5093-111524

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3, 4

-Article 5

+ Details

Name: us-gaap_TradeAndOtherAccountsReceivablePolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6061-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6143-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6132-108592

+ Details

Name: us-gaap_UseOfEstimates

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 37 R4.htm IDEA: XBRL DOCUMENT v3.3.0.814

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2015

Sep. 30, 2014

Income Statement [Abstract]

Revenue $ 3,181,623 $ 7,237,619 $ 2,748

Cost of sales 1,469,910 3,103,244 1,685

Gross profit 1,711,713 4,134,375 $ 1,063

Operating expenses

Selling and marketing 814,640 2,228,418

General and administrative 706,806 $ 142,236 1,407,458 $ 787,858

Depreciation and amortization 103,103 282,256

Total operating expenses 1,624,549 $ 142,236 3,918,132 $ 787,858

Income (loss) from operations 87,164 $ (142,236) 216,243 $ (786,795)

Other income (expenses)

Interest expense (212,904) (612,094)

Amortization of debt discount (304,117) (2,575,192)

Amortization of debt issuance cost (37,753) (101,105)

Total other expenses (554,774) (3,288,391)

Net Loss $ (467,610) $ (142,236) $ (3,072,148) $ (786,795)

Net loss per share - basic and diluted $ (0.01) $ (0.00) $ (0.05) $ (0.01)

Weighted average common shares - basic and diluted 68,096,740 60,491,304 67,033,094 108,850,549

X

- Definition
Total costs related to goods produced and sold during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2(a))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_CostOfGoodsSold

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Represents the charge against earnings during the period for commitment fees and debt issuance expenses.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.8)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_GeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1,2)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_GrossProfit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeStatementAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.9)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of accretion of purchase discount on nonoperating securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.8)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_InvestmentIncomeAmortizationOfDiscount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OtherIncomeAndExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.9)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
+ References
No definition available.
+ Details

Name: us-gaap_SellingAndMarketingExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).
+ References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 38 R12.htm IDEA: XBRL DOCUMENT v3.3.0.814

Accounts Payable and Accrued Liabilities
9 Months Ended

Sep. 30, 2015

Payables and Accruals [Abstract]

Accounts Payable and Accrued Liabilities

Note 7 – Accounts Payable and Accrued Liabilities

As of September 30, 2015 and December 31, 2014, accounts payable and accrued liabilities consisted of the following:

September 30, 2015 December 31, 2014

Accrued payroll $ - $ 10,867

Accrued legal fees 56,683 47,916

Manufacturers 1,391,472 -

Promotions 15,000 -

Other 190,141 15,859

Total $ 1,653,296 $ 74,642

X

- Definition
The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a),20,24)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_PayablesAndAccrualsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 39 R11.htm IDEA: XBRL DOCUMENT v3.3.0.814

Related Party Transactions
9 Months Ended

Sep. 30, 2015

Related Party Transactions [Abstract]

Related Party Transactions

Note 6 – Related Party Transactions

On April 2, 2014, the Company granted an option to purchase 1,000,000 shares of the Company’s common stock, valued at approximately $282,000 to the Company owned by Mr. Jack Ross, Chief Executive Officer of the Company.

On October 31, 2014, the Company borrowed $100,000 through a promissory note bearing interest at 10% with a maturity date of October 31, 2015 from a company owned by Mr. Ross, the Company’s chief executive officer. During the nine months ended September 30, 2015, the note was converted into 400,000 shares of the Company’s common stock.

The Company accrued and paid consulting fees of $15,000 per month to a company owned by Mr. Jack Ross, Chief Executive Officer of the Company. As of September 30, 2015, the total outstanding balance was $0.

At September 30, 2015, $175,422 was due from a company owned by Mr. Jack Ross, Chief Executive Officer of the Company in a form of a note receivable.

On January 22, 2015, the Company entered into a Loan Agreement with Knight Therapeutics (Barbados) Inc. (“Knight”), a related party, for the purchase of the Focus Factor assets. At September 30, 2015, the Company owed Knight $5,047,178 on this loan, net of discount (see Note 8).

On June 26, 2015, the Company entered into a Loan Agreement with Knight Therapeutics, through its wholly owned subsidiary, for the purchase of the Neuragen assets. At September 30, 2015, the Company owed Knight $937,500 on this loan (see Note 8).

X

- References
No definition available.
+ Details

Name: us-gaap_RelatedPartyTransactionsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph b

-Article 3A

+ Details

Name: us-gaap_RelatedPartyTransactionsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 40 R23.htm IDEA: XBRL DOCUMENT v3.3.0.814

Stock Options (Tables)
9 Months Ended

Sep. 30, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Summary of Options Outstanding by Price Range

The following table summarizes the changes in options outstanding and the related prices for the shares of the Company’s common stock issued to employees and consultants under a stock option plan at September 30, 2015:

Options Outstanding Options Exercisable

Exercise
Prices ($) Number
Outstanding Weighted
Average
Remaining
Contractual Life
(Years) Weighted
Average
Exercise
Price ($) Number
Exercisable Weighted
Average
Exercise
Price

$ 0.25 1,000,000 3.50 $ 0.25 1,000,000 $ 0.25

Schedule of Stock Options Activity

The stock option activity for the nine months ended September 30, 2015 is as follows:

Options
Outstanding Weighted
Average
Exercise Price

Outstanding at December 31, 2014 1,000,000 $ 0.25

Granted — —

Exercised — —

Expired or canceled — —

Outstanding at September 30, 2015 $ 1,000,000 $ 0.25

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 41 R19.htm IDEA: XBRL DOCUMENT v3.3.0.814

Asset Purchase (Tables)
9 Months Ended

Sep. 30, 2015

Pro forma Results of Acquisition

Pro forma results of operations data (unaudited) for the years ended December 31, 2014 and 2013, as if the acquisition had occurred on January 1, 2013, are as follows:

December 31,

2014 2013

Revenue $ 12,695,295 $ 10,629,171

Net income (loss) (183,471 ) 932,209

Knight Therapeutics Inc [Member]

Purchase Price Allocation Assets Acquired and Liabilities Assumed on Estimated Fair Values

The preliminary allocation of the purchase price to the assets acquired and liabilities assumed based on the estimated fair values is as follows:

Assets

Accounts Receivable $ 58,054

Inventory 204,925

Goodwill 1,137,336

Liabilities

Accounts Payable (51,795 )

Accrued Expenses (148,520 )

$ 1,200,000

Factor Nutrition Labs, LLC [Member]

Purchase Price Allocation Assets Acquired and Liabilities Assumed on Estimated Fair Values

The preliminary allocation of the purchase price to the assets acquired and liabilities assumed based on the estimated fair values is as follows:

Assets

Accounts Receivable $ 2,926,369

Inventory 67,113

Intellectual Property 1,000,000

Non-compete provision 50,000

Non-solicitation provision 50,000

Intangible assets-Customer relationships 1,941,030

Goodwill 1,798,047

Liabilities

Accounts Payable (891,113 )

Accrued Expenses (941,446 )

$ 6,000,000

X

- Definition
Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (h)(2)-(3)

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463

+ Details

Name: us-gaap_BusinessAcquisitionProFormaInformationTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_KnightTherapeuticsIncMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=SNYR_FactorNutritionLabsLLCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 42 R15.htm IDEA: XBRL DOCUMENT v3.3.0.814

Commitments & Contingencies
9 Months Ended

Sep. 30, 2015

Commitments and Contingencies Disclosure [Abstract]

Commitments & Contingencies

Note 10 – Commitments & Contingencies

From time to time the Company may become a party to litigation in the normal course of business. Management believes that there are no current legal matters that would have a material effect on the Company’s financial position or results of operations.

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for commitments and contingencies.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=51674963&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 440

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 43 R13.htm IDEA: XBRL DOCUMENT v3.3.0.814

Notes Payable
9 Months Ended

Sep. 30, 2015

Debt Disclosure [Abstract]

Notes Payable

Note 8 – Notes Payable

On January 22, 2015, the Company entered into a Loan and Security Agreement, pursuant to which Knight Therapeutics (Barbados) Inc. (“Knight”) agreed to loan the Company $6.0 million (the “Loan”), and which amount was borrowed at closing for the purpose of acquiring the Focus Factor Business (see note 1). The Loan bears interest at a rate of 15% per year; provided, however, that upon the occurrence of an equity or convertible equity offering by the Company of at least $1.0 million, the interest rate will drop to 13% per year. Interest accrues quarterly and is payable in arrears on March 31, June 30, September 30 and December 31 in each year, beginning on March 31, 2015. All outstanding principal and accrued and unpaid interest is due on the earliest to occur of either January 20, 2017, or the date that Knight, in its discretion, accelerates the Company’s obligations due to an event of default.

In connection with the Loan, the Company issued warrants that were recorded as a debt discount at an initial aggregate value of $3,415,514 (see note 1). The value of these warrants was amortized during the nine months ended September 30, 2015, resulting in a final debt discount balance of $840,322 as of September 30, 2015.

On January 22, 2015, the Company issued a 0% promissory note in a principal amount of $1,500,000 in connection with an Asset Purchase Agreement (see note 1). The note has a maturity date of January 20, 2017, with $750,000 to be paid on or before January 20, 2016 and an additional $750,000 to be paid on or before January 20, 2017.

On June 26, 2015, the Company, through its wholly owned subsidiary, Neuragen Corp. (“Neuragen”), issued a 0% promissory note in a principal amount of $950,000 in connection with an Asset Purchase Agreement (see note 1). The note requires $250,000 to be paid on or before June 30, 2016, and $700,000 to be paid in quarterly installments (beginning with the quarter ending September 30, 2015) equal to the greater of $12,500 or 5% of U.S. net sales, and 2% of U.S. net sales of Neuragen for 60 months thereafter. The payment of such amounts is secured by a security interest in certain assets, undertakings and property (“Collateral”) pursuant to the Security Agreement, which will be released upon receipt of total payments of $1.2 million. The balance at September 30, 2015 was $937,500.

X

- References
No definition available.
+ Details

Name: us-gaap_DebtDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20,22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 44 R14.htm IDEA: XBRL DOCUMENT v3.3.0.814

Stockholders' Deficit
9 Months Ended

Sep. 30, 2015

Equity [Abstract]

Stockholders' Deficit

Note 9 – Stockholders’ Deficit

The total number of shares of all classes of capital stock which the Company is authorized to issue is 75,000,000 shares of common stock with $0.00001 par value. On July 30, 2014, the Company’s board of directors approved an increase of the Company’s authorized common stock from 75,000,000 to 300,000,000 shares, which increase was approved by the Company’s shareholders and became effective on August 5, 2015.

During the nine months ended September 30, 2015, the Company issued 4,595,187 shares of its common stock upon exercise of the ST Warrant at an aggregate exercise price of $1.00 in connection with the Loan Agreement (see note1).

During the nine months ended September 30, 2015, the Company issued 400,000 shares of its common stock to a note holder in a note conversion at $0.25 per share. At the time of conversion, the note was valued at $100,000 for outstanding principal.

During the nine months ended September 30, 2015, the Company issued 2,142,857 shares of its common stock valued at $0.70 per share in accordance with Contribution Agreement entered into with Hand MD Corp. in exchange for 50% of Hand MD Corp.’s outstanding capital securities.

As of September 30, 2015, there were 69,238,044 shares of the Company’s common stock issued and outstanding.

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(d),(e))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SAB TOPIC 4.C)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Preferred Stock

-URI http://asc.fasb.org/extlink&oid=6521494

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section C

+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 45 R16.htm IDEA: XBRL DOCUMENT v3.3.0.814

Stock Options
9 Months Ended

Sep. 30, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock Options

Note 11 – Stock Options

On July 30, 2014, the Company’s board of directors approved the Company’s 2014 Equity Incentive Plan and the reservation of 15,525,000 shares of common stock for issuance under such plan. Such plan was approved by the Company’s shareholders and became effective on August 5, 2015.

On April 2, 2014, the Company granted 1,000,000 options with an exercise price of $0.25 per share.

The following table summarizes the changes in options outstanding and the related prices for the shares of the Company’s common stock issued to employees and consultants under a stock option plan at September 30, 2015:

Options Outstanding Options Exercisable

Exercise
Prices ($) Number
Outstanding Weighted
Average
Remaining
Contractual Life
(Years) Weighted
Average
Exercise
Price ($) Number
Exercisable Weighted
Average
Exercise
Price

$ 0.25 1,000,000 3.50 $ 0.25 1,000,000 $ 0.25

The stock option activity for the nine months ended September 30, 2015 is as follows:

Options
Outstanding Weighted
Average
Exercise Price

Outstanding at December 31, 2014 1,000,000 $ 0.25

Granted — —

Exercised — —

Expired or canceled — —

Outstanding at September 30, 2015 $ 1,000,000 $ 0.25

X

- Definition
The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 40

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51659978&loc=d3e25284-112666

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 46 R34.htm IDEA: XBRL DOCUMENT v3.3.0.814

Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($)

Sep. 30, 2015

Dec. 31, 2014

Payables and Accruals [Abstract]

Accrued payroll $ 10,867

Accrued legal fees $ 56,683 $ 47,916

Manufacturers 1,391,472

Promotions 15,000

Other 190,141 $ 15,859

Accounts payable and accrued liabilities $ 1,653,296 $ 74,642

X

- Definition
Manufactures liabilities current.
+ References
No definition available.
+ Details

Name: SNYR_ManufacturersLiabilitiesCurrent

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Promotions liabilities current.
+ References
No definition available.
+ Details

Name: SNYR_PromotionsLiabilitiesCurrent

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Liabilities

-URI http://asc.fasb.org/extlink&oid=6509677

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccruedProfessionalFeesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_EmployeeRelatedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations, including trade payables, incurred through that date and due within one year (or in the operating cycle if longer) arising from transactions not otherwise specified in the taxonomy.
+ References
No definition available.
+ Details

Name: us-gaap_OtherAccountsPayableAndAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_PayablesAndAccrualsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 47 R21.htm IDEA: XBRL DOCUMENT v3.3.0.814

Fixed Assets and Intangible Assets (Tables)
9 Months Ended

Sep. 30, 2015

Assets

Summary of Fixed and Intangible Assets

As of September 30, 2015 and December 31, 2014, fixed assets and intangible assets consisted of the following:

September 30, 2015 December 31, 2014

Property and equipment $ 4,044 $ -

Less accumulated depreciation (430 ) -

Fixed assets, net $ 3,614 $ -

September 30, 2015 December 31, 2014

FOCUSfactor intellectual property $ 1,000,000 $ -

Intangible assets subject to amortization 2,041,030 -

Less accumulated amortization (281,829 ) -

Intangible assets, net $ 2,759,201 $ -

X

- Definition
Summary of fixed and intangible assets table text block.
+ References
No definition available.
+ Details

Name: SNYR_SummaryOfFixedAndIntangibleAssetsTableTextblock

Namespace Prefix: SNYR_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 48 R26.htm IDEA: XBRL DOCUMENT v3.3.0.814

Summary of Significant Accounting Policies (Details Narrative) - USD ($)
9 Months Ended 12 Months Ended

Sep. 30, 2015

Dec. 31, 2014

Cash equivalents

Property and equipment, useful life 5 years

Percentage of valuation allowance 100.00%

Option to purchase of common stock 1,000,000

Warrants to purchase of common stock 3,584,759

Accumulated deficit $ 4,105,439 $ 1,033,291

Working capital deficit $ 246,252

Assets or liabilities measured at fair value

Minimum [Member]

Property and equipment, useful life 1 year

X

- Definition
Option to purchase of common stock.
+ References
No definition available.
+ Details

Name: SNYR_OptionToPurchaseOfCommonStock

Namespace Prefix: SNYR_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Warrants to purchase of common stock.
+ References
No definition available.
+ Details

Name: SNYR_WarrantsToPurchaseOfCommonStock

Namespace Prefix: SNYR_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Working Capital.
+ References
No definition available.
+ Details

Name: SNYR_WorkingCapital

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

+ Details

Name: us-gaap_CashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41228-113958

+ Details

Name: us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I)

-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.
+ References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 49 R41.htm IDEA: XBRL DOCUMENT v3.3.0.814

Stock Warrants - Summary of Stock Warrants Activity (Details) - Warrant [Member]
9 Months Ended

Sep. 30, 2015

$ / shares

shares

Warrants Outstanding, Beginning balance

Warrants, Granted 8,179,946

Warrants, Exercised (4,595,187)

Warrants, Expired or canceled

Warrants Outstanding, Ending balance 3,584,759

Warrants Outstanding, Weighted Average Exercise Price, Beginning balance | $ / shares

Weighted Average Exercise Price, Granted | $ / shares $ 0.15

Weighted Average Exercise Price, Exercised | $ / shares $ 0.00000022

Weighted Average Exercise Price, Expired or canceled | $ / shares

Warrants Outstanding, Weighted Average Exercise Price, Ending balance | $ / shares $ 0.34

X

- Definition
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Exercise Price.
+ References
No definition available.
+ Details

Name: SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice

Namespace Prefix: SNYR_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price.
+ References
No definition available.
+ Details

Name: SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: SNYR_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Share Based Compensation Arrangement By Share Based Payment Award Warrants Outstanding Weighted Average Exercise Price Equity Instruments Other Than Options Nonvested Number
+ References
No definition available.
+ Details

Name: SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber

Namespace Prefix: SNYR_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Share Based Compensation Arrangements By Share Based Payment Award Warrants Exercises In Period Weighted Average Exercise Price
+ References
No definition available.
+ Details

Name: SNYR_ShareBasedCompensationArrangementsByShareBasedPaymentAwardWarrantsExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: SNYR_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(3)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(iii)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(iii)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_PlanNameAxis=us-gaap_WarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 50 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Cash Flows from Operating Activities

Net loss $ (3,072,148) $ (786,795)

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

Depreciation and amortization 282,256

Amortization of debt issuance cost 101,105

Stock based compensation expense $ 28,000 $ 310,247

Loss on acquisition $ 109,040

Amortization of debt discount $ 2,575,192

Changes in operating assets and liabilities:

Accounts receivable 1,660,167 $ (150)

Inventory (201,346) (30,500)

Prepaid expense (118,976) (10,000)

Accounts payable and accrued liabilities (454,220) 9,705

Net cash provided by (used in) operating activities 800,030 $ (398,453)

Cash Flows from Investing Activities

Payments for acquisition of fixed assets (4,045)

Payments for acquisition of Factor Nutrition Labs (4,500,000)

Payments for acquisition transaction with Knight Therapeutics Inc. (250,000)

Net cash used in investing activities (4,754,045)

Cash Flows from Financing Activities

Proceeds from notes payable 6,000,000

Repayment of notes payable (762,500) $ (92,840)

Payment of debt issuance cost (299,531)

(Repayments to) advances from related party note (159,345)

Warrant exercise $ 1

Proceeds from issuance of common stock $ 500,000

Net cash provided by financing activities $ 4,778,625 407,160

Net increase in cash and cash equivalents 824,610 8,707

Cash and Cash Equivalents, beginning of period 338 3,230

Cash and Cash Equivalents, end of period 824,948 $ 11,937

Supplemental Disclosure of Cash Flow Information:

Interest $ 612,094

Income taxes

Supplemental Disclosure of Non-cash Investing and Financing Activities:

Common stock issued for settlement of debt $ 100,000

Beneficial conversion feature on warrants issued concurrent with debt 3,415,514

Assumption of liabilities as part of acquisition transaction 9,332,559 $ 84,040

Assumption of liabilities as part of acquisition transaction with Knight Therapeutics Inc. 1,400,315

Note issued as part of asset purchase agreement 1,500,000

Common stock issued as part of contribution agreement $ 1,500,000

Cancellation of common stock as part of purchase transaction $ 1,359

Financing for prepaid insurance 20,000

Issuance of shares as part of acquisition transaction $ 25,000

X

- Definition
Cancellation of common stock as part of purchase transaction.
+ References
No definition available.
+ Details

Name: SNYR_CancellationOfCommonStockAsPartOfPurchaseTransaction

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Common stock issued as part of contribution agreement.
+ References
No definition available.
+ Details

Name: SNYR_CommonStockIssuedAsPartOfContributionAgreement

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Financing for prepaid insurance.
+ References
No definition available.
+ Details

Name: SNYR_FinancingForPrepaidInsurance

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Gains Losses on Acquisition.
+ References
No definition available.
+ Details

Name: SNYR_GainsLossesOnAcquisition

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Issuance of shares as part of acquisition transaction.
+ References
No definition available.
+ Details

Name: SNYR_IssuanceOfSharesAsPartOfAcquisitionTransaction

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Liabilities Assumed Related Party.
+ References
No definition available.
+ Details

Name: SNYR_LiabilitiesAssumedRelatedParty

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.8)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_AmortizationOfDebtDiscountPremium

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of noncash expense included in interest expense to allocate debt discount and premium, and the costs to issue debt and obtain financing over the related debt instruments. Alternate captions include noncash interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_AmortizationOfFinancingCostsAndDiscounts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 230

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906

+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

+ Details

Name: us-gaap_ConversionOfStockAmountConverted1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586

+ Details

Name: us-gaap_DebtConversionConvertedInstrumentAmount1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

+ Details

Name: us-gaap_IncomeTaxesPaidNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInInventories

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of cash paid for interest during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_InterestPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The fair value of liabilities assumed in noncash investing or financing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

+ Details

Name: us-gaap_LiabilitiesAssumed1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NoncashInvestingAndFinancingItemsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash outflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 27

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3581-108585

+ Details

Name: us-gaap_PaymentsForHedgeFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The net cash outflow or inflow from other investing activities. This element is used when there is not a more specific and appropriate element in the taxonomy.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3098-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3095-108585

+ Details

Name: us-gaap_PaymentsForProceedsFromOtherInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

+ Details

Name: us-gaap_PaymentsOfDebtIssuanceCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireBusinessesGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow from the additional capital contribution to the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromIssuanceOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from a borrowing supported by a written promise to pay an obligation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_ProceedsFromNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow for a borrowing supported by a written promise to pay an obligation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

+ Details

Name: us-gaap_RepaymentsOfNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Value of stock issued pursuant to acquisitions during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_StockIssuedDuringPeriodValueAcquisitions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 51 R10.htm IDEA: XBRL DOCUMENT v3.3.0.814

Fixed Assets and Intangible Assets
9 Months Ended

Sep. 30, 2015

Fixed Assets And Intangible Assets

Fixed Assets and Intangible Assets

Note 5 – Fixed Assets and Intangible Assets

As of September 30, 2015 and December 31, 2014, fixed assets and intangible assets consisted of the following:

September 30, 2015 December 31, 2014

Property and equipment $ 4,044 $ -

Less accumulated depreciation (430 ) -

Fixed assets, net $ 3,614 $ -

September 30, 2015 December 31, 2014

FOCUSfactor intellectual property $ 1,000,000 $ -

Intangible assets subject to amortization 2,041,030 -

Less accumulated amortization (281,829 ) -

Intangible assets, net $ 2,759,201 $ -

Depreciation and amortization expense for the nine months ended September 30, 2015 and 2014 was $282,256 and $0, respectively. Depreciation and amortization expense for the three months ended September 30, 2015 and 2014 was $103,103 and $0, respectively. Annual amortization expense will be $408,206 per year through 2020.

X

- References
No definition available.
+ Details

Name: SNYR_FixedAssetsAndIntangibleAssetsAbstract

Namespace Prefix: SNYR_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Fixed assets and intangible assets [Text Block]
+ References
No definition available.
+ Details

Name: SNYR_FixedAssetsAndIntangibleAssetsTextBlock

Namespace Prefix: SNYR_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 52 R27.htm IDEA: XBRL DOCUMENT v3.3.0.814

Asset Purchase (Details Narrative) - USD ($)
9 Months Ended

Jun. 26, 2015

Sep. 30, 2015

Sep. 30, 2014

Aggregate purchase price of business $ 250,000

Amortize over their estimated useful life 5 years

Company's expected revenues $ 13,000,000

Company's expected EBITDA 2,000,000

Knight Therapeutics Inc [Member]

Amount payable under the purchase agreement $ 1,200,000

Total payments of acquire assets $ 1,200,000

Knight Therapeutics Inc [Member] | U.S [Member]

Percentage of sale revenue net 2.00%

June 30, 2016 [Member] | Knight Therapeutics Inc [Member]

Amount payable under the purchase agreement $ 250,000

September 30, 2015 [Member] | Knight Therapeutics Inc [Member]

Amount payable under the purchase agreement 700,000

September 30, 2015 [Member] | Knight Therapeutics Inc [Member] | U.S [Member] | Maximum [Member]

Net sales $ 12,500

Percentage of sale revenue net 5.00%

Focus Factor Business [Member]

Aggregate purchase price of business 6,000,000

Amount payable under the purchase agreement 4,500,000

Company's expected revenues 7,015,763

Company's expected EBITDA (3,067,567)

Focus Factor Business [Member] | January 20, 2016 [Member]

Amount payable under the purchase agreement 750,000

Focus Factor Business [Member] | January 20, 2017 [Member]

Amount payable under the purchase agreement $ 750,000

X

- Definition
Amount payable under the purchase agreement.
+ References
No definition available.
+ Details

Name: SNYR_AmountPayableUnderPurchaseAgreement

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Expected earnings interest taxes depreciation and amortization.
+ References
No definition available.
+ Details

Name: SNYR_ExpectedEarningsInterestTaxesDepreciationAndAmortization

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Company's expected evenues.
+ References
No definition available.
+ Details

Name: SNYR_ExpectedEvenues

Namespace Prefix: SNYR_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Percentage of sale revenue net.
+ References
No definition available.
+ Details

Name: SNYR_PercentageOfSaleRevenueNet

Namespace Prefix: SNYR_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireBusinessesGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the purchase of all investments (debt, security, other) during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.
+ References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_SalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_KnightTherapeuticsIncMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=SNYR_USMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreationDateAxis=SNYR_JuneThirtyTwoThousandSixteenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreationDateAxis=SNYR_SeptemberThirtyTwoThousandFifteenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TitleOfIndividualAxis=SNYR_FocusFactorBusinessMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreationDateAxis=SNYR_JanuaryTwentyTwoThousandSixteenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreationDateAxis=SNYR_JanuaryTwentyTwoThousandSeventeenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 53 FilingSummary.xml IDEA: XBRL DOCUMENT 3.3.0.814 html 47 226 1 false 24 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://synergystripscorp.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheet Sheet http://synergystripscorp.com/role/BalanceSheet Condensed Consolidated Balance Sheet Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheet (Parenthetical) Sheet http://synergystripscorp.com/role/BalanceSheetParenthetical Condensed Consolidated Balance Sheet (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://synergystripscorp.com/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://synergystripscorp.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 00000006 - Disclosure - Nature of the Business Sheet http://synergystripscorp.com/role/NatureOfBusiness Nature of the Business Notes 6 false false R7.htm 00000007 - Disclosure - Summary of Significant Accounting Policies Sheet http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 7 false false R8.htm 00000008 - Disclosure - Asset Purchase Sheet http://synergystripscorp.com/role/AssetPurchase Asset Purchase Notes 8 false false R9.htm 00000009 - Disclosure - Inventory Sheet http://synergystripscorp.com/role/Inventory Inventory Notes 9 false false R10.htm 00000010 - Disclosure - Fixed Assets and Intangible Assets Sheet http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets Fixed Assets and Intangible Assets Notes 10 false false R11.htm 00000011 - Disclosure - Related Party Transactions Sheet http://synergystripscorp.com/role/RelatedPartyTransactions Related Party Transactions Notes 11 false false R12.htm 00000012 - Disclosure - Accounts Payable and Accrued Liabilities Sheet http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilities Accounts Payable and Accrued Liabilities Notes 12 false false R13.htm 00000013 - Disclosure - Notes Payable Notes http://synergystripscorp.com/role/NotesPayable Notes Payable Notes 13 false false R14.htm 00000014 - Disclosure - Stockholders' Deficit Sheet http://synergystripscorp.com/role/StockholdersDeficit Stockholders' Deficit Notes 14 false false R15.htm 00000015 - Disclosure - Commitments & Contingencies Sheet http://synergystripscorp.com/role/CommitmentsContingencies Commitments & Contingencies Notes 15 false false R16.htm 00000016 - Disclosure - Stock Options Sheet http://synergystripscorp.com/role/StockOptions Stock Options Notes 16 false false R17.htm 00000017 - Disclosure - Stock Warrants Sheet http://synergystripscorp.com/role/StockWarrants Stock Warrants Notes 17 false false R18.htm 00000018 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies 18 false false R19.htm 00000019 - Disclosure - Asset Purchase (Tables) Sheet http://synergystripscorp.com/role/AssetPurchaseTables Asset Purchase (Tables) Tables http://synergystripscorp.com/role/AssetPurchase 19 false false R20.htm 00000020 - Disclosure - Inventory (Tables) Sheet http://synergystripscorp.com/role/InventoryTables Inventory (Tables) Tables http://synergystripscorp.com/role/Inventory 20 false false R21.htm 00000021 - Disclosure - Fixed Assets and Intangible Assets (Tables) Sheet http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssetsTables Fixed Assets and Intangible Assets (Tables) Tables http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets 21 false false R22.htm 00000022 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) Sheet http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilitiesTables Accounts Payable and Accrued Liabilities (Tables) Tables http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilities 22 false false R23.htm 00000023 - Disclosure - Stock Options (Tables) Sheet http://synergystripscorp.com/role/StockOptionsTables Stock Options (Tables) Tables http://synergystripscorp.com/role/StockOptions 23 false false R24.htm 00000024 - Disclosure - Stock Warrants (Tables) Sheet http://synergystripscorp.com/role/StockWarrantsTables Stock Warrants (Tables) Tables http://synergystripscorp.com/role/StockWarrants 24 false false R25.htm 00000025 - Disclosure - Nature of the Business (Details Narrative) Sheet http://synergystripscorp.com/role/NatureOfBusinessDetailsNarrative Nature of the Business (Details Narrative) Details http://synergystripscorp.com/role/NatureOfBusiness 25 false false R26.htm 00000026 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies 26 false false R27.htm 00000027 - Disclosure - Asset Purchase (Details Narrative) Sheet http://synergystripscorp.com/role/AssetPurchaseDetailsNarrative Asset Purchase (Details Narrative) Details http://synergystripscorp.com/role/AssetPurchaseTables 27 false false R28.htm 00000028 - Disclosure - Asset Purchase - Purchase Price Allocation Assets Acquired and Liabilities Assumed on Estimated Fair Values (Details) Sheet http://synergystripscorp.com/role/AssetPurchase-PurchasePriceAllocationAssetsAcquiredAndLiabilitiesAssumedOnEstimatedFairValuesDetails Asset Purchase - Purchase Price Allocation Assets Acquired and Liabilities Assumed on Estimated Fair Values (Details) Details 28 false false R29.htm 00000029 - Disclosure - Asset Purchase - Pro forma Results of Acquisition (Details) Sheet http://synergystripscorp.com/role/AssetPurchase-ProFormaResultsOfAcquisitionDetails Asset Purchase - Pro forma Results of Acquisition (Details) Details 29 false false R30.htm 00000030 - Disclosure - Inventory - Schedule of Carrying Value of Inventory (Details) Sheet http://synergystripscorp.com/role/Inventory-ScheduleOfCarryingValueOfInventoryDetails Inventory - Schedule of Carrying Value of Inventory (Details) Details 30 false false R31.htm 00000031 - Disclosure - Fixed Assets and Intangible Assets (Details Narrative) Sheet http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssetsDetailsNarrative Fixed Assets and Intangible Assets (Details Narrative) Details http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssetsTables 31 false false R32.htm 00000032 - Disclosure - Fixed Assets and Intangible Assets - Summary of Fixed and Intangible Assets (Details) Sheet http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets-SummaryOfFixedAndIntangibleAssetsDetails Fixed Assets and Intangible Assets - Summary of Fixed and Intangible Assets (Details) Details 32 false false R33.htm 00000033 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://synergystripscorp.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://synergystripscorp.com/role/RelatedPartyTransactions 33 false false R34.htm 00000034 - Disclosure - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details) Sheet http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details) Details 34 false false R35.htm 00000035 - Disclosure - Notes Payable (Details Narrative) Notes http://synergystripscorp.com/role/NotesPayableDetailsNarrative Notes Payable (Details Narrative) Details http://synergystripscorp.com/role/NotesPayable 35 false false R36.htm 00000036 - Disclosure - Stockholders' Deficit (Details Narrative) Sheet http://synergystripscorp.com/role/StockholdersDeficitDetailsNarrative Stockholders' Deficit (Details Narrative) Details http://synergystripscorp.com/role/StockholdersDeficit 36 false false R37.htm 00000037 - Disclosure - Stock Options (Details Narrative) Sheet http://synergystripscorp.com/role/StockOptionsDetailsNarrative Stock Options (Details Narrative) Details http://synergystripscorp.com/role/StockOptionsTables 37 false false R38.htm 00000038 - Disclosure - Stock Options - Summary of Options Outstanding by Price Range (Details) Sheet http://synergystripscorp.com/role/StockOptions-SummaryOfOptionsOutstandingByPriceRangeDetails Stock Options - Summary of Options Outstanding by Price Range (Details) Details 38 false false R39.htm 00000039 - Disclosure - Stock Options - Summary of Stock Options Activity (Details) Sheet http://synergystripscorp.com/role/StockOptions-SummaryOfStockOptionsActivityDetails Stock Options - Summary of Stock Options Activity (Details) Details 39 false false R40.htm 00000040 - Disclosure - Stock Warrants - Summary of Warrants Outstanding by Price Range (Details) Sheet http://synergystripscorp.com/role/StockWarrants-SummaryOfWarrantsOutstandingByPriceRangeDetails Stock Warrants - Summary of Warrants Outstanding by Price Range (Details) Details 40 false false R41.htm 00000041 - Disclosure - Stock Warrants - Summary of Stock Warrants Activity (Details) Sheet http://synergystripscorp.com/role/StockWarrants-SummaryOfStockWarrantsActivityDetails Stock Warrants - Summary of Stock Warrants Activity (Details) Details 41 false false All Reports Book All Reports In ''Condensed Consolidated Balance Sheet'', column(s) 3, 4 are contained in other reports, so were removed by flow through suppression. In ''Condensed Consolidated Statements of Cash Flows (Unaudited)'', column(s) 2, 3 are contained in other reports, so were removed by flow through suppression. snyr-20150930.xml snyr-20150930_cal.xml snyr-20150930_def.xml snyr-20150930_lab.xml snyr-20150930_pre.xml snyr-20150930.xsd true true XML 54 R38.htm IDEA: XBRL DOCUMENT v3.3.0.814

Stock Options - Summary of Options Outstanding by Price Range (Details) - Stock Option Plan [Member]
9 Months Ended

Sep. 30, 2015

$ / shares

shares

Options Outstanding, exercise price $ 0.25

Options Outstanding, Number Outstanding | shares 1,000,000

Options Outstanding, Remaining Average Contractual Life 3 years 6 months

Options Outstanding, Weighted Average Exercise Price $ 0.25

Options Exercisable, Number Exercisable | shares 1,000,000

Options Exercisable, Weighted Average Exercise Price $ 0.25

X

- Definition
The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (g)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(iii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_PlanNameAxis=SNYR_StockOptionPlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 55 R20.htm IDEA: XBRL DOCUMENT v3.3.0.814

Inventory (Tables)
9 Months Ended

Sep. 30, 2015

Inventory Disclosure [Abstract]

Schedule of Carrying Value of Inventory

The carrying value of inventory consisted of the following:

September 30, 2015 December 31, 2014

Energy product $ 24,451 $ 26,064

Components 172,936 -

Finished goods 266,655 -

Raw Materials 35,406 -

Total inventory $ 499,448 $ 26,064

X

- References
No definition available.
+ Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 2

-Paragraph 6

-Subparagraph a,b,c

-Article 5

+ Details

Name: us-gaap_ScheduleOfInventoryCurrentTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

Related Party Transactions (Details Narrative) - USD ($)			1 Months Ended	9 Months Ended
	Apr. 02, 2014	Apr. 02, 2014	Oct. 31, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Options Outstanding, Granted	1,000,000
Proceeds from promissory note				$ 6,000,000
Debt instruments interest rate				15.00%
Promissory note converted into number of shares				400,000
Accrued consulting fees per month				$ 15,000
Repayment of related party debt				0
Due from related party				175,422		$ 16,077
Promissory note				750,000
Knight Therapeutics Inc [Member]
Loan net amount				5,047,178
Promissory note				$ 937,500
Mr. Jack Ross [Member]
Options Outstanding, Granted		1,000,000
Value of granted options		$ 282,000
Proceeds from promissory note			$ 100,000
Debt instruments interest rate			10.00%
Debt instruments maturity date			Oct. 31, 2015

Nature of the Business (Details Narrative) - USD ($)			3 Months Ended		9 Months Ended
Nature of the Business (Details Narrative) - USD ($)	Aug. 18, 2015	Jun. 26, 2015	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Loan amount			$ 6,000,000		$ 6,000,000
Loan origination fee			$ 120,000		120,000
Work fee for loan					60,000
Expenses associated with the Loan					$ 40,000
Debt instrument interest rate percentage			15.00%		15.00%
Convertible equity offering			$ 1,000,000		$ 1,000,000
Change in loan interest rate					13.00%
Company's expected revenues					$ 13,000,000
Company's expected EBITDA					2,000,000
Secured loan obligation			300,000		300,000
Maximum aggregate consideration to be paid			$ 100,000		100,000
Capital expenditures					$ 100,000
Additional bear interest rate			5.00%		5.00%
Number of shares issued for business acquisition					4,595,187
Exercise price of common stock			$ 0.25		$ 0.25
Warrant issued to purchase of common stock					3,584,759
Aggregate purchase price of business					$ 250,000
Common stock shares contributed as per agreement					400,000
Amount paid for marketing and sales related services			$ 814,640		$ 2,228,418
Term of distribution agreement					15 years
Contribution Agreement [Member]
Agreement date	Aug. 18, 2015
Contribution Agreement [Member] \| Hand Md Corp [Member]
Exercise price of common stock	$ 0.70		$ 0.70		$ 0.70
Aggregate purchase price of business	$ 97,000
Common stock shares contributed as per agreement	2,142,857
Percentage of ownership transfered	50.00%
License Agreement [Member] \| Hand Md Corp [Member]
Agreement date	Aug. 18, 2015
Royalty percentage	5.00%
Royalty amount	$ 500,000
Consulting Agreement [Member] \| Hand MD LLC [Member]
Agreement date	Aug. 18, 2015
Amount paid for marketing and sales related services	$ 10,000
Knight Therapeutics Inc [Member]
Additional bear interest rate		10.00%
Amount payable under purchase agreement		$ 1,200,000
Total payments of acquire assets		$ 1,200,000
Knight Therapeutics Inc [Member] \| U.S [Member]
Percentage of sale revenue net		2.00%
Closing Date [Member] \| Knight Therapeutics Inc [Member]
Amount payable under purchase agreement		$ 250,000
June 30, 2016 [Member] \| Knight Therapeutics Inc [Member]
Amount payable under purchase agreement		250,000
September 30, 2015 [Member] \| Knight Therapeutics Inc [Member]
Amount payable under purchase agreement		700,000
September 30, 2015 [Member] \| Knight Therapeutics Inc [Member] \| U.S [Member] \| Maximum [Member]
Net sales		$ 12,500
Percentage of sale revenue net		5.00%
Focus Factor Business [Member]
Company's expected revenues					$ 7,015,763
Company's expected EBITDA					(3,067,567)
Aggregate purchase price of business					6,000,000
Amount payable under purchase agreement					4,500,000
Focus Factor Business [Member] \| January 20, 2016 [Member]
Amount payable under purchase agreement					750,000
Focus Factor Business [Member] \| January 20, 2017 [Member]
Amount payable under purchase agreement					$ 750,000
ST Warrant [Member]
Exercise price of common stock			1.00		$ 1.00
LT Warrant [Member]
Exercise price of common stock			$ 0.34		$ 0.34
Percentage of shares purchasable under the agreement			25.00%		25.00%

Stock Options (Details Narrative) - $ / shares	Apr. 02, 2014	Sep. 30, 2014
Options Outstanding, Granted	1,000,000
Stock options exercise price per share	$ 0.25
Equity Incentive Plan 2014 [Member]
Common stock shares reserved for issuance		15,525,000

Asset Purchase - Pro forma Results of Acquisition (Details) - Focus Factor Business [Member] - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Revenue	$ 12,695,295	$ 10,629,171
Net income (loss)	$ (183,471)	$ 932,209

Asset Purchase - Purchase Price Allocation Assets Acquired and Liabilities Assumed on Estimated Fair Values (Details) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Factor Nutrition Labs, LLC [Member]
Accounts Receivable		$ 2,926,369
Inventory		67,113
Intellectual Property		1,000,000
Non-compete provision		50,000
Non-solicitation provision		50,000
Intangible assets-Customer relationships		1,941,030
Goodwill		1,798,047
Accounts Payable		(891,113)
Accrued Expenses		(941,446)
Total Liabilities		$ 6,000,000
Knight Therapeutics Inc [Member]
Accounts Receivable	$ 58,054
Inventory	204,925
Goodwill	1,137,336
Accounts Payable	(51,795)
Accrued Expenses	(148,520)
Total Liabilities	$ 1,200,000

Inventory - Schedule of Carrying Value of Inventory (Details) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Energy product	$ 24,451	$ 26,064
Components	172,936
Finished goods	266,655
Raw Materials	35,406
Total inventory	$ 499,448	$ 26,064

Fixed Assets and Intangible Assets - Summary of Fixed and Intangible Assets (Details) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Assets
Property and equipment	$ 4,044
Less accumulated depreciation	(430)
Fixed assets, net	3,614
FOCUSfactor intellectual property	1,000,000
Intangible assets subject to amortization	2,041,030
Less accumulated amortization	(281,829)
Intangible assets, net	$ 2,759,201

Stock Warrants - Summary of Warrants Outstanding by Price Range (Details) - Warrant [Member]	9 Months Ended
	Sep. 30, 2015 $ / shares shares
Warrants Outstanding, exercise prices	$ 0.34
Warrants Outstanding, Number Outstanding \| shares	3,584,759
Warrants Outstanding, Remaining Average Contractual Life	9 years 3 months 26 days
Warrants Outstanding, Weighted Average Exercise Price	$ 0.34
Warrants Exercisable, Number Exercisable \| shares	3,584,759
Warrants Exercisable, Weighted Average Exercise Price	$ 0.34

Condensed Consolidated Balance Sheet - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Current Assets:
Cash	$ 824,948	$ 338
Accounts Receivable	1,327,154	2,898
Receivable from related party	175,422	16,077
Prepaid expenses	122,576	10,000
Inventory	499,448	26,064
Total Current Assets	2,949,548	$ 55,376
Fixed assets, net	3,614
Investment in Hand MD Corp.	1,500,000
Goodwill	2,935,383
Intangible assets, net	2,759,201
Debt issuance cost, net	198,429
Total Assets	10,346,175	$ 55,376
Current Liabilities:
Accounts payable and accrued liabilities	$ 1,653,296	74,642
Notes payable, related party		$ 100,000
Current portion of long-term debt	$ 750,000
Current portion of long-term debt, related party	300,000	$ 6,400
Total Current Liabilities	2,703,296	$ 181,042
Long-term Liabilities:
Note payable	750,000
Note payable, net of debt discount, related party	5,047,178
Total Long-term Liabilities	5,797,178
Total Liabilities	$ 8,500,474	$ 181,042
Commitments and contingencies
Stockholders' Equity (Deficit):
Common stock, $0.00001 par value; 300,000,000 shares and 75,000,000 authorized, respectively; 69,238,044 and 62,100,000 shares issued and outstanding, respectively	$ 692	$ 621
Common stock to be issued	68,000	40,000
Additional paid in capital	5,882,448	867,004
Accumulated deficit	(4,105,439)	(1,033,291)
Total stockholders' equity (deficit)	1,845,701	(125,666)
Total Liabilities and Stockholders' Equity (Deficit)	$ 10,346,175	$ 55,376

Notes Payable (Details Narrative) - USD ($)		9 Months Ended
Notes Payable (Details Narrative) - USD ($)	Jun. 26, 2015	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Loan amount		$ 6,000,000
Debt instrument interest rate percentage		15.00%
Convertible equity offering		$ 1,000,000
Change in loan interest rate		13.00%
Debt discount aggregate value		$ 3,415,514
Debt discount value		840,322
Note issued as part of asset purchase agreement		1,500,000
Notes payable		750,000
Knight Therapeutics Inc [Member]
Note issued as part of asset purchase agreement	$ 950,000
Amount payable under the purchase agreement	1,200,000
Total payments of acquire assets	$ 1,200,000
Percentage of issued promissory note	0.00%
Notes payable		937,500
Knight Therapeutics Inc [Member] \| U.S [Member]
Percentage of sale revenue net	2.00%
June 30, 2016 [Member] \| Knight Therapeutics Inc [Member]
Amount payable under the purchase agreement	$ 250,000
September 30, 2015 [Member] \| Knight Therapeutics Inc [Member]
Amount payable under the purchase agreement	700,000
September 30, 2015 [Member] \| Knight Therapeutics Inc [Member] \| U.S [Member] \| Maximum [Member]
Net sales	$ 12,500
Percentage of sale revenue net	5.00%
Focus Factor Business [Member]
Amount payable under the purchase agreement		4,500,000
Focus Factor Business [Member] \| January 20, 2016 [Member]
Amount payable under the purchase agreement		750,000
Focus Factor Business [Member] \| January 20, 2017 [Member]
Amount payable under the purchase agreement		$ 750,000

Stockholders' Deficit (Details Narrative) - USD ($)		9 Months Ended
Stockholders' Deficit (Details Narrative) - USD ($)	Aug. 18, 2015	Sep. 30, 2015	Dec. 31, 2014
Common stock, shares authorized		300,000,000	75,000,000
Common stock value		$ 692	$ 621
Common stock, par value		$ 0.00001	$ 0.00001
Time of conversion		$ 100,000
Sale of common stock, shares		400,000
Common stock purchase price per share		$ 0.25
Issuance of common stock, shares for acquisition		4,595,187
Common stock, shares issued		69,238,044	62,100,000
Common stock, shares outstanding		69,238,044	62,100,000
Board of Directors [Member] \| Minimum [Member]
Common stock, shares authorized		75,000,000
Board of Directors [Member] \| Maximum [Member]
Common stock, shares authorized		300,000,000
ST Warrant [Member]
Common stock purchase price per share		$ 1.00
Contribution Agreement [Member] \| Hand Md Corp [Member]
Common stock value		$ 2,142,857
Sale of common stock, shares	2,142,857
Common stock purchase price per share	$ 0.70	$ 0.70
Percentage of outstanding capital		50.00%

Condensed Consolidated Balance Sheet (Parenthetical) - $ / shares	Sep. 30, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	300,000,000	75,000,000
Common stock, shares issued	69,238,044	62,100,000
Common stock, shares outstanding	69,238,044	62,100,000

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2015	Nov. 03, 2015
Document And Entity Information [Abstract]
Entity Registrant Name	Synergy CHC Corp.
Entity Central Index Key	0001562733
Document Type	10-Q
Document Period End Date	Sep. 30, 2015
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		69,238,044
Trading Symbol	SNYR
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2015

Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Payables and Accruals [Abstract]
Accrued payroll		$ 10,867
Accrued legal fees	$ 56,683	$ 47,916
Manufacturers	1,391,472
Promotions	15,000
Other	190,141	$ 15,859
Accounts payable and accrued liabilities	$ 1,653,296	$ 74,642

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Cash equivalents
Property and equipment, useful life	5 years
Percentage of valuation allowance	100.00%
Option to purchase of common stock	1,000,000
Warrants to purchase of common stock	3,584,759
Accumulated deficit	$ 4,105,439	$ 1,033,291
Working capital deficit	$ 246,252
Assets or liabilities measured at fair value
Minimum [Member]
Property and equipment, useful life		1 year

Stock Warrants - Summary of Stock Warrants Activity (Details) - Warrant [Member]	9 Months Ended
	Sep. 30, 2015 $ / shares shares
Warrants Outstanding, Beginning balance
Warrants, Granted	8,179,946
Warrants, Exercised	(4,595,187)
Warrants, Expired or canceled
Warrants Outstanding, Ending balance	3,584,759
Warrants Outstanding, Weighted Average Exercise Price, Beginning balance \| $ / shares
Weighted Average Exercise Price, Granted \| $ / shares	$ 0.15
Weighted Average Exercise Price, Exercised \| $ / shares	$ 0.00000022
Weighted Average Exercise Price, Expired or canceled \| $ / shares
Warrants Outstanding, Weighted Average Exercise Price, Ending balance \| $ / shares	$ 0.34

Asset Purchase (Details Narrative) - USD ($)		9 Months Ended
Asset Purchase (Details Narrative) - USD ($)	Jun. 26, 2015	Sep. 30, 2015	Sep. 30, 2014
Aggregate purchase price of business		$ 250,000
Amortize over their estimated useful life		5 years
Company's expected revenues		$ 13,000,000
Company's expected EBITDA		2,000,000
Knight Therapeutics Inc [Member]
Amount payable under the purchase agreement	$ 1,200,000
Total payments of acquire assets	$ 1,200,000
Knight Therapeutics Inc [Member] \| U.S [Member]
Percentage of sale revenue net	2.00%
June 30, 2016 [Member] \| Knight Therapeutics Inc [Member]
Amount payable under the purchase agreement	$ 250,000
September 30, 2015 [Member] \| Knight Therapeutics Inc [Member]
Amount payable under the purchase agreement	700,000
September 30, 2015 [Member] \| Knight Therapeutics Inc [Member] \| U.S [Member] \| Maximum [Member]
Net sales	$ 12,500
Percentage of sale revenue net	5.00%
Focus Factor Business [Member]
Aggregate purchase price of business		6,000,000
Amount payable under the purchase agreement		4,500,000
Company's expected revenues		7,015,763
Company's expected EBITDA		(3,067,567)
Focus Factor Business [Member] \| January 20, 2016 [Member]
Amount payable under the purchase agreement		750,000
Focus Factor Business [Member] \| January 20, 2017 [Member]
Amount payable under the purchase agreement		$ 750,000

Stock Options - Summary of Options Outstanding by Price Range (Details) - Stock Option Plan [Member]	9 Months Ended
	Sep. 30, 2015 $ / shares shares
Options Outstanding, exercise price	$ 0.25
Options Outstanding, Number Outstanding \| shares	1,000,000
Options Outstanding, Remaining Average Contractual Life	3 years 6 months
Options Outstanding, Weighted Average Exercise Price	$ 0.25
Options Exercisable, Number Exercisable \| shares	1,000,000
Options Exercisable, Weighted Average Exercise Price	$ 0.25